Patent Journal 03.08
advertisement
3/2008 התשס"ח/'ח רשומות ISRAEL STATE RECORDS ב' בסיון התשס"ח June 5, 2008 יומן הפטנטים והמדגמים PATENTS AND DESIGNS JOURNAL PATENTS Applications filed Applications accepted Patents granted Patents renewed Patents not in force Patents extensions Notices Changes in particulars entered in register Corrigenda Country codes Indices of applications accepted DESIGNS Designs registered Designs renewed Designs void עמוד Page 891 985 1221 1221 1223 1224 1225 פטנטים 1237 1238 i בקשות שהוגשו בקשות שקובלו פטנטים שניתנו פטנטים שחודשו פטנטים שתוקפם פקעו הארכת פטנטים הודעות שינויים בפרטים רשומים בפנקס תיקוני טעויות קודים למדינות מפתחות לבקשות שקובלו 1240 1250 1251 מדגמים מדגמים שנרשמו מדגמים שחודשו מדגמים שבוטלו 1236 ידיעות כלליות : וכו' בענייני פטנטים ומדגמים יש לשלוח אל, מסמכים,מכתבים ירושלים,4 רח' הסדנא,רשם הפטנטים והמדגמים ירושלים והיא פתוחה לציבור בימי חול, תלפיות,4 לשכת הפטנטים נמצאת ברח' הסדנא .12:30 - ו8:30 שאינם ערבי שבת או מועד בין השעות שקלים בעד כל2.50 לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של .עמוד או חלק ממנו 'אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מס יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה.0-24145-2 .שולמה GENERAL INFORMATION Letters, documents, etc. concerning Patents and Designs should be addressed to: The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs. The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50 per page or part thereof. Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together with the application for the action for which the fee has been paid. Copyright by the State of Israel. No Extracts may be published except with the permission of the Patent Office. זכות היוצרים בתקצירים אלה שמורה אין להעתיק מת,למדינת ישראל קצירים .אלה אלא ברשות לשכת הפטנטים Price per single issue (incl. VAT) : NIS 96. .₪ 96 ).מ.ע. לכל חוברת בודדת (כולל מ:מחיר Annual subscription (incl. VAT): NIS 1,152. Available at the Distribution Service of Government Publications, 29 B-Street, Hakirya, Tel-Aviv. June 5, – ב' בסיון התשס"ח .₪ 1,152 ).מ.ע.דמי חתימה לשנה (כולל מ :אפשר להשיג אצל ' רחוב ב,שרות ההפצה של פרסומי הממשלה .אביב- תל, הקריה,29 'מס 890 2008 NOTICE UNDER SECTION 16 OF THE PATENTS LAW, 5727-1967 In the following there are listed new Applications complying with the Provisions of rule 32(a) of the Patent Regulations, 5728-1968 Particulars of the applications are given in the following order: Number and date of application And the first four symbols of the International Classification Title of invention (as proposed by applicant) Applicant Priority right: Convention country – Number and date of Foreign application לחוק הפטנטים16 הודעה לפי סעיף 1967 - תשכ"ז להלן רשימת בקשות חדשות הממלאות אחר הדרישות שנקבעו ,(א) לתקנות הפטנטים32 בתקנה :1968–תשכ"ח פרטי הבקשות מובאים לפי :סדר זה מספר הבקשה – ותאריך הגשתה וארבעה הסמנים הראשונים של הסיווג הבינלאומי שם האמצאה (כפי שהוצע ע"י )המבקש המבקש – מדינת האיגוד:דין קדימה תאריך ומספר בקשת החוץ International Application Number מספר בקשה בינלאומית International Publication Number מס' פרסום בינלאומי 891 June 5, 2008– ב' בסיון התשס"ח 25/10/2005 181580 GASTRIC INHIBITORY POLYPEPTIDE (GIP) ANTIGEN ARRAYS AND USES THEREOF CYTOS BIOTECHNOLOGY AG US 60/621465 25/10/2004 PCT/EP/2005/055529 WO/2006/045796 30/08/2005 20/09/2005 TECHNIQUE FOR COMPENSATING UNDESIRED EFFECTS IN OPTICAL LINKS OF AN OPTICAL COMMUNICATION NETWORK ECI TELECOM LTD. June 5, – ב' בסיון התשס"ח A61K שימוש במעכבי המרה של הורמון בלוטת התריס 181844 FAN CASE REINFORCEMENT IN A GAS TURBINE JET ENGINE JAMES L. CARDARELLA JR. US 10/947923 23/09/2004 PCT/US/2005/033564 WO/2006/137875 02/05/2007 מערכי אנטיגן של פוליפפטיד מעכב קיבתי והשימוש בהם 181593 USE OF THYROID HORMONE CONVERSION INHIBITORS TRUSTEES OF BOSTON UNIVERSITY US 60/606481 01/09/2004 PCT/US/2005/030919 WO/2006/028835 A61K F01D מחזק למארז מניפה במנועים המונעים ע"י טורבינת גז 182937 H04J טכנולוגית קיזוז של תופעות לא רצויות בקווי רשת תקשורת אופטית טלקום בע"מ. איי. סי.אי 892 2008 10/06/2007 183796 מגן שיריון לגוף חיים גולדנבלום A PROTECTIVE BODY ARMOUR HAIM GOLDENBLUM 11/07/2007 184534 METHOD FOR SECURING TRANSMISSION OF DATA ALONG AN OPTICAL COMMUNICATION LINE ECI TELECOM LTD. 19/07/2007 ROTATING SUSPENSION LUG RAFAEL ADVANCED DEFENSE SYSTEMS LTD. 893 H04B שיטה למסירת נתונים בטוחה דרך קו תקשורת אופטי טלקום בע"מ. איי. סי.אי 184747 A METHOD AND DEVICE FOR COUNTING WEAPON BULLETS UZI EZRA HAVOSHA 23/07/2007 F41A F42D שיטה ומתקן לספירת כדורי ירי עוזי עזרא חבושה 184789 A47F מיתלה מסתובב רפאל מערכות לחימה מתקדמות בע"מ June 5, 2008– ב' בסיון התשס"ח 23/07/2007 184794 העברת מידע דיגיטלי TRANSFERRING DIGITAL DATA NDS LIMITED 25/07/2007 184823 A METHOD FOR ESTABLISHING A MESH WIRELESS NETWORK ECI TELECOM LTD. 27/01/2006 טלקום בע"מ. איי. סי.אי 184844 C08B נגזרות של ציקלודקסטרין – ? כחומרים אנטיבקטריאלים 185034 1,5-DIARYLPYRROLE DERIVATIVES, PREPARATION METHOD THEREOF AND APPLICATION OF SAME IN THERAPEUTICS SANOFI-AVENTIS FR 0501660 17/02/2005 PCT/FR/2006/000356 WO/2006/087476 June 5, – ב' בסיון התשס"ח H04L אלחוטיתMESH שיטה להקמת רשת ?-CYCLODEXTRIN DERIVATIVES AS ANTIBACTERIAL AGENTS PINNACLE PHARMACEUTICALS, INC. US 60/647841 28/01/2005 PCT/US/2006/002801 WO/2006/083678 16/02/2006 H04L C07D , שיטה להכנתן,–דיארילפירול5 ,1 תולדות ויישומן בטיפולים 894 2008 23/03/2006 185114 לטיפולD שימוש בתרכובות של ויטמין במחלת רירית הרחם USE OF VITAMIN D COMPOUNDS TO TREAT ENDOMETRIOSIS BIOXELL SPA GB 0505954.8 23/03/2003 60/667367 31/03/2005 US PCT/EP/2006/060983 WO/2006/100285 17/02/2006 185165 USE OF A PYRAZOLE DERIVATIVE FOR PREPARING MEDICINES USEFUL FOR PREVENTING OR TREATING RENAL DISEASES SANOFI-AVENTIS FR 0501919 23/02/2005 0504798 12/05/2005 FR PCT/FR/2006/000369 WO/2006/090047 13/02/2006 185223 185227 C10 CYCLOPROPYL ESTER SUBSTITUTED TAXANE COMPOSITIONS FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. US 60/652834 14/02/2005 PCT/US/2006/004914 WO/2006/088767 895 C07D שימוש בתולדה של פיראזול להכנת תרופות לטיפול במחלות כליה או למניעתן COMPOUNDS AND USES THEREOF COMBINATORX, INC. US 60/652624 14/02/2005 PCT/US/2006/005006 WO/2006/088786 13/02/2006 C07C A61K תרכובות ושימושים עבורן C07D C10 תכשירי טקסנים מותמרים ב ציקלופרופיל אסטר June 5, 2008– ב' בסיון התשס"ח 21/03/2006 185242 3,4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION NOVARTIS AG GB 0505969.6 23/03/2005 PCT/EP/2006/002578 WO/2006/100036 20/02/2006 3 נגזרות של פירולידין מותמרות בעמדות לטיפול ביתר לחץ דם4–ו 185248 185265 AEROSOL AND INJECTABLE FORMULATIONS OF NANOPARTICULATE BENZODIAZEPINE ELAN PHARMA INTERNATIONAL LTD. US 60/653034 15/02/2005 PCT/US/2006/005224 WO/2006/088894 26/02/2006 June 5, – ב' בסיון התשס"ח A61K פורמולציות בצורת תרסיס וניתנות להזרקה של ננוחלקיקים של בנזודיאצפין 185532 APPARATUS AND METHOD FOR DETECTION OF RADIATION ADVANCED FUEL RESEARCH, INC. US 60/656980 28/02/2005 PCT/US/2006/006914 WO/2007/075181 C08B תולדות אמיד של חומצת היילורוניק באוסטאוארטרוזיס AMIDE DERIVATIVES OF HYALURONIC ACID IN OSTEOARTHROSIS FIDIA FARMACEUTICI S.P.A. IT PD2005A000056 02/03/2005 PCT/EP/2006/001644 WO/2006/092233 15/02/2006 C07D G01T מערכת ושיטה לגילוי קרינה 896 2008 02/08/2006 185693 שיטה לפוקוס אוטומטי יעיל עבור רדאר פתחים נישא בחלל בדגם אוניה בעלת שני גופים זהים EFFICIENT AUTOFOCUS METHOD FOR SWATH SAR RAYTHEON COMPANY US 11/200836 PCT/US/2006/030025 WO/2007/075198 05/04/2006 10/08/2005 186050 NOVEL ISOINDOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME, PREPARATION THEREOF AND PHARMACEUTICAL USES THEREOF IN PARTICULAR AS INHIBITORS OF CHAPERONE PROTEIN HSP90 ACTIVITIES AVENTIS PHARMA S.A. FR 0503511 08/04/2005 PCT/FR/2006/000750 WO/2006/108948 24/04/2006 186213 TREATMENT OF GAS FROM AN IN SITU CONVERSION PROCESS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. US 60/674081 22/04/2005 PCT/US/2006/015286 WO/2006/116207 897 G01S C07D תכשירים,ניגזרות איזואינדול חדישות ושימושים, הכנתן,המכילים אותן בפרט כמעכבי,פרמצבטיים שלהן HSP90 פעילויות של חלבון מלווה E21B טיפול בגז מתהליך המרה פנימי June 5, 2008– ב' בסיון התשס"ח 04/04/2006 186241 MEDICAL SCAFFOLD, METHODS OF FABRICATION AND USING THEREOF TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. US 60/667666 04/04/2005 PCT/IL/2006/000421 WO/2006/106506 03/04/2006 186458 SKIN ENRICHMENT USING COQ10 AS THE DELIVERY SYSTEM ZYMES, LLC US 60/667380 01/04/2005 60/668273 05/04/2005 US PCT/US/2006/012215 WO/2006/107825 12/04/2006 186538 PHARMACEUTICAL COMPOSITIONS CONTAINING ROFLUMILAST NYCOMED GMBH EP 05103147.4 19/04/2005 PCT/EP/2006/061557 WO/2006/111495 07/04/2006 186641 USE OF SELECTIVE CHLORIDE CHANNEL MODULATORS TO TREAT ALCOHOL AND/OR STIMULANT SUBSTANCE ABUSE HYTHIAM, INC. US 11/111435 21/04/2005 PCT/US/2006/013155 June 5, – ב' בסיון התשס"ח A61L שיטות לייצור ושימוש בפיגומים רפואיים מוסד הטכניון למחקר ופתוח בע"מ C07C COQ10–העשרת עור על ידי שימוש ב כמערכת שחרור C07D תכשירי רוקחות המכילים רופלומילסט C07D שימוש במאפנני תעלות כלוריד סלקטיבים לטיפול בשימוש לרעה באלכוהול ובחומרים ממריצים 898 2008 WO/2006/115743 17/04/2006 186656 EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN WARNER CHILCOTT COMPANY, INC US 11/112290 22/04/2005 PCT/US/2006/014367 WO/2006/115871 13/04/2006 09/05/2006 C07C טיפול משולב בסרטן באמצעות תרכובות של ביס(תיאוהידרזיד)אמיד 186731 METHOD OF MODULATING STRESSACTIVATED PROTEIN KINASE SYSTEM INTERMUNE, INC. US 60/679471 10/05/2005 60/732230 01/11/2005 US PCT/US/2006/017988 WO/2006/122154 899 מינון אסטרוגן ממושך למשטר של מניעת ילודה 186662 COMBINATION CANCER THERAPY WITH BIS(THIOHYDRAZIDE) AMIDE COMPOUNDS SYNTA PHARMACEUTICALS CORP. US 60/672139 15/04/2005 PCT/US/2006/014531 WO/2006/113695 C07J C07D שיטה לוויסת מערכת פרוטאין–קינאז המופעל על–ידי עקה June 5, 2008– ב' בסיון התשס"ח 08/05/2006 186804 A COMBINATION OF A PDE4 INHIBITOR AND A TETRAHYDROBIOPTERIN DERIVATIVE NYCOMED GMBH EP 05103938.6 11/05/2005 PCT/EP/2006/062117 WO/2006/120176 27/09/2005 186871 EXTERNAL PREPARATION FOR SKIN COSMO OIL CO., LTD 2005JP 28/04/2005 131171 PCT/JP/2005/017681 WO/2006/117885 28/04/2006 186963 METHODS AND COMPOSITIONS FOR TREATING PAIN THERAQUEST BIOSCIENCES LLC US 60/675442 28/04/2005 PCT/US/2006/016078 WO/2006/116626 04/05/2006 186973 COMPOSITIONS AND METHODS FOR TREATMENT FOR NEOPLASMS COMBINATORX, INC. US 60/678078 05/05/2005 PCT/US/2006/017686 WO/2006/122007 June 5, – ב' בסיון התשס"ח C07D ותולדות שלPDE4 שלוב של מעכב טטראהידרוביופטארין C07C תכשיר חיצוני לשימוש על העור A61K שיטות ותרכובות לטיפול בכאב A61K הרכבים ושיטות לטיפול בגידולים 900 2008 28/04/2006 186985 GENERATION OF PHOSPHORUS OXYCHLORIDE AS BY-PRODUCT FROM PHOSPHORUS PENTACHLORIDE AND DMF AND ITS USE FOR CHLORINATION REACTION BY CONVERTING INTO VILSMEIERHAACK REAGENT PHARMED MEDICARE PRIVATE LIMITED, IN 545/MUM/2005 04/05/2005 PCT/IN/2006/000151 WO/2007/017891 18/05/2006 03/05/2006 A61K שילובים סינרגיסטיים של תרופות לא סטרואידיות אנטי דלקתיות עם ליגנדים של – דלתא2 – אלפא 187128 STABLE NANOPARTICLE FORMULATIONS SANOFI-AVENTIS U.S. LLC US 60/678086 05/05/2005 PCT/US/2006/017059 WO/2007/086911 901 ייצור של אוקסיכלוריד פוספטי כתוצר DMF–לוואי מפנטאכלוריד פוספטי ו ושימושו עבור תגובת כלורינציה –באמצעות הפיכתו לריאגנט וילסמייר HAACK 187092 SYNERGISTIC COMBINATIONS OF NON - STEROIDAL ANTIINFLAMMATORY DRUGS WITH ALPHA - 2 - DELTA LIGANDS PFIZER LIMITED US 60/683391 20/05/2005 PCT/IB/2006/001655 WO/2006/123247 C07F A61K פורמולציות ננו–חלקיקיות יציבות June 5, 2008– ב' בסיון התשס"ח 05/05/2006 187142 COMBINATION THERAPY WITH SULODEXIDE AND A BLOOD PRESSURE REDUCING AGENT IN THE TREATMENT OF DIABETIC NEPHROPATHY KERYX BIOPHARMACEUTICALS, INC. US 60/679096 05/05/2005 60/736973 14/11/2005 US PCT/US/2006/017403 WO/2006/121853 05/04/2006 תרפייה משולבת עם סולודקסיד וחומר להורדת לחץ דם בטיפול במחלת כיליה הנובעת מסכרת 187167 187207 COMBINATIONS OF A SQUALENE SYNTHASE INHIBITOR AND A HMGCOA REDUCTASE INHIBITOR FOR TREATING HYPERLIPIDEMIA TAKEDA PHARMACEUTICAL COMPANY LIMITED US 60/685871 01/06/2005 60/728329 20/10/2005 US PCT/JP/2006/311362 WO/2006/129859 June 5, – ב' בסיון התשס"ח G10L שמעCODEC מסנן AUDIO CODEC POST-FILTER MICROSOFT CORPORATION US 11/142603 31/05/2005 PCT/US/2006/012641 WO/2006/130226 31/05/2006 A61K A61K צירופים של מעכב סקאלן סינתאז ומעכב רדוקטאז לטיפולHMA–COA בהיפרליפידמיה 902 2008 28/07/2005 187236 COMPOSITIONS AND METHODS FOR INHIBITING GASTRIC ACID SECRETION VECTA LTD. US 60/679664 11/05/2005 PCT/IB/2005/002223 WO/2006/120500 10/05/2006 תכשירים ושיטות לעיכוב הפרשת חומצה בקיבה פלד-וקטה בע"מ אצל דר' אסנת בר 187238 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE EPIDERMAL DISEASES DERMIPSOR LTD US 60/679556 10/05/2005 PCT/IL/2006/000553 WO/2006/120682 26/04/2006 08/05/2006 903 דרמיפסור בע"מ C07C שימוש של גליצרידים דוקוסאהקסאנויקים עבור הטיפול במחלות של גידולים 187275 VASOACTIVE KIT AND COMPOSITION AND USES THEREOF FOAMIX LTD US 11/124676 09/05/2005 PCT/IB/2006/003525 WO/2007/023396 C07D תכשירים ושיטות לטיפול במחלות של התחלקות יתר של האפידרמיס 187274 USE OF DOCOSAHEXAENOIC GLYCERIDES FOR THE TREATMENT OF TUMORAL DISEASES PROYECTO EMPRESARIAL BRUDY, S.L. PES 12/05/2005 200501141 PCT/EP/2006/061833 WO/2006/120120 A61K A61K ערכה ואזואקטיבית ומרכיב ושימושיו פואמיקס בע"מ June 5, 2008– ב' בסיון התשס"ח 09/05/2006 187276 SACCHARIDE FOAMABLE COMPOSITION FOAMIX LTD US 60/679020 09/05/2005 60/784793 21/03/2006 US PCT/IB/2006/003628 WO/2007/039825 09/05/2006 187277 FOAMABLE VEHICLE AND PHARMACEUTICAL COMPOSITION THEREOF FOAMIX LTD US 60/679020 09/05/2005 60/784793 21/03/2006 US PCT/IB/2006/003519 WO/2007/054818 12/06/2006 187339 PHARMACEUTICAL FORMULATIONS FOR MINIMIZING DRUG-DRUG INTERACTIONS BAXTER INTERNATIONAL INC. US 60/690322 14/06/2005 11/423491 12/06/2006 US PCT/US/2006/022715 WO/2006/138202 13/06/2006 187486 DOSAGE REGIMEN FOR PRASUGREL ELI LILLY AND COMPANY US 60/691740 17/06/2005 PCT/US/2006/023006 WO/2006/138317 June 5, – ב' בסיון התשס"ח C07H סכריד במרקם מוקצף פואמיקס בע"מ A61K אמצעי נשיאה מוקצף והרכב רפואי שלו פואמיקס בע"מ A61K פורמולציות רוקחיות להקטנת אינטראקציות סם–סם A61K משטר מינון לפראסוגרל 904 2008 13/05/2006 187508 COMBINATION THERAPY COMPRISING A DIARYL UREA COMPOUND AND A P13, AKT KINASE OR MTOR INHIBITORS (RAPAMYCINS) FOR CANCER TREATMENT BAYER HEALTHCARE AG EP 05011477.6 27/05/2005 PCT/EP/2006/004524 WO/2006/125540 22/06/2000 22/06/2000 A61K )–רבוקסטין בטיפול במצביS,S(–שימוש ב כאב ואי–התאפקות 187513 USE OF (S,S)-REBOXETINE IN THE TREATMENT OF PAIN CONDITIONS AND INCONTINENCE PHARMACIA & UPJOHN COMPANY LLC US 60/141968 01/07/1999 60/144131 16/07/1999 US 60/158256 06/10/1999 US 60/170381 13/12/1999 US PCT/US/2000/017256 WO/2001/001973 905 טיפול משולב המכיל תרכובת של דיאריל קינאז או מעכביP13, AKT–אוריאה ו (ראפמיצינים) לטיפול בסרטןMTOR 187512 USE OF (S,S)-REBOXETINE IN THE TREATMENT OF PAIN CONDITIONS AND INCONTINENCE PHARMACIA & UPJOHN COMPANY LLC US 60/141968 01/07/1999 60/144131 16/07/1999 US 60/158256 06/10/1999 US 60/170381 13/12/1999 US PCT/US/2000/017256 WO/2001/001973 C07H A61K )–רבוקסטין בטיפול במצביS,S(–שימוש ב כאב ואי–התאפקות June 5, 2008– ב' בסיון התשס"ח 16/11/2005 187552 PHARMACEUTICAL COMPOSITIONS CONTAINING NEBIVOLOL MYLAN LABORATORIES, INC. US 11/141235 31/05/2005 11/272562 10/11/2005 US 11/273992 15/11/2005 US PCT/US/2005/041275 WO/2006/130174 08/06/2006 187614 MEDICAL GUIDE SYSTEM IBM CORPORATION 2005JP 08/06/2005 168921 PCT/JP/2006/311533 WO/2006/132320 02/06/2006 187759 USES OF PROSTACYCLIN ANALOGS THE REGENTS OF THE UNIVERSITY OF COLORADO, US 60/687016 02/06/2005 PCT/US/2006/021666 WO/2006/130879 16/06/2006 188146 INHIBITION OF OSTEOLYTIC LESIONS BY SRC KINASE INHIBITORS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM US 60/691933 17/06/2005 PCT/US/2006/023529 WO/2006/138590 June 5, – ב' בסיון התשס"ח C07D תכשירי רוקחות המכילים נביבולול G06Q מערכת הדרכה רפואית C07C שימושים באנלוגים של פרוסטציקלין A61K SRC מניעת הרס עצמות על ידיד מעכבי קינאז 906 2008 27/06/2006 188237 C07J COMPOSITIONS AND METHODS FOR TREATMENT OF CYCLE-RELATED SYMPTOMS WYETH US 60/695077 28/06/2005 PCT/US/2006/025449 WO/2007/002862 29/06/2006 תכשירים ושיטות לטיפול בתסמינים הקשורים למחזור 188583 PHARMACEUTICAL DOSAGE FORM CONTAINING AN ACTIVE PRINCIPLE COMBINATION OF NIFEDIPINE AND/OR NISOLDIPINE AND OF AN ANGIOTENSIN II ANTAGONIST BAYER HEALTHCARE AG DE 102005031577.1 06/07/2005 PCT/EP/2006/006293 WO/2007/003330 06/07/2006 BAYER HEALTHCARE AG DE 102005031576.3 PCT/EP/2006/006600 WO/2007/025595 06/07/2006 A61K שימוש במשפעלי גווינילאט ציקלאז מסיסים לטיפול בנזק הנגרם מזילוח נשנה 06/07/2005 188602 NON-FLAMMABLE INSECTICIDE COMPOSITION AND USES THEREOF FOAMIX LTD US 60/696878 06/07/2005 PCT/IB/2006/004026 WO/2007/085899 907 צורות מינון רוקחית המכילה שילוב יסוד או ניסולדיפין ושל/פעיל של ניפדיפין ו אנטגוניסט של אנגיוטנסין 188584 USE OF SOLUBLE GUANYLATE CYCLASE ACTIATORS FOR TREATING REPERFUSION DAMAGE C07D A01N הרכב מדביר–חרקים לא דליק ושימושיו פואמיקס בע"מ June 5, 2008– ב' בסיון התשס"ח 07/07/2006 188633 תכשיר רוקחי של אוקסקארבזפין OXCARBAZEPINE FORMULATION TARO PHARMACEUTICALS U.S.A. INC. US 60/697840 08/07/2005 PCT/US/2006/026311 WO/2007/008576 21/03/1996 189037 03/08/2006 30/03/1995 06/06/1995 189067 COMPOSITIONS AND METHODS FOR PRODUCTION OF IMMUNOGLOBULINS FRAUNHOFER USA, INC. US 60/705653 03/08/2005 PCT/US/2006/030545 WO/2007/117264 June 5, – ב' בסיון התשס"ח C07D –כלורוקוינזולינים מותמרים4 באלקוקסי ALKOXY-SUBSTITUTED 4CHLOROQUINAZOLINES PFIZER PRODUCTS, INC. US 413300 WO PCT/IB95/00436 A61K C12N תכשירים ושיטות לייצור אימונוגלובולינים 908 2008 25/06/2003 189070 RADIO NETWORK CONTROLLER PEER-TO-PEER EXCHANGE OF USER EQUIPMENT MEASUREMENTS INFORMATION INTERDIGITAL TECHNOLOGY CORPORATION US 60/392122 27/06/2002 PCT/US/2003/019958 WO/2004/004306 02/02/2001 בקר רשת רדיו עבור החלפת מידע עמית לעמית על ציוד לקוח 189071 SUPPORT OF MULTIUSER DETECTION IN THE DOWNLINK INTERDIGITAL TECHNOLOGY CORPORATION US 60/180402 04/02/2000 PCT/US/2001/003380 WO/2001/058041 05/04/2001 189072 BASE STATION SYNCHRONIZATION FOR WIRELESS COMMUNICATION SYSTEMS INTERDIGITAL TECHNOLOGY CORPORATION US 60/195543 07/04/2000 60/223405 04/08/2000 US PCT/US/2001/010983 WO/2001/080461 909 H04N H04B תמיכה בגילוי משתמשים רבים בערוץ הבא מלוויין H04Q תחנת בסיס לתיאום ביצוע זמני עבור מערכות תקשורת אל–חוטיות June 5, 2008– ב' בסיון התשס"ח 22/05/2003 189106 INFORMATION PROCESSING SYSTEM MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. 2002JP 23/05/2002 148705 PCT/JP/2003/006387 WO/2003/101048 15/12/2004 189107 METHOD FOR PREPARING SOLID DOSAGE FORM OF DESMOPRESSIN FERRING B.V. EP 03029897.0 29/12/2003 01/09/1997 189132 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PROSTATE HYPERTROPHY AND PROSTATE CANCER ZENTARIS GmbH US 60/025990 12/09/1996 60/043228 10/04/1997 US PCT/EP/1997/004740 WO/1998/010781 June 5, – ב' בסיון התשס"ח H04L מערכת לעיבוד מידע A61K שיטה להכנת צורת מינון מוצקת של דסמופרסין C07K תכשירי רוקחות לטיפול בגדילת יתר של בלוטת הערמונית ובסרטן בלוטת הערמונית 910 2008 22/08/1997 189136 GLUCAGON-LIKE INSULINOTROPIC PEPTIDE ANALOGS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NOVO NORDISK A/S DK 0931/96 30/08/1996 1259/96 08/11/1996 DK 1470/96 20/12/1996 DK PCT/DK/1997/000340 WO/1998/008871 08/08/2006 07/08/2006 C07D תולדות צרקוספוראמיד ותכשירי רוקחות המכילים אותן 189173 METHOD FOR PRODUCING A 3DIMENSIONAL INTEGRATED CIRCUIT (IC) AND AN IC PRODUCED THEREBY ZIPTRONIX, INC. US 11/201321 11/08/2005 PCT/US/2006/030703 WO/2007/021639 911 אנלוגים פפטידים אינסולינוטרופיים דמויי תכשירים המכילים אותם,גלוקגון ושימושים בהם 189172 CERCOSPORAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAIICHI SANKYO COMPANY, LIMITED 2005JP 09/08/2005 230558 2005-379060 28/12/2005 JP PCT/JP/2006/315621 WO/2007/018193 C07K H01L ) תלתIC( שיטה ליצירת מעגל משולב מימד ומעגל משולב המייוצר בה June 5, 2008– ב' בסיון התשס"ח 08/08/2006 189175 METHOD FOR PROCESSING CONDITIONAL ACCESS CONTENTS BY A USER UNIT NAGRAVISION S.A. EP 05107322.9 09/08/2005 PCT/EP/2006/065132 WO/2007/017499 08/08/2006 שיטה לעיבוד תוכנים בעלי גישה מותנית על ידי יחידת משתמש 189177 PROCESS FOR PRODUCING CARCOSPORAMIDE AND PHARMACEUTICAL COMPOSITIONS CONTAINING CERCOSPORAMIDE DAIICHI SANKYO COMPANY, LIMITED 2005JP 09/08/2005 230624 PCT/JP/2006/315622 WO/2007/018194 11/08/2006 189178 THIAZOLYL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME VERTEX PHARMACEUTICALS INCORPORATED US 60/707380 11/08/2005 60/732476 02/11/2005 US PCT/US/2006/031457 WO/2007/021982 June 5, – ב' בסיון התשס"ח G11B C12P תהליך להכנת צרקוספוראמיד ותכשירי רוקחות המכילים צרקוספוראמיד C07D תולדות תיאזוליל ותכשירי רוקחות המכילים אותן 912 2008 26/07/2006 189179 A PHARMACEUTICAL COMPOSITION CONTAINING ADIPOSE TISSUEDERIVED STROMAL CELLS BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE US 11/194270 01/08/2005 PCT/US/2006/028886 WO/2007/016112 16/08/2005 תכשיר רוקחות המכיל תאי סטומה המופקים מרקמה אדיפוזית 189181 NOVEL 4-AMINO-THIENO[3,2C]PYRIDINE-7CARBOXYLIC ACID AMIDES F. HOFFMANN-LA ROCHE AG A61F C07D –אמינו–תיאנו4 אמידים חדשים של חומצה –קרבוקסילית7–]פירידינC–3,2[ PCT/EP/2005/054022 WO/2007/019884 29/08/2006 189183 NOVEL INDOLE COMPOUNDS LABORATOIRES FOURNIER S.A. FR 0508858 30/08/2005 PCT/FR/2006/050818 WO/2007/026097 19/08/2005 913 189185 C07D תרכובות אינדול חדשות G01N June 5, 2008– ב' בסיון התשס"ח USE OF AN ENDOPLASMIN FRAGMENT AND DERIVATIVES THEREOF AS A BIOMARKER FOR COLORECTAL ADENOMA AND/OR CARCINOMA; METHOD FOR DETECTION AND TEST SYSTEM INDIVUMED GMBH שימוש במקטע אנדופלסמין ותולדות שלו או/כסמן ביולוגי לאדנומה של המעי הגס ו קרצינומה; שיטה לזיהוי ומערכת בחינה PCT/EP/2005/009005 WO/2007/019875 21/08/2006 189186 PYRAZOLONE DERIVATIVES AS 11BETA HSD1 INHIBITORS F. HOFFMANN-LA ROCHE AG EP 05107970.5 31/08/2005 PCT/EP/2006/065471 WO/2007/025880 25/08/2006 189187 POLYMER CONJUGATES OF K-252A AND DERIVATIVES THEREOF CREABILIS THERAPEUTICS S.P.A. US 60/710890 25/08/2005 60/720454 27/09/2005 US 60/811469 07/06/2006 US PCT/EP/2006/008374 WO/2007/022999 12/09/2006 June 5, – ב' בסיון התשס"ח 189188 C07D HSD1 –בטא11 תולדות פירזולון כמעכבי C08G A252–Kקונג'וגאטים של פולימר של ותולדות שלהם C07D 914 2008 PESTICIDE THIAZOLYLOXY SUBSTITUTED PHENYLAMIDINE DERIVATIVES BAYER CROPSCIENCE AG EP 05356155.1 13/09/2005 PCT/EP/2006/066273 WO/2007/031513 31/08/2006 קוטל מזיקים של תולדות פנילאמידין מותמרות בתיאזולילוקסי 189189 PYRROLOPYRIDINE DERIVATIVES AND USE OF SAME AS PPAR RECEPTOR MODULATORS LABORATOIRES FOURNIER S.A. US 60/713459 01/09/2005 0510482 14/10/2005 FR PCT/FR/2006/050827 WO/2007/026104 28/02/2000 09/08/2006 915 תולדות פירולופירידין ושימושן כמאפננים PPAR לרצפטור 189190 USE OF FLUORINATED TRIAZOLES FOR TREATING PAIN AND AFFECTIVE OR ATTENTION DISORDERS NOVARTIS AG US 09/259911 01/03/1999 09/259910 01/03/1999 US PCT/EP/2000/001626 WO/2000/051577 C07D A61P שימוש של טריאזולים שעברו פלואורינציה לטיפול בכאב והפרעות רגשיות או הפרעות קשב 189191 C07D June 5, 2008– ב' בסיון התשס"ח THIAZOLYL PIPERIDINE DERIVATIVES USEFUL AS H3 RECEPTOR MODULATORS F. HOFFMANN-LA ROCHE AG EP 05107586.9 18/08/2005 PCT/EP/2006/065167 WO/2007/020213 01/08/2006 תיאזוליל פיפרידין המשמשות,נגזרות רצפטורH3 ביעילות כמודולטורים של 189192 מעכבים של סרין פרוטאזות INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED US 60/704772 02/08/2005 PCT/US/2006/029988 WO/2007/016589 14/09/2006 189193 TRANSPLASTOMIC PLANTS EXPRESSING LUMEN-TARGETED PROTEIN BAYER CROPSCIENCE SA EP 05356163.5 16/09/2005 60/718931 20/09/2005 US PCT/EP/2006/066345 WO/2007/031547 30/08/2006 June 5, – ב' בסיון התשס"ח C12N צמחים טרנספלסטומיים המבטאים חלבון מוכוון–חלל 189194 SUBSTITUTED BENZIMIDAZOLES AS KINASE INHIBITORS NOVARTIS AG US 60/712539 30/08/2005 60/713108 30/08/2005 US 60/731591 27/10/2005 US 60/774684 17/02/2006 US PCT/US/2006/034088 WO/2007/030377 C07D C07D בנזימידאזולים מותמרים כמעכבי קינאז 916 2008 02/08/2006 189196 מיכל המכיל מספר תאים MULTIPLE CHAMER CONTAINER BAXTER INTERNATIONAL INC. US 60/704555 02/08/2005 PCT/US/2006/030064 WO/2007/037793 02/08/2006 189197 OXYGEN INDICATOR FOR USE IN MEDICAL PRODUCTS BAXTER INTERNATIONAL INC. US 60/704555 02/08/2005 PCT/US/2006/030051 WO/2007/016611 02/08/2006 01/08/2006 917 A61J מוצרים רפואיים ופורמולציות למתן לתוך כלי הדם 189199 BOOLEAN COMPLEMENT METHODS AND SYSTEMS FOR VIDEO IMAGE PROCESSING A REGION OF INTEREST HONEYWELL INTERNATIONAL INC. US 11/197158 03/08/2005 PCT/US/2006/029916 WO/2007/019140 A61J מחוון חמצן לשימוש במוצרים רפואיים 189198 MEDICAL PRODUCTS AND PARENTERAL FORMULATIONS BAXTER INTERNATIONAL INC. US 60/704555 02/08/2005 PCT/US/2006/030058 WO/2007/016615 A61J G06T שיטות משלימות בוליאניות ומערכות לעיבוד תמונת וידאו באיזור מעניין June 5, 2008– ב' בסיון התשס"ח 03/08/2006 189200 רובוט לניקוי בריכות מים מיטרוניקס בע"מ POOL CLEANING ROBOT MAYTRONICS LTD. US 11/196737 04/08/2005 PCT/IL/2006/000901 WO/2007/015251 31/08/2006 189202 SYNTHETIC METHODS AND INTERMEDIATES FOR STEREOISOMERIC COMPOUNDS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS ARYX THERAPEUTICS, INC. US 60/713149 31/08/2005 60/747762 19/05/2006 US PCT/US/2006/034322 WO/2007/028073 24/08/2006 189203 June 5, – ב' בסיון התשס"ח C12P RNA SENSE שיטות ומערכות לייצור 189206 INTERRUPT CONTROLLER UTILISING PROGRAMMABLE PRIORITY VALUES ARM LIMITED GB 0526007.0 21/12/2005 PCT/GB/2006/003953 WO/2007/071894 C07D שיטות מלאכותיות ותוצרי ביניים לתרכובות סטריאוסומריות לשימוש בטיפול בהפרעות מערכת העיכול ובמערכת העצבים METHODS AND KITS FOR SENSE RNA SYNTHESIS DATASCOPE INVESTMENT CORPORATION US 11/210602 24/08/2005 PCT/US/2006/033338 WO/2007/025195 24/10/2006 E04H G06F הפרעה להפקת תועלת של תיכנות ערכי עדיפות של בקר 918 2008 19/07/2006 189207 גישה לזיכרון MEMORY ACCESS INGENIA TECHNOLOGY LIMITED GB 0516003.1 03/08/2005 60/707196 03/08/2005 US PCT/GB/2006/002676 WO/2007/015055 30/06/2000 189208 METHOD AND APPARATUS FOR DETERMINING A REVERSE LINK TRANSMISSION RATE IN A WIRELESS COMMUNICATION SYSTEM QUALCOMM INCORPORATED US /09346882 02/07/1999 PCT/US/2000/018322 WO/2001/003357 17/08/2006 919 H04L שיטה וציוד להגדרת קצב שידור בקשר הפוך המערכת תקשורת אל–חוטית/נגדי 189209 ISOLATED SOY PROTEIN HAVING HIGH MOLECULAR WEIGHT PROTEIN FRACTIONS AND LOW MOLECULAR WEIGHT PROTEIN FRACTIONS SOLAE, LLC US 60/708947 17/08/2005 60/727324 17/10/2005 US 11/465090 16/08/2006 US PCT/US/2006/032121 WO/2007/022341 G11C A23J חלבון סויה מבודד עם פרקציות חלבוניות בעלות משקל מולקולרי גבוה June 5, 2008– ב' בסיון התשס"ח 16/08/2006 189210 METHODS FOR THE PREPARATION OF HCV POLYMERASE INHIBITORS PFIZER INC US 60/711042 24/08/2005 60/744273 04/04/2006 US 60/804644 13/06/2006 US PCT/IB/2006/002342 WO/2007/023381 02/08/2006 HCV שיטות להכנת מעכבי פולימראז 189211 METHODS AND COMPOSITIONS FOR TREATING FEMALE INFERTILITY USING CLOMIPHENE REPROS THERAPEUTICS INC. US 60/706094 05/08/2005 PCT/US/2006/030053 WO/2007/019165 18/08/2006 189217 C07D –מעכבים מגושרים סולפומאמידו בי ציקליים של גמא סקרטאז 189218 PLATINUM ALLOY AND METHOD OF PRODUCTION THEREOF ALLGEMEINE GOLD- UND SILBERSCHEIDEANSTALT AG EP PCT/EP2005/008419 03/08/2005 PCT/EP/2005/008453 WO/2007/014576 June 5, – ב' בסיון התשס"ח A61K שיטות והרכבים לטיפול בעקרית נקבית באמצעות קלומיפן BRIDGED N-BICYLIC SULFONAMIDO INHIBITORS OF GAMMA SECRETASE ELAN PHARMACEUTICALS, INC. US 60/709961 19/08/2005 PCT/US/2006/032261 WO/2007/024651 04/08/2005 C07D C22C סגסוגת פלטיניום ושיטה להפקת אותו דבר 920 2008 31/08/2006 189219 A01N פורמולציות הרבצידיות של סולפונילאוריאה נוזלית LIQUID SULFONYLUREA HERBICIDE FORMULATIONS E.I. DU PONT DE NEMOURS AND COMPANY US 60/713518 01/09/2005 PCT/US/2006/033986 WO/2007/027863 04/08/2005 189220 סגסוגת פלטיניום ושיטה להפקת אותו דבר PLATINUM ALLOY AND METHOD OF PRODUCTION THEREOF ALLGEMEINE GOLD- UND SILBERSCHEIDEANSTALT AG EP PCT/EP2005/008405 03/08/2005 PCT/EP/2005/008454 WO/2007/014577 20/06/2007 189221 189222 LINE TRANSFORMER FOR IMPEDANCE MATCHING ROHDE & SCHWARZ GMBH & CO. KG DE 102005037616.9 09/08/2005 PCT/EP/2006/005863 WO/2007/017000 921 C07D נגזרות של פירזין ושימושים בהן לניטור הכליות PYRAZINE DERIVATIVES AND USES THEREOF IN RENAL MONITORING MALLINCKRODT INC. US 60/815712 22/06/2006 PCT/US/2007/014370 WO/2007/149479 19/06/2006 C22C H01F שנאי קו להתאמת עכבה June 5, 2008– ב' בסיון התשס"ח 03/08/2006 189224 METHOD FOR PREPARATION OF STABLE SOLUTIONS OF INORGANICORGANIC POLYMERS ORION SOLAR PHOTOVOLTAICS LTD US 60/705180 04/08/2005 PCT/IL/2006/000899 WO/2007/015249 03/08/2006 189225 METHOD FOR PREPARATION OF STABLE METAL OXIDE NANOPARTICLES SUSPENSIONS BAR-ILAN UNIVERSITY US 60/705190 04/08/2005 PCT/IL/2006/000898 WO/2007/015248 03/08/2006 189226 METHOD FOR PRODUCTION OF NANOPOROUS ELECTRODES FOR PHOTOELECTROCHEMICAL APPLICATIONS BAR-ILAN UNIVERSITY US 60/705188 04/08/2005 PCT/IL/2006/000900 WO/2007/015250 June 5, – ב' בסיון התשס"ח C04B שיטה להכנת תמיסות יציבות של פולימרים אי–אורגניים–אורגניים אוריון סולאר פוטווולטאיקס בע"מ B82B שיטה להכנת תרחיפים יציבים הכוללים ננו–חלקיקים של תחמוצת מתכת אילן-אוניברסיטת בר B82B שיטה לייצור אלקטרודות בעלות מבנה ננו–נקבובי ליישומים פוטואלקטרוכימיים אילן-אוניברסיטת בר 922 2008 03/08/2006 189227 MODULATING THE KV1.1 VOLTAGEGATED POTASSIUM CHANNEL IN TCELLS FOR REGULATING THE SYNTHESIS AND SECRETION OF TUMOR NECROSIS FACTOR ? (TNF-?) AND TREATING HUMAN DISEASES OR INJURIES MEDIATED BY DETRIMENTALLY HIGH OR LOW LEVELS OF TNF-? MINEUET THERAPEUTICS LTD. US 60/704728 03/08/2005 PCT/US/2006/030361 WO/2007/019267 22/08/2005 C07K KV1.1 כוונון תעלת האשלגן מווסתת מתח לשם וויסות הסינתזה וההפרשהT בתאי FACTOR NECROSIS TUMOR (?– ? של )TNF וטיפול במחלות או פציעות בבני אדם גבוהות או,המתווכות ע"י רמות מזיקות TNF–? של,נמוכות מדי מיה לויטה 189228 H04M מודם עם יכולת זיווג אקוסטי MODEM WITH ACOUSTIC COUPLING ULTRA PROIZVODNJA ELEKTRONSKIH NAPRAV D.O.O. PCT/EP/2005/009063 WO/2007/022788 04/12/2003 189233 DETECTION SYSTEM INCLUDING AVALANCHE PHOTODIODE FOR USE IN HARSH ENVIRONMENTS H01J מערכת גילוי כולל דיודת גלשון רגישת אור לשימוש בסביבות קשות GENERAL ELECTRIC COMPANY US 314986 10/12/2002 923 June 5, 2008– ב' בסיון התשס"ח 01/09/2006 189262 –אימידזופירידינים מותמרים עםH1 הידרוקסי ושיטות HYDROXY SUBSTITUTED 1HIMIDAZOPYRIDINES AND METHODS PFIZER INC. US 60/713704 02/09/2005 PCT/US/2006/034427 WO/2007/028129 23/05/2002 189272 COOLING SYSTEM FOR A PHOTOCOSMETIC DEVICE PALOMAR MEDICAL TECHNOLOGIES, INC. US 60/292827 23/05/2001 10/052474 18/01/2002 US 60/363798 12/03/2002 US 60/363871 12/03/2002 US PCT/US/2002/016435 WO/2002/094116 22/09/2006 June 5, – ב' בסיון התשס"ח A61B מערכת קירור להתקן פוטוקוסמטי 189273 CAPSULE FORMULATION OF PIRFENIDONE AND PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS INTERMUNE, INC. US 60/720257 22/09/2005 PCT/US/2006/037057 WO/2007/038315 C07D A61B תצורה קפסולרית של פירפנידון וחומרי תרופה בלתי–פעילים המתאימים מבחינה פרמצבטית 924 2008 09/08/2006 189279 ווסת נוזלים עם חיבור FLUID CONTROLLER WITH JOINT FUJIKIN INCORPORATED 2005JP 10/08/2005 231564 PCT/JP/2006/315714 WO/2007/018228 11/08/2006 189280 STAIR CHAIR WITH AN ADJUSTABLE GLIDE TRACK RESISTANCE AND BRAKING DEVICE FERNO-WASHINGTON, INC. US 60/707426 11/08/2005 11/462064 03/08/2006 US PCT/US/2006/031553 WO/2007/022037 04/08/2006 925 A61G כסא למדרגות הכולל התקן עבור התנגדות מסלול ובלימה מכוונות 189281 IN VITRO DIAGNOSTIC METHOD AND KIT FOR IDENTIFICATION OF HUMAN PAPILLOMAVIRUS IN CLINICAL SAMPLES GENOMICA S.A.U. GB 0516145.0 05/08/2005 PCT/GB/2006/050231 WO/2007/017699 F16K C12Q שיטה איבחונית לשימוש מחוץ לגוף וערכה לזיהוי נגיף פפילומא אנושי בדגימות קליניות June 5, 2008– ב' בסיון התשס"ח 26/07/2006 189286 NOVEL CYSTEINE PROTEASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS HYBRIGENICS SA EP 05291683.0 05/08/2005 11/197525 05/08/2005 US PCT/IB/2006/002637 WO/2007/017758 07/08/2006 189287 TISSUE PROTECTIVE PEPTIDES AND USES THEREOF WARREN PHARMACEUTICALS, INC. US 60/705741 05/08/2005 60/706276 08/08/2005 US 60/831737 18/07/2006 US PCT/US/2006/031061 WO/2007/019545 21/08/2006 189288 HARDMETAL MATERIALS FOR HIGH-TEMPERATURE APPLICATIONS GENIUS METAL, INC. US 60/710016 19/08/2005 PCT/US/2006/032654 WO/2007/022514 June 5, – ב' בסיון התשס"ח C07D מעכבים חדשים של ציסטאין פרוטאז וישומיהם הרפואיים C07D פפטידים מגיני רקמות ושימושיהם C22C חומרים ממתכת קשיחה לישומים בעלי טמפרטורה גבוהה 926 2008 15/08/2006 189289 חיסון רוטאווירוס המשרה הגנה הטרוטיפית משולבת ROTAVIRUS VACCINE INDUCING HETEROTYPIC CROSS PROTECTION GLAXOSMITHKLINE BIOLOGICALS S.A. GB 0516944.6 17/08/2005 0521164.4 18/10/2005 GB 0608962.7 05/05/2006 GB PCT/EP/2006/008094 WO/2007/020078 28/08/2006 189290 189291 189292 2D EDITING METAPHOR FOR 3D GRAPHICS MICROSOFT CORPORATION US 60/715659 09/09/2005 11/302006 12/12/2005 US PCT/US/2006/035158 WO/2007/030763 927 A61M קטטר אנטי–חיידקי ANTI-MICROBIAL CATHETER I-FLOW CORPORATION US 11/216534 31/08/2005 PCT/US/2006/033375 WO/2007/027545 06/09/2006 A61K הרכב ארגאטרובאן ARGATROBAN FORMULATION BAXTER INTERNATIONAL INC. US 60/713403 01/09/2005 PCT/US/2006/033432 WO/2007/027565 28/08/2006 A61K G06T מטפורה לעריכה דו–מימדית עבור גרפיקה תלת–מימדית June 5, 2008– ב' בסיון התשס"ח 06/09/2006 189294 תלת–מימד/ביצוע משולב דו–מימד 2D/3D COMBINED RENDERING MICROSOFT CORPORATION US 60/715916 09/09/2005 11/301799 12/12/2005 US PCT/US/2006/035080 WO/2007/030728 01/03/2007 189295 189296 189297 PREPARATION OF THIOALKYLAMINES WITH HIGH YIELDS BAYER CROPSCIENCE AG EP 05018347.4 24/08/2005 PCT/EP/2006/008060 WO/2007/022900 June 5, – ב' בסיון התשס"ח C07D מעכבי קינאז פנטאציקלי PENTACYCLIC KINASE INHIBITORS GENENTECH, INC. US 60/707902 12/08/2005 PCT/US/2006/031682 WO/2007/022102 16/08/2006 C07C שיטה ליצור מלח פוספאטי של חומצה אמינית METHOD FOR PRODUCTION OF PHOSPHATE SALT OF AMINO ACID COSMO OIL CO., LTD 2006JP 13/03/2006 066967 PCT/JP/2007/053962 WO/2007/119302 14/08/2006 G06T C07C הכנה של תיאואלקילאמינים עם תפוקות גבוהות 928 2008 12/10/2006 189298 3.5-DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF DOPAMINE MEUROTRANSMISSION NEUROSEARCH SWEDEN AB SE 0502254.6 13/10/2005 PCT/EP/2006/009866 WO/2007/042295 22/09/2006 5– ו3 פניל פיפרידנים מותמרים בעמדות כמאפננים של הולכה עצבית דופאמינית 189299 APPARATUS AND METHOD FOR SIMULTANEOUS TESTING OF MULTIPLE ORTHOGONAL FREQUENCY DIVISION MULTIPLEXED TRANSMITTERS WITH SINGLE VECTOR SIGNAL ANALYZER LITEPOINT CORPORATION US 60/596444 23/09/2005 11/533971 21/09/2006 US PCT/US/2006/036995 WO/2007/038279 24/01/1999 929 H04J מכשיר ושיטה לבחינה בו– זמנית של יחידVSA רבים עםOFDM משדרי 189303 CHIP CARRIER SUBSTRATE AMITEC- ADVANCED MULTILAYER INTERCONNECT TECHNOLOGIES LTD. C07D H05K מצע נושא שבבים אדוואנס מולטילאייר אנטרקונקט-אמיטק טכנולוג'יס בע"מ June 5, 2008– ב' בסיון התשס"ח 15/08/2006 189304 B60R UNIVERSAL ELECTRONIC IMMOBILIZING FOR A VEHICLE SALOMON SYDNEY OHAYON US 60/707986 15/08/2005 PCT/IL/2006/000946 WO/2007/020637 07/08/2006 משבת אלקטרוני ואוניברסלי לרכב עמיחי אוחיון 189305 HIGH THROUGHPUT CHEMICAL MECHANICAL POLISHING COMPOSITION FOR METAL FILM PLANARIZATION ADVANCED TECHNOLOGY MATERIALS, INC. US 60/706206 05/08/2005 PCT/US/2006/030508 WO/2007/019342 01/08/2006 H01L תרכובת כימית לליטוש מיכני בעלת תפוקה גבוהה עבור השטחה של שכבה מתכתית 189306 FLAME RETARDED STYRENIC POLYMER FOAMS AND FOAM PRECURSORS ALBEMARLE CORPORATION US 60/706646 08/08/2005 PCT/US/2006/029814 WO/2007/019120 09/08/2006 קצפים מעכבי בערה מבוססי פולימר סטירני וחומרים מקדימים לקצף 189307 DEVICE FOR CONNECTING FLEXIBLE HOSES BUCCHI S.R.L. IT RN2005A000057 08/09/2005 PCT/IB/2006/002201 WO/2007/029068 June 5, – ב' בסיון התשס"ח C08K F16L מתקן לחיבור צנורות גמישים 930 2008 31/07/2006 189309 C01B PROCESS FOR PRODUCING FULLERENE DISPERSION LIQUID, AND FULLERENE DISPERSION LIQUID ABSIZE INC. 2005JP 10/08/2005 232390 PCT/JP/2006/315178 WO/2007/018068 04/08/2006 תהליך ליצור נוזל תרסיס פולריני ונוזל תרסיס פולריני 189310 INTRAVENOUS PROPOFOL EMULSION COMPOSITIONS HAVING PRESERVATIVE EFFICACY BHARAT SERUMS & VACCINES LTD. IN 906/MUM/2005 05/08/2005 PCT/IN/2006/000281 WO/2007/052288 29/08/2006 189311 COMPREHENSIVE STRENGTH IMPROVEMENT OF CEMENT AND GYPSUM PRODUCTS JOSEF ATOON US 60/711694 29/08/2005 PCT/IL/2006/000997 WO/2007/026352 26/07/2006 189312 A LOCK AND KEY SYSTEM WITH IMPROVED TUMBLERS IN THE LOCK WINLOC AG SE 0501782-7 05/08/2005 PCT/SE/2006/000913 WO/2007/018456 931 A61K תרכובות אמולסיית פרופופול אינפוזיה בעלות יעילות שמרנית H01R שיפור חוזק כוללני של מוצרי מלט וגבס E05B מערכת מנעול ומפתח הכוללת פינים במנעול June 5, 2008– ב' בסיון התשס"ח 03/08/2006 189313 VIRUS-LIKE PARTICLES AS VACCINES FOR PARAMYXOVIRUS UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL US 60/706126 05/08/2005 11/497888 02/08/2006 US PCT/US/2006/030319 WO/2007/019247 25/08/2006 189314 TOOL WITH SINTERED BODY POLISHING SURFACE AND METHOD OF MANUFACTURING THE SAME HIROSHI ISHIZUKA 2005JP 25/08/2005 243529 2006-209236 31/07/2006 JP PCT/JP/2006/316737 WO/2007/023949 30/07/2006 189317 FLUID SUPPLY FOR ENDOSCOPE STRYKER GI LTD. US 11/207093 18/08/2005 PCT/IL/2006/000880 WO/2007/020624 June 5, – ב' בסיון התשס"ח A61K –חלקיקים דמויי וירוס כחיסונים לוירוס פאראמיקסו B24D מכשיר בעל משטח גוף מחמם מבריק ושיטה לייצורו A61B מערכת להספקת נוזלים לאנדוסקוף בע"מ. אי.סטריקר ג'י 932 2008 07/09/2006 189318 IN-SITU POWER MONITOR PROVIDING AN EXTENDED RANGE FOR MONITORING INPUT OPTICAL POWER INCIDENT ON AVALANCHE PHOTODIODES ALLIED TELESIS, INC. US 11/223646 09/09/2005 PCT/US/2006/035000 WO/2007/030700 13/09/2006 14/09/2006 A61N מתקן יונטופורזה ומתקן מקור כח חשמלי למתקן יונטופורזה 189321 CATHETER TYPE IONTOPHORESIS APPARATUS TTI ELLEBEAU, INC 2005JP 16/09/2005 270862 PCT/JP/2006/318239 WO/2007/032423 933 בקרת כח באתר הנותנת טווח מוגדל לבקרת כח אופטי על פוטודיאודות זנר 189320 IONTOPHORESIS DEVICE AND POWER SUPPLY DEVICE FOR IONTOPHORESIS DEVICE TTI ELLEBEAU, INC 2005JP 14/09/2005 267588 PCT/JP/2006/318174 WO/2007/032398 G06F A61N מתקן יונטופורזה מסוג קטטר June 5, 2008– ב' בסיון התשס"ח 07/08/2006 189322 OXAZOLIDINONE-QUINOLONE HYDRIDS AS ANTIBACTERIAL COMPOUNDS ACTELION PHARMACEUTICALS LTD. EP PCT/EP05/008573 08/08/2005 PCT/IB/2006/052714 WO/2007/017828 08/08/2006 15/09/2006 היברידים של אוקסאזולידינון–קווינולון כתרכובות נגד חיידקים 189323 COMPUTER-CONTROLLED MILLING MACHINE FOR PRODUCING LENSES FOR CLIP-ON ACCESSORY OPTI-CLIP INTERNATIONAL LLC US 11/198391 08/08/2005 PCT/IL/2006/000914 WO/2007/017870 189324 June 5, – ב' בסיון התשס"ח B32B הרכב הניתן לעיצוב הכולל ממשק היקשרות 189325 MOLDABLE FABRIC WITH VARIABLE CONSTITUENTS MILLIKEN & COMPANY US 60/720824 27/09/2005 11/518964 11/09/2006 US PCT/US/2006/036650 WO/2007/038137 B24B מכונת טחינה המבוקרת באמצעות מחשב ליצירת עדשות עבור אביזר נצמד MOLDABLE CONSTRUCTION INCORPORATING BONDING INTERFACE MILLIKEN & COMPANY US 11/235941 27/09/2005 11/518963 11/09/2006 US 11/518965 11/09/2006 US PCT/US/2006/036278 WO/2007/038048 19/09/2006 C07D D03D מבנה הניתן לעיצוב עם מרכיבים משתנים 934 2008 09/08/2006 189329 VACCINATION AGAINST DENGUE VIRUS INFECTION SANOFI PASTEUR US 60/707038 10/08/2005 60/719448 22/09/2005 US PCT/US/2006/030846 WO/2007/021672 29/06/2006 חיסון נגד זיהום נגיף קדחת הדנגה 189333 189334 189336 OPHTHALMIC COMPOSITIONS CONTAINING MUCOADHESIVE POLYSACCHARIDES ABLE TO PROMOTE CORNEAL REEPITHELIZATION OPOCRIN S.P.A. IT RM2005A000443 12/08/2005 PCT/IT/2006/000616 WO/2007/020671 935 A61B מכשיר אור קוסמטי בטוח לעין EYE-SAFE PHOTOCOSMETIC DEVICE PALOMAR MEDICAL TECHNOLOGIES, INC. US 60/706505 08/08/2005 PCT/US/2006/030968 WO/2007/019536 10/08/2006 H04N מערכת להקרנת וידיאו במהירות משתנה VIDEO TRICK MODE SYSTEM NDS LIMITED US 60/708151 15/08/2005 PCT/IL/2006/000762 WO/2007/020621 08/08/2006 A61K A61P תכשירים עיניים המכילים פוליסאככרידים הנדבקים לרירית המסוגלים לגרום לבניה מחדש של אפיתל הקרנית June 5, 2008– ב' בסיון התשס"ח 04/08/2006 189337 תולדות ניטרואוקסי של גלוקוקורטיקואידים NITROOXY DERIVATIVES OF GLUCOCORTICOIDS NICOX SA EP 05019155.0 02/09/2005 PCT/EP/2006/007746 WO/2007/025632 13/09/2006 189340 METHOD FOR VERIFYING A TARGET DEVICE CONNECTED TO A MASTER DEVICE NAGRAVISION S.A. EP 05108446.5 14/09/2005 PCT/EP/2006/066326 WO/2007/031540 30/06/2006 14/08/2006 June 5, – ב' בסיון התשס"ח H04M מערכת לסינון תוכן להתקן תקשורת נייד ושיטה לשימוש בה 189346 NANOPARTICLES NANOCO TECHNOLOGIES LIMITED GB 0516598.0 12/08/2005 PCT/GB/2006/003028 WO/2007/020416 H04N שיטה לאימות התקן יעד מחובר להתקן ראשי 189345 A CONTENT FILTERING SYSTEM FOR A MOBILE COMMUNICATION DEVICE AND METHOD OF USING SAME AGENT MOBILE PTY LTD AU 2005100653 12/08/2005 PCT/AU/2006/000921 WO/2007/019599 C07J B82B ננוחלקיקים 936 2008 11/08/2006 189347 RADIATION-SHIELDING ASSEMBLY HAVING CONTAINER LOCATION FEATURE MALLINCKRODT INC. US 60/707789 12/08/2005 PCT/US/2006/031398 WO/2007/021947 08/08/2006 03/08/2006 מכלול להגנה נגד קרינה עם מאפיין למיקום מכלים 189348 RADIOISOTOPE GENERATION SYSTEM HAVING PARTIAL ELUTION CAPABILITY MALLINCKRODT INC. US 60/706793 09/08/2005 PCT/US/2006/030766 WO/2007/030249 189349 189350 A METHOD OF CONSTRUCTION FOR A LOW COST PLASTIC ULTRASONIC WATER METER FLOWNETIX LIMITED GB 0516754.9 13/08/2005 PCT/GB/2006/002825 WO/2007/020375 937 G21G מערכת לייצור רדיואיזוטופים בעלת יכולת מיצוי חלקית LOW POWER ULTRASONIC FLOW MEASUREMENT FLOWNETIX LIMITED GB 0516752.3 13/08/2005 0615120.3 28/07/2006 GB PCT/GB/2006/002902 WO/2007/020378 28/07/2006 G21F G01F מדידת זרימה על–קולית בשימוש בכוח נמוך G01F –שיטה לבניה של מונה מים פלסטי על קולי מוזל June 5, 2008– ב' בסיון התשס"ח 24/08/2006 189353 צורות גבישיות של דלתא ואפסילון של אימטיניב מסילאט DELTA AND EPSILON CRYSTAL FORMS OF IMATINIB MESYLATE NOVARTIS AG US 60/711738 26/08/2005 60/711737 26/08/2005 US 60/712206 29/08/2005 US PCT/EP/2006/065662 WO/2007/023182 28/08/2006 189354 PROCESS FOR THE PRODUCTION OF ANILINES SYNGENTA PARTICIPATIONS AG CH 1416/05 30/08/2005 PCT/EP/2006/008398 WO/2007/025693 06/06/2003 16/08/2006 June 5, – ב' בסיון התשס"ח C07D קדם–תרופות של חומצות אמינו מעוררות 189356 p38 MAP KINASE INHIBITORS AND METHODS FOR USING THE SAME F. HOFFMANN-LA ROCHE AG US 60/712010 25/08/2005 PCT/EP/2006/065330 WO/2007/023111 C07C תהליך לייצור אנילינים 189355 PRODRUGS OF EXCITATORY AMINO ACIDS ELI LILLY AND COMPANY EP 02380120.2 11/06/2002 02380121.0 11/06/2002 EP 60/415,936 03/10/2002 US 60/415,937 03/10/2002 US PCT/US/2003/015405 WO/2003/104217 C07D C07D קינאז ושיטות לשימושMAP 38p מעכבי בהם 938 2008 27/12/2001 189357 תרכובות חדשות NOVEL COMPOUNDS WARNER-LAMBERT COMPANY LLC US 60/260505 09/01/2001 PCT/IB/2001/002729 WO/2002/055519 27/12/2001 189358 NOVEL PROCESS FOR THE SYNTHESIS OF 5 - (4 FLUOROPHENYL) - 1 - [2 - ((2R, 4R)- 4 - HYDROXY - 6 - OXO -TETRAHYDRO - PYRAN - 2 - YL) - ETHYL] - 2 ISOPROPYL- 4 - PHENYL - 1H PYRROLE - 3 - CARBOXYLIC ACID PHENYLAMIDE WARNER-LAMBERT COMPANY LLC US 60/260505 09/01/2001 PCT/IB/2001/002729 WO/2002/055519 27/12/2001 939 C07D תהליך חדש לסינתזה של פנילאמיד של –2[–1–)–פלואורופניל4(–5 חומצה ––אוקסו6––הידרוקסיR2,R4)–4(( –2–]–יל)–אתיל2–טתראהידרו–פיראן –3––פירולH1––פניל4–איסופרופיל קרבוקסילית 189359 NOVEL PROCESS FOR THE SYNTHESIS OF 5 - (4 FLUOROPHENYL) - 1 - [2 - ((2R, 4R)- 4 - HYDROXY - 6 - OXO -TETRAHYDRO - PYRAN - 2 - YL) - ETHYL] - 2 ISOPROPYL- 4 - PHENYL - 1H PYRROLE - 3 - CARBOXYLIC ACID PHENYLAMIDE WARNER-LAMBERT COMPANY LLC US 60/260505 09/01/2001 PCT/IB/2001/002729 WO/2002/055519 C07D C07D תהליך חדש לסינתזה של פנילאמיד של R2–R4)––2[–1–)–פלואורופניל4(–5 חומצה ––אוקסו–טתראהידרו–פיראן6––הידרוקסי4 –H1––פניל4––איסופרופיל2–]–יל)–אתיל2 –קרבוקסילית3–פירול June 5, 2008– ב' בסיון התשס"ח 25/07/2006 189360 WOUND IRRIGATION DEVICE PRESSURE MONITORING AND CONTROL SYSTEM RICHARD C. VOGEL US 11/198148 08/08/2005 11/237880 29/09/2005 US 11/350089 09/02/2006 US PCT/US/2006/028738 WO/2007/019038 03/08/2006 מערכת לניטור ובקרת לחץ של התקן לטיפטוף על פצע 189361 189362 EXCHANGE SYSTEM FOR AXIAL SPINAL PROCEDURES TRANS1 INC. US 60/706704 09/08/2005 PCT/US/2006/031084 WO/2007/021772 June 5, – ב' בסיון התשס"ח C07K שימושים של פפטידים הנקשרים TPO לרצפטור של USE OF PEPTIDES THAT BIND TO TPO RECEPTOR ORTHO-MCNEIL PHARMACEUTICAL, INC. US 11/200416 09/08/2005 PCT/US/2006/030359 WO/2007/021572 09/08/2006 A61M A61B מערכת המרה לפרוצדורות ציריות בעמוד השדרה 940 2008 09/08/2006 189363 IMPROVED FLUTED ANODE WITH MINIMAL DENSITY GRADIENTS AND CAPACITOR COMPRISING SAME KEMET ELECTRONICS CORPORATION US 11/199626 09/08/2005 PCT/US/2006/031025 WO/2007/021738 10/08/2006 אנודה מוארכת משופרת עם מקדם צפיפות מינימלי וקבל הכולל אותה 189364 ESTROGEN COMPOSITIONS AND THERAPEUTIC METHODS OF USE THEREOF DRUGTECH CORPORATION US 60/707662 12/08/2005 PCT/US/2006/031153 WO/2007/021805 12/08/2006 22/08/2006 941 A61K תרכובות אסטרוגן ושיטות תרפויטיות לשימוש בהן 189366 SYSTEMS, DEVICES, AND METHODS FOR OPTICALLY CLEARING TISSUE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM US 60/707778 12/08/2005 PCT/US/2006/031401 WO/2007/021948 H01G A61B מכשירים ושיטות לניקויי רקמות,מערכות באופן אופטי 189370 C07D June 5, 2008– ב' בסיון התשס"ח PROCESS FOR PRODUCING IMIDAZO[1,2-b]PYRIDAZINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED. 2005JP 30/08/2005 248845 PCT/JP/2006/316790 WO/2007/026621 16/01/2001 189371 A METHOD FOR CONVERSION OF INSOLUBLE GLUCAGON-LIKE PEPTIDE (GLP-1) COMPOUNDS TO A SOLUBLE GLP-1 COMPOUND ELI LILLY AND COMPANY US 60/178438 27/01/2000 60/224058 09/08/2000 US PCT/US/2001/000010 WO/2001/055213 15/08/2006 b[–2,1]תהליך עבור ייצור תרכובת אימידאזו פירידאזין שיטה להמרה של תרכובות בלתי מסיסות )GLP–1(1 של פפטיד דמוי גלוקאגון GLP–1 לתרכובת מסיסה של 189374 FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG US 60/712012 25/08/2005 PCT/EP/2006/065297 WO/2007/023105 29/08/2006 June 5, – ב' בסיון התשס"ח C07K 189375 C07D קינאזMAP 38p פיראזול מאוחד כמעכבי C07D 942 2008 1-HETEROCYCLYLSULFONYL, 2AMINOMETHYL, 5-(HETERO)ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED 2005JP 30/08/2005 250356 2006-100626 31/03/2006 JP PCT/JP/2006/317408 WO/2007/026916 25/08/2006 189376 COMBINATIONS COMPRISING DMXAA FOR THE TREATMENT OF CANCER ANTISOMA PLC GB 0517386.9 26/08/2005 0604114.9 02/03/2006 GB PCT/GB/2006/003196 WO/2007/023302 25/08/2006 943 A61K לטיפול בסרטןDMXAA צירופים הכוללים 189377 COMBINATIONS COMPRISING DMXAA FOR THE TREATMENT OF CANCER ANTISOMA PLC GB 051738.7 26/08/2005 PCT/GB/2006/003207 WO/2007/023307 16/08/2006 –2 ,–הטרוציקלילסולפוניל1 תולדות –H–1 –(הטרו–)אריל מותמר5 ,אמינומתיל פירול כמעכבי הפרשת חומצה A61K לטיפול בסרטןDMXAA צירופים הכוללים 189381 C07D June 5, 2008– ב' בסיון התשס"ח קינאז ושיטות לשימושMAP 38p מעכבי בהם p38 MAP KINASE INHIBITORS AND METHODS FOR USING THE SAME F. HOFFMANN-LA ROCHE AG US 60/712021 25/08/2005 PCT/EP/2006/065334 WO/2007/023114 16/08/2006 189382 קינאז ושיטות לשימושMAP 38p מעכבי בהם p38 MAP KINASE INHIBITORS AND METHODS FOR USING THE SAME F. HOFFMANN-LA ROCHE AG US 60/712007 25/08/2005 PCT/EP/2006/065335 WO/2007/023115 31/08/2006 189383 DERIVATIVES OF 4-PIPERAZIN-1-YL -4-BENZO[B]THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. 2005JP 31/08/2005 251055 PCT/JP/2006/317704 WO/2007/026959 08/08/2006 June 5, – ב' בסיון התשס"ח C07D C07D –4––יל1––פיפראזינ4 תולדות של ]תיופן המתאימות לטיפול במחלותB[בנזו של מערכת העצבים המרכזית 189385 G01J 944 2008 SYSTEM AND METHOD FOR THE IDENTIFICATION AND QUANTIFICATION OF A BIOLOGICAL SAMPLE SUSPENDED IN A LIQUID POCARED DIAGNOSIS, LTD. US 60/706489 08/08/2005 11/500163 07/08/2006 US PCT/US/2006/030765 WO/2007/019462 28/08/2006 189386 IRRIGATION PIPE COMPRISING A MULTILAYERED PIPE WALL NETAFIM LTD US 11/220376 07/09/2005 PCT/IL/2006/000992 WO/2007/029234 26/07/2006 189388 SPLIT TERMINATION FOR SECURE COMMUNICATION PROTOCOLS RIVERBED TECHNOLOGY, INC. US 60/707804 10/08/2005 11/489414 18/07/2006 US PCT/US/2006/029158 WO/2007/021483 08/08/2006 945 189389 מערכת ושיטה לזיהוי וכימות של דוגמה ביולוגית המורחפת בנוזל A01G צינור השקייה המכיל איזור רב–שכבתי נטפים בע"מ G06F סיום מפוצל עבור פרוטוקלי תקשורת מוגנים C12N June 5, 2008– ב' בסיון התשס"ח פפטידים אנטיגניים דוחי גידולים אשר )GPC3( 3–הינם תולדות של גליפיקאן היעילים לשימוש בחולים אשר חיובי ותכשיריA–HLA2–מסווגים כ רוקחות המכילים אותם GLYPICAN-3 (GPC3)-DERIVED TUMOR REJECTION ANTIGENIC PEPTIDES USEFUL FOR HLA-A2 POSITIVE PATIENTS AND PHARMACEUTICAL COMPRISING THE SAME KUMAMOTO UNIVERSITY 2005JP 09/08/2005 230702 PCT/JP/2006/315631 WO/2007/018199 21/08/2006 189390 C07D (INDOL-3-YL)HETEROCYCLE DERIVATIVES AS AGONISTS OF THE CANNABINOID CB1 RECEPTOR N.V. ORGANON EP 05107725.3 23/08/2005 PCT/EP/2006/065496 WO/2007/023143 18/10/2006 –יל)–הטרוציקליות3–תולדות (אינדול CB1 כאגוניסטים של קולטן 189392 METHOD FOR PREPARING THE OVULATED EGGS OF AQUATIC ANIMALS FOR QUALITY FOODSTUFFS AND OVULATED EGGS PREPARED USING SAID METHOD STIFTUNG ALFRED-WEGENERINSTITUT FUR POLAR-UND MEERESFORSCHUNG DE 102005050723.9 19/10/2005 PCT/DE/2006/001867 WO/2007/045233 11/08/2006 June 5, – ב' בסיון התשס"ח 189394 A23L שיטה להכנת ביצים מבוייצות מחיות מימיות למצרכי מאכל יוקרתיים וביצים מבוייצות תוך שימוש בשיטה האמורה C07D 946 2008 SUBSTITUTED PYRAZOLECARBOXYLIC ACID ANILIDE DERIVATIVES AGRICULTURAL COMPOSITIONS CONTAINING THE SAME NIHON NOHYAKU CO., LTD. 2005JP 12/08/2005 234405 2005-322531 07/11/2005 JP 2006-114937 18/04/2006 JP PCT/JP/2006/316198 WO/2007/020986 22/08/2006 189395 METHOD FOR PRODUCING SULFONYL CHLORIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED. 2005JP 30/08/2005 248846 PCT/JP/2006/316813 WO/2007/026625 07/08/2006 תולדות חומצת פיראזולקרבוקסילית אניליד ותכשירים לשימוש בחקלאות המכילים אותם שיטה עבור ייצור תרכובת סולפוניל כלוריד 189397 MANAGEMENT OF EXPERT RESOURCES USING SEEKER PROFILES XPERTUNIVERSE, INC. US 11/200520 08/08/2005 PCT/US/2006/030796 WO/2007/019470 09/08/2006 FLUID FLOW DEVICES SWAGELOK COMPANY 947 C07D 189399 G06F ניהול של משאבים מומחים תוך שימוש בפרופילים נדרשים F16L התקני זרימה לנוזלים June 5, 2008– ב' בסיון התשס"ח US 60/706846 PCT/US/2006/031096 WO/2007/021779 09/08/2005 10/08/2005 189400 USE OF ?-1,3(4)ENDOGLUCANOHYDROLASE, ?-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION STEVEN BRUCE PUNTENNEY A61K ,)–אנדוגלוקנוהידרולאז4(3,1–שימוש בבתא אדמה מכילה,)–גלוקאן4(3,1–בתא חומר מינרלי וגלוקומנן להגדלת,חילוקיות פונקציה חיסונית PCT/US/2005/028529 WO/2007/021262 11/08/2006 189402 METHODS AND COMPOSITIONS FOR DRIED CELLULAR FORMS PRESIDENT AND FELLOWS OF HARVARD COLLEGE US 60/707425 11/08/2005 60/788133 31/03/2006 US PCT/US/2006/031580 WO/2007/022053 16/08/2006 189403 FINE GRAINED POLYCRYSTALLINE ABRASIVE MATERIAL June 5, – ב' בסיון התשס"ח C12N שיטות ותכשירים עבור צורות תאיות יבשות C22C חומר שיוף רב גבישי בגירעון עדין 948 2008 ELEMENT SIX (PRODUCTION) (PTY) LTD ZA 2005/06534 16/08/2005 PCT/IB/2006/002229 WO/2007/020518 14/08/2006 189404 TETRACYCLIC BENZOFURAN DERIVATIVES WITH THERAPEUTIC ACTIVITIES PHARMOS CORPORATION US 60/708367 16/08/2005 PCT/IL/2006/000940 WO/2007/020631 09/08/2006 189407 PEPTIDES FOR TREATMENT AND DIAGNOSIS OF AUTOIMMUNE DISEASE ARPI MATOSSIAN-ROGERS GB 0516527.9 11/08/2005 0609920.4 18/05/2006 GB 0609921.2 18/05/2006 GB PCT/GB/2006/002977 WO/2007/017686 10/08/2006 189409 PORTABLE DIALER DEVICE AND METHOD NIR RON US 60/706780 10/08/2005 PCT/IL/2006/000936 WO/2007/017881 31/07/2006 CARRY AND DRIVE DEVICE AND METHOD FOR DENTAL IMPLANT AND/OR COMPONENTS THEREOF 949 189412 C07D נגזרות בנזופוראן טטרהציקליות בעלות פעילות תרפואטית פארמוס קורפוריישן C07K פפטידים לטיפול ואבחון מחלות אוטואימוניות H04J שיטה והתקן לחייגן נייד A61C מנשא והתקן הנעה ושיטה להשתלות דנטליות ורכיבים קשורים June 5, 2008– ב' בסיון התשס"ח LIFECORE BIOMEDICAL INC. US 11/201175 10/08/2005 PCT/US/2006/029728 WO/2007/021519 10/08/2006 189413 INHIBITORS OF CANCER CELL, TCELL AND KERATINOCYTE PROLIFERATION 4SC AG EP 05017391.3 10/08/2005 PCT/EP/2006/007933 WO/2007/017284 11/08/2006 C07K T תאי,מעכבי פרוליפרציה של תאי סרטן וקרטינוציטים 189414 C07K פרוטאינים מאוחים של מונוציטים )MCP1(1–כמוטקטיים של פרוטאין MCP1 FUSIONS SCHERING CORPORATION US 60/707731 12/08/2005 PCT/US/2006/031155 WO/2007/021807 11/08/2006 189415 IMPROVED PROCESS AND APPARATUS FOR SELECTING AN ITEM FROM A DATABASE KANNUU PTY LTD. AU 2005904378 12/08/2005 PCT/AU/2006/001151 WO/2007/019610 08/08/2006 June 5, – ב' בסיון התשס"ח 189416 G06F תהליך משופר ומכשיר לבחירת פריט מתוך מאגר מידע C07D 950 2008 AZINYL-3-SULFONYLINDAZOLE DERIVATIVES AS 5HYDROXYTRYPTAMINE-6 LIGANDS WYETH US 60/708317 15/08/2005 PCT/US/2006/030837 WO/2007/032833 28/08/2006 –סולפונילאינדזול3–נגזרות אזיניל HT–56 המשמשות כליגנדים לרצפטור 189418 DECELLULARIZATION AND RECELLULARIZATION OF ORGANS AND TISSUES REGENTS OF THE UNIVERSITY OF MINNESOTA, US 60/711501 26/08/2005 60/815242 19/06/2006 US PCT/US/2006/033415 WO/2007/025233 16/08/2006 דה–סלולריזציה ורה–סלולוריזציה של איברים ורקמות 189419 189420 METHOD FOR THE RECOMBINANT EXPRESSION OF A POLYPEPTID F. HOFFMANN-LA ROCHE AG EP 05023003.6 21/10/2005 06010665.5 24/05/2006 EP PCT/EP/2006/010067 WO/2007/045465 29/08/2006 951 B31F תוף להתקן מקמט DRUM FOR A CREASING DEVICE TECH-NI-FOLD LTD. GB 0517115.2 20/08/2005 PCT/GB/2006/003057 WO/2007/023258 19/10/2006 A61M C12N שיטה לביטוי רקומביננטי של פוליפפטיד 189421 H04N June 5, 2008– ב' בסיון התשס"ח MULTIMEDIA COLOR MANAGEMENT SYSTEM MICROSOFT CORPORATION US 11/216626 31/08/2005 PCT/US/2006/033822 WO/2007/027745 29/08/2006 189422 SCRIPT MARKUP MICROSOFT CORPORATION US 60/716293 12/09/2005 11/318305 23/12/2005 US PCT/US/2006/034121 WO/2007/032925 09/08/2006 189423 SURGICAL FASTENERS AND DEVICES FOR SURGICAL FASTENING ENDOGUN MEDICAL SYSTEMS LTD. US 60/706907 11/08/2005 PCT/IL/2006/000917 WO/2007/017872 10/08/2006 189424 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS AND METHODS ODEM MEDICAL LTD US 60/707155 11/08/2005 PCT/IL/2006/000932 WO/2007/017879 June 5, – ב' בסיון התשס"ח מערכת ניהול מולטימדיה צבעונית G06F סימני עריכה למסמך A61B מהדקים כירורגיים והתקנים להידוק כירורגי אנדוגן מערכות רפואיות בע"מ A61N מערכות ושיטות לקיצוב מחדש של הלב אודם מדיקל בע"מ 952 2008 10/08/2006 189425 DEVICE FOR TRAPPING SUBSEA FRESH WATER RESURGENCES AND METHOD FOR THE OPERATION THEREOF MICHEL PERIL GR 20050100426 11/08/2005 PCT/GR/2006/000039 WO/2007/017703 09/08/2006 17/08/2006 התקן לתפיסת התחדשויות תת–ימיות של מים טריים ושיטה להפעלתו 189426 RARE-GAS-BASED BERNOULLI HEAT PUMP AND METHOD MACHFLOW ENERGY, INC. US 60/707257 11/08/2005 PCT/IB/2006/002176 WO/2007/017741 189427 189429 3,4,5-SUBSTITUTED PIPERIDINES AS RENIN INHIBITORS SPEEDEL EXPERIMENTA AG US 66/666556 31/03/2005 60/750853 16/12/2005 US PCT/EP/2006/061197 WO/2006/103277 953 F25B המבוססת עלBERNOULLI משאבת חם גזים אצילים ושיטה WAVE ENERGY CONVERSION SEAPOWER PACIFIC PTY LTD. AU 2005904436 17/08/2005 PCT/AU/2006/001187 WO/2007/019640 30/03/2006 E03B F03B המרת אנרגיית גלים C07D 5,4,3 פיפרידינים המותמרים בעמדות כמעכבי רנין June 5, 2008– ב' בסיון התשס"ח 09/11/1999 189430 13-MEMBERED AZALIDES AND THEIR USE AS ANTIBIOTIC AGENTS PFIZER PRODUCTS, INC. US 60/109399 20/11/1998 PCT/IB/1999/001803 WO/2000/031097 28/08/2006 189434 7-(2-AMINO-1-HYDROXY-ETHYL)-4HYDROXYBENZOTHIAZOL-2(3H)ONE-DERIVATIVES AS ?2 ADRENOCEPTOR AGONISTS ASTRAZENECA AB SE 0501905-4 29/08/2005 0601331-2 15/06/2006 SE PCT/SE/2006/000981 WO/2007/027134 13/08/2006 189437 IMPLANTABLE DEVICE FOR OBESITY PREVENTION STIMPLANT LTD US 60/707227 11/08/2005 PCT/IL/2006/000934 WO/2007/017880 June 5, – ב' בסיון התשס"ח C12P אטומים ושימושם13 אזאלידים בעלי כחומרים אנטיביוטיים C07D –)–הידרוקסי–אתיל1––אמינו2(–7 תולדות )–אוןH3(2––הידרוקסיבנזותיאזול4 אדנורצפטוריםB2 כאגוניסטים של A61F מתקן בעל יכולת השתלה למניעת השמנת יתר סטימפלנט בע"מ 954 2008 10/08/2006 189440 MEDICAL TREATMENT SYSTEM AND METHOD USING RADIOACTIVITY BASED POSITION SENSOR NAVOTEK MEDICAL LTD IL PCT/IL2005/000871 IL PCT/IL2005/001101 60/773930 US 60/773931 US 60/804178 US PCT/IB/2006/052771 WO/2007/017847 15/08/2006 189456 189457 PANCREATIN MICROPELLET CORES SUITABLE FOR ENTERIC COATING SOLVAY PHARMACEUTICALS GMBH EP 05107474.8 15/08/2005 60/708526 15/08/2005 US PCT/EP/2006/065313 WO/2007/020260 955 מערכת טיפול רפואי ושיטה המשתמשים בגלאי מיקום מבוסס רדיואקטיביות נבוטק מדיקל בע"מ 11/08/2005 19/10/2005 16/02/2006 16/02/2006 08/06/2006 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID LABILE DRUGS SOLVAY PHARMACEUTICALS GMBH EP 05107472.2 15/08/2005 60/708692 15/08/2005 US PCT/EP/2006/065311 WO/2007/020259 15/08/2006 A61N A61K תכשירי רוקחות לשחרור מבוקר של תרופות שאינן יציבות בחומצה A61K מיקרו כדוריות העשויות מליבה לבלבית המתאימות לציפוי המעי June 5, 2008– ב' בסיון התשס"ח 25/08/2006 189463 NON-STEROIDAL COMPOUNDS USEFUL AS GLUCOCORTICOID RECEPTOR MODULATORS N.V. ORGANON EP 05107896.2 29/08/2005 PCT/EP/2006/065696 WO/2007/025938 07/09/2006 189468 PRODUCING A RADIATION SENSOR THALES FR 0509777 23/09/2005 PCT/EP/2006/066116 WO/2007/036417 16/07/2006 189474 COMBINED VISUAL-OPTIC AND PASSIVE INFRA-RED TECHNOLOGIES AND THE CORRESPONDING SYSTEM FOR DETECTION AND IDENTIFICATION OF SKIN CANCER PRECURSORS, NEVI AND TUMORS FOR EARLY DIAGNOSIS SMOLIAK YAFIM US 60/708389 16/08/2005 PCT/IL/2006/000954 WO/2007/020643 June 5, – ב' בסיון התשס"ח C07D תרכובות שאינן סטרואידיות היעילות כמאפננות קולטן גלוקוקורטיקואיד H01L יצור חיישן קרינה A61B טכנולוגיות משולבות ויזואלית–אופטית ואינפרה אדום פסיבית ומערכת מקבילה נבי,לגילוי וזיהוי של מקדמי סרטן עור וגידולים לדיאגנוסטיקה מוקדמת שמוליק יפים 956 2008 08/05/2002 189480 )– טריפלורופרופיל3,3,3( תרכובת מאלונוניתריל (3,3,3- TRIFLUOROPROPYL) MALONONITRILE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED 2001JP 09/05/2001 138331 PCT/JP/2002/004449 WO/2002/090320 10/08/2006 189489 RESTRICTIVE REUSE SET MANAGEMENT ALGORITHM FOR EQUAL GRADE OF SERVICE ON FORWARD LINK TRANSMISSION QUALCOMM INCORPORATED US 11/203038 12/08/2005 PCT/US/2006/031403 WO/2007/021950 20/09/2006 CLEAVAGE OF ANTIFOLATE COMPOUNDS PROTHERICS MEDICINES DEVELOPMENT LIMITED H04Q סט ניהול אלגוריתם לשימוש חוזר מוגבל עבור דירוג שירות שווה בקישור תשדורת של העברה קדימה 189495 RANKING FUNCTIONS USING DOCUMENT USAGE STATISTICS MICROSOFT CORPORATION US 11/231955 21/09/2005 PCT/US/2006/037206 WO/2007/035919 24/08/2005 C07C 189498 G06F דירוג פונקציות באמצעות סטטיסטיקות של שימוש במסמכים A61K ביקוע של תרכובות אנטי–פולאטיות PCT/GB/2005/003297 WO/2007/023243 957 June 5, 2008– ב' בסיון התשס"ח 05/10/1999 189502 METHODS AND COMPOSITIONS FOR INHIBITING NEOPLASTIC CELL GROWTH GENENTECH, INC. US 60/104080 13/10/1998 PCT/US/1999/023089 WO/2000/021996 12/07/1999 DEVICE SERCONET LTD. US 123486 PCT/US/1999/015644 WO/2000/007322 12/07/1999 DEVICE SERCONET LTD. US 123486 PCT/US/1999/015644 WO/2000/007322 01/08/2006 שיטות ותכשירים לעיכוב הגידול של תאים נאופלסטים 189507 H04L התקן סרקונט בע"מ 28/07/1998 189508 H04L התקן סרקונט בע"מ 28/07/1998 189516 USE OF CHOLINE TO PREVENT THROMBOSIS ASSOCIATED WITH TOTAL PARENTERAL NUTRITION ALAM L. BUCHMAN US 60/708395 16/08/2005 PCT/US/2006/029869 WO/2007/021529 June 5, – ב' בסיון התשס"ח A61K A23L שימוש בכולין למניעת פקקת הקשורה להזנה תוך ורידית 958 2008 29/08/2006 189526 MEDIA ACCESS CONTROL ARCHITECTURE OPTIMAL INNOVATIONS, INC. US 60/713052 01/09/2005 PCT/US/2006/033657 WO/2007/027667 07/09/2006 ארכיטקטורת שליטה בגישה לתקשורת 189545 PYRIMIDINE DERIVATIVES AND THEIR USE AS KCNQ POTASSIUM CHANNELS OPENERS H. LUNDBECK A/S DK PA200501262 09/09/2005 PCT/DK/2006/050039 WO/2007/065449 21/06/2006 H04L נגזרות פירימידין והשימוש בהן כפותחני KCNQ תעלות אשלגן מסוג 189604 STOP ASSEMBLY FOR PIPE COUPLING VICTAULIC COMPANY US 11/210376 24/08/2005 PCT/US/2006/024103 WO/2007/024326 11/08/2006 F16L מכלול עצירה לצימוד צינורות 189605 USE OF NERVE GROWTH FACTOR IN EYE-DROPS FOR THERAPY OF PATHOLOGIES OF THE CENTRAL NERVOUS SYSTEM, SUCH AS ALZHEIMER'S AND PARKINSON'S DISEASE ANABASIS S.R.L. IT RM2005A000447 19/08/2005 PCT/IT/2006/000620 WO/2007/020672 959 C07D A61B בטיפות–עינייםNGF –שימוש ב לטיפול בפתולוגיות של מערכת כגון מחלות,העצבים המרכזית אלצהיימר ופרקינסון June 5, 2008– ב' בסיון התשס"ח 18/08/2006 189607 EXENDIN FOR TREATING DIABETES AND REDUCING BODY WEIGHT AMYLIN PHARMACEUTICALS, INC. US 60/709604 19/08/2005 60/779216 03/03/2006 US PCT/US/2006/032354 WO/2007/024700 03/08/2006 12/09/2006 אקסנדין לטיפול בסכרת ולהורדת משקל 189608 NEEDLE ASSEMBLY FOR A PREFILLED SYRINGE SYSTEM CILAG GMBH INTERNATIONAL EP 05255298.1 30/08/2005 PCT/IB/2006/002792 WO/2007/026248 189609 189611 TREATMENT OF INFLAMMATORY BOWEL DISEASE ITH IMMUNE THERAPY HOLDINGS AB SE 0501916-1 31/08/2005 PCT/SE/2006/000959 WO/2007/027132 June 5, – ב' בסיון התשס"ח A61M מכלול מחט עבור מערכת הזרקה המלאה טרם ההזרקה 4-SUBSTITUTED PYRROLIDIN-2ONES AND THEIR USE UCB PHARMA S.A. EP 05020080.7 15/09/2005 05023133.1 24/10/2005 EP PCT/EP/2006/008852 WO/2007/031263 22/08/2006 A61L C07D 4 –אונים מותמרים בעמדה2–פירולידין ושימוש בהם C12N טיפול במחלת מעיים הגורמת לנפיחות 960 2008 22/11/2005 189614 PHARMACEUTICAL COMPOSITIONS OF TELMISARTAN TEVA PHARMACEUTICAL INDUSTRIES LTD. A61K הרכבים רוקחיים של טלמיסרטן טבע תעשיות פרמצבטיות בע"מ PCT/US/2005/042700 WO/2007/061415 18/10/2000 189615 MELANOMA VACCINE AND METHODS OF MAKING AND USING SAME ST. VINCENT'S HOSPITAL AND MEDICAL CENTER OF NEW YORK US 60/240933 18/10/1999 PCT/US/2000/028837 WO/2001/028583 25/08/2006 HAIRSTYLING DEVICE MOURAD, JOSEPH AU 2005904653 PCT/AU/2006/001244 WO/2007/022600 24/08/2006 תרכיב חיסון נגד מלנומה ושיטות להכנתו ולשימוש בו 189616 A45D מכשיר לעיצוב שיער 26/08/2005 189617 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA GB PCT/GB2005/003285 24/08/2005 PCT/GB/2006/003170 WO/2007/023290 961 A61K C07D טטראהידרוקוינולינונים והשימוש בהם כמאפננים לרצפטורים של גלוטמט מטבוטרופי June 5, 2008– ב' בסיון התשס"ח 20/10/2004 189618 IMPROVED PROCESS FOR THE PREPARATION OF FATTY ACID METHYL ESTER (BIODIESEL) FROM TRIGLYCERIDE OIL THROUGH TRANSESTERIFICATION COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH C10L תהליך משופר להכנת חומצת שומן מתיל אסתר (ביודיזל) משמן טריגליצריד באמצעות טרנסאסטריפיקציה PCT/IN/2004/000329 WO/2006/043281 24/12/2004 189619 AN IMPROVED IODIZED SALT AND A PROCESS FOR ITS PREPARATION COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH A23L מלח מיודד משופר ותהליך להכנתו PCT/IN/2004/000405 WO/2006/067798 28/08/2006 189620 PREVENTIVE OR THERAPEUTIC AGENT FOR DISEASE CAUSED BY DECREASE IN LACRIMAL FLUID KISSEI PHARMACEUTICAL CO., LTD. 2005JP 29/08/2005 247563 PCT/JP/2006/316836 WO/2007/026630 June 5, – ב' בסיון התשס"ח A61K גורם מונע ומרפא למחלה הנגרמת מהפחתה בנוזל הדמעות 962 2008 31/08/2005 189621 EGG COUNTER FOR COUNTING EGGS TRANSFERRED BY EGG COLLECTION CONVEYER AGRO SYSTEM CO. LTD G06M מונה ביצים לספירת ביצים המועברות באמצעות מסוע של ערימת ביצים PCT/JP/2005/016351 WO/2007/029316 28/09/2005 189622 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INNER EAR DISORDERS AURIS MEDICAL AG. A61K –תכשירי רוקחות לטיפול באי–סדרים פנים אוזניים PCT/EP/2005/010478 WO/2007/038949 06/09/2006 189623 COATING COMPOSITIONS COMPRISING A LATENT ACTIVATOR FOR MARKING SUBSTRATES CIBA SPECIALTY CHEMICALS HOLDING INC. EP 05108480.4 15/09/2005 PCT/EP/2006/066064 WO/2007/031454 963 B41M תכשירי ציפוי המכילים משפעל לטנטי לסימון סובטרטים June 5, 2008– ב' בסיון התשס"ח 25/09/2006 189624 MIMO BEAMFORMING-BASED SINGLE CARRIER FREQUENCY DIVISION MULTIPLE ACCESS SYSTEM INTERDIGITAL TECHNOLOGY CORPORATION US 60/722022 29/09/2005 PCT/US/2006/037391 WO/2007/041086 28/08/2006 מערכת מרובת כניסות המחולקת לתדרים BEAMFORMING והמבוססת על טכניקת רבת קלט ורבת פלט 189625 NOVEL CYCLOALKANE CARBOXAMIDES AS FACTOR XA INHIBITORS F. HOFFMANN-LA ROCHE AG EP 05107992.9 01/09/2005 PCT/EP/2006/065732 WO/2007/025949 30/08/2006 189627 THIAZOLE DERIVATIVES ASTELLAS PHARMA INC. 2005JP 31/08/2005 252464 2006-177436 28/06/2006 JP PCT/JP/2006/317102 WO/2007/026761 June 5, – ב' בסיון התשס"ח H04L C07D קרבוקסאמידים ציקלואלקאנים חדשים XA כמעכבי פקטור C07D תולדות תיאזול 964 2008 22/08/2005 189628 AN ANTI-CA6 MONOCLONAL ANTIBODY AND A CA6 ANTIGEN SPECIFIC CYTOTOXIC CONJUGATE CONTAINING THE SAME IMMUNOGEN, INC. C12N וצמד ציטורעילCA6 נוגדן מונושבטי נגד המכיל אותןCA6 ספציפי נגד אנטיגן PCT/US/2005/030115 WO/2007/024222 24/08/2000 189629 CTLA –4 תכשירים המכילים נוגדנים ל אנושי COMPOSITIONS CONTAINING HUMAN CTLA-4 ANTIBODIES MEDAREX, INC. US 60/150452 24/08/1999 PCT/US/2000/023356 WO/2001/014424 27/04/2001 189630 A HEMOSTATIC AGENT INCLUDING AN OXYACID SALT BIOLIFE, L.L.C. US 60/200207 28/04/2000 09/592344 13/06/2000 US 09/766513 19/01/2001 US PCT/US/2001/013765 WO/2001/082896 25/08/2006 965 A61K גורם היממסטתי המכיל מלח של חומצה מחמצנת 189631 A CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING HYPROMELLOSE BPSI HOLDINGS, INC. US 60/711724 26/08/2005 PCT/US/2006/033309 WO/2007/025182 C12N A61K תכשיר רוקחות עם שחרור מבוקר המכיל היפרומלוז June 5, 2008– ב' בסיון התשס"ח 23/08/2006 189632 METHODS FOR PREPARING POLYMERS HAVING TERMINAL AMINE GROUPS ENZON PHARMACEUTICALS, INC. US 11/212901 26/08/2005 11/291546 01/12/2005 US PCT/US/2006/032971 WO/2007/024981 22/08/2006 שיטות להכנת פולימרים עם קבוצות אמין קצה 189633 METHOD FOR PRODUCTION OF SINGLE-AND MULTI-LAYER MICROCAPSULES TAGRA BIOTECHNOLOGIES LTD. US 11/208007 22/08/2005 PCT/IL/2006/000977 WO/2007/023495 22/08/2006 189634 DISTRIBUTED PROTOCOL OVER A WIRELESS CONNECTION QUALCOMM INCORPORATED US 60/710365 22/08/2005 PCT/US/2006/032769 WO/2007/024854 June 5, – ב' בסיון התשס"ח C08G B01J –שיטה לייצור מיקרוקפסולות חד–ורב שכבתיות טאגרה ביוטכנולוגיות בע"מ H04L פרוטוקול מבוזר על גבי חיבור אלחוטי 966 2008 22/08/2006 189635 METHOD AND APPARATUS FOR SELECTION OF VIRTUAL ANTENNAS QUALCOMM INCORPORATED US 60/710371 22/08/2005 60/711144 24/08/2005 US 11/261823 27/10/2005 US 11/377458 15/03/2006 US PCT/US/2006/032860 WO/2007/024913 24/07/2006 189638 METHODS AND APPARATUS FOR REDUCING PROTEIN CONTENT IN SPERM CELL EXTENDERS XY, INC. US 60/704001 29/07/2005 11/219607 02/09/2005 US PCT/US/2006/028846 WO/2007/016090 14/08/2006 189640 DISPOSABLE CAP FOR ENDOSCOPE STRYKER GI LTD. US 60/714480 06/09/2005 PCT/IL/2006/000937 WO/2007/029230 06/09/2006 189642 HUMAN MONOCLONAL ANTIBODIES TO ACTIVIN RECEPTOR-LIKE KINASE 1 PFIZER, INC. US 60/715292 07/09/2005 PCT/US/2006/035096 WO/2007/040912 967 H04B שיטה והתקן לבחירה של אנטנות ורטואלית A01N שיטות והתקן להפחתת תכולת חלבון במגדילי נפח תא זרע A61B כיסוי חד פעמי לאנדוסקופ בע"מ. אי.סטריקר ג'י A61K 1–נוגדנים אנושיים מונושבטיים לקינז הדומה לקולט אקטיבין June 5, 2008– ב' בסיון התשס"ח 07/09/2006 189644 A PROCESS FOR THE PRODUCTION OF CRYSTALLINE SHORT CHAIN AMYLOSE TATE & LYLE INGREDIENTS AMERICAS, INC. US 60/715832 09/09/2005 PCT/US/2006/034666 WO/2007/030507 27/06/2006 C08B תהליך להכנת עמילוזה גבישית עם שרשרת קצרה 189649 F01K שיטת עיבוי CONDENSATION METHOD GEA ENERGIETECHNIK GMBH DE 102005040380.8 25/08/2005 PCT/DE/2006/001097 WO/2007/022738 22/09/2006 189650 AMINO-5-[4-(DIFLUOROMETHOXY) PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS AS INHIBITORS OF THE BETA-SECRETASE (BACE) WYETH US 60/720589 PCT/US/2006/036985 WO/2007/038271 June 5, – ב' בסיון התשס"ח C07D –4[–5–תרכובות אמינו –5–](דיפלואורומתוקסי)פניל –פנילאימידאזולון כמעכבות של בתא ) BACE( סקרטאז 26/09/2005 968 2008 28/03/2002 189651 COMPOSITIONS COMPRISING 3-ODEACTIVATED-4'MONOPHOSPHORYL LIPID A (3DMLA) LIPOPOLYSACCHARIDES (LPA) AND MONOPHOSPHORYL LIPID A (MLA) CORIXA CORPORATION US 60/280089 30/03/2001 PCT/US/2002/009731 WO/2002/078637 06/02/2003 189657 N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES NOVARTIS AG GB 0202873.6 07/02/2002 PCT/EP/2003/001188 WO/2003/066613 06/02/2003 189658 N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES NOVARTIS AG GB 0202873.6 07/02/2002 PCT/EP/2003/001188 WO/2003/066613 17/08/2006 189660 IMAGE PROCESSING METHOD, IMAGE PROCESSING PROGRAM, AND IMAGE PROCESSING DEVICE NIHON MEDI-PHYSICS CO, LTD. 2005JP 23/08/2005 241624 PCT/JP/2006/316147 WO/2007/023723 969 C12P –'4––דמשופעלO–3 תכשירים המכילים ) A (MLA – D3 מונופוספוריל ליפיד ) ומונופוספורילLPA( ליפופוליסאכרידים ) A (MLA ליפיד C07C –פירימידין–אמין2––פנילN נגזרות של C07C –פירימידין–אמין2––פנילN נגזרות של G06T תכנית לעיבוד,שיטה לעיבוד תמונה ומכשיר לעיבוד תמונה,תמונה June 5, 2008– ב' בסיון התשס"ח 20/09/2006 189661 ELECTROPLATING COMPOSITION FOR COATING A SUBSTRATE SURFACE WITH A METAL ALCHIMER FR 0509571 20/09/2005 PCT/FR/2006/050914 WO/2007/034116 20/09/2006 הרכב ציפוי מתכת באמצעות אלקטרוליזה עבור ציפוי תשתית משטח במתכת 189662 ELECTROPLATING METHOD FOR COATING A SUBSTRATE SURFACE WITH A METAL ALCHIMER S.A. FR 0509572 20/09/2005 PCT/FR/2006/050915 WO/2007/034117 05/09/2006 189663 NOVEL HETEROBICYCLIC DERIVATIVES USEFUL AS INHIBITORS OF LIVER CARNITINE PALMITOYL TRANSFERASE F. HOFFMANN-LA ROCHE AG EP 05108468.9 15/09/2005 PCT/EP/2006/065989 WO/2007/031429 June 5, – ב' בסיון התשס"ח C25D H01L שיטת ציפוי מתכתי באמצעות אלקטרוליזה לציפוי פני שטח במתכת C07D תולדות הטרוביציקליות חדשות השימושיות כמעכבים של קרניטין פלמיטויל טרנספרז של כבד 970 2008 21/08/2006 189664 BENZOOXAZOLE, OXAZOLOPYRIDINE, BENZOTHIAZOLE AND THIAZOLOPYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG EP 05108035.6 02/09/2005 PCT/EP/2006/065522 WO/2007/025897 07/09/2006 , אוקסזולופירידין,תולדות בנזואוקסזול בנזותיאזול ותיאזולופירידין 189665 TREATMENT OF AUTOIMMUNE DISEASES NOVARTIS AG US 60/715990 09/09/2005 PCT/EP/2006/066150 WO/2007/028821 05/09/2006 28/08/2006 971 C07D ] C– 3,2[ – אמינו –תיאנו4 תולדות חומצה –קרבוקסילית7–פירידין 189668 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED US 60/711530 26/08/2005 PCT/US/2006/033770 WO/2007/025307 A61K טיפול במחלות אוטואימוניות 189667 4-AMINO-THIENO[3,2-C]PYRIDINE-7CARBOXYLIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG US 60/717271 15/09/2005 60/832460 21/07/2006 US PCT/EP/2006/065986 WO/2007/031428 C07D C07D מעכבים של סרין פרוטאזות June 5, 2008– ב' בסיון התשס"ח 19/07/2006 189669 VERIFICATION OF AUTHENTICITY INGENIA TECHNOLOGY LIMITED GB 0515460.4 27/07/2005 60/702732 27/07/2005 US PCT/GB/2006/002689 WO/2007/012816 28/08/2006 189670 TRAIL RECEPTOR 2 POLYPEPTIDES AND ANTIBODIES AMGEN, INC. US 60/713433 31/08/2005 60/713478 31/08/2005 US PCT/US/2006/033763 WO/2007/027713 22/08/2006 189671 MEDICATION DISPENSER AND CARRIER THEREFOR MEDI-STREAM PTY LTD, AU 2005904543 22/08/2005 PCT/AU/2006/001212 WO/2007/022573 24/08/2006 189672 CHEMOSENSITIVITY TESTER HEPAHOPE, INC. US 11/210511 24/08/2005 60/712964 30/08/2005 US 60/782029 13/03/2006 US 60/785308 23/03/2006 US 60/791966 14/04/2006 US 11/466730 23/08/2006 US PCT/US/2006/033263 WO/2007/025154 June 5, – ב' בסיון התשס"ח G07D אימות אמינות C07K עוקבים2–פוליפפטידים רצפטורים ונוגדנים A61M מחלק תרופות ונשא עבורו G01N בוחן כמוסנסיטיביות 972 2008 24/08/2006 189673 NOVEL ENHANCED PROCESSES FOR DRUG TESTING AND SCREENING USING HUMAN TISSUE HEPAHOPE, INC. US 11/210511 24/08/2005 11/466730 23/08/2006 US PCT/US/2006/033262 WO/2007/025153 25/08/2006 תהליכים מואצים חדשים לבדיקת תרופות וסריקה ע"י שימוש ברקמה אנושית 189674 STEM CELL FUSION MODEL OF CARCINOGENESIS THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA US 60/711249 25/08/2005 PCT/US/2006/033366 WO/2007/025216 17/08/2006 189675 AGENTS FOR PREVENTING AND TREATING DISORDERS INVOLVING MODULATION OF THE RYR RECEPTORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK US 11/212413 25/08/2005 PCT/US/2006/032405 WO/2007/024717 973 G01N A61K מודל מיזוג תאי של סרטון C07D גורמים למניעת וטיפול באי סדרים RYR הקשורים באפנון קולטני June 5, 2008– ב' בסיון התשס"ח 13/09/2005 189676 APPARATUS AND METHOD FOR REMOVING AMBIENT NOISE AND MOBILE COMMUNICATION TERMINAL EQUIPPED WITH THE APPARATUS PISHON ANC CO, LTD 10-2005KP 05/09/2005 0082380 PCT/KR/2005/003011 WO/2007/029899 19/10/2001 מכשיר ושיטה להסרת רעש סביבתי ומסוף תקשורת נייד המצוייד עם המכשיר 189677 PROCESS FOR PREPARING NITROGENOUS AROMATIC RING COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. 2000JP 20/10/2000 320420 2000-386195 20/12/2000 JP 2001-46685 22/02/2001 JP PCT/JP/2001/009221 WO/2002/032872 23/08/2006 June 5, – ב' בסיון התשס"ח C07D תהליך להכנת תרכבות מעגליות ארומטיות חנקניות 189679 IMIDAZOLE DERIVATIVES FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS SCHERING CORPORATION US 60/711398 25/08/2005 PCT/US/2006/032911 WO/2007/024944 H04B C07D נגזרות אימידזול כאגוניסטים סלקלטיביים C2פונקציונלית לקולטן אדרנלין אלפא 974 2008 17/08/2006 189681 A61K SUSTAINED-RELEASE PREPARATION NISSAN CHEMICAL INDUSTRIES, LTD. 2005JP 23/08/2005 241776 PCT/JP/2006/316181 WO/2007/023729 19/07/2006 תכשיר לשחרור מושהה 189684 DEVICE AND METHOD FOR CONTINUOUSLY PRODUCING A DEFECTIVE-FREE CARRIER STRIP BIELOMATIK LEUZE GMBH & CO. KG DE 102005041024.3 23/08/2005 PCT/EP/2006/007084 WO/2007/022835 22/08/2006 189685 COMPOSITIONS AND METHODS FOR ANALYZING PROTEIN INTERACTIONS RESEARCH DEVELOPMENT FOUNDATION US 60/710597 22/08/2005 PCT/US/2006/032810 WO/2007/024877 975 G06K התקן ושיטה ליצור מתמשך של רצועה נושאת ללא פגמים C40B תכשירים ושיטות לניתוח אינטרקציה בין חלבונים June 5, 2008– ב' בסיון התשס"ח 15/09/2006 189686 OPTICALLY ACTIVE DIAMINE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME DAIICHI SANKYO COMPANY, LIMITED 2005JP 16/09/2005 269642 PCT/JP/2006/318432 WO/2007/032498 22/08/2006 תולדות דיאמין אופטי אקטיבי ותהליך עבור ייצור הנ"ל 189687 PROCESS OF PREPARING BROMOPICRIN BROMINE COMPOUNDS LTD. US 60/711272 26/08/2005 PCT/IL/2006/000978 WO/2007/023496 21/08/2006 תרכובות ברום בע"מ 189689 A61M –כוונון ניפוח בלונית של צינור הנשמה תוך קני הוספיטק הנשמה בע"מ 189690 A METHOD FOR EVALUATION OF A GEMSTONE GALATEA LTD DE 102005039679.8 22/08/2005 PCT/IB/2006/052884 WO/2007/023444 June 5, – ב' בסיון התשס"ח C07C תהליך להכנת ברומופיקרין ADJUSTMENT OF ENDOTRACHEAL TUBE CUFF FILLING HOSPITECH RESPIRATION LTD US 60/710678 24/08/2005 60/721965 30/09/2005 US 60/754191 28/12/2005 US PCT/IL/2006/000974 WO/2007/023492 21/08/2006 C07C G01N שיטה להערכה של אבני חן גאלאתיאה בע"מ 976 2008 16/11/2006 189693 METAL CARBONITRIDE LAYER AND METHOD FOR THE PRODUCTION OF A METAL CARBONITRIDE LAYER BOEHLERIT GMBH &CO. KG AT A1876/2005 17/11/2005 AT A1585/2006 22/09/2006 PCT/AT/2006/000469 WO/2007/056785 18/09/2006 שכבת קרבוניטריד מתכתית ושיטה ליצור שכבה קרבוניטריד מתכתית 189694 BIPHENYL DERIVATIVES AND THEIR USE IN TREATING HEPATITIS C ARROW THERAPEUTICS LIMITED GB 0518971.7 16/09/2005 0610663.7 30/05/2006 GB 0610664.5 30/05/2006 GB PCT/GB/2006/003469 WO/2007/031791 21/07/2006 189696 FLUID CONTROL DEVICE FUJIKIN INCORPORATED 2005JP 12/09/2005 263231 PCT/JP/2006/314468 WO/2007/032147 977 C23C C07D נגזרות ביפניל והשימוש בהן לטיפול C בהפטיטיס F16L התקן לוויסות נוזלים June 5, 2008– ב' בסיון התשס"ח 31/08/2006 189697 PYRIDAZINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME WAKUNAGA PHARMACEUTICAL CO., LTD. US 60/712825 01/09/2005 PCT/JP/2006/317691 WO/2007/026950 01/09/2006 189698 THIOMORPHOLINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF MITSUBISHI TANABE PHARMA CORPORATION 2005JP 01/09/2005 253105 PCT/JP/2006/317798 WO/2007/026966 30/08/2006 189702 TRANSMISSION MODE SELECTION, PRECODING AND SDMA SUPPORT QUALCOMM INCORPORATED US 60/713029 30/08/2005 60/731014 27/10/2005 US 11/401979 10/04/2006 US PCT/US/2006/033937 WO/2007/027825 June 5, – ב' בסיון התשס"ח C07D תולדות פירידאזינון ותכשירי רוקחות המכילים אותן C07D תולדות תיומורפולין ותהליכים להכנתן H04L (גישהSDMA–קידוד מוקדם ותמיכה ב )מרובה לחלוקת מרחב 978 2008 20/10/2005 189705 METHOD TO PREDICT OR MONITOR THE RESPONSE OF A PATIENT TO AN ERBB RECEPTOR DRUG NATIONAL CANCER CENTER GB PCT/GB2005/03823 05/10/2005 PCT/GB/2005/004036 WO/2007/039705 24/08/2006 189706 WAFER INSPECTION SYSTEM AND A METHOD FOR TRANSLATING WAFERS [PD] CAMTEK LTD. US 60/711427 26/08/2005 PCT/IL/2006/000987 WO/2007/023501 29/08/2006 979 שיטה לניבוי או לניטור תגובת ERBB מטופל לתרופת קולטן G01R מערכת בחינה למצעים ושיטה להזזה מצעים קמטק בע"מ 189707 AN INSPECTION SYSTEM AND A METHOD FOR INSPECTING A DICED WAFER CAMTEK LTD. US 60/712142 30/08/2005 60/712143 30/08/2005 US 60/712144 30/08/2005 US PCT/IL/2006/000996 WO/2007/026351 C12Q G11B מערכת בחינה ושיטה לבחינת מצע חתוך קמטק בע"מ June 5, 2008– ב' בסיון התשס"ח 29/08/2006 189708 AN INSPECTION SYSTEM AND A METHOD FOR DETECTING DEFECTS BASED UPON A REFERENCE FRAME CAMTEK LTD. US 60/712142 30/08/2005 60/712143 30/08/2005 US 60/712144 30/08/2005 US PCT/IL/2006/000995 WO/2007/026350 29/08/2006 27/08/2006 קמטק בע"מ C23C מערכת בחינה רב שלבית ושיטה לבחינת מצע חתוך קמטק בע"מ 189710 METHOD AND SYSTEM FOR AUTOMATIC DEFECT DETECTION OF ARTICLES IN VISUAL INSPECTION MACHINES [EYEQ] CAMTEK LTD. US 60/711425 26/08/2005 177689 24/08/2006 IL PCT/IL/2006/000990 WO/2007/023502 June 5, – ב' בסיון התשס"ח מערכת בחינה ושיטה לגילוי פגמים בהתבסס על מסגרת ייחוס 189709 A PIPELINED INSPECTION SYSTEM AND A METHOD FOR INSPECTING A DICED WAFER CAMTEK LTD. US 60/712142 30/08/2005 60/712143 30/08/2005 US 60/712144 30/08/2005 US PCT/IL/2006/000994 WO/2007/026349 B01D G06T שיטה ומערכת לגילוי אוטומטי של פגמים בעצמים במכונות בחינה חזותיות קמטק בע"מ 980 2008 16/08/2006 189711 DEVICE AND METHOD FOR CONTROLLING AN ANGULAR COVERAGE OF A LIGHT BEAM CAMTEK LTD. US 60/711428 26/08/2005 PCT/IL/2006/000951 WO/2007/023487 24/08/2006 התקן ושיטה לשליטה בכיסוי זוויתי של קרן אור קמטק בע"מ 189712 DEVICE AND METHOD FOR INSPECTING AN OBJECT CAMTEK LTD. US 60/711432 26/08/2005 PCT/IL/2006/000986 WO/2007/023500 30/08/2006 30/08/2006 981 קמטק בע"מ G21K שיטה ומערכת ליצירת תמונת ייחוס תוך שימוש בתבניות איכות לא ידועות 189714 A METHOD AND A SYSTEM FOR ESTABLISHING AN INSPECTIONRECIPE CAMTEK LTD. IL 170610 01/09/2005 PCT/IL/2006/001007 WO/2007/026361 G06T התקן ושיטה לבחינת חפץ 189713 A METHOD AND A SYSTEM FOR CREATING A REFERENCE IMAGE USING UNKNOWN QUALITY PATTERNS CAMTEK LTD. IL 170609 01/09/2005 PCT/IL/2006/001006 WO/2007/026360 G02B קמטק בע"מ B01D שיטה ומערכת לקביעת מרשם–בחינה קמטק בע"מ June 5, 2008– ב' בסיון התשס"ח 25/08/2006 189715 AN APPARATUS FOR CIRCUMCISING A PENIS SHANG JIANZHONG CN 200520106272.6 26/08/2005 PCT/CN/2006/002178 WO/2007/022730 22/08/2006 31/08/2006 מכשיר למילה של איבר מין זכרי 189716 METHOD AND APPARATUS FOR ACCESSING AN UPLINK RANDOM ACCESS CHANNEL IN A SINGLE CARRIER FREQUENCY DIVISION MULTIPLE ACCESS SYSTEM INTERDIGITAL TECHNOLOGY CORPORATION US 60\710599 23/08/2005 PCT/US/2006/032623 WO/2007/024791 189717 A22C שיטה ומתקן לטיפול באוויר מזוהם ביולוגית מגאייר בע"מ 189719 APPARATUS FOR FIRE DETECTION IN AN ELECTRICAL EQUIPMENT RACK AMRONA AG DE 102005052777.9 04/11/2005 PCT/EP/2006/009825 WO/2007/051517 June 5, – ב' בסיון התשס"ח H04J שיטה ומערכת להשגת גישה לערוץ גישה אקראי לקשר מהארץ ללוויין במערכת FDMA– SC METHOD AND APPARATUS FOR TREATING BIOLOGICALLY CONTAMINATED AIR MEGAIR LTD. IL 170605 01/09/2005 PCT/IL/2006/001010 WO/2007/026363 11/10/2006 A61B G08B מכשיר לגילוי אש בציוד חשמלי 982 2008 21/08/2006 189720 SELF-SEALING T-PIECE AND VALVED T-PIECE AEROGEN, INC. US 60/710932 23/08/2005 PCT/US/2006/032677 WO/2007/024812 31/08/2006 189721 HOST CELL LINES FOR PRODUCTION OF ANTIBODY CONSTANT REGION WITH ENHANCED EFFECTOR FUNCTION CENTOCOR, INC. US 60\713055 31/08/2005 712858\60 31/08/2005 US PCT/US/2006/034382 WO/2007/028106 04/04/2000 VACCINE ADJUVANTS SMITHKLINE BEECHAM BIOLOGICALS S.A. GB 9908885.8 09/301829 US PCT/EP/2000/002920 WO/2000/062800 12/12/2000 189736 ושסתוםT–אוטם–עצמי בצורת מחבר T–בצורת מחבר A61K רצפי תאים פונדקאים לייצור אזור נוגדן קבוע בעל פונקצית אפקטור מוגברת A61K תרכיב חיסון 19/04/1999 29/04/1999 189758 ADAMANTANE DERIVATIVES ASTRAZENECA AB SE 9904651-8 17/12/1999 0015744.6 27/06/2000 GB 0017942.4 22/07/2000 GB PCT/SE/2000/002505 WO/2001/044170 983 A61M C07C נגזרות של אדמנטאן June 5, 2008– ב' בסיון התשס"ח NOTICE UNDER SECTION 26 OF THE PATENTS LAW, 5727-1967 The applications, particulars of which are set out below, have been accepted pursuant to Section 17 of the Patents Law. Any person wishing to oppose the grant of a patent on any of the applications published here, may, within three months from the date of this journal, give to the Commissioner of Patents notice under Section 30 of the Patents Law, in the manner prescribed in regulations 57 et seq of the Patents Regulations, 5728-1968 Particulars of the applications, where applicable, are given in the following order: [11] [21] Number of application [54] Title of invention [22] Application date [31] [32] [33] Number and date of foreign application – convention country. *[51] Int.Cl. [61] Application for patent of addition [62] Divisional application [71] Applicant [72] Inventor [87] International Publication Number [74] Address for service [57] Abridgement of invention (in the language in which the specification is drawn up) *Note: As from Patents and Designs Journal No.1/06, patent applications are classified according to the Eighth Edition of the International Patent Classification (2006) June 5, – ב' בסיון התשס"ח - לחוק הפטנטים תשכ"ז26 הודעה לפי סעיף 1976 הבקשות שפרטיהן מתפרסמים להלן קובלו כל המעונין. לחוק הפטנטים17 לפי סעיף להתנגד למתן פטנט על פי בקשה מהבקשות תוך שלושה חדשים,המתפרסמות רשאי להגיש לרשם הפטנטים,מתאריך יומן זה לחוק30 הודעת התנגדות לפי סעיף ואילך57 הפטנטים בדרך הקבועה בתקנה .1968 – תשכ"ח,לתקנות הפטנטים פרטי הבקשות במידה ויישימים מובאים לפי :סדר זה מספר הבקשה שם האמצאה תאריך הבקשה מספר ותאריך של בקשות החוץ – מדינת האגוד *סיווג בינלאומי בקשה לפטנט מוסף בקשת חלוקה המבקש הממציא מס' פרסום של בקשה הבינלאומית מען למסירת מסמכים )תקציר האמצאה (בשפה בה ערוך הפירוט ' החל מיומן הפטנטים והמדגמים מס:*הערה ניתן ציון לבקשות פטנטים הסיווג לפי1/06 המהדורה השמינית של הסיווג הבינלאומי )2006 של פטנטים (משנה 984 2008 ]11[]21[ ]54[ WARHEAD WITH EJECTABLE FRAGMENTS ]22[ ]51[ ]71[ 17.03.1994 Int. Cl.8 F42B 012/10, 012/22 RAFAEL ADVANCED DEFENSE SYSTEMS LTD. ]72[ ]74[ YOAV ME-BAR, ZEEV YAEGER GLUCKSMAN - LOWY, 10A ELHANAN ST., P.O.B. 6202, HAIFA 31061 [57] A warhead (1) having an explosive charge (2), means (3) for initiating the explosive charge at a desired distance from a target, and projectile means, characterized in that said projectile means comprise a body (5) of packed fragments having a geometry configured to correspond to a desired impact pattern, 109014 ראש קרבי עם חלקיקים הניתנים לפליטה ,רפאל מערכות לחימה מתקדמות בע"מ חיפה זאב יגר,בר-יואב מי , לוי- גלוקסמן חיפה,6202 .ד. ת, 'א10 רחוב אלחנן which body, upon detonation of the explosive charge is ejected from the warhead to form a cloud of fragments having super-critical density in certain regions which on impact upon the target has a super-critical density of impact sufficient to create percolation cuts and cause localized target shattering. __________ 985 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ 119135 מולקולות של חומצות גרעין קטליטיות ]54[ CATALYTIC NUCLEIC ACID MOLECULES ]22[ ]51[ ]71[ ]74[ 26.08.1996 Int. Cl.8 A61K 048/00, C12N 009/22, 015/11, C12Q 001/68 GENETICO LTD. הרצליה,ג'נטיקו בע"מ REINHOLD COHN AND ,ריינהולד כהן ושותפיו PARTNERS, תל אביב,4060 .ד. ת, 21 רחוב אחד העם 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A proto-nucleozyme of a nucleozyme, the nucleozyme having a catalytic activity under a set of conditions, the proto-nucleozyme differing from the nucleozyme in a sequence of one or more nucleotides that is present in the nucleozyme and is absent in the protonucleozyme or replaced in the protonucleozyme by a different sequence of nucleotides, the proto-nucleozyme not having the catalytic activity of the nucleozyme under said set of conditions, and the proto-nucleozyme having said catalytic activity in the presence of a nonnucleic acid co-factor, wherein the nonnucleic acid cofactor is not a nucleotide, nucleoside, or a derivative thereof, and wherein the non-nucleic acid cofactor is a molecule which chemically interacts with nucleotides to provide the component missing in the proto-nucleozyme to convert the proto-nucleozyme into a catalytically active nucleozyme. ___________ ]11[]21[ ]54[ ISOTOPIC GAS ANALYZER ]22[ ]51[ ]71[ ]72[ 17.09.1997 Int. Cl.8 G01N 033/497 EXALENZ BIOSCIENCE LTD. LEWIS COLEMAN, EPHRAIM CARLEBACK, ILAN BEN OREN EITAN MEHULAL LAW GROUP, 10 ABBA EBEN BLVD., P.O. B. 2081, HERZLIYA 46120 ]74[ [57] An isotopic gas analyzer for determining the ratio of at least a first and a second isotopic component of a gas, June 5, – ב' בסיון התשס"ח 121793 מנתח גזים איזוטופיים ירושלים,אקסלנז ביוסיינס בע"מ אילן בן אורן, אפרים קרליבך,לואיס קולמן עורכי- מהולל עורכי דין- קבוצת איתן ,פטנטים הרצליה,2081 .ד. ת, 10 שדרות אבא אבן comprising: at least one wavelength-stable source of radiation (49) of wavelengths characteristic of at least one of said at least 986 2008 first and second isotopic components; at least a first sample chamber (44) comprising a first sample of said gas to be analyzed; at least a first reference chamber (41) containing a reference gas comprising said first and second isotopic components; at least a second sample chamber (45) comprising a second sample of said gas to be analyzed; at least a second reference chamber (42) containing a reference gas comprising said first and second isotopic components; and at least one detector (16) detecting transmission through said at least first sample chamber and transmission through said at least first reference chamber, of radiation of wavelengths characteristic of said first isotopic component of said gas, and transmission through said at least second sample chamber and transmission through said at least second reference chamber, of radiation of wavelengths characteristic of said second isotopic component of said gas. __________ ]11[]21[ 124794 שיטה לקבלת אנזים בעל עניין ]54[ METHOD FOR OBTAINING AN ENZYME OF INTEREST ]22[ ]31[ 06.12.1996 60/008316 ]32[ 07.12.1995 ]33[ US 60/008317 07.12.1995 US 60/008311 07.12.1995 US 08/651568 22.05.1996 US 08/692002 02.08.1996 US Int. Cl.8 C12N 015/10, C12Q 001/00, 001/68 VERENIUM CORPORATION, U.S.A. WO/1997/020918 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] A method for obtaining an enzyme activity of interest, said method including the steps of: 987 (a) providing a first library with DNA obtained from at least one microorganism; June 5, 2008– ב' בסיון התשס"ח (b) binding at least a portion of the coding sequences of the first library to a nucleic acid probe specific for the enzyme activity or interest to create a DNA subset; (c) providing a second library which is an expression library using DNA from the DNA subset obtained from step (b); and (d) screening the second library for the enzyme activity. __________ ]11[]21[ 125939 חלבון טירוסין פוסספטייזים של תאים הימטופוייטיים ]54[ PROTEIN TYROSINE PHOSPHATASES OF HEMATOPOIETIC CELLS ]22[ ]31[ ]51[ ]71[ ]72[ 17.03.1997 08/620526 ]32[ 22.03.1996 ]33[ US Int. Cl.8 A61K 038/46, C07K 016/40, C12N 009/16, 015/55, C12Q 001/42, 001/68 GENENTECH, INC., U.S.A. LAURENCE A. LASKY, JILL CHENG WO/1997/035019 JEREMY M. BEN-DAVID & CO. ,דוד ושות' בע"מ- בן.ירמיהו מ LTD., ,45087 .ד. ת, הר חוצבים,רחוב המרפא HAR HOTZVIM HI-TECH PARK, ירושלים P.O.B. 45087, JERUSALEM 91450 ]87[ ]74[ [57] An isolated non-receptor protein tyrosine phosphatase of hematopoietic stem cells (PTP HSC), which (1) is encoded by DNA hybridizing under stringent conditions to the complement of the nucleic acid of SEQ ID NO:1 or SEQ ID NO:16; (2) is expressed in early hematopoietic stem cells or progenitor cells; (3) its expression is downregulated in differentiated hematopoietic cells; and (4) comprises an N-terminal tyrosine phosphatase domain, followed by a region rich in serine, thereonine, and proline, and a carboxy terminal region of about 15 to 25 amino acids rich in basic amino acid residues. __________ June 5, – ב' בסיון התשס"ח 988 2008 ]11[]21[ ]54[ RESILIENT CLAMPING MECHANISM FOR INSERTS ]22[ ]51[ ]71[ ]72[ ]74[ 22.11.1998 Int. Cl.8 B26D 001/03 ISCAR LTD. GIDEON BARAZANI MICHAEL KAI, C/O ISCAR LTD., PATENT DIVISION, P.O.B. 11, TEFEN 127192 מנגנון הידוק גמיש לשימות תפן,ישקר בע"מ גדעון ברזני ,ד"ר מיכאל קאי .ד. ת, מחלקת פטנטים,אצל ישקר בע"מ תפן,11 [57] For use in a cutting tool, the cutting tool comprising a body portion and a clamping portion, a cutting insert clamping mechanism comprising: a base jaw; a clamping jaw having an upper side and a lower side, the lower side opposing the base jaw and comprising a forward clamping surface spaced apart from a rearward clamping surface, the base jaw and the clamping jaw having a gap between them forming an insert receiving pocket having an insert pocket opening at a leading end thereof; a first aperture extending from a rear section of the insert receiving pocket in a direction generally towards the upper side of the clamping jaw; a first narrow bridge section connecting the clamping jaw to the body portion of the cutting tool; a second narrow bridge section extending generally towards the rearward clamping surface; wherein a first resilience axis of rotation is associated with the first narrow bridge section and a second resilience axis of rotation is associated with the second narrow bridge section. __________ 989 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ 128652 הטרוציקליתN6 תולדות אדנוסין מוחלפי ותכשירי רוקחות המכילים אותן ]54[ HETEROCYCLIC SUBSTITUTED ADENOSINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 20.08.1997 08/702234 ]32[ 27.08.1996 ]33[ US Int. Cl.8 A61K 031/7076, A61P 009/00, C07H 019/16 CV THERAPEUTICS, INC., U.S.A. WO/1998/008855 SANFORD T.COLB & CO., ,' קולב ושות.סנפורד ט P.O.B. 2273, רחובות,2273 .ד. ת, מרמורק,4 שער הגיא REHOVOT 76122 [57] A compound of the formula: wherein R1 is an unsubstituted monocyclic heterocyclic group containing from 5 to 7 atoms, at least one of which is selected from the group consisting of N, O, and S(O)0-2 and wherein R1 is not a monocyclic lactam or imide, and wherein R1 does not contain an epoxide group, and wherein if R1 is an unsaturated monocyclic heterocylic group, then R1 is not a 5membered ring. __________ June 5, – ב' בסיון התשס"ח 990 2008 ]11[]21[ ]54[ CUTTING TOOL ASSEMBLY AND CUTTING INSERT THEREFOR ]22[ ]51[ ]71[ ]72[ ]74[ 29.04.1999 Int. Cl.8 B23C 005/20 ISCAR LTD. RAFAEL MORGULIS MICHAEL KAI, C/O ISCAR LTD., PATENT DIVISION, P.O.B. 11, TEFEN [57] A cutting tool assembly rotatable about an axis of rotation (A) and comprising: a tool comprising a tool body and a crown; and a plurality of repleaceable cutting inserts clamped in insert receiving pockets peripherally distributed in the tool; wherein the tool body has a front face divided into a peripheral portion having a periphery, and an inner portion, the peripheral portion has equally peripherally distributed substantially radially directed recesses, is frutso-conical in shape and is inwardly rearwardly directed from the periphery to the inner portion slanting at an angle (α); the crown has a front face, a rear face, a peripheral side face therebetween and a plurality of peripherally distributed generally radially directed insert receiving slots opening into the front, rear and peripheral side faces, the crown being distinct from the tool body and the tool 991 129665 כלי שיבוב ושימה עבורו תפן,ישקר בע"מ רפאל מורגוליס ,ד"ר מיכאל קאי .ד. ת, מחלקת פטנטים,אצל ישקר בע"מ תפן,11 being adjustable between a disassembled position in which the crown and tool body are separated from each other and an assembled position in which the crown is affixed to the tool body with the insert receiving slots of the crown merging with the recesses of the tool body; the insert receiving pockets comprise the insert receiving slots bound axially by the peripheral portion of the tool body front face, when the tool is in the assembled position; each insert receiving pocket has tangential, radial and axial abutment surfaces, being generally tangentially, radially and axially directed, respectively, for locating the cutting insert therein, the axial abutment surface being a portion of the peripheral portion of the front face of the tool body; each insert receiving pocket is open in a radial direction so that at least a portion of the insert clamped therein extends radially beyond the tool. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ HIGH VOLTAGE REED SWITCH ]22[ ]51[ ]71[ ]74[ 19.05.1999 Int. Cl.8 H01H 051/28 VLADIMIR GUREVICH VLADIMIR GUREVICH, 8 HAESHCHAR ST., HAIFA 35844 [57] High voltage reed switch relay consisting of a fixed insulating body (1) with a cylindrical chamber (2) and a mobile insulator (10) formed as a cylindrical tube inserted in said chamber, a coil (5) with Π-shaped ferromagnetic core (6) in the fixed insulator and a reed switch (8) eccentric to a ferromagnetic shunt (9) mounted in a mobile insulator characterized that in order to extend the application fields an additional chamber (4) is added to the fixed insulating body in which an impulse current transformer (16), electronic amplifier (18) and output June 5, – ב' בסיון התשס"ח 130032 ממסר למתח גבוה חיפה,ולדימיר גורביץ ,ולדימיר גורביץ חיפה,8 רח' האשחר switching element (15) are located, with the primary winding of the transformer formed as a wire coated with high voltage insulator to be operated under full working voltage of the device, and the secondary winding connected at the electronic amplifier input whose output is connected to the switching element control circuit, such as a thyristor, with the reed switch outputs exiting the mobile insulator and entering the said additional chamber connected to the same switching element control circuit. 992 2008 _________ ]11[]21[ 131435 שיטה להכנת ספרית ביטוי לחלבון או הקשור קוולנטית לדנ"א המקודד,פפטיד ספריה המתקבלת והשימוש בה,לו ]54[ METHOD OF PRODUCING A PEPTIDE OR PROTEIN COVALENTLY ASSOCIATED WITH ITS ENCODING DNA EXPRESSION LIBRARY, A LIBRARY PRODUCED THEREBY AND USES THEREOF ]22[ ]31[ ]51[ 18.02.1998 9703369.0 ]32[ 18.02.1997 ]33[ GB Int. Cl.8 C07K 014/01, C12N 015/10, 015/31, 015/62, C12Q 001/68, C40B 002/004000 003/004000 004/006000 005/00600 ISOGENICA LIMITED, UNITED KINGDOM WO/1998/037186 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]71[ ]87[ ]74[ [57] A method of producing a peptide or protein expression library which displays a diverse population of peptides or proteins, wherein the peptides or proteins are specifically associated with the DNA encoding them through covalent protein: DNA binding, said method comprising at least the following steps: (1) preparing an amplifiable genetic library of DNA molecules which contain 993 (i) a nucleotide sequence encoding an amino acid sequence wherein the amino acid sequence binds specifically to its encoding sequence through covalent protein: DNA binding (binding moiety), and (ii) a nucleotide sequence encoding an amino acid sequence for display (display moiety), and June 5, 2008– ב' בסיון התשס"ח (2) expressing the genetic library thus formed, wherein said DNA molecule when expressed yields a translation product which contains the display moiety and the binding moiety and wherein said DNA molecule has at least one site of attachment for the binding moiety. ___________ ]11[]21[ ]54[ BIS(ETHYLENE GLYCOL) TETRAALKYL ESTERS OF MONOHYDROBENZOPORPHYRIN DERIVATIVES AS PHOTOACTIVE AGENTS ]22[ ]31[ ]51[ ]71[ 06.05.1998 08/852494 ]32[ 07.04.1997 Int. Cl.8 A61K 031/409, 038/41, C07D 487/22 QLT INC., CANADA THE UNIVERSITY OF BRITISH COLUMBIA, CANADA WO/1998/050387 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ 132066 –תולדות של מונוהידרובנזופורפירין ביס(אתילן גליקול) טטראאלקיל אסטרים כגורמים פעילי אור ]33[ US ,ריינהולד כהן ושותפיו תל,4060 .ד. ת, 21 רחוב אחד העם אביב [57] A compound of the formula June 5, – ב' בסיון התשס"ח 994 2008 and the metallated and/or labeled and/or conjugated forms thereof, wherein each R1 is independently alkyl (1-6C); each n is independently an integer of 0-6; and R2 is vinyl or a derivative form thereof. __________ ]11[]21[ ]54[ SYNTHESIS OF 6 - 0 - METHYL ERYTHROMYCIN A AND SOME NOVEL 9 - (DISUBSTITUTED BENZOYL) OXIME DERIVATIVES THEREOF ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 17.11.1998 08/972155 ]32[ 17.11.1997 Int. Cl.8 C07H 017/08, C12P 019/62 ABBOTT LABORATORIES, U.S.A. WO/1999/025723 DR. SHLOMO COHEN & CO., 124 IBN GABIROL ST., P.O.B. 11490, TEL AVIV 62038 [57] A process of preparing 6-O-methyl erythromycin A from the 9-oxime erythromycin A derivative comprising the steps of: (a) benzoylating the 9-oxime group of the 9-oxime erythromycin A derivative; (b) protecting the 2'-hydroxyl group of the 995 135517 A –מתיל אריתרומיצין0–6 סינתזה של – (די–מותמר9 וכמה נגזרות חדשות של בנזואיל) אוקסים הנובאות ממנה ]33[ US ,'ד"ר שלמה כהן ושות תל אביב,11490 .ד. ת, 124 אבן גבירול 9-oxime erythromycin A derivative; wherein steps (a) and (b) may be performed in any order; and wherein performing said steps in any order results in the formation of 2'-protected 9benzoyloxime erythromycin A derivative; June 5, 2008– ב' בסיון התשס"ח (c) methylating the 2'-protected-9benzoyloxime erythromycin A derivative to form a 2'-protected-6-O-methyl-9benzoyloxime erythromycin A derivative; (d) removing the benzoyl and O-protecting groups from the 2'-protected-6-O-methyl9-benzoyloxime erythromycin A derivative to form 6-O-methyl-9-oxime erythromycin A; and (e) deoximating the 6-O-methyl-9-oxime erythromycin A to form 6-O-methyl erythromycin A; wherein the reaction in step(a) is performed with a benzoylating reagent of the formula RCOX, where X is halide and R is a di-substituted benzene, and wherein the substituent groups are selected from Cl, Br, I and alkoxy. Also claimed as new is a compound of the structure where R5 is a disubstituted benzene, R6 is hydrogen or methyl and R7 and R8 are each independently hydrogen, trimethylsilyl or an O-protecting group. __________ ]11[]21[ 135528 תכשיר חיסון מקפסומר של וירוס הפטוטמת ושיטות לשימוש ]54[ PAPILLOMA VIRUS CAPSOMERE VACCINE FORMULATIONS AND METHODS OF USE ]22[ ]31[ ]51[ ]71[ 06.10.1998 08/944368 ]32[ 06.10.1997 ]33[ US Int. Cl.8 A61K 039/12, C07K 014/025, C12N 015/62 LOYOLA UNIVERSITY OF CHICAGO, U.S.A. WO/1999/018220 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] An antigenic formulation comprising June 5, – ב' בסיון התשס"ח 996 2008 a human papilloma virus capsomere, said capsomere comprising a fusion protein comprising human papilloma virus L1 protein adjacent amino acid residues from a second protein, said L1 protein and said amino acids from said second protein positioned to inhibit virus-like particle formation, said formulation evoking an immune response which neutralizes human papilloma virus virions. ,190554 The applications for division from this application have not yet been published בקשות חלוקה מבקשה זו .שטרם פורסמו _________ ]11[]21[ 135604 ביצים וחלבון המיוצרים ע"י,עוף טרנסגני העוף הנ"ל ושיטות ליצירת הביצים והחלבון הנ"ל ]54[ TRANSGENIC BIRD, EGGS AND PROTEIN PRODUCED BY SAID BIRD AND METHODS FOR PRODUCING SAID EGGS AND PROTEIN ]22[ ]31[ ]51[ ]71[ 15.10.1998 60/062172 ]32[ 16.10.1997 ]33[ US Int. Cl.8 A01K 067/00, C12N 015/11, 015/12, 015/85, 015/86, 015/90 UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC., U.S.A. AVIGENICS, U.S.A. WO/1999/019472 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] A transgenic bird having a transgene in the genetic material of its germ-like tissue, wherein the transgene comprises an exogenous gene and a promoter, in operational and positional relationship to express exogenous gene, and said exogenous gene is expressed in the tubular gland cells of the avian oviduct of the transgenic bird. __________ ]11[]21[ ]54[ 997 GROUP B STREPTOCOCCUS PROTEINS AND POLYPEPTIDES 137921 חלבונים ופוליפפטידים של סטרפטוקוקוס B קבוצה June 5, 2008– ב' בסיון התשס"ח ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 17.02.1999 60/075425 ]32[ 20.02.1998 ]33[ US Int. Cl.8 A61K 039/09, C07K 014/315, C12N 015/31 ID BIOMEDICAL CORPORATION, CANADA WO/1999/042588 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [57] An isolated polynucleotide encoding a polypeptide having at least 70% identity to a second polypeptide having a sequence selected from the group consisting of SEQ ID NO:39 and SEQ ID NO:44, or a The applications for division from this application have not yet been published , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, fragment of said polypeptide, wherein said polypeptide or fragment of said polypeptide retains the capacity to induce an immune response specific for group B streptococcus. ,190018 בקשות חלוקה מבקשה זו .שטרם פורסמו ________ ]11[]21[ ]54[ VEGF-E POLYPEPTIDES, NUCLEIC ACIDS ENCODING THE SAME, PROCESS FOR THEIR PREPARATION, COMPOSITIONS, VECTORS, HOST CELLS AND METHODS USING SUCH POLYPEPTIDES 138488 חומצות גרעין,VEGF–E פוליפפטידים , תהליך להכנתם,המקודדות להם תאי מאכסן ושיטות, וקטורים,תכשירים העושות שימוש בפוליפפטידים כאלה ]22[ ]31[ 10.03.1999 09/040220 ]32[ 17.03.1998 ]33[ US 09/184216 02.11.1998 US ]51[ Int. Cl.8 A61K 038/18, A61P 009/00, 017/02, 019/08, C07K 014/52, C12N 015/19 ]71[ GENENTECH, INC., U.S.A. ]87[ WO/1999/047677 ]74[ S. HOROWITZ & CO., ,' הורוביץ ושות.ש ZION HOUSE, תל,41-45 שדרות רוטשילד,בית ציון 41-45 ROTHSCHILD BLVD., אביב TEL AVIV 65784 [57] An isolated nucleic acid comprising polypeptide comprising amino acid a nucleotide sequence encoding a vascular residues 1 through 345 of Figure 2 as endothelial cell growth factor-E (VEGF-E) shown in the specification (SEQ ID NO:2). June 5, – ב' בסיון התשס"ח 998 2008 The applications for division from this application have not yet been published ,189573,189572,189571 בקשות חלוקה מבקשה זו .שטרם פורסמו __________ ]11[]21[ ]54[ MULTIPLE VIEW ENDOSCOPES ]22[ ]51[ ]71[ ]72[ 21.09.2000 Int. Cl.8 A61B 001/00 MEDIGUS LTD. MINELU ZONNENSCHEIN, ELAZAR ZONNENSCHEIN, RANDAL B. CHINNOCK LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]74[ [57] An endoscope (200) comprising: a single continuous shaft including a sheath (203), an articulation section attached to the distal end of said sheath, a distal tipattached to the distal end (201A) of said articulation section, and two or more separate optical channels that produce two or more distinct views, each of said optical channels comprising an objective lens (1), located at the distal end of said optical channel and a means of capturing and/or viewing the image; wherein the objective lens of the separate optical channel, which 999 138632 אנדוסקופ רב מבטים עומר,מדיגוס בע"מ רנדל צ'ינוק, אלעזר זוננשיין,מנשה זוננשיין ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה produces the first of said distinct views is located at a first location, said first location located on said distal tip, and the objective lens of the optical channel, which produces the second of said distinct views is located at a second location, said second location located either on the proximal end of said articulation section or on the sheath of said endoscope; wherein the distance between said first location and said second location, measured along the longitudinal axis of said endoscope, is fixed. June 5, 2008– ב' בסיון התשס"ח _________ ]11[]21[ ]54[ PREPARATION OF 9-AMINO OCTAHYDRO - 6, 10 - DIOXO- 6H PYRIDAZINO [1,2-A][1,2] DIAZEPIN - 1 - CARBOXYLIC ACID DERIVATIVES ]22[ ]31[ ]51[ ]71[ ]72[ 26.04.1999 98/05243 ]32[ 27.04.1998 Int. Cl.8 C07K 005/06 AVENTIS PHARMA S.A., FRANCE COLETTE COLLADANT, VERONIQUE CROCQ, JOHN PATRICK LARKIN, PATRICK ROUSSEL WO/1999/055724 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 ]87[ ]74[ 139102 –אמינו9 הכנת תולדות של חומצה – H6– –דיאוקסו10, 6– אוקטאהידרו – 1– דיאזפיןa /2,1// – 2,1/ פירידאזינו קרבוקסילית ]33[ FR , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר [57] A process for the preparation of a compound of the formula June 5, – ב' בסיון התשס"ח 1000 2008 of SR configuration or a SR+SS mixture wherein R is selected from the group consisting of hydrogen, alkyl of up to 18 carbon atoms and aryl and aralkyl of up to 18 carbon atoms and the –NH2 radical is free or protected, comprising reacting a compound of the formula where Hal is halogen and alk is an alkyl radical of 1 to 8 carbon atoms with a compound of the formula where Aryl is an aryl radical of up to 14 carbon atoms to form a compound of the formula reacting the latter with a basic agent to form a compound of the formula 1001 June 5, 2008– ב' בסיון התשס"ח optionally subjecting the latter compound to an alkylating agent to form a compound of the formula reacting the latter with a compound of the formula wherein Hal1 is halogen, Ar is aryl or aralkyl radical of up to 18 carbon atoms, R1 is selected from the group consisting of June 5, – ב' בסיון התשס"ח 1002 2008 Ra, Rb, Rc and Rd are individually selected from the group consisting of alkyl of up to 18 carbon atoms, aryl of up to 18 carbon atoms and monocyclic and polycyclic groups containing at least one nitrogen atom, X is selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms and aryl of up to 14 carbon atoms and R2 is hydrogen or R1 and R2 together with the nitrogen form a monocyclic or polycyclic radical with at least one heteroatom to obtain a compound of the formula of SR configuration or a SR+SS mixture, reacting the latter with a hydrogenation agent to form a compound of the formula of SR configuration or a SR+SS mixture, reacting the latter with a condensation agent to obtain a compound of the formula 1003 June 5, 2008– ב' בסיון התשס"ח and optionally deprotecting the amino group to obtain a compound of formula I wherein the amino group is free. ,190120 The applications for division from this application have not yet been published בקשות חלוקה מבקשה זו .שטרם פורסמו _________ ]11[]21[ 139478 חלבון היבריד ]54[ HYBRID PROTEIN ]22[ ]31[ ]51[ ]71[ 12.05.1999 19821285.2 ]32[ 13.05.1998 ]33[ DE Int. Cl.8 A61K 038/16, A61P 037/08, C07K 019/00 BIOTECON GESELLSCHAFT FUR BIOTECHNOLOGISCHE ENTWICKLUNG UND CONSULTING MBH, GERMANY WO/1999/058571 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 ]87[ ]74[ [57] Hybrid protein comprising or consisting of (i) a protein binding to mastocytes and/or basophils and/or being taken up by these cells, , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, (ii) a protease cleaving one or several proteins of the secretion apparatus of the mastocytes and/or basophils. __________ ]11[]21[ June 5, – ב' בסיון התשס"ח 139911 1004 2008 ]54[ DEVICE FOR DETECTION OF LIGANDS USING SIGNAL AMPLIFICATION ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 12.05.1999 09/095196 ]32[ 10.06.1998 Int. Cl.8 G01N 033/543 KENT STATE UNIVERSITY, U.S.A. WO/1999/064862 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [57] A device for the detection of ligands comprising: at least one receptor capable of binding to a ligand to form a receptor-ligand complex, wherein the formation of the receptor-ligand complex produces a signal; and an amplification mechanism, wherein מכשיר לגלוי ליגנדים עם הגברת אות ]33[ US ,' קולב ושות.סנפורד ט רחובות,2273 .ד. ת, מרמורק,4 שער הגיא said amplification mechanism is a lyotropic liquid crystalline material coupled to the receptor, and wherein said amplification mechanism amplifies said signal upon receptor-ligand complex formation. __________ ]11[]21[ 140265 שיטה להכנת חיסון וסובסטרטים נטולי אינטרפרון ]54[ METHODS FOR VACCINE PRODUCTION AND INTERFERON DEFICIENT SUBSTRATES ]22[ ]31[ 11.06.1999 60/089103 ]32[ 12.06.1998 ]33[ US 60/108832 18.11.1998 US 60/117683 29.01.1999 US Int. Cl.8 A61K 035/76, 039/12, 039/145, C07K 014/11, C12N 007/00, 007/04, 015/86 MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY, U.S.A. WO/1999/064570 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] Method for vaccine production comprising: propagating in an interferon deficient substrate an attenuated influenza virus having a mutation in the NS1 gene that diminishes or eliminates the ability of 1005 the NS1 gene product to antagonize the cellular interferon response; and collecting progeny virus, wherein the interferon deficient substrate is the allantoic cavity of an immature embryonated egg six to nine June 5, 2008– ב' בסיון התשס"ח days old or an interferon deficient cell line, with the proviso that said virus is not influenza C virus and the interferon deficient substrate is not Vero cells or STAT1(-) cell lines. ,189766 The applications for division from this application have not yet been published בקשות חלוקה מבקשה זו .שטרם פורסמו __________ ]11[]21[ 140299 תרכובות פוטורזיסטורית הפועלת באופן פוזיטיבי ואלמנט הניתן להדמייה ]54[ POSITIVE ACTING PHOTORESIST COMPOSITION AND IMAGEABLE ELEMENT ]22[ ]51[ ]71[ ]74[ 14.12.2000 Int. Cl.8 B41C 001/10, B41M 005/36, C08F 008/28, G03G 005/047 KODAK IL LTD. הרצליה פתוח,קודאק איי אל בע"מ G.E. EHRLICH (1995) LTD., ,) בע"מ1995( ארליך.אי.ג'י AYALON TOWER, 15TH FLOOR, ,11 רחוב מנחם בגין, 15 קומה,מגדל אילון 11 MENACHEM BEGIN ST., רמת גן RAMAT GAN 52521 [57] A positive-acting thermal resist system comprising a metal sublayer, an alloy sublayer or a printing plate which comprises a substrate having at least one metal surface having adhered thereto a positive-acting thermal resist layer which comprises an acetal polymer having the general formula: wherein R1 is –CnH2n+1 where n=1-12; R2 is a phenol group which may have no substituents or 1 to 3 additional June 5, – ב' בסיון התשס"ח 1006 2008 substituents selected from the group consisting of –OH, -OCH3, Br and –NO2 or -COOH, which may be represented, at least in part, by the formula: wherein R4=-OH; R5= -OH or-OCH3 or –Br or –OCH2-C≡CH; and R6 = -Br or –NO2; R3 = -(CH2)a –COOH or –C≡CH or wherein R7 = COOH, -(CH2)a COOH, -O-(CH2)a COOH and a = 0 or 1 m = 5-40 mole%, g = 10-60 mole%, o = 0-20 mole % p = 2-20 mole %, and q = 5-50 mole%; and an infrared absorbing material in an amount of from 0.01 to 20% by weight of said positive-acting thermal resist layer. __________ ]11[]21[ 140381 ,שיבוטים דלקתיים של וירוס מחלת ניוקסל חיסונים ובדיקות מאבחנות ]54[ NEWCASTLE DISEASE VIRUS INFECTIOUS CLONES, VACCINES AND DIAGNOSTIC ASSAYS ]22[ ]31[ ]51[ ]71[ 17.06.1999 98202054.7 ]32[ 19.06.1998 ]33[ EP Int. Cl.8 A61K 048/00, C12N 007/00, 015/45, 015/86, C12Q 001/70 PEPSCAN SYSTEMS B.V., THE NETHERLANDS 1007 June 5, 2008– ב' בסיון התשס"ח ]72[ ]87[ ]74[ BERNARDUS PETRUS HUBERTUS PEETERS, OLAV SVEN DE LEEUW, GUUS KOCH, ARNOUD LEONARD JOSEF GIELKENS WO/1999/066045 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [57] Avian-paramyxovirus cDNA at least comprising 5'-terminal end of the genome of Newcastle Disease Virus (NDV) corresponding to the 5'-terminal end of , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר NDV as shown in Figure 6 as shown in the specification allowing generating an infections copy of avian-paramyxovirus. __________ ]11[]21[ 140701 שימוש בנוגדן אנטי–אמינופוספוליפידי או באזור קישור האנטיגן שלו להכנת תרופה לטיפול בסרטן ]54[ USE OF AN ANTIAMINOPHOSPHOLIPID ANTIBODY OR ANTIGENBINDING REGION THEREOF FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF CANCER ]22[ ]31[ 12.07.1999 60/092672 ]32[ 13.07.1998 ]33[ US 60/110608 02.12.1998 US Int. Cl.8 A61K 039/00, 039/395, 047/48, C07K 016/28, 016/46 BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, U.S.A. WO/2000/002584 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] Use of a composition comprising a biologically effective amount of an antiaminophospholipid antibody, or antigenJune 5, – ב' בסיון התשס"ח binding region thereof, in the manufacture of a medicament for the treatment of cancer by killing tumor vascular 1008 2008 endothelial cells of a vascularized tumor, inducing coagulation in tumor vasculature or destroying tumor vasculature. __________ ]11[]21[ ]54[ METHOD FOR PREPARING SEMICONDUCTOR WAFER FOR DEFECT ANALYSIS ]22[ ]51[ ]71[ 03.01.2001 Int. Cl.8 G01N 001/28 SELA SEMICONDUCTOR ENGINEERING LABORATORIES LTD. G.E. EHRLICH (1995) LTD., AYALON TOWER, 15TH FLOOR, 11 MENACHEM BEGIN ST., RAMAT GAN 52521 ]74[ 140712 שיטה משופרת להכנת מצע מוליך למחצה לניתוח פסול יוקנעם,סלע הנדסת מוליכים למחצה בע"מ עילית ,) בע"מ1995( ארליך.אי.ג'י ,11 רחוב מנחם בגין, 15 קומה,מגדל אילון רמת גן saw cuts in the wafer which gradually cut away material near the target so as to produce a slimmed down inspection sample; and trimming said inspection sample to produce a band of material, in which the target is located, suitable for inspection by transmission electron microscopy (TEM). [57] A method for preparing a semiconductor wafer for defect analysis, the method comprising: locating a defect, called a target, in a semiconductor wafer; making a series of _________ ]11[]21[ ]54[ ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 1009 140731 ANTIMICROBIAL תולדות קפוראמיצין אנטימיקרוביות CAPURAMYCIN DERIVATIVES ותכשירי רוקחות המכילים אותן AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME 09.07.1999 10-194285 ]32[ 09.07.1998 ]33[ JP 10-269445 24.09.1998 JP Int. Cl.8 A61K 031/7072, A61P 031/04, C07H 019/06, C12P 019/28, C12R 001/545 SEQUELLA, INC., U.S.A. WO/2000/002892 WOLFF, BREGMAN AND GOLLER, , ברגמן וגולר,וולף P.O.B. 1352, ירושלים,1352 .ד. ת, JERUSALEM 91013 June 5, 2008– ב' בסיון התשס"ח [57] A compound of the formula group, R2 is a methyl group, R4 is a hydrogen atom, and X is a methylene group; R1 is a hydrogen atom, R2 is a hydrogen atom, R4 is a hydroxy group, and X is a methylene group; or R1 is a methyl group, R2 is a methyl group, R4 is a hydroxy group, and X is a sulfur atom. or a pharmaceutically acceptable salt thereof wherein: R1 is a methyl group, R2 is a methyl group, R4 is a hydroxy group, and X is a methylene group; R1 is a methyl group, R2 is a hydrogen atom, R4 is a hydroxy group, and X is a methylene group; R1 is a methyl ,187551 The applications for division from this application have not yet been published בקשות חלוקה מבקשה זו .שטרם פורסמו _________ ]11[]21[ 140947 תכשירים סינרגיסטיים המכילים אסקורבאט וליזין עבור מצבים הקשורים לניוון המטריצה החוץ–תאית ]54[ SYNERGISTIC COMPOSITIONS COMPRISING ASCORBATE AND LYSINE FOR STATES RELATED TO EXTRA CELLULAR MATRIX DEGENERATION ]22[ ]51[ ]71[ 17.01.2001 Int. Cl.8 A61K 031/195, 031/197, 031/198, 031/375, 045/00 MATTHIAS RATH, THE NETHERLANDS REINHOLD COHN AND ,ריינהולד כהן ושותפיו PARTNERS, תל אביב,4060 .ד. ת, 21 רחוב אחד העם 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]74[ [57] Use of ascorbate and at least one fibrinolysis inhibitor for the preparation of a medicament for the treatment of infections or inflammatory diseases. ___________ June 5, – ב' בסיון התשס"ח 1010 2008 ]11[]21[ ]54[ RADIOTHERAPY VERIFICATION SYSTEM ]22[ ]31[ ]51[ ]71[ 06.08.1999 60/095528 ]32[ 06.08.1998 Int. Cl.8 A61N 005/10 WISCONSIN ALUMNI RESEARCH FOUNDATION, U.S.A. WO/2000/007667 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] A method of verifying patient dose in the operation of a radiotherapy machine having a radiation source operable to produce multiple rays of radiation having controllable fluence and directed across a patient volume to be received by a detector having multiple detector elements providing detector signals at spatially separated points, each detector element receiving radiation from multiple rays, the method comprising the steps of: (a) receiving a treatment plan to operate the radiation source to produce a set of rays of predetermined fluence; (b) operating the 141203 מערכת אימות לרדיותרפיה ]33[ US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם radiotherapy machine according to the received treatment plan; (c) concurrently with step (b) measuring the detector signals; (d) processing the detector signals using a model of the expected attenuation and path of each ray passing from the radiation source through the patient volume to the detector to deduce a fluence of each of the set of rays; and (e) using the deduced fluence and information about the structure of a patient in the patient volume to determine a dose distribution to the patient. __________ ]11[]21[ 141384 שיטת איבחון המשתמשת בתכשיר המכיל צבע ציאנין או מלחיו בתור גורם ניגוד NIR לקרינה ]54[ DIAGNOSTIC METHOD USING A COMPOSITION CONTAINING A CYANINE DYE OR ITS SALT AS A CONTRAST AGENT FOR NIR RADIATION ]22[ ]31[ ]51[ ]62[ ]71[ 16.11.1995 P4445065.6 ]32[ 07.12.1994 ]33[ DE Int. Cl.8 A61K 049/00, C09B 023/02, 023/08, 069/10 DIVISION FROM 116018 INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH AN DER FREIEN UNIVERSITAT BERLIN, GERMANY 1011 June 5, 2008– ב' בסיון התשס"ח ]74[ WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, [57] An in-vivo diagnostic near infrared radiation method comprising: (a) administering a compound of the formula B1-(F-Wn)m (l) wherein l represents a number from 0 to 6, n represents a number from 0 to 10 and m represents a number from 1 to 100; B is a biological detecting unit having a molecular weight of up to 30,000 that bonds to specific cell populations or selectively to receptors, or accumulates in tissues or tumours, or generally stays in the blood, or is a macromolecule that bonds non-selectively; F represents a dye showing maximum absorption in the range of 650 to 1200 nm of the formula R3 to R12 are same or different, each independently representing a hydrogen atom, a residue B or W, or an alkyl or alkenyl residue containing up to 6 carbon atoms or an aryl or aralkyl residue containing up to 9 carbon atoms, said alkyl, alkenyl, aryl or aralkyl residue optionally carrying an additional residue W or to each pair of adjacent residues R3 to R10 are annealed, with due regard for the interspersed atoms, 5- to 6-member rings that may be saturated, unsaturated or aromatic, and that may optionally carry residue R, R is a halogen atom, a hydroxy, carboxy, acetoxy, amino, nitro, cyano or sulfonic acid group or an alkyl, alkenyl, hydroxyalkyl, carboxyalkyl, alkoxy, alkoxycarbonyl, sulfoalkyl, alkylamino, dialkylamino or halogenalkyl residue containing up to 6 carbon atoms, an aryl, alkylaryl, hydroxyaryl, carboxyaryl, sulfoaryl, arylamino, diarylamino, nitroaryl or halogenaryl residue containing up to 9 carbon atoms, s and t independently represent the number 0 to 1 on the condition that s and t do not represent the number 1 at the same time, X and Y are same or different, each independently representing an O, S, Se or Te or -C(CH3)2-, -CH=CH- or –CR13R14fragment, wherein R13 and R14 independently represent a hydrogen atom, a residue B or W, or an alkyl or alkenyl residue containing up to 6 carbon atoms or an aryl or aralkyl residue containing up to 9 carbon atoms, the alkyl, alkenyl, aryl or aralkyl residue optionally having an additional residue W; W represents a hydrophilic group that improves water-solubility, with the noctanol-water distribution coefficient of the compound according to formula l being less than or equal to 2.0 for l=0; as well as their physiologically tolerable June 5, – ב' בסיון התשס"ח 1012 2008 salts; (b) irradiating the compound with light in the near infrared range; and (c) recording the radiation produced by the compound. _________ ]11[]21[ ]54[ CONTROLLED-RELEASE PHARMACEUTICAL FORMULATIONS CONTAINING A CGMP PDE-5 INHIBITOR ]22[ ]31[ 04.10.1999 9823192.1 ]32[ 23.10.1998 9826392.4 27.10.1998 9825117.6 16.11.1998 Int. Cl.8 A61K 045/00 PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A., IRELAND WO/2000/024383 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]51[ ]71[ ]87[ ]74[ [57] A sustained-release pharmaceutical composition for oral administration for the treatment or prevention of sexual dysfunction containing a cGMP PDE-5 inhibitor, wherein the cGMP PDE-5 1013 141764 פורמולציות רוקחיות בעלות שחרור מבוקר CGMP PDE–5 המכילות מעכב של ]33[ GB GB GB ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה inhibitor makes up 5-50% by weight of the formulation, wherein up to 75% by weight of the cGMP PDE-5 inhibitor is released from the formulation into the gastrointestinal tract after a period of time June 5, 2008– ב' בסיון התשס"ח in the range 1-24 hours following administration and: (a) wherein the cGMP PDE-5 inhibitor is embedded in a matrix from which it is released by diffusion or erosion, or (b) wherein the cGMP PDE-5 inhibitor is present in a core which is coated with a release-rate-controlling membrane, or (c) which comprises a core containing the cGMP PDE-5 inhibitor and an outer coating impermeable to the cGMP PDE-5 inhibitor, the outer coating having an aperture for release of the cGMP PDE-5 inhibitor. _________ ]11[]21[ ]54[ PROCESS FOR PROVIDING SUSTAINED RELEASE LIQUID DOSAGE FORM ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 03.09.1999 60/099619 ]32[ 09.09.1998 Int. Cl.8 A61K 009/00, 009/20, 009/48 ALZA CORPORATION, U.S.A. WO/2000/013663 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 [57] A process for providing a sustained release liquid dosage form, wherein the process comprises the steps as follows: (a) blending an osmotic hydrogel and an osmotically effective solute to provide a composition that increases in volume in the presence of an aqueous fluid; (b) blending a hydroxyalkylcellulose and water to provide a granulation solution; June 5, – ב' בסיון התשס"ח 141914 תהליך ליצירת קפסולה המכילה פורמולציה נוזלית בשחרור איטי ]33[ US ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה (c) spraying the granulation solution (b) onto the composition provided in (a) to provide granules; (d) blending a self emulsifying drug, a surfactant, and a member selected from the group consisting of a mono-and diglyceride to provide a drug formulation which is liquid upon administration and adapted to form an emulsion in an aqueous 1014 2008 environment; (e) adding the drug formulation (d) to a capsule; (f) adding the sprayed composition of (c) to the capsule; (g) coating the capsule with a semipermeable composition to provide a membrane permeable to an aqueous fluid; and, (h) providing an exit in the membrane (g) for delivering the drug at a sustainedrelease and controlled rate over an extended time from the dosage form, and providing a self emulsifying drug. _________ ]11[]21[ 141972 שינוי\תאום פולימרי הנדסה בעזרת בסיסיות וקבוצות החלפת יוניםN– קבוצות בשרשרת צדדית ]54[ MODIFICATION OF ENGINEERING POLYMERS WITH BASIC N GROUPS AND IONEXCHANGE GROUPS IN THE SIDE CHAIN ]22[ ]31[ ]51[ ]71[ 12.08.1999 19836514.4 ]32[ 12.08.1998 ]33[ DE Int. Cl.8 C08G 075/02, 075/20, C08L 081/02, 081/06 UNIVERSITAT STUTTGART (INST. FUR CHEMISCHE VERFAHRENSTECHNIK), GERMANY WO/2000/009588 JEREMY M. BEN-DAVID & CO. ,דוד ושות' בע"מ- בן.ירמיהו מ LTD., ,45087 .ד. ת, הר חוצבים,רחוב המרפא HAR HOTZVIM HI-TECH PARK, ירושלים P.O.B. 45087, JERUSALEM 91450 ]87[ ]74[ [57] A method for producing an aryl main chain polymer having aryl-containing basic N-groups of the formula 1015 June 5, 2008– ב' בסיון התשס"ח wherein P is a polymer comprising the repeating units: wherein R3 is hydrogen, alkyl or aryl, and the units R1 and/or R2 are linked by at least one group selected from the group consisting of: R7 is an aromatic group containing tertiary basic N, R8 is hydrogen, alkyl or aryl, which optionally contains tertiary basic N, X is hydrogen or an alkyl group, comprising reacting a metallized polymer P-Me, wherein Me is Li or Na, with one or more aromatic ketones or aldehydes containing tertiary basic N-groups having the formula to give an intermediate product of the formula: June 5, – ב' בסיון התשס"ח 1016 2008 and protonating or etherifying the intermediate with water or an alkyl halide, to give the aryl main chain polymer having aryl-containing basic N-groups. _________ ]11[]21[ ]54[ MULTI-LAYER PRINTED CIRCUIT BOARD FABRICATION SYSTEM AND METHOD ]22[ ]31[ 02.04.2001 09/708160 ]32[ 08.11.2000 09/792498 23.02.2001 Int. Cl.8 G03F 009/00, H05K 001/02 ORBOTECH LTD. ORBOTECH LTD., P.O.B. 215, YAVNE 81102 ]51[ ]71[ ]74[ [57] Apparatus for recording an electrical circuit pattern on an upper layer of a multilayer printed circuit board substrate, comprising: an alignment pattern generator (920) generating an alignment pattern that is visible on the upper surface (904) of the multi-layer printed circuit board substrate, said alignment pattern having a known orientation with respect to an electrical circuit pattern formed on one non-upper 1017 142354 מערכת ושיטה לייצור מעגל לוח מודפס רב שכבתי ]33[ US US יבנה,אורבוטק בע"מ ,אורבוטק בע"מ יבנה,215 .ד. ת, אזור תעשייה layer of the substrate, said substrate having at least two layers of circuitry already formed thereon; an alignment pattern location sensor (926) sensing a location of the alignment pattern; and an electrical circuit pattern generator (932) recording an electrical circuit pattern on said upper surface in a desired orientation with reference to the alignment pattern. June 5, 2008– ב' בסיון התשס"ח _________ ]11[]21[ 142759 D אנלוגים של ויטמין ]54[ ANALOGUES OF VITAMIN D ]22[ ]31[ ]51[ 28.10.1999 98/13747 ]32[ 02.11.1998 ]33[ FR Int. Cl.8 A61K 000/823000 000/825000 000/833000 000/834000 000/837000 000/841000 031/05, 031/075, 031/085, 031/095, 031/13, 031/21, 031/35, A61P 017/00, 019/00, 019/10, 027/02, 035/00, 037/00, C07C 039/00, 039/15, 039/21, 043/166, 043/23, 069/017, 069/66, 217/86, 219/34, 323/20, C07D 309/02, C07F 007/08 GALDERMA RESEARCH & DEVELOPMENT, S.N.C., FRANCE WO/2000/026167 LUZZATTO & LUZZATTO, ,לוצאטו את לוצאטו INDUSTRIAL PARK, OMER, באר שבע,5352 .ד. ת, עומר,גן תעשייה P.O.B. 5352, BEER-SHEVA 84152 ]71[ ]87[ ]74[ [57] Compounds of the formula June 5, – ב' בסיון התשס"ח 1018 2008 in which: R1 represents a hydrogen atom, a methyl radical or a radical-(CH2)n-OR7, R2 represents a radical –(CH2)n-OR8, n, R7 and R8 having the meanings given below, X-Y represents a bond chosen from the bonds of the following formulae (a) and (b) which may be read from the left to the right or conversely: R9 and W having the meanings given below, R3 represents the chain in vitamin D2 or in vitamin D3, the dotted lines represent the bond linking the chain to the benzene ring represented in Figure (I), or R3 represents a chain having from 4 to 8 carbon atoms which is substituted with one or more hydroxyl groups, it being possible for the hydroxyl groups to be protected in the form of acetoxy, methoxy or ethoxy, trimethylsilyloxy, tertbutyldimethylsilyloxy, tetrahydropyranyloxy and optionally in addition: which is substituted with one or more linear or branched alkyl groups having from 1 to 6 carbon atoms or cycloalkyl groups and/or which is substituted with one or more halogen atoms and/or which is substituted with one or more CF3 groups and/or in which one or more carbon atoms of the chain are replaced by one or more oxygen, sulphur or nitrogen atoms, it being possible for the nitrogen atoms to be optionally substituted with linear or branched alkyl radicals having from 1 to 6 carbon atoms and/or in which one or more single bonds of the chain are replaced by one or more double and/or triple bonds, R3 being positioned on the benzene ring at the para or meta position with respect to the X-Y bond, 1019 June 5, 2008– ב' בסיון התשס"ח R4, R5 and R6, which are identical or different, represent a hydrogen atom, a linear or branched alkyl radical having from 1 to 6 carbon atoms, a halogen atom, a radical –OR10, a polyether radical having from 2 to 5 carbon atoms interrupted by at least 2 oxygen atoms, R10 having the meaning given below, n being 0, 1 or 2, R7 and R8, which are identical or different, represent a hydrogen atom, an acetyl radical, a trimethylsilyl radical, a tertbutyldimethylsilyl radical, a tetrahydropyranyl radical, R9 represents a hydrogen atom or a linear or branched alkyl radical having from 1 to 6 carbon atoms, W represents an oxygen atom, a sulphur atom, a radical –CH2- or a radical –NH- which may be optionally substituted with a linear or branched alkyl radical having from 1 to 6 carbon atoms, R10 represents a hydrogen atom or a linear or branched alkyl radical having from 1 to 6 carbon atoms, and the optical and geometric isomers of the said compounds of formula (I) as well as their salts. __________ ]11[]21[ 142929 תכשירים והתקנים לשחרור מקומי של תרופות במעי הגס ושימוש בהם לטיפול מקומי במחלות המעי הגס ]54[ COMPOSITION OR DRUG DELIVERY DEVICE FOR LOCALIZED DRUG RELEASE IN THE COLON AND USE THEREOF FOR LOCAL TREATMENT OF COLONIC DISEASES ]22[ ]31[ ]51[ ]71[ ]72[ 12.11.1999 09/190127 ]32[ 12.11.1998 ]33[ US Int. Cl.8 A61K 009/00, 009/20, C07C 313/04 DEXXON LTD. חדרה,דקסון בע"מ MOSHE FLASHNER, ITZHAK E. עאדל פינחסי, יצחק לרנר,משה פלשנר LERNER, ADEL PENHASI WO/2000/028974 G.E. EHRLICH (1995) LTD., ,) בע"מ1995( ארליך.אי.ג'י AYALON TOWER, 15TH FLOOR, ,11 רחוב מנחם בגין, 15 קומה,מגדל אילון 11 MENACHEM BEGIN ST., רמת גן RAMAT GAN 52521 ]87[ ]74[ [57] A composition or drug delivery June 5, – ב' בסיון התשס"ח 1020 2008 device for localized drug release in the colon, said composition or device comprising one or more drugs in a core, and a coating surrounding said core, said coating having an outer surface, wherein said coating comprises water insoluble hydrophilic particulate matter embedded in a water-insoluble carrier, such that when said composition or device enters the gastrointestinal tract, said particulate matter absorbs liquid, thus forming channels that interconnect said core with said outer surface of said coating and through which channels said one or more drugs are released into the colon, such that at least one of said drugs is preferentially metabolized to a more active metabolite in the colon. _________ ]11[]21[ 143019 של אבידין ושימושןHABA תולדות ]54[ HABA DERIVATIVES OF AVIDIN AND USES THEREOF ]22[ ]31[ ]51[ 10.11.1999 126990 ]32[ 10.11.1998 ]33[ IL Int. Cl.8 A61K 038/02, A61P 043/00, C07D 273/02, C07K 001/13, 014/36, G01N 033/545 YEDA RESEARCH AND רחובות,ידע חברה למחקר ופיתוח בע"מ DEVELOPMENT CO. LTD. MEIR WILCHEK, EDWARD A. מרגריטה, אדוארד באייר,מאיר וילצ'ק BAYER, MARGHERITA הייקה הופשטטר,מורפורגו MORPURGO, HEIKE HOFSTETTER WO/2000/027814 PAULINA BEN-AMI, BEN-AMI & ,' בן עמי ושות, עמי-פאולינה בן ASSOCIATES, רחובות,94 .ד.ת P.O.B. 94, REHOVOT 76100 ]71[ ]72[ ]87[ ]74[ [57] A covalent conjugate or a 4hydroxyazobenzene-2-carboxylic acid derivative (hereinafter HABA) and an 1021 avidin-type molecule, said conjugate being referred to herein as "HABAyalted avidin" and having the formula: June 5, 2008– ב' בסיון התשס"ח wherein A is (CH2)n or –CH=CH-, wherein n is an integer from 0-10; B is (CH2)n wherein n is an integer from 2 to 10; m is zero or 1; and Av is the residue of an avidin-type molecule selected from the group consisting of native egg-white avidin, recombinant avidin, deglycosylated avidins, bacterial streptavidin, recombinant streptavidin and truncated streptavidin. Claimed as novel is a cyclic HABA derivative of the formula _________ ]11[]21[ ]54[ RECOMBINANT METHODS AND MATERIALS FOR PRODUCING EPOTHILONE AND EPOTHILONE DERIVATIVES ]22[ ]31[ 19.11.1999 60/109401 60/119386 60/122620 60/130560 ]32[ June 5, – ב' בסיון התשס"ח 20.11.1998 10.02.1999 03.03.1999 22.04.1999 143069 שיטות רקומביננטיות וחומרים לייצור אפותילון ותולדות אפותילון ]33[ US US US US 1022 2008 ]51[ ]71[ ]87[ ]74[ Int. Cl.8 A61P 035/00, C12N 015/52, C12P 017/18 KOSAN BIOSCIENCES, INC., U.S.A. WO/2000/031247 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 [57] A method to produce epothilone C and/or epothilone D, which method comprises culturing an isolated or recombinant host cell that contains a nucleic acid that codes for expression of Sorangium cellulosum epothilone polyketide synthase ("PKS") but does not contain a functionally active product of a Sorangium cellulosum epoK gene under conditions wherein the nucleic acid is expressed to obtain a functional PKS, and epothilone C and/or epothilone D are produced. __________ ]11[]21[ 143403 שימושים ותכשירים להכת תרופות טיפול באי–סדר עירורי רעילותי ]54[ METHODS AND COMPOSITIONS FOR THE PREPARATION OF MEDICAMENTS FOR TREATING DISORDERS INVOLVING EXCITOTOXICITY ]22[ ]31[ 03.12.1999 PCT/US98/25676 ]32[ 03.12.1998 ]33[ WO 09/238243 27.01.1999 US 09/325602 03.06.1999 US Int. Cl.8 A61K 038/17, A61P 025/14, 025/16, 025/28, C07K 014/47 CURIS, INC., U.S.A. WO/2000/035948 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, אביב TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] Use of a lipophilic modified hedgehog polypeptide in the preparation of a medicament for treating a disorder characterized by loss of dopaminergic and/or GABAergic neurons, wherein said hedgehog polypeptide comprises an amino acid sequence encodable by a nucleic acid sequence that hybridizes under stringent 1023 conditions to a nucleic acid sequence designated in at least one of SEQ ID NOs: 1-9, and wherein said lipophilic modification comprises at least one fatty acid moiety on one or more internal sites or on an N-terminal amino acid residue of the mature hedgehog polypeptide. June 5, 2008– ב' בסיון התשס"ח _________ ]11[]21[ 143699 שיטה לאבחון בבעיות עור והחלמת פצעים ]54[ METHOD FOR THE DIAGNOSIS OF SKIN DISORDERS AND WOUND HEALING DISORDERS ]22[ ]31[ 12.06.2001 10030149.5 ]32[ 20.06.2000 ]33[ DE 60/222081 01.08.2000 US Int. Cl.8 A61K 038/17, C07K 014/00, C12Q 001/68, G01N 033/567 SWITCH BIOTECH AG, GERMANY REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]74[ [57] A method of diagnosing a skin disorder in a patient, said method comprising determining, in a sample from said patient, the level of a nucleic acid encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:34, wherein a level of said nucleic acid in said sample from said patient that differs from the level in a control sample indicates that said patient has a skin disorder selected from the group consisting of psoriasis, eczema, acne, Urticaria, disorders of pigmentation of the skin, senile skin, and disorders of hair growth and hair metabolism. _________ ]11[]21[ ]54[ PROPHYLACTIC ARTICLE USEFUL FOR BOTH PROTECTION AND DIAGNOSIS AND METHOD FOR USE AND PRODUCTION THEREOF ]22[ ]51[ ]71[ 18.06.2001 Int. Cl.8 A61F 006/00, G01N 033/52 ALEXANDER SCHOENFELD EMIL KATZ June 5, – ב' בסיון התשס"ח 143810 אמצעי מניעה השימושי להגנה ולאבחון ושיטה לשימוש בו ולהכנתו תל אביב,אלכסנדר שיינפלד סביון,אמיל כץ 1024 2008 ]74[ ,' זיסמן ושות, רוברטס, ישראלי,שיבולת תל אביב,4' רחוב ברקוביץ,מגדל המוזיאון SHIBOLETH, YISRAELI, ROBERTS, ZISMAN & CO., MUSEUM TOWER, 4 BERKOWITZ ST., TEL AVIV 64238 [57] A prophylactic article, comprising: (a) a body shaped to conform to a mammalian reproductive organ or to a mammalian appendage, said body acting as a physical barrier for protecting the mammalian user from contacting hazardous or infectious material; (b) a probe for rapidly detecting the presence of hazardous or infectious material, said probe capable of interacting with said hazardous or infectious material and undergoing a visible change in response to said interaction, said probe present upon at least a portion of said body. ________ ]11[]21[ 144998 מכשיר בעל הקרנה פועמת פלסמתית לשם הוצאת אור ברצועות תחזיתיות של משמעות ביולוגית ]54[ PULSED PLASMA RADIATION DEVICE FOR EMITTING LIGHT IN BIOLOGICALLY SIGNIFICANT SPECTRAL BANDS ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 18.12.2000 467124 ]32[ 20.12.1999 ]33[ US Int. Cl.8 A61L 002/08, 002/14, A61N 005/06 ROBERT G. JAMES, U.S.A. WO/2001/045794 JEREMY M. BEN-DAVID & CO. ,דוד ושות' בע"מ- בן.ירמיהו מ LTD., ,45087 .ד. ת, הר חוצבים,רחוב המרפא HAR HOTZVIM HI-TECH PARK, ירושלים P.O.B. 45087, JERUSALEM 91450 [57] Apparatus for illuminating biological matter with preselected frequency spectra, comprising: a vacuum tube (25) of a generally elongate form defined by a cylindrical exterior wall made of translucent material; an anode formed in 1025 one end of said tube; a cathode (26) formed in the other end of said tube; a tubular conductive shield formed around a first portion of said tube adjacent said anode, said tubular shield being electrically connected to said anode; a June 5, 2008– ב' בסיון התשס"ח reflective surface (22) mounted proximate a second portion of said tube adjacent said cathode, said reflective surface comprising conductive material electrically connected to said cathode; a magnetic piece (32) of a generally planar configuration aligned along said reflective surface distal of said second portion of said tube, said magnetic piece being transversely magnetized along a magnetic direction generally orthogonal to said tube; an enclosure including a handle conformed to receive said first portion of said tube together with said tubular shield, and a reflector extending from said handle over said second portion of said tube together with said reflective surface and said magnetic piece; a source of electrical excitation connected between said anode and said cathode, said source including pulsing means for modulating said electrical excitation in a frequency domain of electrochemical reactions of said biological matter; and gases in said tube of molecular combinations of H2O = 66% CO2 = 24% N2 = 3% H2CO3 = 3% +/- 5%, by weight. _________ ]11[]21[ ]54[ MONOCLONAL ANTIBODIES, ANTIGENS AND DIAGNOSIS AND THERAPY OF MALIGNANT DISEASES ]22[ ]31[ ]51[ ]71[ 30.09.1999 129299 ]32[ 31.03.1999 Int. Cl.8 G01N 033/574 MOR RESEARCH APPLICATIONS, LTD. BRITTA HARDY, ABRAHAM NOVOGRODSKY WO/2000/058363 ]72[ ]87[ June 5, – ב' בסיון התשס"ח 145535 אנטיגנים ואבחון,נוגדנים מונוקלוניים וטיפול במחלות ממאירות ]33[ IL פתח – תקוה,מור יישום מחקרים בע"מ אברהם נובוגרודסקי,בריטה הרדי 1026 2008 ]74[ ,'ד"ר וב ושות רחובות,2189 .ד. ת, 2 רח' פקריס WEBB & ASSOCIATES, 2 PEKERIS ST., P.O.B. 2189, REHOVOT 76121 [57] An assay for identifying a tested individual with high probability of having a malignant disease comprising: (a) contacting a body fluid sample obtained from an individual with at least one of the monoclonal antibodies (mAbs) having a variable region selected from the group consisting of: (i) a monoclonal antibody having a heavy chain variable region comprising the amino acid sequence of Fig. 1; (ii) a monoclonal antibody having a Kappa light chain variable region comprising the amino acid sequence of Fig. 2, both figures as shown in the specification; (iii) a monoclonal antibody having the heavy chain variable region comprising the amino acid sequence of Fig. 1 and the Kappa light chain variable region comprising the amino acid sequence of Fig. 2; (iv) a monoclonal antibody having a heavy chain variable region having at least 70% identity to the amino acid sequence of Fig. 1; and (v) a monoclonal antibody having a Kappa light chain variable region having 70% identity to the amino acid sequence of Fig. 2; (b) determining the extent of binding of said mAbs to T-cells within said sample; and (c) comparing the extent of (b) to the extent of binding of the mAbs to T-cells in a sample obtained from a healthy individual, a significant difference between the above two extents of binding indicating that said tested individual has a high probability of having a malignant disease. __________ ]11[]21[ 145842 הכנת מולקולות בעלות פעילות ביולוגית ]54[ PREPARATION OF BIOLOGICALLY ACTIVE MOLECULES ]22[ ]31[ ]51[ ]71[ 13.04.2000 129427 ]32[ 13.04.1999 ]33[ IL Int. Cl.8 C07K 014/54, 014/545, C12N 015/19, 015/24, 015/57, C12P 021/02 YEDA RESEARCH AND רחובות,ידע חברה למחקר ופיתוח בע"מ DEVELOPMENT CO. LTD. MENACHEM RUBINSTEIN, DANIELA NOVICK, PIERRE GRABER, BIANLING LIU WO/2000/061768 INTERLAB LTD., ,אינטר לאב בע"מ 18 HAKISHON ST. יבנה,18 הקישון YAVNE 81220 ]72[ ]87[ ]74[ [57] A method for the production of a biologically active cytokine from its biologically inactive precursor comprising 1027 mutating its natural cleavage site to a site which is capable of being cleaved by a protease, and cleaving the mutated inactive June 5, 2008– ב' בסיון התשס"ח precursor to yield a biologically active cytokine, wherein the cytokine is selected from IL-18β and IL-18 and wherein the natural cleavage site is a caspase-1 cleavage site. ________ ]11[]21[ 146222 שימוש בתרכובות המכילות בנזודיאזפינים להכנת תרופות לטיפול במצבים הקשורים לחוסר סדירות של מות תאים ותכשירים רוקחיים המכילים אותם ]54[ USE OF COMPOSITIONS COMPRISING BENZODIAZEPINES FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH DYSREGULATION OF CELL DEATH AND PHARMACEUTICAL COMPOSITIONS THEREOF ]22[ ]31[ 27.04.2000 60/131761 ]32[ 30.04.1999 ]33[ US 60/165511 15.11.1999 US 60/191855 24.03.2000 US Int. Cl.8 A61K 031/5513, A61P 035/00, C07D 243/14, 401/12, 403/12 THE REGENTS OF THE UNIVERSITY OF MICHIGAN, U.S.A. WO/2000/066106 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] Use of a benzodiazepine compound for the manufacture of a medicament for the treatment of a condition associated with dysregulation of cell death in a subject through induction of cellular apoptosis, wherein the benzodiazepine June 5, – ב' בסיון התשס"ח compound does not bind to a central benzodiazepine receptor and binds only with low affinity to a peripheral benzodiazepine receptor, wherein the benzodiazepine compound is selected from the group consisting of: 1028 2008 and enantiomers and pharmaceutically acceptable salts thereof: wherein R1 is an aliphatic group having up to 20 carbon atoms and up to 41 hydrogen atoms or an aryl group having up to 20 carbon atoms and up to 20 hydrogen atoms; wherein each of R2 and R3 is independently selected from the group consisting of hydrogen, hydroxy, C1-4 alkoxy, halo, amino, C1-4 alkyl-substituted-amino, acetylamino, hydroxyamino, an aliphatic group having up to 8 carbons and up to 17 hydrogens, an aryl group having from 6 to 14 carbon atoms, and a heterocyclic group having a 3-6 membered ring containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur; and wherein R4 is aliphatic or aryl. ________ ]11[]21[ ]54[ VERY HIGH EFFICIENCY ORGANIC LIGHT EMITTING DEVICES BASED ON ELECTROPHOSPHORESCENCE ]22[ ]31[ ]51[ ]71[ 11.05.2000 09/311126 ]32[ 13.05.1999 Int. Cl.8 H01L 033/00 THE TRUSTEES OF PRINCETON UNIVERSITY, U.S.A. THE UNIVERSITY OF SOUTHERN CALIFORNIA, U.S.A. WO/2000/070655 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 ]87[ ]74[ [57] An organic light emitting device comprising an anode, a cathode, and an emissive layer, wherein the emissive layer is located between the anode and the 146242 התקנים פולטי אור אורגניים בעלי יעילות מבוססי אלקטרופוספורטים,גבוהה ]33[ US , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר cathode, and the emissive layer comprises a phosphorescent organometallic iridium complex having an aromatic ligand. ________ 1029 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ 146267 מערכת תקשורות אלחוטית המשמשת CDMA באפנון תדר אות רדיו בשיטת בתיאום עם פרוטוקול ממשך רשתית GSM A תקשורת ]54[ WIRELESS COMMUNICATIONS SYSTEMS UTILIZING CDMA RADIO FREQUENCY SIGNAL MODULATION IN CONJUNCTION WITH THE GSM A-INTERFACE TELECOMMUNICATIONS NETWORK PROTOCOL ]22[ ]31[ ]51[ ]62[ ]71[ 19.06.1998 08/575413 ]32[ 20.12.1995 ]33[ US Int. Cl.8 H04B 007/216, H04Q 007/22, 007/30 DIVISION FROM 125009 QUALCOMM INCORPORATED, U.S.A. WO/1997/023108 SANFORD T.COLB & CO., ,' קולב ושות.סנפורד ט P.O.B. 2273, רחובות,2273 .ד. ת, מרמורק,4 שער הגיא REHOVOT 76122 ]87[ ]74[ [57] A base station controller, including: (a) a CDMA RF interface module configured to provide a bi-directional interface with a subscriber unit; (b) a GSM A-interface transport module configured to provide a bi-directional interface with GSM MSC; (c) a transparent signaling transport module, coupled to the CDMA RF interface module and to the GSM Ainterface transport module; (d) signal processing resources; and June 5, – ב' בסיון התשס"ח (e) a processing and service conversion module, coupled to the signal processing resources, the CDMA RF interface module, the GSM A-interface transport module, and to the transparent signaling transport module, the processing and service conversion module being configured to receive and examine signaling messages from the CDMA RF interface module and the GSM A-interface and to configure and control the signal processing resources in response to such 1030 2008 signaling messages. _________ ]11[]21[ 146363 מערכת ושיטה להפעלת תחנה ניידת במצב קול או במצב איתורית ]54[ SYSTEM AND METHOD FOR OPERATING A MOBILE STATION IN A VOICE MODE OR PAGER MODE ]22[ ]31[ ]51[ ]71[ 10.05.2000 09/309336 ]32[ 11.05.1999 ]33[ US Int. Cl.8 H04B 007/26, H04M 003/00, 011/06, H04Q 007/22, 007/32, 007/38 QUALCOMM INCORPORATED, U.S.A. WO/2000/069193 SANFORD T.COLB & CO., ,' קולב ושות.סנפורד ט P.O.B. 2273, רחובות,2273 .ד. ת, מרמורק,4 שער הגיא REHOVOT 76122 ]87[ ]74[ [57] A system for operating a mobile station in two modes, comprising: a mobile station; and a base station, wherein said mobile station is capable of operating in a first mode suitable for receiving telephone calls and in which said mobile station scans portions of a channel at a first rate; wherein said mobile station is capable of 1031 operating in a second mode suitable for receiving pages only and in which said mobile station scans portions of the channel at a second rate; wherein the first rate is higher than the second rate; and wherein said mobile station is capable of switching between the two modes at the option of the user thereof. June 5, 2008– ב' בסיון התשס"ח _________ ]11[]21[ ]54[ NEEDLE-LESS LUER ACTIVATED MEDICAL CONNECTOR ]22[ ]51[ ]71[ 01.06.1999 Int. Cl.8 A61M 025/00 CREATIVE PLASTIC TECHNOLOGY, LLC, U.S.A. WO/2001/023026 S. HOROWITZ & CO., ZION HOUSE, 41-45 ROTHSCHILD BLVD., TEL AVIV 65784 ]87[ ]74[ [57] A needle-less Luer actuated medical connector having a longitudinal axis, said connector comprising: (a) a valve housing (20) having a fluid flow passage therein aligned with said longitudinal axis, a valve seat therein, an open end for receiving a compressible valve element and a connection end for connecting said connector to a fluid flow line aligned with said longitudinal axis; June 5, – ב' בסיון התשס"ח 146498 מחבר רפואי ללא מחט המופעל על ידי לואר ,' הורוביץ ושות.ש תל אביב,41-45 שדרות רוטשילד,בית ציון (b) a valve actuator (30) having a fluid flow passage therein having an end aligned with said longitudinal axis of said connector, a valve compressing end wall received in said open end of said housing, and said fluid flow passage extending through said end wall, said valve actuator being mounted in said open end of said housing for rotation about said longitudinal axis with respect to said housing; (c) a resilient valve element (40) 1032 2008 compressed between said valve seat and said valve compressing end wall of said actuator, said valve element having a fluid flow passageway (34) therethrough extending from an axially aligned opening on a first side of said valve element substantially straight through said valve element to an off-center opening on an opposite side of said valve element; said off-center opening of said fluid passageway in said valve element being aligned with an off-center positioned end of said flow passage in said valve actuator when said actuator is rotated relative to said housing to open said valve and said off-center positioned opening of said passageway in said valve element being circumferentially displaced from said offcenter positioned opening of said flow passage in said valve actuator when said actuator is rotated relative to said housing to close the valve; (d) means connecting said valve element to said housing to prevent relative rotation between said valve element and said housing; (e) positioning means on said actuator and said housing to hold said actuator in either a valve open position or in a valve closed position relative to said housing; (f) restraining means on said housing and on said actuator for restraining relative axial movement therebetween while permitting relative rotation therebetween. _________ ]11[]21[ 146608 שיטה ומערכת להכנסת מידע לתוך מסמך ]54[ METHOD AND SYSTEM FOR PROVIDING INFORMATION IN A DOCUMENT ]22[ ]31[ 24.05.2000 PQ0559 ]32[ 25.05.1999 ]33[ AU PQ1313 30.06.1999 AU Int. Cl.8 B41J 002/175, G06K 015/00, H04N 001/00 ]51[ 1033 June 5, 2008– ב' בסיון התשס"ח ]71[ ]87[ ]74[ SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2000/072202 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A method for providing information in a document, including: establishing personalized user content preferences; selecting and formatting information corresponding to the content preferences; and printing the formatted information in a document with at least one user interactive element, the formatted information including visible information having a spatial extent which corresponds to the user interactive element and coded data, ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם the coded data being coincident with the visible information and enabling a user to indicate a response to associated information in the document, by interacting with the element using a sensing device which is adapted to sense the coded data when placed in an operative position relative to the visible information and transmit response data to a computer system using the sensed coded data. _________ ]11[]21[ ]54[ IDENTITY-CODED SURFACE WITH REFERENCE POINTS June 5, – ב' בסיון התשס"ח 146671 משטח עם נקודות יחוס שזהותו מקודדת 1034 2008 ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 24.05.2000 PQ0559 ]32[ 25.05.1999 PQ1313 30.06.1999 PQ3457 15.10.1999 PQ4392 01.12.1999 Int. Cl.8 G06K 005/00 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2000/072249 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A region defined in relation to a surface, coded data (3) and additional data (2) being disposed within the region, wherein the coded data comprises machine-readable data which is substantially inscrutable to the average unaided human and is indicative of: a region identity associated with the region; and a plurality of points within the region, ]33[ AU AU AU AU ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם wherein the additional data is humanreadable data which is substantially visible to the average unaided human eye, at least some of the additional data being indicative of an interactive element (6), at least some of the coded data in the vicinity of the at least some additional data also being indicative of the interactive element. _________ ]11[]21[ 1035 146708 June 5, 2008– ב' בסיון התשס"ח ]54[ DELAYED TOTAL RELEASE TWO PULSE GASTROINTESTINAL DRUG DELIVERY SYSTEM ]22[ ]31[ ]51[ ]71[ 02.06.2000 09/325748 ]32[ 04.06.1999 Int. Cl.8 A61K 009/00, 009/20, 009/28 DEXCEL PHARMA TECHNOLOGIES LTD. MOSHE FLASHNER, ITZHAK E. LERNER, ADEL PENHASI WO/2000/074655 G.E. EHRLICH (1995) LTD., AYALON TOWER, 15TH FLOOR, 11 MENACHEM BEGIN ST., RAMAT GAN 52521 ]72[ ]87[ ]74[ [57] A controlled two pulse delivery device for delivering one or more desired agents to the gastrointestinal tract of a subject in need of the same, wherein said device comprises: (a) a core comprising said one or more desired agents and a core material that swells in the presence of an aqueous liquid; (b) an inner coat that surrounds said core, wherein said inner coat does not contain a drug and wherein said inner coat has an outer surface and comprises waterinsoluble hydrophilic particulate matter embedded in a water-insoluble carrier such that in the presence of an aqueous liquid, said particulate matter forms channels in said inner coat that interconnect said core with said outer surface of said inner coat for controlling the entry of aqueous liquid to said core, and wherein said inner coat bursts when said core is swollen, thereby releasing said one or more desired agents from said core, such that said inner coat controls release and lag time to release of מערכת לשחרור מושהה של תרופות במערכת העיכול בשתי פעימות ]33[ US הדרה,דקסל פארמה טכנולוגיות בע"מ עאדל פינחסי, יצחק לרנר,משה פלשנר ,) בע"מ1995( ארליך.אי.ג'י ,11 רחוב מנחם בגין, 15 קומה,מגדל אילון רמת גן said one or more desired agents from said core; wherein said water-insoluble carrier includes at least one hydrophobic polymer; and (c) an outer coat that surrounds said outer surface of said inner coat, wherein said outer coat comprises one or more desired agents which may be identical to or different from the one or more desired agents that are present in said core, said outer coat comprising at least one excipient for controlling immediate or sustained release of said one or more desired agents, wherein said inner coat physically separates said outer coat from said inner core; wherein release of said one or more desired agents from said core and release of said one or more desired agents from said outer coat are separated by a predetermined period of time and such that said immediate or sustained release of said one or more desired agents from said outer core is controlled separately from said release of said one or more desired agents from said core. _________ ]11[]21[ June 5, – ב' בסיון התשס"ח 147565 1036 2008 מערכת מרובת ערוצים אופטיים לבדיקות ]54[ MULTIPLE OPTICAL INPUT INSPECTION SYSTEM ]22[ ]31[ ]51[ ]71[ ]74[ 10.01.2002 09/782626 ]32[ 13.02.2001 Int. Cl.8 G01R 031/309 ORBOTECH LTD. ORBOTECH LTD., P.O.B. 215, YAVNE 81102 ]33[ יבנה,אורבוטק בע"מ ,אורבוטק בע"מ יבנה,215 .ד. ת, אזור תעשייה [57] A method of inspecting electrical circuits comprising: obtaining first image data relating to at least a part of an electrical circuit; obtaining second image data generally corresponding to said part of the electrical circuit, said second image data including at least some image data for an optical characteristic that is different from said first image data; generating a first representation of said electrical circuit from said first image data independently of said second image data; modifying said first representation by employing said second image data thereby to produce an enhanced representation of the electrical circuit; and inspecting the enhanced representation with reference to a reference representation of the electrical circuit to detect defects in the electrical circuit. ,190096 The applications for division from this application have not yet been published US בקשות חלוקה מבקשה זו .שטרם פורסמו ________ ]11[]21[ ]54[ PROCESS FOR PREPARING CHIRAL AROMATIC ALPHAHYDROXY KETONES USING ACETOHYDROXYACID SYNTHASE ]22[ ]51[ ]71[ 24.01.2002 Int. Cl.7 C07C 049/245, C12P 007/26 BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY DAVID M. CHIPMAN, ZE'EV BARAK, STANISLAV ENGEL, MARIA VYAZMENSKY LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]72[ ]74[ 1037 147823 תהליך להכנת קטונים כירליים ארומטיים של אלפא–הידרוקסי על ידי שימוש באצטוהידרוקסיאציד סינטאז הרשות למחקר,גוריון בנגב-אוניברסיטת בן שבע- באר,ופיתוח , סטניסלב אנג'ל, זאב ברק,דוד מאיר צי'פמן מריה ויאזמנסקי ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה June 5, 2008– ב' בסיון התשס"ח [57] A process of preparing an aromatic α-hydroxy ketone of the formula wherein R is H or C1-6 alkyl, and Ar is aryl, wherein said aryl optionally contains one or more heteroatoms chosen from N, S and O, and optionally consists of fused rings, and said alkyl and aryl are optionally substituted by 1 to 3 substituents chosen from C1-3 alkyl, C1-3 alkoxy, F, Cl, Br, I, OH, NH2, CN, and NR1R2, wherein R1 and R2 can be independently H or C1-4 alkyl, and said C1-3 alkyl can be further substituted by a substituent chosen from F, Cl, Br, I, and OH; which process comprises reacting an aldehyde of the formula with a 2-oxoacid of the formula wherein Ar and R in formulae (II) and (III) have the meaning defined for formula (I); in the presence of a mixture comprising 2hydroxy-3-oxoacid synthase chosen from TSAS and acetohydroxyacid synthase (AHAS), thiamin pyrophosphate (TPP), flavine adenine dinucleotide (FAD), metal ions, and a buffer. ________ ]11[]21[ June 5, – ב' בסיון התשס"ח 147824 1038 2008 ]54[ MODULAR METHOD AND SYSTEM FOR PERFORMING DATABASE QUERIES ]22[ ]31[ ]51[ ]71[ 28.07.2000 09/364808 ]32[ 30.07.1999 Int. Cl.8 G06F 017/30 COMPUTER ASSOCIATES THINK, INC., U.S.A. WO/2001/009754 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]87[ ]74[ [57] A method for performing database queries, comprising: providing a library of data drivers, each data driver operable to execute a specified database operation; receiving a query request for a database; identifying from the library data drivers to perform the request using an application independent, intelligent dataset associated שיטה ומערכת מודולריות לביצוע שאילתות בסיס נתונים ]33[ US ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה with a business intelligence system; determining an order of the data drivers to perform the request; generating a driver chain including the data drivers in the order; and performing the request by executing in order the data drivers in the driver chain. _________ ]11[]21[ 147872 C-חומצות גרעין כליגנדיים של טנסין ]54[ TENASCIN-C NUCLEIC ACID LIGANDS ]22[ ]31[ ]51[ ]71[ ]87[ 28.01.2000 364902 ]32[ 29.07.1999 ]33[ US Int. Cl.8 A61K 047/48, C07H 021/00, C12Q 001/68 GILEAD SCIENCES, INC., U.S.A. WO/2001/009390 1039 June 5, 2008– ב' בסיון התשס"ח REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם [57] A nucleic acid ligand to tenascin-C identified according to the method comprising: (a) contacting a candidate mixture of nucleic acids with tenascin-C, wherein nucleic acids having an increased affinity to tenascin-C relative to the candidate mixture may be partitioned from the remainder of the candidate mixture; (b) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture; (c) amplifying the increased affinity nucleic acids to yield a mixture of nucleic acids enriched for nucleic acids with relatively higher affinity and specificity for binding to tenascin-C, whereby a nucleic acid ligand of tenascin-C may be identified. ]74[ _________ ]11[]21[ 148196 תולדות קפוראמיצין ותכשירי רוקחות המכילים אותן ]54[ CAPURAMYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 18.08.2000 11/233934 ]32[ 20.08.1999 ]33[ JP Int. Cl.8 A61K 031/7072, A61P 031/04, 031/06, C07H 019/06, C12P 017/06 SEQUELLA, INC., U.S.A. WO/2001/014399 WOLFF, BREGMAN AND GOLLER, , ברגמן וגולר,וולף P.O.B. 1352, ירושלים,1352 .ד. ת, JERUSALEM 91013 [57] An antimicrobial compound of the formula June 5, – ב' בסיון התשס"ח 1040 2008 a pharmaceutically acceptable ester, ether or N-alkyl derivative thereof, or a pharmaceutically acceptable salt thereof: (wherein X1 represents an oxygen atom, a sulfur atom or a group of formula –N(R4)-(in which R4 is a hydrogen atom, a C1-C3 alkyl group, or R4, together with R1 and the nitrogen atom to which they are attached, forms a 3- to 7-membered cyclic amine which may have a ring oxygen or sulfur atom); X2 represents an oxygen atoms, a sulfur atom or a group of formula –N(R5)-(in which R5 is a hydrogen atom, a C1-C3 alkyl group, or R5, together with R2 and the nitrogen atom to which they are attached, forms a 3- to 7-membered cyclic amine which may have a ring oxygen or sulfur atom); R1 and R2 are the same or different and each represents: (1) a hydrogen atom, (2) a C6-C10 aryl group which may have one or more substituents said one or more substituents are selected from Group A, consisting of a halogen atom, a hydroxyl group, an amino group (said amino group may be substituted with one or more C1-C6 alkyl groups), a nitro group, a cyano group, a carboxyl group, a C1-C4 alkoxycarbonyl group, a carbamoyl group, a C1-C10 alkylenedioxy group, a C7-C14 aralkyloxy group, a C1-C16 alkyl group (said alkyl group may be substituted with one or more halogen atoms), a C2-C16 alkenyl group, a C1-C16 alkoxy group (said alkoxy group may be substituted with one or more halogen atoms), a C1-C6 alkylthio group (said alkylthio group may be 1041 substituted with one or more halogen atoms), a C6-C10 arylazo group, and a heterocyclic group which has 1-4 ring nitrogen, sulfur or oxygen atoms]; (3) a heterocyclic group which has 1-4 nitrogen, sulfur or oxygen atoms and which may have one or more substituents [said one or more substituents are selected from Group B, consisting of an oxo group, a thiooxo group, an imino group, a halogen atom, a hydroxyl group, an amino group (said amino group may be substituted with one or more C1-C16 alkyl groups), a nitro group, a cyano group, a carboxyl group, a C1-C4 alkoxycarbonyl group, a carbamoyl group, a C7-C14 aralkyloxy group, a C1-C16 alkyl group (said alkyl group may be substituted with one ore more halogen atoms), a C2-C16 alkenyl group, a C1-C16 alkoxy group (said alkoxy group may be substituted with one or more halogen atoms), and a C1-C16 alkylthio group (said alkylthio group may be substituted with one or more halogen atoms); (4) a C1-C14 alkyl group which is substituted with one to three C6-C10 aryl groups which may be the same of different and may each have one or more substituents [said one or more substituents on the aryl group are selected from Group A]; (5) a C1-C14 alkyl group which is substituted with one to three heterocyclic groups which may be the same or different, have 1-4 nitrogen, sulfur or oxygen atoms and may have one or more substituents [said one or more substituents on the heterocyclic group are selected from Group B]; (6) a C1-C22 alkyl group which may have one or more substituents [said one or more June 5, 2008– ב' בסיון התשס"ח substituents are selected from Group C, consisting of a halogen atom, a hydroxyl group, an amino group, a nitro group, a cyano group, a carboxyl group, a C1-C4 alkoxycarbonyl group, a carbamoyl group, a C1-C16 alkoxy group (said alkoxy group may be substituted with one or more halogen atoms), and a C1-C16 alkylthio group (said alkylthio group may be substituted with one or more halogen atoms)]; (7) a C2-C22 alkenyl group which may have one or more substituents [said one or more substituents are selected from those listed in (2) or (3) above or from Group C]; or (8) a group of the formula (in which n represents an integer from 1 to 20 and m represents 0 or 2); and R3 represents a hydrogen atom or hydroxyl group; with the proviso that: a compound wherein X1 and X2 represent a group of formula –NH-, R1 represents a hydrogen atom or a group of formulae R2 is a hydrogen atom and R3 is a hydroxyl group, and a compound wherein X1 is an oxygen atom, X2 represents a group of the formula –NH-, R1 represents a hydrogen atom or a methyl group, R2 is a hydrogen atom and R3 is a hydroxyl group are excluded. __________ ]11[]21[ ]54[ PROTECTIVE NETTING AGAINST SMALL INSECTS AND FINE PARTICLES ]22[ ]51[ ]71[ 05.03.2002 Int. Cl.8 A01K 013/00 KLAYMAN METEOR LTD. June 5, – ב' בסיון התשס"ח 148526 רשת מגן כנגד חרקים וחלקיקים קטנים ושיטה לייצורה פתח תקווה,קליימן מטאור בע"מ 1042 2008 DR. EYAL BRESSLER, 11 TOVAL ST., RAMAT GAN 52522 ,ד"ר אייל ברסלר רמת – גן,11 תובל [57] A stand-alone non-framed netting, useful for standing in strong terrestrial winds, especially useful for hindering the passage of small insects and any fine particles through said netting; said netting comprising a plurality of bristly fibers and non-bristly fibers, in the quantitative ratio of 2:1 to 1;4; wherein said non-bristly fibers provide the mechanical stability of said netting. ]74[ __________ ]11[]21[ ]54[ NEUTRON BRACHYTHERAPY DEVICE ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 13.09.2000 395324 ]32[ 13.09.1999 Int. Cl.8 A61M 036/12, A61N 005/10 ISOTRON, INC., U.S.A. WO/2001/019450 SELIGSOHN GABRIELI & CO., 31 YAVNE ST., P.O.B. 1426, TEL AVIV 61013 [57] A neutron source for performing neutron brachytherapy, the neutron source comprising: a neutron emitting source material (90), the neutron emitting source material radioactively decaying and releasing helium gas and neutrons during the decay; a capsule (91) within which the 1043 148634 התקן לריפוי בקרינת ניוטרונים ]33[ US ,'זליגסון גבריאלי ושות תל אביב,1426 .ד. ת, 31 רח' יבנה neutron emitting source material is encapsulated with capsule walls that do not interfere with the neutrons and the capsule being sufficiently small so that it can be inserted interstitially into the body of a patient to treat tumor cells locally by releasing neutrons into the tumor cells and June 5, 2008– ב' בסיון התשס"ח damaging the tumor cells with the neutrons; and a guide wire (92) attached to the capsule, the guide wire controlling the positioning of the capsule within the patient. ___________ ]11[]21[ 148864 תכשירי רוקחות המכילים נימסוליד ]54[ PHARMACEUTICAL COMPOSITIONS CONTAINING NIMESULIDE ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 27.09.2000 1297/DE/99 ]32[ 28.09.1999 ]33[ IN Int. Cl.8 A61K 009/20, 009/22, 031/18, C07C 311/08 PANACEA BIOTEC LIMITED, INDIA WO/2001/022791 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [57] A pharmaceutical composition in the form of a compressed, oral solid dosage form consisting of nimesulide as an active agent from 5% to 95% w/w of the composition, one or more release , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, controlling materials from 2% to 95% w/w of the composition and pharmaceutical excipients from 0% to 90% w/w of the composition. __________ June 5, – ב' בסיון התשס"ח 1044 2008 ]11[]21[ 149029 חלבונים עם כמות גבוה של מנוז ותהליכים להכנתם ]54[ HIGH MANNOSE PROTEINS AND METHODS FOR PRODUCING THE SAME ]22[ ]31[ ]51[ ]71[ 17.08.2001 09/641471 ]32[ 18.08.2000 ]33[ US Int. Cl.8 A61K 038/47, C07D 211/46, C12N 009/42, 015/56, 015/85 SHIRE HUMAN GENETIC THERAPIES, INC., U.S.A. WO/2002/015927 WOLFF, BREGMAN AND GOLLER, , ברגמן וגולר,וולף P.O.B. 1352, ירושלים,1352 .ד. ת, JERUSALEM 91013 ]87[ ]74[ [57] A method of producing a high mannose glucocerebrosidase (hmGCB), comprising: providing a cell which is capable of expressing a human glucocerebrosidase (GCB); contacting the cell with kifunensine such that the removal of at least one mannose residue distal to the pentasaccharide core of the precursor oligosaccharide of GCB is prevented; and allowing the cell to produce hmGCB-, to thereby produce an hmGCB preparation. ____________ ]11[]21[ 149141 תרופות מונעות הריון המבוססות על פרוגסטרון ואסטרוגן ושיטה לייצורן ]54[ CONTRACEPTIVE MEDICAMENT BASED ON A PROGESTERONE AND AN OESTROGEN ]22[ ]31[ ]51[ ]71[ 24.10.2000 PCT/FR99/02587 ]32[ 25.10.1999 ]33[ WO Int. Cl.8 A61K 031/57, 045/00, A61P 005/30, C07J 001/00 LABORATOIRE THERAMEX, MONACO WO/2001/030358 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, אביב TEL AVIV 61040 ]87[ ]74[ [57] Use of a composition comprising (i) from 0.3 mg 3 mg of estradiol or an ester thereof, (ii) from 0.1 mg to 2.5 mg of nomegestrol acetate and (iii) pharmaceutically acceptable excipients, in the manufacture of a contraceptive product. _________ 1045 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ 149171 ELISA באמצעותVEGF בדיקת ]54[ ELISA FOR VEGF ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 15.11.2000 60/165736 ]32[ 16.11.1999 Int. Cl.8 G01N 033/53, 033/68 GENENTECH, INC., U.S.A. WO/2001/036972 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A method for detecting multiple isoforms of vascular endothelial growth factor (VEGF) in a biological sample, comprising: (a) incubating a biological sample with a capture reagent immobilized on a solid support to bind multiple isoforms of VEGF to the capture reagent, wherein the capture reagent comprises a mixture comprising a polyclonal antibody that binds VEGF and a monoclonal antibody that specifically ]33[ US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם binds to C-terminal amino acid residues 111-165 of human VEGF; and (b) separating the biological sample from the immobilized capture reagents; (c) contacting the bound VEGF bound to the immobilized capture reagent with a detectable antibody that binds to Nterminal amino acid residues 1-110 of VEGF; (d) measuring an amount of VEGF bound to the capture reagent using detection means for the detectable antibody. __________ ]11[]21[ ]54[ PROCESS FOR PREPARING 4"SUBSTITUTED-9-DEOXO-9A-AZA9A- HOMOERYTHROMYCIN A DERIVATIVES ]22[ ]31[ ]51[ ]71[ ]74[ 19.04.2002 60/287203 ]32[ 27.04.2001 Int. Cl.8 C07H 005/06, 017/00, 017/08 PFIZER PRODUCTS, INC., U.S.A. LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 [57] A process for preparing a compound of the formula June 5, – ב' בסיון התשס"ח 149226 A 9– –דאוקסו9 תהליך להכנת נגזרות של מותמרA – – הומואריתרומיציןAZA – 9A 4 בעמדה ]33[ US ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה 1046 2008 or a pharmaceutically acceptable salt thereof, which comprises reacting a compound of the formula R3 is –CH2 NR8R15; R8 is C1-C10 alkyl; R15 is H or C1-C10 alkyl. with an amine of the formula NHR8 R15, in an organic solvent comprising isopropanol; wherein the reaction is carried out at a temperature of at least about 40o C; wherein: The applications for division from this application have not yet been published ,182418 בקשות חלוקה מבקשה זו .שטרם פורסמו ________ ]11[]21[ 149322 שיטה ומערכת לאימות בקשת לקוח ]54[ METHOD AND SYSTEM FOR VERIFYING A CLIENT REQUEST ]22[ ]31[ ]51[ ]71[ 25.10.2000 60/161473 ]32[ 25.10.1999 ]33[ US Int. Cl.8 G06F 002/100000 013/00, H04L 009/00 WATCHFIRE CORPORATION, CANADA WO/2001/031415 ]87[ 1047 June 5, 2008– ב' בסיון התשס"ח ]74[ ,'זליגסון גבריאלי ושות תל אביב,1426 .ד. ת, 31 רח' יבנה SELIGSOHN GABRIELI & CO., 31 YAVNE ST., P.O.B. 1426, TEL AVIV 61013 [57] A method for authorizing execution of requested actions transmitted between clients and servers of a data processing system, the method comprising: receiving a plurality of server messages from a server, each server message including a set of actions; simulating execution of each set of actions upon receipt of the plurality of server messages; based on each simulated execution, building or supplementing a list of allowable actions or user-definable inputs to the allowable actions in response to receiving a server message corresponding to the simulated execution; receiving one or more client messages from one or more clients, each client message including one or more userrequested actions or inputs; comparing the list of allowable actions or user-definable inputs in existence prior to receipt of the one or more client messages to the userrequested actions or inputs; and where the list of allowable actions or user-definable inputs includes the user-requested actions or inputs, authorizing execution of the user requested actions or inputs, and supplementing the list of allowable actions or user-definable inputs upon receipt of a subsequent server message in response to the authorized execution. _________ ]11[]21[ ]54[ SUPPLEMENTARY SAFETY DEVICE OF LIGHT FIREARM TO PREVENT UNAUTHORIZED USE ]22[ ]31[ ]51[ 05.05.2002 BS2001A000036 ]32[ Int. Cl.8 F41A 017/44 June 5, – ב' בסיון התשס"ח 18.05.2001 149475 התקן הבטחה נוסף המונע שימוש בלתי מורשה של נשק קל ]33[ IT 1048 2008 ]71[ ]74[ FABBRICA D'ARMI PIETRO BERETTA S.P.A, ITALY EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [57] A supplementary safety device that may be inserted into the chamber of light firearms including at least one of shotguns, rifles and handguns, the safety device comprising: a first body (10) including a lock (21) with a rotating pan controlled by a specific key; a second body (11) movably connected to the first body in an axial direction without rotating, between a position of unlocking with a position distant from the first body and a position of locking with a position close to the said first body, said second body being rotationally fixed with said first body; a screw pin (13) driven in rotation without moving axially in the first body, the screw , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר pin being connected to and controlled by the lock for rotation of said screw pin and to be linked directly or indirectly with the second body for the movement of the second body between the positions of unlocking and locking following the turning of the screw pin; and a flexible element (19) deformable by compression and located between the first and second bodies in order to expand radially and project peripherally from the first and second bodies when the second body is in the locking position, thus creating the locking of the device in the chamber of the barrel in which it is housed, wherein the screw pin is screwed to the second body. __________ ]11[]21[ ]54[ SYSTEM AND METHOD FOR ANALYSIS OF IMAGERY DATA ]22[ ]31[ 07.05.2002 146597 ]32[ 20.11.2001 PCT/IL01/01074 08.01.2002 Int. Cl.8 A61B 005/00, G06K 009/00 ]51[ 1049 149523 מערכת ושיטה לאבחון נתונים צורניים ]33[ IL WO June 5, 2008– ב' בסיון התשס"ח ]71[ MAGNOLIA MEDICAL TECHNOLOGIES LTD. ]72[ GOREN GORDON, DORON DINSTEIN, BARAK GORDON SOROKER-AGMON, 14 SHENKAR ST., HERZLIYA PITUAH 46725 ]74[ [57] A medical diagnostics system having an imagery data analysis application operative in the processing of imagery data for generating meaningful imagery data summaries, the system comprising the elements of: at least one imagery input device to acquire imagery data of at least one subject and to transmit a stream of the acquired imagery data to at least one associated data processing apparatus; at least one data processing device associated with the at least one imagery input device, the data processing device comprising the elements of: at least one data storage device to store the stream of acquired imagery data, to store imagery data processing control parameters and to store programs constituting the imagery data analysis application; at least one processor device to process the stream of imagery ,מגנוליה מדיקל טכנולוג'יס בע"מ הרצליה פיתוח ברק גורדון, דורון דינשטיין,גורן גורדון ,אגמון-סורוקר הרצליה,14 רחוב שנקר,בית נולטון פיתוח data through the application of the at least one imagery data analysis application; an imagery data analysis application for the generation of meaningful summaries of the imagery data received from the at least one imagery input device, the imagery data analysis application comprises the elements of: an imagery data stream manipulation component to partition the distinct records of the stream of imagery data into specifically sized data blocks; a complexity calculation component to assign complexity values to the partitioned blocks of the imagery data records; an indicative parameter calculation component; and a final result generating component; and at least one user interface device to enable at least one user of the system to control suitably the operation of the system. __________ June 5, – ב' בסיון התשס"ח 1050 2008 ]11[]21[ 149954 שיטה ומערכת לבקרת טלפון ]54[ METHOD AND SYSTEM FOR TELEPHONE CONTROL ]22[ ]31[ ]51[ 27.11.2000 PQ4392 ]32[ 01.12.1999 ]33[ AU Int. Cl.8 B41J 003/42, 021/00, 029/38, G06K 007/00, 007/10, 019/06, H04M 001/00, 001/72, 003/42 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2001/041413 REINHOLD COHN AND ,ריינהולד כהן ושותפיו PARTNERS, תל אביב,4060 .ד. ת, 21 רחוב אחד העם 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]71[ ]87[ ]74[ [57] A method of enabling at least one function of a telephone to be controlled, the telephone being operative to perform the at least one function in response to at least one command from a computer system, the method including the steps of: providing a control interface on a printed media surface containing printed information relating to the at least one function, the control interface including printed coded data indicative of an identity of the control interface and of at least one reference point of the control interface; 1051 receiving, in the computer system, indicating data from a sensing device regarding the identity of the control interface and a position of the sensing device relative to the control interface, the sensing device, when placed in an operative position relative to the control interface, generating the indicating data using at least some of the coded data; and effecting, in the computer system and from the indicating data, at least one operation relating to the at least one command. June 5, 2008– ב' בסיון התשס"ח _________ ]11[]21[ ]54[ COMPOSITIONS CONTAINING A NON-STEROIDAL ANTIINFLAMMATORY DRUG ]22[ ]31[ 30.11.2000 9929077.7 ]32[ 09.12.1999 9929078.5 09.12.1999 Int. Cl.8 A61K 009/00 RECKITT BENCKISER HEALTHCARE (UK) LIMITED, UNITED KINGDOM WO/2001/041733 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733 ]51[ ]71[ ]87[ ]74[ [57] A compressed tablet composition comprising: a granular component comprising a plurality of solidified melt granules of a non-steroidal antiinflammatory drug having a melting point in the range of 30-300 oC and incorporating a disintegrant uniformly dispersed therein; characterised in that the granules comprise a continuous phase of 150030 תכשירים המכילים תרופה אנטי–דלקטית לא–סטרואידית ]33[ GB GB ,פרל כהן צדק לצר ,12704 .ד. ת, 5 רח' שנקר,1 ים-מרכז גב הרצליה said anti-inflammatory drug obtainable by combining the non-steroidal antiinflammatory drug in fully molten form with the disintegrant and further characterised in that the tablet composition comprises silicon dioxide present in an amount of 0.05-5.0% by weight of the composition. _________ ]11[]21[ 150069 שיטות להשתמש בספריות אקראיות של חלבוני אצבע עם אבץ לזיהוי פעולה של גן ]54[ METHODS OF USING RANDOMIZED LIBRARIES OF ZINC FINGER PROTEINS FOR THE IDENTIFICATION OF GENE FUNCTION ]22[ ]31[ ]51[ ]71[ 06.12.2000 09/456100 ]32[ 06.12.1999 ]33[ US Int. Cl.8 C12N 005/16, 015/10, 015/12, C40B 004/00800 SANGAMO BIOSCIENCES, INC., U.S.A. June 5, – ב' בסיון התשס"ח 1052 2008 ]72[ ]87[ ]74[ CASEY CHRISTOPHER CASE, QIANG LIU, EDWARD J. REBAR, ALAN P. WOLFFE WO/2001/040798 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A method of identifying a gene or genes associated with a selected phenotype, the method comprising the steps of: (a) providing a nucleic acid library comprising nucleotide sequences that encode at least partially randomized zinc finger proteins; (b) transducing cells with expression vectors, each comprising a nucleotide sequence from the library; (c) culturing the cells so that zinc finger proteins are expressed in the cells, The applications for division from this application have not yet been published ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם wherein the zinc finger proteins modulate gene expression in at least some of the cells; (d) assaying the cells for a selected phenotype and determining whether or not the cells exhibit the selected phenotype; and (e) identifying, in cells that exhibit the selected phenotype, the gene or genes whose expression is modulated by expression of a zinc finger protein, wherein the gene so identified is associated with the selected phenotype. ,187848 בקשות חלוקה מבקשה זו .שטרם פורסמו _________ ]11[]21[ 150126 –8(–(פיפרזיניל4 ,קואינולינל)מתיל)בנזאמידים תכשירי רוקחות המכילים אותם ושימושם בהכנת תרופות עבור תרפיה ]54[ 4-(PIPERAZINYL(8QUINOLINYL)METHYL)BENZAMIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR THERAPY ]22[ ]31[ ]51[ ]71[ ]72[ 15.12.2000 9904673-2 ]32[ 20.12.1999 ]33[ SE Int. Cl.8 A61K 031/395, A61P 029/00, C07D 401/10, 401/14, 405/14, 409/14 ASTRAZENECA AB, SWEDEN CHRISTOPHER WALPOLE, NIKLAS PLOBECK, WILLIAM BROWN WO/2001/045637 LUZZATTO & LUZZATTO, ,לוצאטו את לוצאטו INDUSTRIAL PARK, OMER, באר,5352 .ד. ת, עומר,גן תעשייה P.O.B. 5352, שבע BEER-SHEVA 84152 ]87[ ]74[ 1053 June 5, 2008– ב' בסיון התשס"ח [57] A compound of the formula wherein R1 is selected from (i) phenyl; (ii) pyridinyl (iii) thiophenyl (iv) furanyl (v) imidazolyl June 5, – ב' בסיון התשס"ח 1054 2008 (vi) triazolyl where each phenyl ring and heteroaromatic ring may optionally and independently be further substituted by 1, 2 or 3 substituents selected from straight and branched C1-C6 alkyl, NO2, CF3, C1-C6 alkoxy, chloro, fluoro, bromo, and iodo; as well as pharmaceutically acceptable salts thereof and isomers thereof. _________ ]11[]21[ 150172 מערכת רדיו עם ממשק תקשורת אוניברסלי ]54[ RADIO SYSTEM WITH UNIVERSAL COMMUNICATION INTERFACE ]22[ ]31[ ]51[ ]71[ 15.12.2000 9929634.5 ]32[ 16.12.1999 ]33[ GB Int. Cl.8 H04B 001/38, 001/40, 001/44, 007/26, H04M 001/00, 001/247 SELEX COMMUNICATIONS LIMITED, UNITED KINGDOM WO/2001/045282 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] A radio system comprising a radio, a switch unit adapted to be connected to the radio and a PTT switch forming part of the switch unit and arranged so that, when operated, it allows a user to transmit over a first communications system using the radio, characterised in that the switch unit 1055 is designed to be releasably connected to the radio and includes a second PTT switch, and in that the system includes means for connecting the second PTT switch so that, when operated, it allows the user to transmit over a second communications system. June 5, 2008– ב' בסיון התשס"ח ___________ 150201 1056 2008 []11[]21 ב' בסיון התשס"ח – June 5, תהליך,תולדות פיפרידין ופיפרזין חדשות תכשירי רוקחות המכילים אותן,להכנתן ושימושן בתראפיה ]54[ PIPERIDINE AND PIPERAZINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE THEREOF IN THERAPY ]22[ ]31[ ]51[ 18.12.2000 9904738-3 ]32[ 22.12.1999 ]33[ SE Int. Cl.8 A61K 031/395, A61P 011/00, 019/00, 029/00, 037/02, 043/00, C07D 211/34, 211/54, 241/04, 401/12, 403/04, 403/14, 413/12, 451/02, 471/02, 473/34, 487/02, 495/04, 513/04 ASTRAZENECA AB, SWEDEN PREMJI MEGHANI, COLIN BENNION WO/2001/046200 LUZZATTO & LUZZATTO, ,לוצאטו את לוצאטו INDUSTRIAL PARK, OMER, באר שבע,5352 .ד. ת, עומר,גן תעשייה P.O.B. 5352, BEER-SHEVA 84152 ]71[ ]72[ ]87[ ]74[ [57] A compound of the formula wherein, X represents a nitrogen atom or a group C(R5); Y represents an oxygen or sulphur atom or a group NR6; either R1 and R2 each independently represent a hydrogen atom or a C1-C4 alkyl group but do not both simultaneously represent a hydrogen atom, or R1 and R2 together represent a group – CH2ZCH2-; Z represents a bond, an oxygen or sulphur atom or a group CH2 or NR7; m is 0 or 1; R3 represents a 5- to 10-membered unsaturated ring system which may comprise from 1 to 4 ring heteroatoms independently selected from nitrogen, 1057 oxygen and sulphur, the ring system being optionally substituted by one or more substituents independently selected from halogen, nitro, cyano, NR8R9, C1-C4 alkylC(O)NH-, NHR12C(O)-, C1-C4 alkyl-SO2-, C1-C4 alkyl-SO2NH-, C1-C4 alkyl-NHSO2-, C1-C4 alkoxy, and C1-C4 alkyl optionally substituted by one or more fluorine atoms; R4 represents a phenyl or pyridinyl group, each of which is substituted in an ortho position with a substituent selected from halogen, C1-C4 alkoxy, C1-C4 alkylthio, and C1-C4 alkyl optionally substituted by one or more fluorine atoms, the phenyl or pyridinyl group being optionally further substituted by one or more substituents June 5, 2008– ב' בסיון התשס"ח independently selected from halogen, cyano, hydroxyl, C1-C4 alkylthio, C1-C4 alkyl, -NH-, NHR18, C1-C4 alkyl-, C1-C4 alkyl-SO2-, C1-C4 alkyl-SO2NH-, C1-C4 alkyl-NHSO2-, C1-C4 alkyl-C(O)NH-, C1C4 alkyl-NHC(O)-, -D-G, C1-C4 alkoxy optionally substituted by –NR14R15 or by R16, and C1-C4 alkyl optionally substituted by one or more fluorine atoms or by one or more hydroxyl groups, or R4 represents a 9- or 10-membered unsaturated bicyclic ring system selected from naphthyl, benzimidazolyl, quinolinyl, indolinyl, isoquinolinyl, benzofuranyl, isobenzofuranyl, benzothienyl, indolyl, isoindolyl, benzthiazolyl and benzoxazolyl, the bicyclic ring system being optionally substituted by one or more substituents independently selected from halogen, oxo C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylthio and –NR10R11; D represents an oxygen atom or a group (CH2)n or CH2NH; n is 1, 2 or 3; G represents a piperazinyl, morpholinyl or 2, 5-diazabicyclo [2.2.1] heptyl group, or G represents a piperidinyl group optionally substituted by amino; R5 represents a hydrogen atom, or a hydroxyl or C1-C4 alkoxy group; R6 represents a hydrogen atom, or a cyano, nitro, hydroxyl, C1-C4 alkyl or C1-C4 alkoxy group; R7, R8 and R9 each independently represent a hydrogen atom or a C1-C4 alkyl group; R10 and R11 each independently represent a hydrogen atom or a C1-C4 alkyl group, or R10 and R11 together with the nitrogen atom to which they are attached form a 5or 6-membered saturated heterocyclic ring comprising one or two ring nitrogen atoms; R12 represents a hydrogen atom, or a C1-C14 alkyl group optionally substituted by amino; R13 represents a hydrogen atom, or a C1-C4 alkyl group optionally substituted by hydroxyl; R14 and R15 each independently represent a hydrogen atom or a C1-C4 alkyl group optionally substituted by hydroxyl, or R14 and R15 together with the nitrogen atom to which they are attached form a 5- or 6membered saturated heterocyclic ring comprising one or two ring nitrogen atoms; and R16 represents a 1-(C1-C4alkyl)-piperidinyl group; with the proviso that when m is 0, X is N and Y is O, then R4 does not represent 2-benzothiazolyl; or a pharmaceutically acceptable salt or solvate thereof. __________ ]11[]21[ June 5, – ב' בסיון התשס"ח 150366 1058 2008 ]54[ 4-PHENYL-1-PIPERAZINYL,PIPERIDINYL AND – TETRAHYDROPYRIDYL DERIVATIVES ,–פיפראזיניל1––פאניל4 תולדות –פיפרידיניל,פיפראזיניל וטטרההידרופירידיל ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 22.12.2000 PA199901887 ]32[ 30.12.1999 ]33[ DK Int. Cl.8 A61K 031/395, A61P 025/00, C07D 295/04, 401/06, 401/12, 403/06, 403/12 H. LUNDBECK A/S, DENMARK WO/2001/049679 DR. YITZHAK HESS & PARTNERS, ,ד"ר יצחק הס ושותפיו 279 HAYARKON ST., תל אביב,6451 .ד. ת, 279 רחוב הירקון P.O.B. 6451, TEL AVIV 61063 [57] A compound of the formula wherein W is C, CH or N, and the dotted line emanating from W indicates a bond when W is C and no bond when W is N or CH; R1 and R2 are independently selected from hydrogen and halogen, provided at least one of R1 and R2 is a halogen atom; R3 is selected from hydrogen, halogen, C16-alkyl, C2-6-alkenyl, C2-6-alkynyl, trifluoromethyl, C1-6-alkoxy, aryloxy, aralkoxy, hydroxy, amino C1-6-alkylamino, di(C1-6-alkyl) amino, nitro and cyano; n is 2, 3, or 5; X is CH, CO, CS, SO or SO2; and Q is an optionally substituted 1-indolinyl group of the formula wherein R4, R5, R6, R7, R8 and R9 are independently selected from hydrogen, halogen, trifluoromethyl, nitro, cyano, C16-alkyl, C2-6-alkenyl, C2-6-alkenyl, C1-6alkoxy, C1-6alkylthio, C1-6-alkylsulfonyl, hydroxy, hydroxy-C1-6 alkyl, amino, C1-6- alkylamino, di(C1-6-alkyl) amino, acyl, aminocarbonyl, C1-6-alkylaminocarbonyl and di(C1-6-alkyl) aminocarbonyl; and any of its enatiomers and acid addition salts thereof. 1059 June 5, 2008– ב' בסיון התשס"ח ,186954 The applications for division from this application have not yet been published בקשות חלוקה מבקשה זו .שטרם פורסמו __________ ]11[]21[ 150736 )MVA( נגיף ווציניה אנקארה ששונה ]54[ MODIFIED VACCINIA VIRUS ANKARA (MVA) ]22[ ]31[ ]51[ ]71[ 10.03.2001 PA200000410 ]32[ 14.03.2000 ]33[ DK Int. Cl.8 C12N 007/00, 007/08, 015/39, 015/863 BAVARIAN NORDIC A/S, DENMARK WO/2001/068820 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] A modified vaccinia virus Ankara adapted for growing in cells of a The applications for division from this application have not yet been published continuous cell line, wherein said cell line is a Vero cell line. ,188667 בקשות חלוקה מבקשה זו .שטרם פורסמו _________ ]11[]21[ 150842 תהליכים,–פירולידין1––אוקסו2 תולדות להכנתם והשימוש בהן ]54[ 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 21.02.2001 0004297.8 ]32[ 23.02.2000 ]33[ GB Int. Cl.8 A61K 031/4015, A61P 025/08, C07D 207/27, 403/04, 409/04 UCB, S.A., BELGIUM WO/2001/062726 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 June 5, – ב' בסיון התשס"ח 1060 2008 [57] Compounds of the formula or a pharmaceutically acceptable salt thereof, wherein X is –CA1NR5R6 or or –CA1-R8; A1 and A2 are indepdnently oxygen, sulfur or – NR9; R1 is hydrogen, C1-20 alkyl alkyl, aryl or –CH2R1a wherein R1a is aryl, heterocycle, halogen, hydroxy, amino, nitro or cyano; R3 is hydrogen, halogen, thiol, nitro, nitrooxy, cyano, azido, carboxy, amido, sulfonic acid, sulfonamide, C1-20 alkyl, alkenyl, alkynyl, ester, ether, aryl, heterocycle, alkynyloxy, acyloxy, oxyester, oxamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy, aralkoxy, heterocyclooxy or a thio derivative, acyl derivative, sulfonyl derivative or sulfinyl derivative; R3a is hydrogen, halogen, C1-C20 alkyl, alkenyl, alkynyl or aryl; R5, R6 and R9 are the same or different and each is independently hydrogen, hydroxy, C1-20 alkyl, aryl, heterocycle or an oxy derivative; and R8 is hydrogen, hydroxy, thiol, halogen, C1-20 alkyl, aryl, heterocycle or a thio derivative; each alkyl may independently be optionally substituted by 1 to 5 halogen, hydroxy, thiol amino, nitro, cyano, thiocyanate, acyl, acyloxy, sulfonyl derivative, sulfinyl derivative, alkylamino, carboxy, ester, ether, amido, azido, cycloalkyl, sulfonic acid, sulfonamide, thio derivative, oxyester, oxyamido, heterocycle, vinyl, C1-5 alkoxy, C6-10 aryloxy, or C6-10 aryl; each aryl may independently be optionally substituted by 1061 1 to 5 halogen, hydroxy, thiol, amino, nitro, cyano, acyl, acyloxy, sulfonyl, sulfinyl, alkylamino, carboxy, ester, ether, azido, suflonic acid, sulfonamide, alkylsulfonyl, alkylsulfinyl, alkylthio, oxyester, oxyamido, aryl, C1-6 alkoxy, C6-10 aryloxy, C1-6 alkyl, C1-6 haloalkyl; each heterocycle may independently be optionally substituted by one or more alkyl, halogen, hydroxy, thiol, amino, nitro, cyano, thiocyanato, acyl, acyloxy, sulfonyl derivative, sulfinyl derivative, alkylamino, carboxy, ester, ether, amino azido, cycloalkyl, sulfonic acid, sulfonamide, thio derivative, oxyester, oxyamido, heterocycle, vinyl, C1-5 alkoxy, C6-10 aryloxy or C6-10 aryl; each alkenyl and alkynyl may independently be optionally substituted by at least one halogen, hydroxy, thiol, amino, nitro, cyano, aryl or heterocycle; with the provisos that at least one of R3 and R3a is other than hydrogen; and that when the compound is a mixture of all possible isomers, X is –CONR5R6, A2 is oxygen and R1 is hydrogen, methyl, ethyl, or propyl then substitution on the pyrrolidine ring is other than mono-, di-methyl or mono- ethyl; and that when R1 and R3a are both hydrogen, A2 is oxygen and X is – CONR5R6 then R3 is different from carboxy, ester, amido, substituted oxopyrrolidine, methyl, naphthyl, phenyl optionally substituted by oxy derivatives or in the para position by an halogen atom. June 5, 2008– ב' בסיון התשס"ח Claimed as novel are neurological intermediate compounds of the formula wherein X, R1, R3 and R3a are as defined above and Q1 together with the oxygen to which it is attached is a leaving group. The applications for division from this application have not yet been published ,170181,170071 בקשות חלוקה מבקשה זו .שטרם פורסמו ___________ ]11[]21[ ]54[ MAGNETIC COUPLING SYSTEM ]22[ ]51[ ]71[ ]74[ 22.07.2002 Int. Cl.8 F04D 013/10, F16D 007/00 MAYTRONICS LTD. WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [57] A magnetic coupling system (10), comprising: a housing (2) having a tightly closable cover member (4) and defining a dry domain; an electric motor (8) mountable inside said housing and fixedly attached to said cover member by means of a hollow base member (12), said motor having a first drive shaft (16), a driving end of the first drive shaft entering and being mountable in said base member; a first disk-like member (24) keyed to the driving end of said first drive shaft; a first ferromagnetic tubular section (30) fixedly attached to a rim (28) of said disk-like member, a first unit of permanent magnets June 5, – ב' בסיון התשס"ח 150848 מערכת צימוד מגנטית עמק יזרעאל,מיטרוניקס בע"מ , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, (32) comprised of a plurality of permanent magnets fixedly attached to the inside surface of said first ferromagnetic tubular section; a chamber (34) delimited by a substantially cylindrical wall (36) and constituted by a first, substantially bowllike structure (35), descending from said cover member and separating the dry domain prevailing below outside the chamber from a wet domain prevailing above and inside the chamber; a second disk-like member (38) keyed to, or integral with, a second drive shaft (40) mounted in bearing means (46, 48) said second drive shaft being located outside of said dry 1062 2008 domain and adapted to drive an impeller (54); a second ferromagnetic tubular section (42) fixedly attached to the rim of said second disk-like member; a second unit of permanent magnets (44) comprised of a plurality of permanent magnets fixedly attached to the outside surface of said second ferromagnetic tubular section and facing said first unit of magnets, said chamber wall being interposed with clearance between the first and the second unit of permanent magnets; wherein said first unit of permanent magnets, when rotated by said first drive shaft, drags along the second unit of permanent magnets by magnetic effect, thereby causing said second drive shaft to be rotated and to operate said impeller. __________ 1063 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ 150965 גורם תרפויטי או מניעתי לכיב דלקתי של המעי הגס ולמחלת קרוהן המכיל תולדת דיאמינוטריפלואורומתילפירידין ]54[ THERAPEUTIC OR PREVENTIVE AGENT FOR ULCERATIVE COLITIS AND CROHN'S DISEASE CONTAINING A DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVE ]22[ ]31[ ]51[ ]71[ ]72[ 30.01.2001 2000-22817 ]32[ 31.01.2000 ]33[ JP Int. Cl.8 A61K 031/44, A61P 001/00, C07D 213/72, 405/12, 409/12 ISHIHARA SANGYO KAISHA LTD., JAPAN SHUICHI YOTSUYA, HIROHIKO KIMURA, TADAO BAMBA WO/2001/056568 EITAN MEHULAL LAW GROUP, – קבוצת איתן – מהולל עורכי דין 10 ABBA EBEN BLVD., ,עורכי פטנטים P.O. B. 2081, ,2081 .ד. ת, 10 שדרות אבא אבן HERZLIYA 46120 הרצליה ]87[ ]74[ [57] A therapeutic or preventive agent for ulcerative colitis and Crohn's disease, containing as an active ingredient a diaminotrifluormethylpyridine derivative represented by the formula or its salt: wherein X is a –CW1R1 group a, – COCOR2 group, a –CW1NHCOR2 group, a –C(=W1)W2R3 group or a –CW1N(R4)R5 group; Y is an alkyl group, a –CW3R6 group, a – COCOR7 group, a –NHCOR7 group, a –C(=W3)W4R8 group, a – (NH)nSO2R9 group, a –(NH)mSO2R9 group, a –(NH)mSO2OR10 group or a – (NH)mSO2N(R11)R12 group; each of R1, R6 and R9 which are independent of one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon June 5, – ב' בסיון התשס"ח group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted; each of R2 and R7 which are independent of each other, is an alkyl group which may be substituted, an alkoxy group which may be substituted, a phenyl group which may be substituted or a phenoxy group which may be substituted; each of R3, R8 and R10 which are independent of one another, is an alkyl group which may be substituted, an alkenyl group which may be substituted, an alkynyl group which may be substituted, a cycloalkyl group 1064 2008 which may be substituted or a benzyl group which may be substituted; each of R4, R5, R11 and R12 which are independent of one another, is an alkyl group which may be substituted; each of W1, W2, W3 and W4 which are independent of one another, is an oxygen atom or a sulfur atom; and m is 0 or 1, excluding a case where one of X and Y is a –COCF2X1 group (wherein X1 is a hydrogen atom, a halogen atom, an alkyl group or a haloalkyl group), and the other is a – COCF2X2 group (wherein X2 is a hydrogen atom, a halogen atom, an alkyl group, a haloalkyl group or an alkylcarbonyl group), a –COOX3 group (wherein X3 is an alkyl group which may be substituted or a phenyl group which may be substituted) or a –COX4 group (wherein X4 is an alkyl group, a haloalkyl group, an alkenyl group, an alkynyl group, a phenyl group which may be substituted, a furanyl group or a naphthyl group). __________ ]11[]21[ ]54[ COMBINATION OF AZELASTINE WITH SUBSTANCES WHICH INFLUENCE LEUKOTRIENE ACTION FOR THE TREATMENT OF RHINITIS/CONJUNCTIVITIS ]22[ ]31[ ]51[ ]71[ 05.02.2001 10007203.8 ]32[ 17.02.2000 Int. Cl.8 A61K 031/55, 045/00, 045/06 MEDA PHARMA GMBH & CO. KG, GERMANY HILDEGARD KUSS, JURGEN ENGEL, ISTVAN SZELENYI WO/2001/060407 G.E. EHRLICH (1995) LTD., AYALON TOWER, 15TH FLOOR, 11 MENACHEM BEGIN ST., RAMAT GAN 52521 ]72[ ]87[ ]74[ [57] Pharmaceutical preparation for the treatment of allergic and/or vasomotor rhinitis or allergic conjunctivitis which is suitable for topical or oral administration of single doses, with the following ingredients, separately or together: (a) an effective amount of azelastine; (b) an effective amount of a leukotriene antagonist or of one of its 151106 תכשיר המכיל אזלאסטין וחומרים המשפיעים על פעולת לאוקוטריאן לטיפול דלקת עיניים/ בדלקת האף ]33[ DE ,) בע"מ1995( ארליך.אי.ג'י ,11 רחוב מנחם בגין, 15 קומה,מגדל אילון רמת גן pharmaceutically acceptable salts selected from a group consisting of a leukotriene D4 antagonist or a 5-lipoxygenase inhibitor or a FLAP antagonist; (c) converntional physiologically acceptable carriers and/or extenders or excipients. __________ 1065 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ HEARTBURN AND REFLUX DISEASE TREATMENT APPARATUS WITH WIRELESS ENERGY SUPPLY ]22[ ]31[ ]51[ ]71[ 08.02.2001 09/501266 ]32[ 09.02.2000 Int. Cl.8 A61B 017/12, A61F 002/06 OBTECH MEDICAL AG, SWITZERLAND WO/2001/047432 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 ]87[ ]74[ [57] A heartburn and reflux disease treatment apparatus comprising: a restriction device (4) implantable in a patient, who suffers from heartburn and reflux disease, for engaging the stomach close to the cardia or engaging the esophagus, to form a restricted food passageway in the stomach or esophagus, the restriction device being operable to change the restriction of the food passageway; an energy transmission device (10) for wireless transmission of energy from outside the patient's body to inside the patient's body; and an energy 151134 מתקן לטפול בצרבת ובמחלת רפלוקס בעל אספקת אנרגיה אלחוטית ]33[ US , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר transforming device (6) implantable in the patient and comprising at least one electrical junction element having a positive region and a negative region, the junction element being capable of creating an electric field between the positive and negative regions when exposed to the energy transmitted by the energy transmission device, the electric field producing electrical energy for use in connection with the operation of the restriction device including to enlarge or restrict the food passageway, when the restriction device is implanted. _________ June 5, – ב' בסיון התשס"ח 1066 2008 ]11[]21[ 151249 שימוש בציאנוקינולינים לטיפול ועיכוב פוליפים במעי הגס ]54[ USE OF CYANOQUINOLINES FOR TREATING OR INHIBITING COLONIC POLYPS ]22[ ]31[ ]51[ ]71[ 06.03.2001 524196 ]32[ 13.03.2000 ]33[ US Int. Cl.8 A61K 031/47, A61P 001/00, C07D 215/48, 401/12, 405/12, 413/12, 491/04 WYETH HOLDINGS CORPORATION, U.S.A. WO/2001/068186 REINHOLD COHN AND ,ריינהולד כהן ושותפיו PARTNERS, תל אביב,4060 .ד. ת, 21 רחוב אחד העם 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] Use of a compound of the formula wherein: X is cycloalkyl of 3 to 7 carbon atoms, which may be optionally substituted with one or more alkyl of 1 to 6 carbon atom groups; or is a pyridinyl, pyrimidinyl, or phenyl ring; wherein the pyridinyl, pyrimidinyl, or phenyl ring may be optionally mono-,di-, or tri-substituted with a substituent selected from the group consisting of halogen, alkyl of 1-6 carbon atoms, alkenyl of 2-6 carbon atoms, alkynyl of 2-6 carbon atoms, azido, hydroxyalkyl of 1-6 carbon atoms, halomethyl, alkoxymethyl of 2-7 carbon atoms, alkanoyloxymethyl of 2-7 carbon atoms, alkoxy of 1-6 carbon atoms, 1067 alkylthio of 1-6 carbon atoms, hydroxy, trifluoromethyl, cyano, nitro, carboxy, carboalkoxy of 2-7 carbon atoms, carboalkyl of 2-7 carbon atoms, phenoxy, phenyl, thiophenoxy, benzoyl, benzyl, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 2 to 12 carbon atoms, phenylamino, benzylamino, alkanoylamino of 1-6 carbon atoms, alkenoylamino of 3-8 carbon atoms, alkynoylamino of 3-8 carbon atoms, and benzoylamino; n is 0-1; Y is --NH--, --O--, --S--, or –NR--; R is alkyl of 1-6 carbon atoms; R1, R2, R3, and R4 are each, independently, hydrogen, halogen, alkyl of 1-6 carbon June 5, 2008– ב' בסיון התשס"ח atoms, alkenyl of 2-6 carbon atoms, alkynyl of 2-6 carbon atoms, alkenyloxy of 2-6 carbon atoms, alkynyloxy of 2-6 carbon atoms, hydroxymethyl, halomethyl, alkanoyloxy of 1-6 carbon atoms, alkenoyloxy of 3-8 carbon atoms, alkynoyloxy of 3-8 carbon atoms, alkanoyloxymethyl of 2-7 carbon atoms, alkenoyloxymethyl of 4-9 carbon atoms, alkynoyloxymethyl of 4-9 carbon atoms, alkoxymethyl of 2-7 carbon atoms, alkoxy of 1-6 carbon atoms, alkylthio, of 1-6 carbon atoms, alkylsulphinyl of 1-6 carbon atoms, alkylsuphonyl of 1-6 carbon atoms, alkylsulfonamido of 1-6 carbon atoms, alkenylsulfonamido of 2-6 carbon atoms, alkynylsulfonamido of 2-6 carbon atoms, hydroxy, trifluoromethyl, cyano, nitro, carboxy, carbalkoxy of 2-7 carbon atoms, carboalkyl of 2-7 carbon atoms, phenoxy, phenyl, thiophenoxy, benzyl, amino, hydroxyamino, alkoxyamino of 1-4 carbon atoms, alkylamino of 1-6 carbon atoms, dialkylamino of 2 to 12 carbon atoms, aminoalkyl of 1-4 carbon atoms, Nalkylaminoalkyl of 2-7 carbon atoms, N,Ndialkylaminoalkyl of 3-14 carbon atoms, phenylamino, benzylamino, R5 is alkyl of 1-6 carbon atoms, alkyl optionally substituted with one or more halogen atoms, phenyl, or phenyl optionally substituted with one or more halogen, alkoxy of 1-6 carbon atoms, trifluoromethyl, amino, nitro, cyano, or alkyl of 1-6 carbon atoms groups; R6 is hydrogen, alkyl of 1-6 carbon atoms, or alkenyl of 2-6 carbon atoms; R7 is chloro or bromo; June 5, – ב' בסיון התשס"ח 1068 2008 R8 is hydrogen, alkyl of 1 -6 carbon atoms, aminoalkyl of 1-6 carbon atoms, Nalkylaminoalkyl of 2-9 carbon atoms, N,Ndialkylaminoalkyl of 3-12 carbon atoms, N-cycloalkylaminoalkyl of 4-12 carbon atoms, N-cycloalkyl-N-alkylaminoalkyl of 5-18 carbon atoms, N,Ndicycloalkylaminoalkyl of 7-18 carbon atoms, morpholino-N-alkyl wherein the alkyl group is 1-6 carbon atoms, piperidino-N-alkyl wherein the alkyl group is 1-6 carbon atoms, N-alkyl-piperidino-Nalkyl wherein either alkyl group is 1-6 carbon atoms, azacycloalkyl-N-alkyl of 311 carbon atoms, hydroxyalkyl of 1-6 carbon atoms, alkoxyalkyl of 2-8 carbon atoms, carboxy, carboalkoxy of 1-6 carbon atoms, phenyl, carboalkyl of 2-7 carbon atoms, chloro, fluoro, or bromo; Z is amino, hydroxy, alkoxy of 1-6 carbon atoms, alkylamino wherein the alkyl moiety is of 1-6 carbon atoms, dialkylamino wherein each of the alkyl moieties is of 1-6 carbon atoms, morpholino, piperazino, N-alkylpiperazino wherein the alkyl moiety is of 1-6 carbon atoms, or pyrrolidino; m=1-4, q=1-3, and p=0-3; any of the substituents R1, R2, R3 or R4 that are located on contiguous carbon atoms can together be the divalent radical –O– C(R8)2 –O--; or a pharmaceutically acceptable salt thereof with the proviso that when Y is – NH--, R1, R2, R3, and R4 are hydrogen, and n is 0, X is not 2-methylphenyl; for the preparation of a medicament for treating or inhibiting colonic polyps in a mammal susceptible to the formation of colonic polyps. __________ ]11[]21[ 151350 שיטה והתקן לזיהוי אירועים מסויימים ביישום תחנה ניידת ]54[ METHOD AND APPARATUS FOR A MOBILE STATION APPLICATION TO IDENTIFY SPECIFIED EVENTS ]22[ ]31[ ]51[ ]71[ 29.03.2001 09/539495 ]32[ 30.03.2000 ]33[ US Int. Cl.8 H04B 007/26, H04L 012/56, 029/06 QUALCOMM INCORPORATED, U.S.A. WO/2001/076177 SANFORD T.COLB & CO., ,' קולב ושות.סנפורד ט P.O.B. 2273, רחובות,2273 .ד. ת, מרמורק,4 שער הגיא REHOVOT 76122 ]87[ ]74[ [57] A method for a mobile station application to identify a plurality of specified events, the method comprising: communicating between a mobile station communication protocol stack and a communication network; communicating between the mobile station communication 1069 protocol stack and the mobile station application through a mobile station application interface; enabling, by the mobile station application interface, at least one of the specified events based on the state of the mobile station application interface; and identifying, by the mobile June 5, 2008– ב' בסיון התשס"ח station application, the specified events that are enabled. __________ ]11[]21[ 151417 פיראזין וטריאזין, פירימידין,תולדות פירידין המותמרות באריל ותכשירי רוקחות המכילים אותן ]54[ ARYL SUBSTITUTED PYRIDINE, PYRIMIDINE, PYRAZINE AND TRIAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME ]22[ ]31[ ]51[ ]71[ 12.03.2001 60/188188 ]32[ 10.03.2000 ]33[ US Int. Cl.8 A61K 031/395, C07D 213/24, 213/60, 241/14, 251/14, 251/24 EURO-CELTIQUE S.A., LUXEMBOURG WO/2001/068612 WOLFF, BREGMAN AND GOLLER, , ברגמן וגולר,וולף P.O.B. 1352, ירושלים,1352 .ד. ת, JERUSALEM 91013 ]87[ ]74[ [57] A compound of the formula or a pharmaceutically acceptable salt, June 5, – ב' בסיון התשס"ח 1070 2008 ester, amide or solvate thereof, wherein: Y is provided that when Y is R7, R1 is aminocarbonyl; A1, A2 and A3 are independently CR2 or N, provided that A1, A2 and A3 are not all N at the same time; R1 is selected from the group consisting of alkyl optionally substituted with halogen, halo (C1-6) alkyl, hydroxy (C1-6) alkyl, amino (C1-6) alkyl, hydroxy, nitro, C1-6 alkyl, alkoxy, and amino, amino, alkylthio, C(O)R8, SO2R8, OC(O)NH2, 2imidazolinyl, 2-imidazolyl, 3-pyrazolyl, 5isoxazolyl, and 3-(1,2,4) – triazolyl; each R2 is selected from the group consisting of hydrogen, alkyl, alkenyl or alkynyl optionally substituted with halogen, halo (C1-6) alkyl, hydroxy (C1-6) alkyl, amino (C1-6) alkyl, hydroxy, nitro, C1-6 alkyl, alkoxy, and amino, halogen, hydroxy, cycloalkyl, cyano, amino, alkylamino, dialkylamino, alkoxy, aminocarbonyl, alkylaminocarbonyl, arylaminocarbonyl, aralkylaminocarbonyl, alkylcarbonylamino, arylcarbonylamino, and aralkylcarbonylamino; R3, R4, R5, and R6 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, halogen, haloalkyl, hydroxyalkyl, hydroxy, nitro, amino, cyano, amido, carboxyalkyl, alkoxyalkyl; ureido, acylamino, thio, acyloxy, azido, alkoxy, carboxy, carbonylamido and alkylthiol; R7 is alkyl optionally substituted with halogen, halo (C1-6) alkyl, hydroxy (C1-6) alkyl, amino (C1-6) alkyl, hydroxy, nitro, C1-6 alkyl, alkoxy, and amino; R8 is selected from the group consisting of alkyl, alkenyl, alkynyl, OR9, amino, 1071 alkylamino, dialkylamino, alkenylamino, alkenylamino, dialkylaminoalkenyl, dialkylaminoalkylamino, dialkylaminoalkenylamino, alkylaminoalkenylamino, hydroxyaminoalkenylamino, cycloalkyl, heterocycloalkyl, cycloalkylalkyalmino, heterocycloalkylamino, aryl, arylalkyl, arylalkenyl, arylalkynyl, and arylalkylamino, all of which can be optionally substituted with halogen, halo (C1-6) alkyl, hydroxy (C1-6) alkyl, amino (C1-6) alkyl, hydroxy, nitro, C1-6 alkyl, alkoxy, and amino, provided that R8 is not OR9 when R1 is SO2R8; wherein R9 is selected from the group consisting of hydrogen, alkyl optionally substituted with halogen, halo (C1-6) alkyl, hydroxy (C1-6) alkyl, amino (C1-6) alkyl, hydroxy, nitro, C1-6 alkyl, alkoxy, and amino, and an alkali metal; and X is one of O, S, NH, or CH2 when Y is other than R7; or X is one of O, S, NH, CH2 or absent when Y is R7; with the provisos that: (1) R2 is not methoxy if R5 is trifluromethyl, R6 is H, X is O and R1 is SO2CH2Ph; (2) R2 is not NH2 if R1 is methylthio, X is O and two of A1, A2 and A3 are N; (3) R2 is not methyl if R1 is SO2R8, wherein R8 is methylphenyl, R3 and R4 are methoxy, X is S and two of A1, A2 and A3 are N; or (4) R2 is not CCl3 if R1 is CCl3, X is S and two of A1, A2 and A3 are N; (5) R1 and R2 are not both NH2 if X is O or S and two of A1, A2 and A3 are N; or June 5, 2008– ב' בסיון התשס"ח (6) R2 is not alkylcarbonylamino if R1 is NH2; X is O; R3, R4, R5 and R6 are each hydrogen; and A1 and A3 are N. __________ ]11[]21[ 151518 – 4,3,1 – – אלקוקסי5 – – פניל3 – און מותמר ושיטה2– אוקסדיאזול להכנה ]54[ SUBSTITUTED 3-PHENYL- 5ALKOXY- 1,3,4- OXDIAZOL-2 – ONE AND METHOD FOR ITS PREPARATION ]22[ ]31[ 20.02.2001 19910968.3 ]32[ 07.03.2000 ]33[ DE 10102265.4 18.01.2001 DE Int. Cl.8 A61K 031/4245, A61P 003/06, C07D 271/113, 413/12, 413/14 SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY WO/2001/066531 EITAN, PEARL, LATZER AND , לצר וכהן צדק, פרל,איתן COHEN ZEDEK, הרצליה,12688 .ד. ת, 7 רחוב שנקר P.O.B. 12688, HERZLIYA 46733 ]51[ ]71[ ]87[ ]74[ [57] A compound of the formula in which the meanings are: R1 C1-C6-alkyl, C3-C9-cycloalkyl, it being possible for both groups to be substituted one or more times by phenyl, C1-C4alkyloxy, S-C1-C4-alkyl, N(C1-C4-alkyl)2, and for phenyl in turn to be substituted one or more times by halogen, C1-C4-alkyl, C1C4-alkyloxy, nitro, CF3; and R2, R3, R4 and R5 independently of one another hydrogen, halogen, nitro, C1-C4alkyl, C1-C9-alkyloxy; June 5, – ב' בסיון התשס"ח C6-C10-aryl-C1-C4-alkyloxy, C6-C10aryloxy, C6-C10-aryl, C3-C8-cycloalkyl or O-C3-C8-cycloalkyl, each of which may be substituted once, twice or three times by halogen, CF3, C1-C4-alkyloxy or C1-C4alkyl; 2-oxopyrrolidin-1-yl, 2, 5-dimethylpyrrol1-yl or NR6-A-R7, with the proviso that R2, R3, R4 and R5 are not simultaneously hydrogen, and at least one of the radicals R2, R3, R4 or R5 is the radical 2- 1072 2008 oxopyrrolidin-1-yl, 2, 5-dimethylpyrrol-1yl or NR6-A-R7, with R6 hydrogen, C1-C4-alkyl or C6-C10-arylC1-C4-alkyl, where aryl may be substituted by halogen, CF3, C1-C8-alkyloxy or C1-C4alkyl; A a single bond, COn, SOn or CONH; n 1 or 2; R7 hydrogen; C1-C18-alkyl or C2-C18-alkenyl, each of which may be substituted once to three times by C1-C4-alkyl, halogen, CF3, C1-C4alkyloxy, N(C1-C4-alkyl)2, -COOH, C1-C4alkyloxycarbonyl, C6-C12-aryl, C6-C12aryloxy, C6-C12-arylcarbonyl, C6-C10-arylC1-C4-alkyloxy or oxo, where aryl in turn may be substituted by halogen, C1-C4alkyl, aminosulfonyl or methylmercapto; C6-C10-aryl-C1-C4-alkyl, C5-C8-cycloalkylC1-C4-alkyl, C5-C8-cycloalkyl, C6-C10-arylC2-C6-alkenyl, C6-C10-aryl, diphenyl, diphenyl-C1-C4-alkyl, indanyl, each of which may be substituted once or twice by C1-C18-alkyl, C1-C18-alkyloxy, C3-C8- cycloalkyl, COOH, hydroxyl, C1-C4alkylcarbonyl, C6-C10-aryl-C1-C4-alkyl, C6C10-aryl-C1-C4-alkyloxy, C6-C10-aryloxy, nitro, cyano, C6-C10-aryl, fluorosulfonyl, C1-C6-alkyloxycarbonyl, C6-C10arylsulfonyloxy, pyridyl, NHSO2-C6-C10aryl, halogen, CF3 or OCF3, where alkyl may be substituted again by C1-C4alkyloxycarbonyl, CF3 or carboxyl, and aryl by halogen, CF3 or C1-C4-alkyloxy; or the group Het-(CH2)r-, with r=0, 1, 2 or 3 and Het = saturated or unsaturated 5-7membered heterocycle which may be benzo-fused and substituted by C1-C4alkyl, C6-C10-aryl, halogen, C1-C4alkyloxy, C1-C4-alkyloxycarbonyl, C6-C10aryl-C1-C4-alkyl, C6-C10-aryl-C1-C4alkylmercapto or nitro, where benzo-fused aryl may in turn be substituted by halogen, C1-C4-alkyloxy or CF3 and alkyl in arylalkyl by methoxy and CF3, and the pharmacologically suitable salts and acid addition salts thereof. __________ ]11[]21[ ]54[ VARIABLE OPTICAL POWER SPECTACLES FOR EYESIGHT REHABILITATION AND METHODS FOR LENS OPTICAL POWER CONTROL ]22[ ]51[ ]71[ 04.09.2002 Int. Cl.8 G02C 007/00 JOSEF BEKERMAN ANATOLY BEKKERMAN ]74[ GOLD-PATENTS & FINANCIAL SERVICES LTD., 43 RUBINSTEIN ST., HAIFA 34987 [57] Eyesight rehabilitation optical device for improving the eyesight of a user, said optical device comprises: at least one liquid lens (14) of two liquid lenses, each liquid lens comprises two juxtaposed 1073 151592 משקפיים בעלות כוח אופטי משתנה לשיקום הראיה ושיטה לבקרת כוח אופטי של העדשה חיפה,יוסף בקרמן חיפה,אנטולי בקרמן ,) בע"מ1992( פטנטים וייעוץ כלכלי-גולד חיפה,43 רובינשטיין transparent membranes (20) that confine an amount of transparent liquid in a gap (22) between said two juxtaposed transparent membranes, wherein at least one of said two juxtaposed transparent June 5, 2008– ב' בסיון התשס"ח membranes is an elastic membrane having changeable curvature that changes upon change in the amount of transparent liquid; a rim (12) for supporting said at least one liquid lens of two liquid lenses opposite an eye of the user; two shafts (16) provided on said rim, wherein at least one shaft of said two shafts is provided with a cavity (27) that is fluidically connected to said gap in the liquid lens that resides next to said at least one shaft, and wherein said cavity is provided with additional transparent liquid; a flexible container (25) that is connected to said at least one shaft, wherein said flexible container is fluidically connected to said cavity; whereby portions of said additional transparent liquid adds up to the amount of transparent liquid in the gap between said two juxtaposed transparent membranes upon changes in the inclination of the two shafts from substantially horizontal position to a position in which the liquid lens is downwardly moved, and wherein when the user wears the optical device and inclines his head forwards, the curvature of the liquid lens is changed while rendering the liquid lenses autofocus features. _________ June 5, – ב' בסיון התשס"ח 1074 2008 ]11[]21[ 151626 , תהליך להכנתן,תרכובות קווינאזולין תכשירי רוקחות המיכלים אותן והשימוש בהן בייצור תרופות ליצירת השפעה נוגדת או השפעה המפחיתה/היווצרותכלי–דם ו חדירות כלי–דם בחיה בעלת דם חם ]54[ QUINAZOLINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE THEREOF IN THE MANUFACTURE OF MEDICAMENTS FOR THE PRODUCTON OF AN ANTIANGIOGENIC AND /OR VASCULAR PERMEABILITY REDUCING EFFECT IN A WARMBLOODED ANIMAL ]22[ ]31[ 03.04.2001 00400967.6 ]32[ 07.04.2000 ]33[ EP 00400968.4 07.04.2000 EP 00401034.4 13.04.2000 EP 00401033.6 13.04.2000 EP Int. Cl.8 A61K 031/505, A61P 035/00, C07D 239/94, 403/00, 417/02 ASTRAZENECA AB, SWEDEN WO/2001/077085 S. HOROWITZ & CO., ,' הורוביץ ושות.ש ZION HOUSE, תל,41-45 שדרות רוטשילד,בית ציון 41-45 ROTHSCHILD BLVD., אביב TEL AVIV 65784 ]51[ ]71[ ]87[ ]74[ [57] A compound of the formula [wherein: ring A is phenyl; 1075 Z is –O-, -NH- or –S-; m is an integer from 0 to 5 inclusive; June 5, 2008– ב' בסיון התשס"ח R1 is hydrogen, hydroxy, halogen, nitro, trifluormethyl, cyano, C1-3 alkyl, C1-3 alkoxy, C1-3 alkylthio, or –NR5R6 (wherein R5 and R6, which may be the same or different, are hydrogen or C1-3 alkyl); R2 is hydrogen, hydroxy, halogeno, C1-3 alkyl, C1-3 alkoxy, trifluoromethyl, amino or nitro; R3 is hydroxy, halogeno, C1-3 alkyl, C1-3 alkoxy, C1-3 alkanoyloxy, trifloromethyl, cyano, amino or nitro; X1 is –O-, -CH2-, -S-, -SO-, -SO2-, NR7-, NR7CO-, -CONR7-, -SO2NR7 – OR – NR7SO2-, (wherein R7 is hydrogen, C1-3 alkyl or C1-3 alkoxy C2-3 alkyl); R4 is selected from one of the following groups: (1) –Y1X2COR8 [wherein –Y1 – is a C2-5 alkylene chain wherein each methylene group (other than that of the α-carbon) is optionally substituted by 1 substitutuent independently selected from hydroxy, halogeno, amino and C1-4 alkanoyloxy, provided that there is at least 1 and no more than 3 substituents on the C2-5 alkylene chain; X2 is –O- or –NR9- (in which R9 is hydrogen, C1-3 alkyl or C1-3 alkoxy C2-3 alkyl) and R8 is C1-3 alkyl, NR10R11 or –OR12 (wherein R10, R11 and R12, which may be the same or different, are hydrogen, C1-3 alkyl or C1-3 alkoxy C2-3 alkyl)]; (2) –Y2-X3R13 [wherein –Y2- is C2-5 alkylene, C3-5 alkenylene or C3-5 alkynylene wherein each methylene group (other than that of the α-carbon) is optionally substituted by 1 substituent independently selected from hydroxy, halogeno, amino and C1-4 alkanoyloxy, provided that there is at least 1 substituent and no more than 3 substituents on the alkylene, alkenylene or alkynylene chain; X3 is –O-, -S-, -SO-, -SO2-, -OCO-, NR7CO-, -CONR7-, SO2NR7- -NR7SO2 – or –NR7 – (wherein R7 is as herein defined) and R13 is hydrogen or C1-3 alkyl, wherein the C1-3 alkyl group may bear one June 5, – ב' בסיון התשס"ח or two substituents selected from oxo, hydroxy, halogeno and C1-4 alkoxy]; (3) –Y1-X6C1-5 alkylR14 [wherein Y1 is as herein defined and X6 is –O-, -S-, -SO-, SO2-; -NR7CO-, -CONR7-, -SO2NR7-m – NR7SO2 or –NR7 – (wherein R7 is as herein defined ) and R14 is C3-7 cycloalkyl or a 3 to 7 membered saturated or partially saturated heterocyclic group containing up to 3 ring heteroatoms selected independently from O, S and N, wherein the carbocyclic or heterocyclic group is optionally substituted by one or two substituents selected from oxo, hydroxy, halogeno, C1-4 alkyl, (wherein the C1-4 alkyl group is optionally substituted by 1 or 2 substituents selected from hydroxy, cyano, halogeno, amino, nitro, morpholino, C3-5 cycloalkyl, piperidin-1-yl), C2-4 alkenyl, C2-4 alkynyl, C1-4 hydroxyalkyl, C1-4 alkoxy, carbamoyl, C1-3 alkylcarbamoyl, N,N-di(C1-3 alkyl) carbamoyl, C2-4 alkanoyl, C1-4 alkoxycarbonyl, C1-4 alkylthio, C1-4 alkylsulphinyl, C1-4 alkylsulphonyl, C2-4 alkanoylamino, N-C1-3 alkyl-C2-4 alkanoylamino, N-C1-3 alkylsulphamoyl, N,N-di-[C1-3 alkyl] sulphamoyl, C1-3 alkanesulphonylamino and N-C1-3 alkylC1-3 alkanesulphonylamino, or R14 is a pyridone group, a phenyl group or a 5 or 6membered aromatic heterocylic group containing 1 to 3 ring heteroatoms independently selected from O, N and S, and wherein the pyridone, phenyl or heterocyclic group is optionally substituted by up to 5 substituents selected from halogeno, amino, C1-4 alkyl, C1-4 alkoxy, C1-4 hydroxyalkyl, C1-4 hydroxyalkyl, C1-4 aminoalkyl, C1-4 alkylamino, C1-4 hydroxyalkoxy, carboxy, cyano, C1-4 alkylthio, C1-4 alkylsulphinyl, C1-4 alkylsulphonyl, N-C1-3 alkylsulphamoyl, N, N-di-[C1-3 alkyl] sulphamoyl, C1-3 alkanesulphonylamino, N-C1-3 alkanesulphonylamino, -CONR10R11 and – 1076 2008 NR10COR11 (wherein R10 and R11 are as herein defined)]; (4) –Y1-X4C1-5 alkyl X5X15 [wherein Y1 is as herein defined and X4 and X5 which may be the same or different are each –O-, -S-, -SO-, -SO2-, -NR7CO-, -CONR7-, SO2NR7-, -NR7SO2-or –NR7-(wherein R7 is as herein defined and R15 is hydrogen or C1-3 alkyl)]; (5) –Y1-O-C1-3 alkyl (wherein Y1 is as herein defined) provided that X1 is –O-, S-, -SO- or –SO2-; (6) –Y2-R16 (wherein –Y2- is as herein defined and R16 is a saturated or partially saturated 3 to 7 membered heterocyclic ring containing up to 3 heteroatoms selected from O, S and N [wherein the heterocylic ring is optionally substituted by up to 3 substituents selected from oxo, hydroxy, halogeno, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl and C3-7 cycloalkyl (wherein C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl and C3-7 cycloalkyl are themselves optionally substituted by up to 3 substituents selected from hydroxy, halogeno, cyano, C1-3 alkyl, C1-3 alkoxy, C1-3 alkanoyloxy, trifluoromethyl, amino, nitro and R14 as herein defined), C1-4 alkoxy, carbamoyl, C1-4 alkylcarbamoyl, N-N-di(C1-4 alkyl) carbamoyl, C2-4 alkanoyl, C1-4 alkoxycarbonyl, C3-7 cycloalkyl, C1-4 alkylthio, C1-4 alkylsulphinyl, C1-4 alkylsulphonyl, C2-4 alkanoylamino, N-C1-3 alkyl-C2-4 alkanoylamino, N-C1-3 alkylsulphamoyl, N,N-di-[C1-3 alkyl] sukphamoyl, C1-3 alkanesulphonylamino and N-C1-3 alkyl-C1-3 alkanesulphonylamino] or R16 is a pyridone group, a phenyl group or a 5 or 6membered aromatic heterocyclic group containing 1 to 3 ring heteroatoms independently selected from O, N and S, and wherein the pyridone, phenyl or heterocylic group is optionally substituted by up to 5 substituents selected from halogeno, amino, C1-4 alkyl, C1-4 alkoxy, C1-4 hydroxyalkyl, C1-4 aminoalkyl, C1-4 alkylamino, C1-4 hydroxyalkoxy, carboxy, cyano, C1-4 alkylthio, C1-4 alkylsulphinyl, C1-4 alkylsulphonyl, N-C1-3 alkylsulphamoyl, N,N-di-[C1-3 alkyl] sulphamoyl, C1-3 alkanesulphonylamino, N-C1-3 alkyl-C1-3 alkanesulphonylamino, CONR10R11 and –NR10COR11 (wherein R10 and R11 are as herein defined)]; (7) –Y2-X6-R14 (wherein Y2, X6 and R14 are as herein defined); and (8) –Y2-NR17R18 [wherein Y2 is as herein defined and R17 and R18 are independently selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl or C1-3 alkoxy C1-6 alkyl (wherein any alkyl group in R17 or R18 is optionally substituted by up to 2 substituents selected from hydroxy, halogeno, C1-3 alkyl, C1-3 alkoxy, C1-3 alkanoyloxy, trifluoromethyl, cyano, amino or nitro)]; provided that when: m is an integer from 1 to 3; R1 is methoxy; R2 is hydrogen; Z is –NH-; R3 is halogeno or C1-3 alkyl; and X1 is –O-; then R4 is not selected from one of the following three groups: (a) –C2-5 alkyl R19 (wherein R19 is piperidin-4-yl which may bear one or two substituents selected from hydroxy, halogeno, C1-4 alkyl, C1-4 hydroxyalkyl and C1-4 alkoxy); (b) –C2-5 alkenyl R19 (wherein R19 is as defined herein); (c) –C2-5 alkynyl R19 (wherein R19 is as defined herein); wherein any alkylene, alkenylene or alkynylene chain in groups (a) to (c) above are optionally substituted by one or more substituents selected from hydroxy, halogeno and amino]; or a salt thereof. __________ 1077 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ PROTECTION SYSTEM AGAINST INFRA-RED GUIDED MISSILES ]22[ ]51[ ]71[ 10.09.2002 Int. Cl.8 F41H 011/02 RAFAEL ADVANCED DEFENSE SYSTEMS LTD. ]72[ ]74[ PATRICK BAR-AVI, ARYE PICK DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520 [57] A system for illuminating and thereby defeating an infrared guided threat (18) to an aircraft comprising: (a) at least two non-laser light sources (58); (b) a trigger configured to activate said at least two non-laser light sources to generate at least two light beams, said light beams overlapping to produce a composite 151672 מערכת הגנה מפני טילים מונחי אינפרא אדום ,רפאל מערכות לחימה מתקדמות בע"מ חיפה אריה פיק,אבי-פטריק בר ,ד"ר מרק פרידמן בע"מ ,7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב גן-רמת beam (72) of enough illumination power density to jam or destroy an infrared seeker of the infrared guided threat; and (c) a DIRCM control system (24), configured to aim said composite beam at the infrared guided threat, thereby illuminating the infrared guided threat with said composite beam thereby jamming or destroying said infrared seeker. ___________ June 5, – ב' בסיון התשס"ח 1078 2008 ]11[]21[ 151706 הכרה דינמית של הודעת קריאה כללית ריקה ]54[ DYNAMIC RECOGNITION OF AN EMPTY GENERAL PAGING MESSAGE ]22[ ]31[ ]51[ ]71[ 30.03.2001 09/540797 ]32[ 31.03.2000 ]33[ US Int. Cl.8 H04B 001/707, 007/26, H04Q 007/32, 007/38 QUALCOMM INCORPORATED, U.S.A. WO/2001/076295 SANFORD T.COLB & CO., ,' קולב ושות.סנפורד ט P.O.B. 2273, רחובות,2273 .ד. ת, מרמורק,4 שער הגיא REHOVOT 76122 ]87[ ]74[ [57] A method for use by a remote unit in a wireless communication system of processing base station signals, comprising: receiving raw data samples of a message from a base station; decoding said raw data samples to obtain decoded data samples; comparing said decoded data samples with a reference pattern before said decoded data samples are parsed; determining the contents of said message as the reference pattern in a memory. __________ 1079 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ DYNAMIC ADJUSTMENT OF SEARCH WINDOW SIZE IN RESPONSE TO SIGNAL STRENGTH ]22[ ]31[ ]51[ ]71[ 30.03.2001 09/540922 ]32[ 31.03.2000 Int. Cl.8 H04B 001/707, H04Q 007/38 QUALCOMM INCORPORATED, U.S.A. WO/2001/076088 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 ]87[ ]74[ [57] A method for determining a size of a search window, the method comprising: measuring a strength of a PN encoded signal transmitted by a preferred base station; selecting the size of the search 151708 כוונון דימוי של גודל חלון חיפוש בתגובה לכוח הסיגנל ]33[ US ,' קולב ושות.סנפורד ט רחובות,2273 .ד. ת, מרמורק,4 שער הגיא window based on said strength of said PN encoded signal; and searching for a PN encoded signal transmitted by a neighboring base station by using the search window. __________ June 5, – ב' בסיון התשס"ח 1080 2008 ]11[]21[ ]54[ CLOTHING VENTILATION DEVICE ALLOWING THE HUMAN BODY TO BREATHE AND METHOD FOR PRODUCING THE DEVICE ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 18.01.2002 PD01A000016 ]32[ 24.01.2001 Int. Cl.8 A41D 027/28 GEOX S.P.A., ITALY WO/2002/058494 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 [57] A ventilation device to be applied to items of clothing in order to allow the human body to breathe, comprising: an assembly with through holes (12), composed of an outer band (13) of material that is at least partially transparent and impermeable provided to be arranged externally with respect to the human body, and a membrane (16) which is impermeable to water and permeable to vapor, provided for being arranged 151834 מכשיר לאוורור בגדים המאפשר לגוף האדם לנשום ושיטה לייצור המכשיר ]33[ IT ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה internally towards the human body, characterized in that said assembly further comprises a layer provided to be placed in view and made of natural or synthetic fabric, natural or synthetic leather, and at least one layer of adhesive polymeric material for mutually joining said outer band and said layer to be placed in view, said membrane being sealed at least perimetrically to said assembly on the side of said layer to be placed in view. __________ 1081 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ STENT FABRICATION METHOD ]22[ ]31[ ]51[ ]62[ ]71[ ]74[ 29.06.1997 08/742422 ]32[ 30.10.1996 Int. Cl.8 A61F 002/06 DIVISION FROM 121186 MEDINOL LTD. EITAN MEHULAL LAW GROUP, 10 ABBA EBEN BLVD., P.O. B. 2081, HERZLIYA 46120 [57] A sheet for fabricating a stent having a longitudinal lumen having a longitudinal axis comprising: (a) a flat piece of metal provided with a plurality of stent patterns, each of said patterns comprising a plurality of flexible connected cells (50), each of said flexible cells comprising: (a) a first member (51) having a longitudinal component (77) having a first end and a second end (61); (b) a second member having a longitudinal component (78) having a first end and a second end (62); (c) a third member having a longitudinal component having a first end and a second end; (d) a fourth member (60) having a longitudinal component having a first end and a second end; (e) a first loop defining a first angle disposed between said first end of said member and said first end of said second member; (f) a second loop defining a second angle disposed between said second end of said third member and said second end of said fourth member, and disposed generally opposite to said first loop; (g) a first flexible compensating member having a first end and a second end disposed between said first member and said third member, said first end of said June 5, – ב' בסיון התשס"ח 152107 שיטה לייצור סטנט ]33[ US אביב- תל,מדינול בע"מ קבוצת איתן – מהולל עורכי דין – עורכי ,פטנטים הרצליה,2081 .ד. ת, 10 שדרות אבא אבן first flexible compensating member communicating with said second end of said first member and said second end of said first flexible compensating member communicating with said first end of said third member, said first and said second ends disposed a variable longitudinal distance from each other; (h) a second flexible compensating member having a first end and a second end disposed between said second member and said fourth member, said first end of said second flexible compensating member communicating with said first end of said fourth member, said first and said second ends disposed a variable longitudinal distance from each other, said first and said second flexible compensating member differentially expandable or compressible when said stent is bent in a curved direction away from said longitudinal axis of said lumen; and (i) said first, said second, said third, and said fourth members and said first and said second loops, and said first and said second flexible compensating members disposed so that as said stent is expanded the distance between said first and said second flexible compensating member increases and the longitudinal component of said first, second, third and fourth members decreases while said first and said second loops remain generally 1082 2008 opposite to one another, the ends of said first and said second flexible compensating member open so as to increase said variable longitudinal distance between said first and said second ends of said first flexible compensating member and so as to increase said variable longitudinal distance between said first and said second ends of said second flexible compensating member so as to compensate for the decreasing of the longitudinal component of said first, second, third, and fourth members and substantially lessen the foreshortening of said stent upon its expansion; each of said plurality of stent patterns having a first long side and a second long side, said first long side provided with a plurality of pairs of engagement trough, said second long side provided with a plurality of pairs of engagement protrusions, said plurality of pairs of engagement troughs and said plurality of pairs of engagement protrusions disposed substantially opposite each other, each of said plurality of pairs of said engagement troughs comprising a first engagement trough and a second engagement trough, said engagement troughs sized and disposed to receive and engage said engagement protrusions when said sheet is deformed and rolled into a tubular shape, each pair of said engagement troughs provided with a bridge disposed between said first engagement trough and said second engagement trough, wherein said first loop, said second loop, said first compensating member, and said second compensating member are wider than said first, second, third and fourth members. _________ ]11[]21[ ]54[ STENT FABRICATION METHOD ]22[ ]31[ ]51[ ]62[ ]71[ ]74[ 29.06.1997 08/742422 ]32[ 30.10.1996 Int. Cl.8 A61F 002/06 DIVISION FROM 121186 MEDINOL LTD. EITAN MEHULAL LAW GROUP, 10 ABBA EBEN BLVD., P.O. B. 2081, HERZLIYA 46120 1083 152109 שיטה לייצר סטנט ]33[ US אביב- תל,מדינול בע"מ עורכי- מהולל עורכי דין- קבוצת איתן ,פטנטים הרצליה,2081 .ד. ת, 10 שדרות אבא אבן June 5, 2008– ב' בסיון התשס"ח [57] An expandable stent having a longitudinal lumen having a longitudinal axis comprising: a stent pattern comprising a plurality of flexible connected cells (50), each of said flexible cells comprising: (a) a first member having a longitudinal component (77) having a first end and a second end; (b) a second member having a longitudinal component (78) having a first end and a second end; (c) a third member having a longitudinal component having a first end and a second end; (d) a fourth member (60) having a longitudinal component having a first end and a second end; (e) a first loop defining a first angle disposed between said first end of said first member and said first end of said second member; (f) a second loop defining a second angle disposed between said second end of said third member and said second end of said fourth member, and disposed generally opposite to said first loop; (g) a first flexible compensating member or flexible link (67) having a first end a second end disposed between said first member and said third member, said first end of said first flexible compensating member or flexible link communicating with said second end of said first member and said second end of said first flexible compensating member or flexible link communicating with said first end of said third member, said first and said second ends of said first flexible compensating member or flexible link disposed a variable longitudinal distance from each other; (h) a second flexible compensating member or flexible link having a first end and a second end disposed between said June 5, – ב' בסיון התשס"ח second member and said fourth member, said first end of said second flexible compensating member or flexible link communicating with said second end of said fourth member, said first and said second ends of said second flexible compensating member or flexible link disposed a variable longitudinal distance from each other, said first and said second flexible compensating members or flexible links differentially extendable or compressible when said stent is bent in a curved direction away from the longitudinal axis of said longitudinal lumen; and (i) said first, said second, said third, and said fourth members and said first and said second loops, and said first and said second flexible compensating members or flexible links disposed so that as said stent is expanded the distance between said first and said second flexible compensating members or flexible links increases and the longitudinal component of said first, second, third, and fourth members decreases while said first and said second loops remain generally opposite to one another, the ends of said first and said second flexible compensating members or flexible links open so as to increase said variable longitudinal distance between said first and said second ends of said first flexible compensating member or flexible link and so as to increase said variable longitudinal distance between said first and said second ends of said second flexible compensating member or flexible link so as to compensate for the decreasing of the longitudinal component of said first, second, third, and fourth members and substantially lessen the foreshortening of said stent upon its expansion; said stent pattern having a first long side and a second long side, said first long side provided with a plurality of pairs of engagement troughs, said second long side provided with a plurality of pairs of 1084 2008 engagement protrusions, said plurality of pairs of engagement troughs and said plurality of pairs of engagement protrusions disposed substantially opposite each other, each of said plurality of pairs of said engagement troughs comprising a first engagement trough and a second engagement trough, said engagement troughs attached to said engagement protrusions. ____________ ]11[]21[ ]54[ DIRECTORY SEARCHING METHODS AND SYSTEMS ]22[ ]31[ ]51[ ]71[ 06.04.2001 PQ6785 ]32[ 07.04.2000 Int. Cl.8 G06F 017/30 COMPUTER ASSOCIATES THINK, INC., U.S.A. WO/2001/077902 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]87[ ]74[ [57] A method of arranging and searching for data in a database comprising: creating a first table for storing data comprising at least one data entry, the data entry comprising a plurality of data components, the first table comprising one row for each data entry; and creating a second table for storing the plurality of data components of the data entry of the first table, the second table comprising one row for each of the 1085 152132 שיטות ומערכות לחיפוש בספריה ]33[ AU ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה plurality of data components of the data entry of the first table; and searching the rows of the second table to identity a particular one of the plurality of data components; and returning the given data entry from the first table that includes the particular one of the plurality of data components in response to identifying the particular one of the plurality of data components in the second table. June 5, 2008– ב' בסיון התשס"ח ____________ ]11[]21[ 152238 תכשירים ותהליכים לטיפול בחומר מסנן ליעילות סינון משופרת ]54[ COMPOSITIONS AND PROCESSES FOR TREATING FILTER MATERIAL FOR IMPROVED FILTRATION EFFICIENCY ]22[ ]31[ ]51[ ]71[ 30.04.2001 60/200343 ]32[ 28.04.2000 ]33[ US Int. Cl.8 B01D 039/00, C08F 251/02, C08J 007/00, C08K 003/20 PURADYN FILTER TECHNOLOGIES INCORPORATED, U.S.A. MOHAN L. SANDUJA, CARL HOROWITZ, LINA ZILBERMAN, PAUL THOTTATHIL WO/2001/083602 JEREMY M. BEN-DAVID & CO. ,דוד ושות' בע"מ- בן.ירמיהו מ LTD., ,45087 .ד. ת, הר חוצבים,רחוב המרפא HAR HOTZVIM HI-TECH PARK, ירושלים P.O.B. 45087, JERUSALEM 91450 ]72[ ]87[ ]74[ June 5, – ב' בסיון התשס"ח 1086 2008 [57] A coating composition for the chemical grafting of an oil, fuel, coolant or air filter material, the composition comprises: about 30-50% by weight of an aqueous acrylic resin wherein the aqueous acrylic resin is an acrylic copolymer, about 3-11% by weight of a high molecular weight silicone in an aqueous suspension, about 20-40% by weight of deionizied, distilled or otherwise pure water, about 516% by weight of a binder, about less than 1% by weight of a catalyst, and about less than 1% by weight of a graft initiator. _________ ]11[]21[ 152248 –b8–אסטראטריאנים מותמרים ב הידרוקרביל לשימוש כאסטרוגנים יחודיים ]54[ 8 BETA – HYDROCARBYLSUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS ]22[ ]31[ 12.04.2001 10019167.3 ]32[ 12.04.2000 ]33[ DE 60/207370 26.05.2000 US Int. Cl.8 A61K 031/565, A61P 005/30, C07J 001/00, 041/00 BAYER SCHERING PHARMA AG, GERMANY WO/2001/077139 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] 8β-Substituted estra-1,3,5(10)-triene derivatives of the formula in which R2 means a hydrogen atom, a halogen atom; a radical R18 – or R18-O-, whereby R18 means a hydrogen atom or a straightchain or branched-chain, saturated or unsaturated hydrocarbon radical with up to 1087 6 carbon atoms, a trifluoromethyl group; a group R19SO2-O-, in which R19 is an R20R21N group, whereby R20 and R21, independently of one another, mean a hydrogen atom, a C1-C5-alkyl radical, a group C(O)R22, in which R22 represents an June 5, 2008– ב' בסיון התשס"ח optionally substituted, straight-chain or branched-chain, saturated or unsaturated in up to three places, optionally partially or completely halogenated hydrocarbon radical with up to 10 carbon atoms, an optionally substituted C3-C7-cycloalkyl radical, an optionally substituted C4-C15cycloalkylalkyl radical or an optionally substituted aryl, heteroaryl or aralkyl radical, or, together with the N-atom, means a polymethylenimino radical with 4 to 6 C atoms or a morpholino radical; R3 means a group R18-O-, R19SO2-O or –OC(O)R22, with R19 and R22 in each case in the meaning that is indicated under R2, whereby a hydrogen atom, a trifluoromethyl group, isopropyl, butyl, isobutyl, tert-butyl, pentyl, isopentyl, neopentyl, heptyl or hexyl radical, or an aryl, heteroaryl or aralkyl radical can stand for R18; R6 and R7 each means a hydrogen atom or together an additional bond; R6 and R7, independently of one another, mean a hydrogen atom, a halogen atom, a group R18-O-R19SO2-O- or R22, with R18, R19 and R22 in each case in the meaning that is indicated under R2; R8 means a straight-chain or branchedchain, optionally partially or completely halogenated alkyl or alkenyl radical with up to 5 carbon atoms, an ethinyl or prop1-inyl radical; R9 means a hydrogen atom, a straightchain or branched-chain, saturated or unsaturated hydrocarbon radical with up to 5 carbon atoms, or together with R11 means an additional bond; R11 means a hydrogen atom or together with R9 or together with R12 means an additional bond; R11 means a hydrogen atom, a halogen atom, a saturated or unsaturated, optionally partially or completely halogenated hydrocarbon radical, which has a maximum linear chain length of 4 carbon atoms, or a group –X-R18, in which X is an oxygen or sulfur atom, and R18 is an alkyl radical with 1 to 3 carbon atoms; June 5, – ב' בסיון התשס"ח R12 means a hydrogen atom or together with R11 means an additional bond; R14 means a hydrogen atom or together with R15 means an additional bond; R15 means a hydrogen atom or together with R14 or together with R16 means an additional bond; R16 means a hydrogen atom or together with R15 means an additional bond; R15' and R16', independently of one another, means a hydrogen atom, a halogen atom, a group R18-O-, R19SO2-O-, R19SO2-O- or –R22, with R18, R19 and R22 in each case in the meaning that is indicated under R2; R17 and R17' each mean a hydrogen atom; a hydrogen atom and a halogen atom; a hydrogen atom and a benzyloxy group; a hydrogen atom and a group R19SO2-O-; a group R18 and a group –C(O)R22 or –OC(O)R22; a group R18-O- and a group R18-; a group R18-O- and a group –O-C(O)R22, in all above cases with R18, R19 and R22 in each case in the meaning that is indicated under R2; or R17 and R17' together mean a group =CR23R24, in which R23 and R24, independently of one represent a hydrogen atom and a halogen atom, or together an oxygen atom; excluding the compounds of general formula (I)', in which R3 is a hydroxy, or acetyl group, and simultaneously R2 represents a hydrogen atom, R6, R6', R7 and R7' in each case represent a hydrogen atom; R8 represents a methyl group, R9 represents a hydrogen atom or R9 and R11 together represent an additional bond, R11' and R12 in each case represent a hydrogen atom, R14, R15, R15', R16 and R16' in each case represent a hydrogen atom, and R17 and R17' for a β-(2-bromoacetyl) oxy group and a hydrogen atom; for a β-acetyl group and a hydrogen atom; or 1088 2008 R17 and R17' together represent an oxygen atom, wherein: a C4-C15-cycloalkylalkyl radical has 3 to 7 carbon atoms in the cycloalkyl portion; and the alkyl portion has up to 8 carbon atoms; an aryl radical is a phenyl, 1- or 2naphthyl radical or a heteroaryl radical; an aralkyl radical is a radical that contains in the ring up to 14, preferably 6 to 10 C atoms and in the alkyl chain 1 to 8 C atoms; the alkyl groups or hydrocarbon radicals can be partially or completely fluorinated or substituted by 1-5 halogen atoms, hydroxy groups or C1-4-alkoxy groups; one or more hydroxyl groups at C atoms 3, 16 and 17 can be esterified with an alphatic, straight-chain or branched-chain, saturated or unsaturated C1-14 mono- or polycarboxylic acid or an aromatic carboxylic acid or with an α-or β-amino acid. ___________ ]11[]21[ ]54[ SPACE WEATHER PREDICTION SYSTEM AND METHOD ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 18.04.2001 552161 ]32[ 18.04.2000 Int. Cl.8 G01W 001/10, G06F 019/00 CARMEL SYSTEMS LLC, U.S.A. WO/2001/080158 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A system for predicting space weather comprising: (a) a source of current solar energetic particle data; (b) a processor capable of accessing the data source, wherein the processor predicts 1089 152301 מערכת ושיטה לחיזוי מזג אוויר בחלל ]33[ US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם a space weather event based on recognizing a complex pattern in the current solar energetic particle data, the pattern being derived from three or more historical solar energetic particle measurements. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ WRAP-AROUND CABLE SLEEVES HAVING AN EXPANDABLE BODY PORTION AND METHODS OF MAKING SAME ]22[ ]31[ ]51[ ]71[ 18.04.2001 556230 ]32[ 24.04.2000 Int. Cl.8 H02G 015/02 TYCO ELECTRONICS CORPORATION, U.S.A. WO/2001/082435 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] A wrap-around cable sleeve for environmentally sealing a cable section, said wrap-around cable sleeve comprising: a longitudinally extending body comprising an electrically insulating material and having a longitudinally extending portion with a corrugated lateral cross-section; wherein the longitudinally extending portion has a flexural modulus of between about 4,000 and 100,000 psi; June 5, – ב' בסיון התשס"ח 152323 שרוולי חוטים העוטפים מכל עבר בעלי יכולת התרחבות ושיטות ליצורם ]33[ US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם wherein the longitudinally extending portion defines a portion of a cable chamber, wherein the cable chamber extends at least substantially around the cable section when the body is wrapped around the cable section; and wherein the cable chamber has a range taking in a radial direction of at least about 15 percent. 1090 2008 _________ ]11[]21[ ]54[ ]22[ ]31[ ]51[ ]71[ שיטה והתקן להתאמת קצב מהירה במעגל סגור בשידור נתונים בעל קצב גבוה של מארזים METHOD AND APPARATUS FOR FAST CLOSED-LOOP RATE ADAPTATION IN A HIGH RATE PACKET DATA TRANSMISSION 11.05.2001 09/570210 ]32[ 12.05.2000 Int. Cl.8 H04L 012/56, H04Q 007/22 QUALCOMM INCORPORATED, U.S.A. ]87[ WO/2001/089162 ]74[ SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [57] An apparatus for adjusting an open loop rate control process, comprising: an estimation element at the access terminal for determining a quality value associated with a forward link channel; an open loop rate control element coupled to the estimation element for generating a plurality of data rate request messages, wherein the open loop rate control element uses the quality value received from the estimation element for determining the contents of the plurality of data rate request messages; a closed loop rate 1091 152712 ]33[ US ,' קולב ושות.סנפורד ט רחובות,2273 .ד. ת, מרמורק,4 שער הגיא control element and a decoder for generating a plurality of indicator messages based on either the quality value from the estimation element or an error value from the decoder, wherein the decoder is configured to decode a plurality of interleaved data slots and gap slots received on the forward link channel; a controller coupled to the decoder and the estimation element for enabling the closed loop rate control element in accordance with a set of threshold values. June 5, 2008– ב' בסיון התשס"ח ,180344 The applications for division from this application have not yet been published בקשות חלוקה מבקשה זו .שטרם פורסמו ____________ ]11[]21[ ]54[ GRENADE LAUNCHER WITH ENHANCED TARGET FOLLOWUP SYSTEM ]22[ ]51[ ]71[ 20.11.2002 Int. Cl.8 F41G 005/00 RAFAEL ARMAMENT DEVELOPMENT AUTHORITY LTD. EYAL BERKOVICH, SHIMON CHACHAMIAN YORAM TSIVION, 2 HATOHEN ST., P.O.B. 3148, PARDESS HANA 38900 ]72[ ]74[ [57] A system for enhancing target follow-up by a gunner of an automatic grenade launcher (AGL), comprising: a system-mount (54); said AGL cradle (46); an axle (50) for vertically rotating said cradle; an electric motor (52) for providing torque to said axle; said AGL-sight borne 152966 מטול רמונים הכולל מערכת עקיבת מטרה משופרת ,רפא"ל רשות לפיתוח אמצעי לחימה בע"מ חיפה שמעון חכמיאן,'איל ברקוביץ ,יורם צביון ,3148 .ד. ת, פארק התעשיה,2 רח' הטוחן חנה-פרדס by a sight-mount; a mount-break means for freezing the vertical angle of said sightmount with respect to said system-mount, and a disengageable linear lock (64) for fixing a vertical angular movement of said sight to said AGL cradle. ___________ June 5, – ב' בסיון התשס"ח 1092 2008 ____________ ]11[]21[ ]54[ WORKSTATION FOR COMPUTERIZED ANALYSIS IN MAMMOGRAPHY ]22[ ]51[ ]71[ 28.11.2002 Int. Cl.8 A61B 006/00, G06K 009/00 SIEMENS COMPUTER AIDED DIAGNOSIS LTD. ]72[ ISAAC LEICHTER, PHILIPPE NATHAN BAMBERGER, NICOLAS J. MERLET JEREMY M. BEN-DAVID & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O.B. 45087, JERUSALEM 91450 ]74[ [57] A method of separating and collating mammogram records, said method including the steps of: scanning at least one radiological film mammogram (420) relating to a patient thereby to obtain at least one digitized image of the at least one film mammogram; storing the at least one digitized image in a memory (425); providing and scanning a separator film having identifiable features which when scanned identify the film as a separator film (440), and including positioning the 1093 153162 תחנת עבודה לניתוח תמונות ממוגרפיה ממוחשב ,סימנס קומפיוטר איידד דיאגנוסיס בע"מ ירושלים יעקב, פיליפ נתן במברגר,יצחק לייכטר מרלה ,דוד ושות' בע"מ- בן.ירמיהו מ ,45087 .ד. ת, הר חוצבים,רחוב המרפא ירושלים separator film immediately after the at least one radiological film of a patient; and repeating said steps of scanning, storing, and providing for the remaining film mammorgrams of N patients in a film mammogram queue, where N≥1; wherein the digitized images generated subsequent to each scanned separator film are stored separately from the stored digitized images obtained from prior scanned film mammograms. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ ROLLING RAZOR AND SHAVING METHOD ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 01.06.2001 09/603816 ]32[ 23.06.2000 Int. Cl.8 B26B 021/52 ROLLING RAZOR, INC., U.S.A. WO/2002/000403 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [57] A shaving razor comprising: a first set of blades having a face defining a first June 5, – ב' בסיון התשס"ח 153208 סכין גילוח מסתובב ושיטת גילוח ]33[ US ,' קולב ושות.סנפורד ט רחובות,2273 .ד. ת, מרמורק,4 שער הגיא plane; a second set of blades having a face defining a second plane; a short neck with 1094 2008 a first end coupled to a shaving head and a second end, the first and the second set of blades coupled to the shaving head; and an open cylindrically shaped handle affixed to the second end of the short neck. ___________ ]11[]21[ תהליך לטחינה רטובה ]54[ WET MILLING PROCESS ]22[ ]31[ 22.06.2001 0015856.8 ]32[ 28.06.2000 0112496.5 22.05.2001 Int. Cl.8 A61K 009/00 SMITHKLINE BEECHAM P.L.C., UNITED KINGDOM WO/2002/000196 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]51[ ]71[ ]87[ ]74[ 153231 [57] Process for preparing a finely divided preparation of a drug substance comprising wet milling a suspension of the drug substance in a mill having at least one ]33[ GB GB ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה chamber and agitation means, said chamber(s) and/or said agitation means comprising internally lubricated nylon. ___________ 1095 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ METHOD FOR DIAGNOSING COLIC IN AN INFANT ]22[ ]51[ ]71[ 09.06.2000 Int. Cl.8 A61K 049/00 CROSSCARE RESEARCH & DEVELOPMENT LIMITED, IRELAND WO/2001/093915 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 ]87[ ]74[ [57] Use of a β-D-galactosidase enzyme for the manufacture of a diagnostic agent for diagnosing colic type in an infant exhibiting one or more symptoms characteristic of unspecified colic, which comprises the steps of: (a) optionally measuring in said infant at least one parameter indicative of unspecified colic; 153263 שיטה לאבחנת עוית–מעיים בתינוק , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, (b) orally administering a liquid formulation of a β-D-galactosidase enzyme separately, simultaneously with or sequentially to a lactose-containing feed; and (c) determining at selected intervals of time any alteration in said infant of colictype symptoms. _________ ]11[]21[ ]54[ METHODS AND DEVICES FOR PREVENTION OF HYPOTHERMIA IN A MAMMAL DURING PROLONGED EXPOSURE TO EXTREME COLD ]22[ ]31[ ]51[ ]71[ 07.06.2001 60/210664 ]32[ 09.06.2000 Int. Cl.8 A61F 007/00 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, U.S.A. WO/2001/093790 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 ]87[ ]74[ [57] A method for preventing a change in the core body temperature of a mammal June 5, – ב' בסיון התשס"ח 153324 שיטות והתקנים למניעת תת–חום ביונק במשך תקופות ארוכות של חשיפה לקור קיצוני ]33[ US ,' קולב ושות.סנפורד ט רחובות,2273 .ד. ת, מרמורק,4 שער הגיא under cold conditions, said method comprising: 1096 2008 (a) a detecting a requirement for thermal energy input in said mammal; and (b) contacting a surface of a portion of said mammal in response to the presence of said requirement with a warm termperature medium under negative pressure conditions for a period of time sufficient to introduce thermal energy into the core body of said mammal, to substantially maintain constant the core body temperature of said mammal in cold conditions in water or at about 30 degrees Fahrenheit or less; whereby the core body temperature of said mammal is prevented from changing under said cold conditions. __________ ]11[]21[ ]54[ ENVIRONMENTALLY FRIENDLY CONDITIONING SYSTEM PARTICULARLY FOR A GREENHOUSE ]22[ ]31[ ]51[ ]71[ 14.06.2001 60/212081 ]32[ 15.06.2000 Int. Cl.8 A01G 009/24 BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY WO/2001/095700 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]87[ ]74[ [57] A system for conditioning an indoor space, comprising: a ducting (80) having an open inlet end (82) and an outlet end (84); water provision system (20) adapted to provide droplets of water within said ducting; air circulation means adapted to 1097 153435 מערכת מיזוג ידידותית לסביבה מתאימה במיוחד עבור חממה ]33[ US הרשות,גוריון בנגב-אוניברסיטת בן באר שבע,למחקר ופיתוח ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה induce an airflow from outside said ducting through said ducting via said inlet end; diffusion arrangement at said outlet end having an outlet area greater than the inlet area thereof. June 5, 2008– ב' בסיון התשס"ח ___________ ]11[]21[ 153496 מוצר דמוי גרגר של חומצה פאראהידרוקסיבנזואית או אסתר של חומצה פאראהידרוקסיבנזואית ותהליך עבור הכנה של הנ"ל ]54[ GRANULAR PRODUCT OF PARAHYDROXYBENZOIC ACID OR PARAHYDROXYBENZOIC ACID ESTER AND PROCESS FOR PREPARING THE SAME ]22[ ]31[ ]51[ ]71[ 18.04.2002 2001-122933 ]32[ 20.04.2001 ]33[ JP Int. Cl.8 B01J 002/00, 002/22, C07C 065/00, 065/03, 069/88 KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO, JAPAN WO/2002/085835 DR. YITZHAK HESS & PARTNERS, ,ד"ר יצחק הס ושותפיו 279 HAYARKON ST., תל אביב,6451 .ד. ת, 279 רחוב הירקון P.O.B. 6451, TEL AVIV 61063 ]87[ ]74[ [57] A granular product of parahydroxybenzoic acid or its ester, characterized in that said product has an average particle size of equal to or more than 150 µm and a hardness of 10-3000g. __________ June 5, – ב' בסיון התשס"ח 1098 2008 ]11[]21[ 153679 תולדות קסנתון פוליציקליות ותכשירי רוקחות המכילים אותן ]54[ POLYCYCLIC XANTHONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 29.06.2001 0016020.0 ]32[ 29.06.2000 ]33[ GB Int. Cl.8 A61K 031/7004, A61P 031/04, C07D 493/04, C07H 017/04 INSTITUTO BIOMAR, S.A., SPAIN WO/2002/000663 WOLFF, BREGMAN AND GOLLER, , ברגמן וגולר,וולף P.O.B. 1352, ירושלים,1352 .ד.ת JERUSALEM 91013 [57] A compound of the formula: where each R1 is the same or different and can be hydrogen, C1-C18 alkyl, C2-C18 alkenyl, benzyl, alkali metal, aryl, wherein the aryl group may be carbocyclic having 6 or 10 carbon atoms or heterocyclic having 5 to 12 carbon atoms, acyl (RCO-), wherein R is C1-C18 alkyl, and/or a mono -, di-, or trisaccharide; R2 and R3 can be hydrogen, alkyl, or together R2 and R3 form an unsaturated bond. ___________ 1099 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ TRANSPOSON MEDIATED MULTIPLEX SEQUENCING ]22[ ]31[ ]51[ ]71[ 05.07.2001 60/216381 ]32[ 07.07.2000 Int. Cl.8 C12Q 001/68 AVENTIS PHARMACEUTICALS INC., U.S.A. WO/2002/004674 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 ]87[ ]74[ [57] A process for parallel, transposonmediated sequencing of DNA, the process comprising: (i) providing one or more target DNA sequences, each inserted into a vector at an insertion site; (ii) amplifying each target DNAcontaining vector and pooling them wherein each target DNA sequence is represented in the pool in an substantially equal amount per kb; (iii) exposing the pool of target DNAcontaining vector to a selectable transposon, wherein the selectable transposon integrates into the target DNAcontaining vectors at substantially random sites to form a pool of target DNA-and transposon-containing vectors; (iv) transforming cells with the pool of target DNA-and transposon-containing vectors and isolating and growing a representative number of individual 153797 סידור רצפים מגוונים מתווך ע"י טרנספוסון ]33[ US , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר transformants into cultures under selection conditions; (v) performing a polymerase chain reaction on DNA from each culture, wherein the polymerase chain reaction uses a pair of primers complementary to the 3' ends of the vector sequence at the insertion site and has an extension time during each reaction cycle sufficient to efficiently produce a full-length copy of the vector sequence but too short to efficiently produce a full-length copy of the vector sequence with the transposon inserted; (vi) measuring the amount of DNA produced in each polymerase chain reaction; and (vii) sequencing the transposon flanking regions of the target DNA-containing vectors from those cultures corresponding to polymerase chain reactions which produced substantial amounts of DNA. ___________ June 5, – ב' בסיון התשס"ח 1100 2008 ]11[]21[ ]54[ ETHERNET ADAPTING APPARATUS ]22[ ]31[ ]51[ ]71[ 15.10.2001 10100363.3 ]32[ 05.01.2001 Int. Cl.8 H04L 012/46, 012/56, 029/06 INFINEON TECHNOLOGIES AG, GERMANY WO/2002/054701 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] An Ethernet adapting apparatus for data transfer between a standard Ethernet data pump (10) and an Ethernet medium access controller via telecommunication medium (4) comprising: (a) a dual mode media independent interface (9) which emulates in a PHYmode the standard Ethernet medium access controller and which emulates in a MACmode the Ethernet medium access controller; (b) a switching device (14) for setting the dual mode media independent interface in the PHY-mode or in the MAC-mode; (c) a data buffer (11) for storing at least one Ethernet data package to be transferred between the standard Ethernet data pump and the Ethernet medium access controller; and 1101 153829 התקן להתאמת אתרנט ]33[ DE ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם (d) a 10BASES® data modem (not shown) connected to the telecommunication medium, wherein the 10BASES® data modem reframes the data stored in the data buffer to 10BASES® data frames sent via the telecommunication medium; and wherein the dual mode media independent interface comprises a serial management interface connectable via a SMI-data line to an Ethernet medium access controller or a standard Ethernet data pump for the exchange of SMI-data frames including SMI-messages, and a data flow interface connectable via a data bus to an Ethernet medium access controller or a standard Ethernet data pump for the exchange of Ethernet data packages. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ 153837 –פניל–פירידין כאנטגוניסטים4 נגזרות של 1–של רצפטור ניורוקינין ]54[ 4-PHENYL-PYRIDINE DERIVATIVES AS NEUROKININ1 RECEPTOR ANTAGONISTS ]22[ ]31[ ]51[ 20.07.2001 00115846.8 ]32[ 24.07.2000 ]33[ EP Int. Cl.8 A61K 031/4427, 031/455, A61P 025/00, 043/00, C07D 213/22, 213/24, 213/60, 213/72, 213/78, 401/04, 403/04, 413/04 F. HOFFMANN-LA ROCHE AG, SWITZERLAND WO/2002/008232 LUZZATTO & LUZZATTO, ,לוצאטו את לוצאטו INDUSTRIAL PARK, OMER, באר שבע,5352 .ד. ת, עומר,גן תעשייה P.O.B. 5352, BEER-SHEVA 84152 ]71[ ]87[ ]74[ [57] Compounds of the formulas wherein compounds of formula IA are those June 5, – ב' בסיון התשס"ח 1102 2008 wherein R1 is 1, 2, 4-triazol-1-yl and R2 is methyl, or R1 is 2-hydroxy-ethylamino and R2 is methyl, or R1 is 4-hydroxy-3,4,5,6-tetrahydropyridin-1-yl and R2 is methyl, or R1 is 4-(2-hydroxy-ethoxy)-3,4,5,6tetrahydro-pyridin-1-yl and R2 is methyl, or R1 is 3-hydroxy-pyrrolidin-1-yl and R2 is methyl, or R1 is 4-hydroxy-3,4,5,6-tetrahydropyridin-l-yl and R2 is chloro, and compounds of formula IB are those wherein R1 is 2-hydroxy-ethylamino and R2 is methyl, or R1 is 2-hydroxy-ethylamino and R2 is chloro, or R1 is 2,3-dihydro-[1,4]oxazin-4-yl and R2 is methyl, or R1 is acetylamino and R2 is methyl, or R1 is acetyl-methylamino and R2 is methyl, or R1 is cyclopropane carboxylic acid amide and R2 is methyl, or R1 is cyclopropane carboxylic acid methylamide and R2 is methyl, or R1 is imidazol-l-yl and R2 is methyl, and pharmaceutically acceptable acid addition salts thereof. __________ ]11[]21[ ]54[ TECHNIQUE FOR POWER CONTROL IN OPTICAL NETWORKS ]22[ ]51[ ]71[ ]74[ 14.01.2003 Int. Cl.8 H04B 010/08, 010/17 ECI TELECOM LTD. ECI TELECOM LTD., 30 HASIVIM ST., PETACH TIKVA 49517 [57] A method for maintaining a required value of power per optical channel in a chain of optical nodes connected by optical fiber spans, wherein at least some of said nodes including optical amplifiers with controllable gains; the method comprising performing automatic gain control at said optical amplifiers so that, in the frame of power gain of an optical amplifier, to compensate a preceding span loss; said span loss being power loss on an optical fiber span incoming said amplifier, obtaining information from a preceding node in the chain about a value of measured output power (MOP) of the preceding node, measuring input power 1103 153941 טכנולוגיה לויסות הספק ברשתות אופטיות פתח תקוה, טלקום בע"מ.איי.סי.אי , טלקום בע"מ. איי. סי.אי פתח תקוה,30רחוב הסיבים (MIP) at a following node, obtaining a difference between the MOP of the preceding node and the MIP of the following node to calculate the span loss between the two nodes, wherein the automatic gain control is performed at the amplifier of the following node in response to the calculated span loss; the method additionally comprises obtaining, from said preceding node, information about power loss (ΔPL) which has not been compensated at the preceding node, thereby ensuring distributed compensation of power loss changes if they occur in one or more spans of the chain. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ ARRANGEMENT AND METHOD FOR INTERACTING WITH AN INTERNAL BODY ORGAN ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 04.07.2001 0002778-9 ]32[ 27.07.2000 Int. Cl.8 A61M 031/00 Q MED AB, SWEDEN WO/2002/009802 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [57] An arrangement to be passed through a body cavity for interacting with an internal body organ, comprising: an elongate sheath (3) having at least one interior passage, said sheath having a proximal end and a distal end, said distal end being open and in communication with said at least one passage; and at least two elongate structural elements (15), each structural element having a proximal end (17) and a distal end (19); wherein the structural elements are inserted in said at least one passage so that at least a distal portion (19) of each element extends there through in the longitudinal direction of the sheath; wherein the structural elements are June 5, – ב' בסיון התשס"ח 154062 סידור ושיטה לאינטראקציה עם איבר פנימי בגוף ]33[ SE , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר arranged to be displaced relative to the sheath from a first position, in which the distal end of each structural element is located inside said at least one passage and in which the arrangement is intended to be passed through a body cavity, to a second position, in which a distal portion of each structural element extends through the open distal end of the sheath and at least partly in the transverse direction away from the sheath for distending and/or expanding interaction between the distal end of each structural element and a body organ approached by the arrangement through a body cavity. 1104 2008 __________ ]11[]21[ ]54[ METHOD FOR THE PRODUCTION OF A PARTICLE – CONTAINING PRODUCT OF TETRAHYDRO-3,5-DIMETHYL1,3,5 –THIADIAZIN-2 –THIONE ]22[ ]31[ ]51[ ]71[ 16.08.2001 10040194.5 ]32[ 17.08.2000 Int. Cl.8 A01N 043/88, C07D 285/34 BASF AKTIENGESELLSCHAFT, GERMANY WO/2002/014296 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] A process for the preparation of a particulate tetrahydro-3,5-dimethyl-1,3,5thiadiazine-2-thione product by combining a first aqueous solution comprising methylammonium Nmethyldithiocarbamate with a second aqueous solution comprising formaldehyde, followed by separation and drying of the resulting solid, which 154094 שיטה ליצור תוצר המכיל חלקיקים של – 5,3,1 – –דימתיל5 ,3 – טטראהידרו – תיאון2 – תיאדיאזין ]33[ DE ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם comprises combining the first and the second aqueous solutions in such a way that the ratio between the concentrations of dithiocarbamate functions and of formaldehyde is essentially constant in the reaction mixture over time during duration of the reaction, and separating the solid from the resulting suspension. __________ 1105 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ 154132 איפשור ניידות ללא תפר של משתמש בסביבת רשת אלחוטית בטווח קצר ]54[ ENABLING SEAMLESS USER MOBILITY IN A SHORT-RANGE WIRELESS NETWORKING ENVIRONMENT ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 08.08.2001 637742 ]32[ 11.08.2000 ]33[ US Int. Cl.8 H04L 012/28, 012/56, 029/06, H04Q 007/34, 007/38 SYMANTEC CORPORATION, U.S.A. WO/2002/015472 SANFORD T.COLB & CO., ,' קולב ושות.סנפורד ט P.O.B. 2273, רחובות,2273 .ד. ת, מרמורק,4 שער הגיא REHOVOT 76122 [57] A method of enabling seamless user mobility in a short-range wireless networking environment, comprising the steps of: providing one or more portable client devices, each of the client devices equipped with a short-range wireless communications capability for communicating in the short-range wireless networking environment; providing a plurality of Handoff Management Points (HMPs), each of the HMPs equipped with a short-range wireless link for communication with the client devices and a link to a networking environment wherein one or more application programs residing on one or more application server can be accessed; providing a Handoff Core Server to manage the HMPs; dynamically making a selected one of the HMPs operational, further comprising the steps of: obtaining an Internet Procotol (IP) address for the selected HMP; discovering by the selected HMP, an identity of the Handoff Core Server; and initiating, by the selected HMP, an HMP presence protocol exchange with the Handoff Core Server, further comprising the step of sending a registration request to the Handoff Core Server to register the selected HMP with the Handoff Core server; obtaining a registration response from the Handoff Core Server; and if the registration response is successful, periodically refreshing the selected HMP's registration with the Handoff Core Server. __________ June 5, – ב' בסיון התשס"ח 1106 2008 ]11[]21[ 154220 תהליך להכנת פנילאצטיוניטרילים מותמרים ]54[ PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENYLACETONITRILES ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 21.08.2001 705/MAS/00 ]32[ 30.08.2000 ]33[ IN Int. Cl.8 C07C 213/02, 217/64, 253/30, 255/37 SANDOZ AG, SWITZERLAND WO/2002/018325 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 [57] A process for the preparation of a compound of the formula wherein R1 is unsubstituted or substituted alkyl, comprising reacting a compound of the formula with a compound of the formula 1107 June 5, 2008– ב' בסיון התשס"ח in the presence of an aqueous base and a phase transfer catalyst. ___________ ]11[]21[ ]54[ 3-(HETEROARYL ACETAMIDO)2-OXO- AZETIDINE-1-SULFONIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS ]22[ ]31[ ]51[ ]71[ 14.09.2001 60/232617 ]32[ 14.09.2000 Int. Cl.8 C07D 417/00 PANTHERIX LIMITED, UNITED KINGDOM WO/2002/022613 DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063 ]87[ ]74[ 154593 –(הטראואריל3 תולדות של חומצות 1 – – אוקסו – אזטידין2 – )אצטאמידו סולפניות כגורמים אנטי–בקטרליים ]33[ US ,ד"ר יצחק הס ושותפיו תל אביב,6451 .ד. ת, 279 רחוב הירקון [57] A compound selected from the group consisting of a Syn isomer of a racemate and an optical isomer of 3-(heteroaryl acetamido)-2-oxo-axetidine-1-sulfonic acid and of the formula wherein M is hydrogen or pharmaceutically acceptable salt forming cation; X is CH, N or C-halogen; R is C1-C3 alkyl which is unsubstituted or substituted with at least one of (a) a June 5, – ב' בסיון התשס"ח 1108 2008 halogen atom, (b) OR5 wherein R5 is hydrogen, CONH2 provided that, when R is methyl, it cannot be substituted with both a halogen atom and OR5; R1 and R2 independently are OH, COOH, CONH2, NH2, dimethylamino, OCH3, NO2, CN, optionally substituted phenyl or C1-C3 alkyl; or R1 and R2 together are –O-CH=CH-CH2-, O-CH2-CH2-O-, -CH2-CH2-CH2-, -CH2CH2-CH2-CH2-, -CH=CH-CH=CH-or-CH=C(OH)C(OH)=CH- which together with the carbon atoms to which they are bound form a 5 membered or six membered cyclic ring; and R3 and R4 independently are hydrogen, optionally substituted C1-C3 alkyl, optionally substituted phenyl or C3C6 cycloalkyl; or R3 and R4 together with C to which they are attached are C3-C6 cycloalkyl. __________ ]11[]21[ ]54[ ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ SWEET DOUGH TRAY 06.09.2001 09/659034 ]32[ 11.09.2000 Int. Cl.8 A21D 010/02 SOCIETE DES PRODUITS NESTLE S.A., SWITZERLAND WO/2002/019829 DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063 [57] A ready-for-use dough product comprising: a tray (10) comprising a top surface (14) and a plurality of recesses, wherein the recesses each have at least one side (16) attached to or continuous with the top surface of the tray and a bottom (12) that is attached to or continuous with the at least one side, wherein the recess defines a . 154594 מגש בצק מתוק ]33[ US ,ד"ר יצחק הס ושותפיו תל אביב,6451 .ד. ת, 279 רחוב הירקון volume adapted to contain dough, and at least one bending line between the recesses where the tray is predisposed to bend; and uncooked refrigerated or frozen sweet dough in an amount at least equal to about 70 percent of the volume of the recesses and disposed at least partially within the recesses. ___________ 1109 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ HEAD ASSEMBLY FOR GUARDRAIL EXTRUDER TERMINAL ]22[ ]31[ ]51[ ]71[ 31.08.2001 60/229486 ]32[ 31.08.2000 Int. Cl.8 E01F 015/14 THE TEXAS A&M UNIVERSITY SYSTEM, U.S.A. WO/2002/018708 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]87[ ]74[ [57] A head assembly (10) for use with a guardrail installation, comprising: a rail feeder chute (16), comprising: a first side portion (40) disposed on a traffic side of the head assembly, and a second side portion disposed opposite the traffic side of the head assembly, the first and second side portions being generally parallel with each other and being generally parallel with a central, longitudinal axis (70) of the rail feeder chute; the first and second side portions being configured to receive a rail member (12) therebetween; an upstream end (50); a downstream end having upper and lower edge portions that form respective acute angles with the central, longitudinal axis; each of the upper and lower edge portions terminating adjacent to and being coupled with respective rounded members that extend perpendicular to the central, longitudinal axis and the first and second side portions; and wherein the respective rounded members extend further downstream than the upper and lower edge portions, the rounded members providing blunt, rounded termination points to the rail feeder chute at the downstream end, during impact with support posts of the guardrail June 5, – ב' בסיון התשס"ח 154684 מכלול ראש לקצה מסילת הגנה ]33[ US ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה installation; and an impact portion (14) coupled to the upstream end of the rail feeder chute and comprising: an impact plate positioned to face oncoming traffic, the impact plate having a greater height than width, an upper overhang extending upwardly, and a lower overhang extending downwardly; top and bottom members forming a coupling between the rail feeder chute and the impact plate; first and second side members cooperating to form a throat (66) configured to receive the rail member as it is forced through the impact plate; the first side member being positioned adjacent the traffic side to the head assembly and including a curved portion (44) that extends away from the traffic side as the first member extends away from the rail feeder chute, the first side member being configured to direct the rail member away from the the roadway during an endon collision; the second side member being positioned opposite the traffic side of the head assembly and terminating at a vertical brace (56) that extends generally perpendicular to the central, longitudinal axis of the rail feeder chute; the top and bottom members each having a traffic side edge (72) positioned to face a roadway, the 1110 2008 traffic side edge being approximately parallel with the central, longitudinal axis of the rail feeder chute; and a connecting plate (46) coupled between the impact plate and the first portion of the first side member, the connecting plate providing an axis of force transmission for the head assembly, wherein the axis of force transmission is offset from the central, longitudinal axis of the head assembly. __________ ]11[]21[ 154719 אספקת גישה בטוחה לרשת עבור התקני מיחשוב אלחוטיים של טווח–קצר ]54[ PROVIDING SECURE NETWORK ACCESS FOR SHORT RANGE WIRELESS COMPUTING DEVICES ]22[ ]31[ 27.08.2001 09/657745 ]32[ 08.09.2000 ]33[ US 09/866297 25.05.2001 US Int. Cl.8 G09C 001/00, H04L 009/08, 012/28, 012/46, 012/56 SYMANTEC CORPORATION, U.S.A. WO/2002/021803 SANFORD T.COLB & CO., ,' קולב ושות.סנפורד ט P.O.B. 2273, רחובות,2273 .ד. ת, מרמורק,4 שער הגיא REHOVOT 76122 ]51[ ]71[ ]87[ ]74[ [57] A method of enabling secure network access in a short-range wireless networking environment, comprising the steps of: providing one or more portable client devices, each of the client devices equipped with a short-range wireless communications capability for communicating in the short-range wireless networking environment; receiving, 1111 by a network access point, a communication from a selected one of the client devices; determining, by the network access point, that the selected client device does not have a valid session key for encryption; obtaining, by the network access point, user credentials for a user of the selected client device; authenticating, by the network access point, the user June 5, 2008– ב' בסיון התשס"ח credentials by contacting an authentication server; establishing the valid session key when the authenticating step completes successfully; and using the established session key, by the selected client device and the network access point, to encrypt packets that are transmitted over a link between the selected client device and the network access point. __________ ]11[]21[ ]54[ VARIABLE FREQUENCY SINUSOIDAL RESONANT DRIVER FOR ELECTRICAL LOADS ]22[ ]51[ ]71[ 06.03.2003 Int. Cl.8 H02M 007/42 BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY SHMUEL BEN-YAAKOV LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]72[ ]74[ [57] Apparatus for providing, to an electrical load, a sinusoidal signal, generated by Resonant-Based inverter June 5, – ב' בסיון התשס"ח 154808 מעגל דירבון סינוסואידלי תוהד בעל תדירות משתנה עבור עומסים חשמליים הרשות למחקר,גוריון בנגב-אוניברסיטת בן באר שבע,ופיתוח שמואל בן יעקב ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה having variable operating frequency, comprising: (a) a Resonant Frequency Controller (RFC), (900) said RFC being capable of 1112 2008 comparing the operating frequency of said sinusoidal signal to a desired frequency and outputting a corresponding signal, for controlling at least one parameter determining said resonance frequency, for obtaining said desired frequency; (c) a Direct Current (DC) power supply (801), for powering said inverter; (d) a current/voltage controlled Steering Switching Assembly (SSA) (802), for providing the current required by said resonant circuitry; (e) a Zero Crossing Detector (ZCD) (803), for detecting the instants at which said sinusoidal signal crosses a zero value, and for outputting a corresponding indication signal at each instant; and (f) a Soft Switching Controller (SSC) (804), the input of which accepts said indication signal, for adjusting the switching times of power switches contained in said SSA to said instants. _________ ]11[]21[ ]54[ AUTONOMOUS FOCUSING OF STARING SYSTEMS ]22[ ]51[ ]71[ 12.03.2003 Int. Cl.8 G02B 001/00, 007/04 RAFAEL ARMAMENT DEVELOPMENT AUTHORITY LTD. EHUD CHISHINSKY YORAM TSIVION, 2 HATOHEN ST., P.O.B. 3148, PARDESS HANA 38900 ]72[ ]74[ [57] A system for autonomously focusing of a staring device system, comprising: an imaging array onto which a focusing lens assembly focuses rays collected by an 1113 154894 מערכת למיקוד אופטי עצמאי ,רפא"ל רשות לפיתוח אמצעי לחימה בע"מ חיפה דני פפושדו, יצחק נבו,אהוד צישינסקי ,יורם צביון ,3148 .ד. ת, פארק התעשיה,2 רח' הטוחן חנה-פרדס objective lens; at least one lighting element for illuminating said imaging array; and a means for retro-reflecting light scattered and reflected from said imaging array. June 5, 2008– ב' בסיון התשס"ח _________ ]11[]21[ ]54[ DEHUMIDIFIER SYSTEM ]22[ ]31[ ]51[ ]62[ ]71[ ]87[ ]74[ 11.11.1998 PCT/IL97/00372 ]32[ 16.11.1997 Int. Cl.7 F24F 003/14 DIVISION FROM 136127 DRYKOR, LTD. WO/1999/026026 FENSTER & COMPANY, INTELLECTUAL PROPERTY LTD., 12 BASEL ST., ENTRANCE 1, P.O.B. 10256 , PETACH TIKVA [57] An air modifying device (10) including: an enclosure (112) including apparatus for modifying air entering the apparatus via an air inlet and having an air outlet for the modified air; a first conduit (14) having an entrance for air and an exit communicating with the inlet; a second conduit (16) having an exit and an entrance June 5, – ב' בסיון התשס"ח 155042 מערכת לייבוש אויר ]33[ WO עתלית,דרייקור בע"מ ,קניין רוחני בע"מ,'פנסטר ושות .ד. ת, קרית אריה,1 כניסה12 בזל פתח תקוה,10256 communicating with the outlet; and a mounting surface adapted for mounting the device on a partition (118) such that the enclosure is on a first side of the partition and the entrance to the first conduit and the exit from the second conduit are situated on a second side of the partition. 1114 2008 __________ ]11[]21[ 155120 תהליך לסינתזה במצב מוצק של אוקסימים חומצות, קיטונים,אלדהידים הידרוקסאמיות ]54[ PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDES, KETONES, OXIMES AND HYDROXAMIC ACIDS ]22[ ]31[ 17.12.1997 032453 ]32[ 19.12.1996 ]33[ US 033881 24.12.1996 US Int. Cl.8 C07C 045/00, 047/00, 049/00, C08F 212/08, 212/36 DIVISION FROM 130040 AVENTIS PHARMACEUTICALS INC., U.S.A. WO/1998/023976 SANFORD T.COLB & CO., ,' קולב ושות.סנפורד ט P.O.B. 2273, רחובות,2273 .ד. ת, מרמורק,4 שער הגיא REHOVOT 76122 ]51[ ]62[ ]71[ ]87[ ]74[ [57] A polymeric tetrafluorophenyl hydroxylamine resin compound of the formula 1115 June 5, 2008– ב' בסיון התשס"ח A is absent or a group of formula –X1-Zwherein X1 is –CHR- or –CHR-Y-CO-(CH2)nwherein R is H, alkyl, phenyl, or phenyl substituted with-H, alkyl, alkoxy, halogen, nitrile or –NO2, Y is -O- or NH-, n is an integer from 1 to 6, and Z is –O- or –NH-; R3 and R4 are independently –H, alkyl, phenyl, or phenyl substituted with one or more substituents selected from alkyl, alkoxy, halogen, nitrile and –NO2; and P1 is H or an amine protecting group. ___________ ]11[]21[ ]54[ HIGH DENSITY FLEX INTERCONNECT FOR CT DETECTORS ]22[ ]31[ ]51[ ]71[ 08.04.2003 125951 ]32[ 19.04.2002 Int. Cl.8 A61B 006/03, G01T 001/00 GE MEDICAL SYSTEMS GLOBAL TECHNOLOGY COMPANY, LLC, U.S.A. SELIGSOHN GABRIELI & CO., 31 YAVNE ST., P.O.B. 1426, TEL AVIV 61013 ]74[ [57] A detector module, comprising: a photosensor array (106) having a first width; and a flexible cable operationally June 5, – ב' בסיון התשס"ח 155286 TCמחבר גמיש בצפיפות גבוהה עבור גלאי ]33[ US ,'זליגסון גבריאלי ושות תל אביב,1426 .ד. ת, 31 רח' יבנה (118) coupled to said photosensor array, said cable having a width greater than said first width. 1116 2008 _________ ]11[]21[ ]54[ AZIDE METHOD AND COMPOSITION FOR CONTROLLING DELETERIOUS ORGANISMS ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 09.10.2001 60/238943 ]32[ 10.10.2000 Int. Cl.8 A01N 025/00, 059/00 AUBURN UNIVERSITY, U.S.A. WO/2002/030195 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A composition for controlling a population of a deleterious organism comprising: an ionic azide; an azide stabilizer comprising an amine selected from the group consisting of ethanolamine, 155319 שיטה ותכשיר המכיל אזיד לשליטה באורגניזמים מזיקים ]33[ US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם dimethylamine, ethylamine, butylamine, diethylamine, diethanolamine, and phenylethylamine in an amount sufficient to stabilize the azide; and a liquid dispersal medium. ___________ 1117 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ 155386 השימוש בהם,–אזאינדולים חדשים7 ושיטות4 כמעכבי פוספודיאסטראזה להכנתם ]54[ 7-AZAINDOLES, USE THEREOF AS PHOSPHODIESTERASE 4 INHIBITORS AND METHOD FOR PRODUCING THE SAME ]22[ ]31[ 25.10.2001 10053275.6 ]32[ 27.10.2000 ]33[ DE 60/244342 30.10.2000 US Int. Cl.8 A61K 031/437, A61P 011/00, C07D 471/04 ELBION AG, GERMANY WO/2002/034747 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] 7-Azaindoles of the formula in which n can be 1 or 2 and R1 represents -C1 to –C10 alkyl, linear or branched, unsubstituted or substituted one or more times with –OH, -SH, -NH2, -NHC1 to – NHC6 alkyl, -N(C1 to C6-alkyl)2, -NHC6 to –NHC14 aryl, - N(C6 to C14 aryl)2, -N(C1 to C6 alkyl) (C6 to C14 aryl), -NO2, -CN, -F, Cl, -Br, -I, -O-C1 to –O-C6 alkyl, -O-C6 to –O-C14 aryl, -S-C1 to –S-C6 alkyl, -S-C6 to –S-C14 aryl, -SO3H, - SO2C1 to –SO2C6 alkyl, -SO2C6 to –SO2C14 aryl, -OSO2C6 alkyl, -OSO2C6 to –OSO2C14 aryl, -COOH, -(CO)C1 to –(CO)C5 alkyl, with mono-, bior tricyclic, saturated or monounsaturated June 5, – ב' בסיון התשס"ח or polyunsaturated carbocylic compounds with 3 to 14 ring elements, with mono-, bior tricyclic saturated or monounsaturated or polyunsaturated heterocyclic groups with 5 to 15 ring elements and 1 to 6 hetero atoms, which preferably are N, O and S, it being possible for the C6 to C14 aryl groups and the carbocyclic and heterocyclic substituents, in turn, to be unsubstituted or monosubstituted or polysubstituted with R4, -C2 to C10 alkenyl, monounsaturated or polyunsaturated, linear or branched, unsubsituted or monosubstituted or polysubstituted with – OH, -SH, -NH2, -NHC1 to – NHC6 alkyl, N(C1 to C6 – alkyl)2, -NHC6 to –NHC14 1118 2008 aryl, -N(C6 to C14 aryl)2, -N(C1 to C6 alkyl) (C6 to C14 aryl), -NO2, -CN, -F, -Cl, -Br, -I, -O-C1 to –O-C6 alkyl, -O-C6 to –O-C14 aryl, -S-C1 to –S-C6 alkyl, -S-C6 to –S-C14 aryl, -SO3H, -SO2C1 to –SO2C6 alkyl – SO2C6 to –SO2C14 aryl, -OSO2C1 to – OSO2C6 alkyl, -OSO2C6 to –OSO2C14 aryl, - COOH, -(CO)C1 to –(CO)C5 alkyl, with mono-, bi- or tricyclic, saturated or monounsaturated or polyunsaturated carbocyclic compounds with 3 to 14 ring elements, with mono-, bi- or tricyclic saturated or monounsaturated or polyunsaturated heterocyclic groups with 5 to 15 ring elements and 1 to 6 hetero atoms, which preferably are N, O and S, it being possible for the C6 to C14 aryl groups and the carbocyclic and heterocyclic substitutents, in turn, to be unsubstituted or monosubstituted or polysubstituted with R4, R2 and R3 may be the same or different, it being possible for only one of the two to represent hydrogen and furthermore, R2 and R3 can represent –C1C5 alkyl, unsubstituted or monosubstituted or polysubstituted with –OH, -SH, -NH2, NHC1 to –NHC6 alkyl, -N(C1 to C6-alkyl)2, -NO2, -CN, -F, -Cl, -Br-, -I, -O-C1 to –OC6 alkyl, -S-C1 to –S-C6 alkyl, -phenyl, pyridyl –phenyl, unsubstituted or monosubstituted or polysubstituted with – OH, -SH, -NH2, - NHC1 to –NHC3 alkyl, N(C1 to C3-alkyl)2, -NO2, -CN, -COOH, COOC1 to –COOC3 alkyl, -F, -Cl, -Br-, O-C1 to –O-C3 alkyl, -S-C1 to –S-C3 alkyl, -pyridyl, unsubstituted or monosubstituted or polysubstituted with –NO2, -CN, COOH, -COOC1 to –COOC3 alkyl, -Cl, Br-, -O-C1 to –O-C3 alkyl, -S-C1 to –S-C3 alkyl as well as furthermore, the –NR2R3 group can represent together and R4 represents -H, -OH, -SH, -NH2, -NHC1 to –NHC6 alkyl, -N(C1 to C6 alkyl)2, NHC6 to NHC14 aryl, N(C6 to C14 aryl)2, -N(C1 to C6 alkyl) (C6 to C14 aryl), -NHCOC1 to –NHCOC6 alkyl, -NO2, -CN, -COOH, -COOC1 to COOC6 alkyl, -(CO)C1 to –(CO)C6 alkyl, (CS)C1 to –(CS)C6 alkyl, -F, -Cl, -Br, -I, - 1119 O-C1 to –O-C6 alkyl, -O-C6 to –O-C14 aryl, -S-C1 to –S-C6 alkyl, -S-C6 to –S-C14 aryl, -SOC1 to –SOC6 alkyl, -SO2C1 to –SO2C6 alkyl, with the proviso that when n = 1 there is no concurrent R1 = -C1 to C6 alkyl R2 = -H or –C1 to C5 alkyl and R3 = June 5, 2008– ב' בסיון התשס"ח where R and R' are independently –C1 to C6 alkyl with or without single or multiple halogen substitution, -C2 to C6 alkenyl, -C3 to C6 cycloalkyloxy, -C3 to C6 cycloalkylC1 to C6 alkyl, -C1 to C6 alkylthio, -C3 to C6 cycloalkylthio, -C3 to C6 cycloalkyl-C1 to C6 alkylthio, -C1 to C6 alkoxy, hydroxyl, halogen, nitro, -CF3, -C2F5, -OCF3, -SCF3, SO2CF3, -SO2F, formyl, -C2 to C6 alkanoyl, cyano, substituted or unsubstituted phenyl, -NR"2, -CONR"2, COOR" or R + R' together are a 5-membered carbocycle or heterocycle, and R" = -H or –C1 to C6 alkyl. ___________ ]11[]21[ 155447 תרכבות מעגליות ארומטיות חנקניות ]54[ NITROGENOUS AROMATIC RING COMPOUNDS ]22[ ]31[ 19.10.2001 2000-320420 ]32[ 20.10.2000 ]33[ JP 2000-386195 20.12.2000 JP 2001-46685 22.02.2001 JP Int. Cl.8 A61K 031/47, A61P 035/00, C07D 213/74, 213/75, 215/48, 239/47, 401/12, 405/12, 409/12, 413/12 EISAI R&D MANAGEMENT CO., LTD., JAPAN YASUHIRO FUNAHASHI, AKIHIKO TSURUOKA, MASAYUKI MATSUKURA, TORU HANEDA, YOSHIO FUKUDA, JUNICHI KAMATA, KEIKO TAKAHASHI, TOMOHIRO MATSUSHIMA, KAZUKI MIYAZAKI, KEN-ICHI NOMOTO, TATSUO WATANABE, HIROSHI WO/2002/032872 ]51[ ]71[ ]72[ ]87[ June 5, – ב' בסיון התשס"ח 1120 2008 ]74[ [57] JEREMY M. BEN-DAVID & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O.B. 45087, JERUSALEM 91450 A compound of the formula: ,דוד ושות' בע"מ- בן.ירמיהו מ ,45087 .ד. ת, הר חוצבים,רחוב המרפא ירושלים [wherein A is a group represented by the formula: [wherein W is a carbon atom; Ra13 is a hydrogen atom; Ra12 is a cyano group or a group represented by the formula: (wherein Va12 and Va13 are each independently a hydrogen atom, a C1-6 alkyl group which may have one or more substituents selected from [group A], a C2-6 alkenyl group which may have one or more substituents selected from [group A], a C2-6 alkynyl group which may have one or more substituents selected from [group A], a C3-8 alicyclic hydrocarbon group which may have one or more substituents selected from [group A], a C6-14 aryl group which may have one or more substituents selected from [group A], a 5- to 14- 1121 membered heterocyclic group which may have one or more substituents selected from [group A] or a 5- to 14-membered aromatic heterocyclic group which may have one or more substituents selected from [group A]); and Ra11 is a group represented by the formula -Va21-Va22-Va23 (wherein Va21 is a C1-6 alkylene group which may have one or more substituents selected from [group A], a single bond or a group represented by the formula: June 5, 2008– ב' בסיון התשס"ח Va22 is a single bond, an oxygen atom, a sulfur atom, -CO-, -SO-, -SO2-, -CONRa14, -SO2NRa14, -NRa14SO2-, -NRa14CO-or – NRa14- (wherein Ra14 is a hydrogen atom, a C1-6 alkyl group which may have one or more substituents selected from [group A] or a C3-8 alicyclic hydrocarbon group which may have one or more substituents selected from [group A]); and Va23 is a hydrogen atom, a C1-6 alkyl group which may have one or more substituents selected from [group A], a C2-6 alkenyl group which may have one or more substituents selected from [group A], a C2-6 alkynyl group which may have one or more substituents selected from [group A], a C3-8 alicyclic hydrocarbon group which may have one or more substituents selected from [group A], a 5- to 14membered heterocyclic group which may have one or more substituents selected from [group A] or a 5- to 14-membered aromatic heterocyclic group which may have one or more substituents selected from [group A])]; X is an oxygen atom or a sulfur atom; E and Y represent as follows: (1) E is a group represented by the formula –NR2-, and Y is a phenyl group which may have one or more substituents selected from [group A], a pyridyl group which may have one or more substituents selected from [group A] or a group represented by the formula: (wherein W11 and W12 are each independently a carbon atom which may have one or more subtituents selected from [group A] or a nitrogen atom); (2) E is a single bond, and Y is a group represented by the formula: (wherein W13 is a carbon atom which may have one or more substituents selected from [group A] or a nitrogen atom), which may have one or more substituents selected from [group A]; R1 and R2 are each independently a June 5, – ב' בסיון התשס"ח 1122 2008 hydrogen atom, a C1-6 alkyl group which may have one or more substituents selected from [group A], a C2-6 alkenyl group which may have one or more substituents selected from [group A], a C2-6 alkynyl group which may have one or more substituents selected from [group A], a C3-8 alicyclic hydrocarbon group which may have one or more substituents selected from [group A], a C2-7 acyl group which may have one or more substituents selected from [group A] or a C2-7 alkoxycarbonyl group which may have one or more substituents selected from [group A]; and Z is a group represented by the formula – Z11-Z12 (wherein Z11 is a single bond, an oxygen atom, a sulfur atom, -CO-, -SO2or a C1-6 alkylene group which may have one or more substituents selected from [group A] and Z12 is a hydrogen atom, a C1-6 alkyl group which may have one or more substituents selected from [group A], a C2-6 alkenyl group which may have one or more substituents selected from [group A], a C2-6 alkynyl group which may have one or more substituents selected from [group A], a C3-8 alicyclic hydrocarbon group which may have one or more substituents selected from [group A], a C614 aryl group which may have one or more substituents selected from [group A], a 5to 14-membered heterocyclic group which may have one or more substituents selected from [group A], a 5- to 14membered aromatic heterocylic group which may have one or more substituents selected from [group A], or a group represented by the formula: (wherein Z31, Z33 and Z34 are each independently a methylene group, -CO-, NH- or –O-, and Z32 is a single bond, a methylene group, -CO-, -NH- or-O-))], a pharmaceutically acceptable salt or a hydrate thereof, wherein [group A] has the following members: halogens, (2) hydroxyl, (3) thiol, ...P (4) nitro, (5) nitrile, (6) oxo, (7) azido, (8) guanidine, (9) hydrazine, (10) isocyano, (11) cyanate, (12) isocyanate, (13) thiocyanate, (14) isothiocyanate, (15) nitroso, (16) carbamido(ureido), (17) formyl, (18) C1-6 imidoyl, (19) optionally halogenated or hydroxylated C1-6 alkyl groups, C2-6 alkenyl groups, C2-6 alkynyl groups, C3-6 cycloalkyl groups, C3-6 cycloalkenyl groups, C3-6 cycloalkenyl groups, C3-6 cycloalkynyl groups, C1-6 alkoxy groups, C2-6 alkenyloxy groups, C2-6 alkynyloxy groups, C3-6 cycloalkyloxy groups, C1-6 alkylthio groups, C2-6 alkenylthio groups, C2-6 alkynylthio groups, C3-6 cycloalkylthio groups or C1-6 alkylenedioxy groups, (20) C6-14 aryl groups, (21) 5- to 14-membered heterocyclic groups, (22) carboxyl, (23) trifluoromethyl, (24) C6-14 aryl-C1-6 alkyl groups, (25) 5-to 14-membered heterocyclic C1-6 alkyl groups or (26) the group represented by the formula –Vxx1 – Vxx2 –Vxx3 –Vxx4 (wherein Vxx2 and Vxx3 are each independently (1) a single bond, (2) oxygen, (3) sulfur, (4) –CO-,(5)-SO(6)-SO2-,(7)-N,Rxx1-, (8)-CONRxx1-, (9)NRxx1CO-, (10) –SO2NRxx1-, (11)NRxx1SO2-, (12) –O-CO-, (13) –C(O)O-, (14) –NRxx1C(O)O-(15)-NRxx1C(O)NRxx2, (16)-O-C(O)NRxx1-, (17) –O-C(O)O-, (18) a C1-6 alkylene group, (19) a C2-6 alkenyl group, (20) a C1-6 alkynyl group (21) a C3-8 alicyclic hydrocarbon group, (22) a C6-14 1123 June 5, 2008– ב' בסיון התשס"ח aryl group, (23) a 5- to 14-membered heterocyclic group or (24) a 5- to 14membered aromatic heterocylic group; and Vxx4, Rxx1 and Rxx2 and Rxx2 are each independently (1) hydrogen, (2) a C1-6 alkyl group, (3) a C2-6 alkenyl group, (4) a The applications for division from this application have not yet been published C1-6 alkynyl group, (5) a C3-8 alicyclic hydrocarbon group, (6) a C6-14 aryl group, (7) a 5- to 14-membered heterocyclic group, (8) a 5- to 14-membered aromatic heterocyclic group or (9) a C1-6 alkoxy group. 189677 בקשות חלוקה מבקשה זו .שטרם פורסמו __________ ]11[]21[ ]54[ TECHNOLOGY FOR IMPROVING STP PROTOCOLS IN ETHERNET NETWORKS SUPPORTING VLANS ]22[ ]51[ ]71[ ]72[ 15.04.2003 Int. Cl.8 H04L 012/46, 012/56 ECI TELECOM LTD. IDAN KASPIT, NOAM GOLDBERG, IGOR BALTER ECI TELECOM LTD., 30 HASIVIM ST., PETACH TIKVA 49517 ]74[ [57] A method for utilizing a Spanning Tree Protocol STP in an Ethernet network wherein a number of VLANs are defined and a plurality of Ethernet switching nodes (A, B, C, D, E, F, G, H) are interconnected via their ports (A1,…,H4) so that each of the ports is initially assigned to one or more VLANs, and each of the VLANs is intended to enable traffic between two or more edge ports (D3, B3), the method being characterized in that, upon establishing a new STP topology related June 5, – ב' בסיון התשס"ח 155449 ברשתותstp שיטה לשיפור פרוטוקול מסוג VLAN התומכות ברשתותETHERNET פתח תקוה, טלקום בע"מ.איי.סי.אי איגור בלטר, נעם גולדברג,עידן כספית , טלקום בע"מ. איי. סי.אי פתח תקוה,30רחוב הסיבים to one or more VLANs, it comprises initiating a pruning procedure of a broadcast domain of at least one of said one or more VLANs to obtain a sub-tree for each pruned VLAN in the new STP topology, wherein each said subtree being bound by the edge ports assigned to the corresponding pruned VLAN, thereby eliminating broadcast traffic of each said pruned VLAN to any Ethernet switch extending beyond the obtained corresponding sub-tree. 1124 2008 __________ ]11[]21[ 155563 מערכת ושיטה לכיול מצלמה ]54[ SYSTEM AND METHOD FOR CAMERA CALIBRATION ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 25.10.2001 09/697605 ]32[ 26.10.2000 ]33[ US Int. Cl.8 H04N 005/225, 007/18, 017/00 IMOVE INC., U.S.A. WO/2002/035831 JEREMY M. BEN-DAVID & CO. ,דוד ושות' בע"מ- בן.ירמיהו מ LTD., ,45087 .ד. ת, הר חוצבים,רחוב המרפא HAR HOTZVIM HI-TECH PARK, ירושלים P.O.B. 45087, JERUSALEM 91450 [57] A method for calibrating a panoramic camera system that captures overlapping single view images that are seamed together into a panorama, the method comprising: capturing a first single view image of a structure, the first single view image including first indicia along an edge of the structure; capturing a second single view image of the structure, the second single view image including second indicia along the same edge of the structure, wherein the first and second single view images are to be seamed 1125 together along the edge; and adjusting one or more camera parameters for a first camera element within the panoramic camera system and adjusting one or more camera parameters for a second camera element within the panoramic camera system to seam together the first indicia with the second indicia, wherein the first single view image is captured by the first camera element and the second single view images is captured by the second camera element. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ AEROGEL COMPOSITE WITH FIBROUS BATTING ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 21.12.2001 60/257437 ]32[ 22.12.2000 Int. Cl.8 B32B 015/04, D04H 001/02 ASPEN AEROGELS, INC., U.S.A. WO/2002/052086 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [57] A composite article (10) to serve as a flexible, durable, light-weight insulation product, said article comprising a lofty June 5, – ב' בסיון התשס"ח 155922 חומר מורכב ארוג'ל עם חומר מילוי סיבי ]33[ US ,' קולב ושות.סנפורד ט רחובות,2273 .ד. ת, מרמורק,4 שער הגיא fibrous batting sheet (12) and a continuous aerogel (11) through said batting. 1126 2008 ___________ ]11[]21[ ]54[ SYSTEM AND METHOD FOR TRAINING IN MILITARY OPERATIONS IN URBAN TERRAIN ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 15.11.2001 721138 ]32[ 22.11.2000 Int. Cl.8 F41G 003/26 CUBIC CORPORATION, U.S.A. WO/2002/103654 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A system for training players in an urban combat environment, comprising: at least one stationary area effects weapon simulator including a first infrared emitter; a plurality of sets of infrared detectors, each set being worn by a player; and a plurality of player units, each player unit being carried by a player and connected to 1127 156006 מערכת ושיטה לאימון פעילות צבאית בשטח עירוני ]33[ US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם a corresponding set of infrared detectors for logging hits on the corresponding set of detectors of infrared energy emitted from the first infrared emitter in the stationary area effects weapon simulator or a second infrared emitter mounted on a mobile small arms weapon. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ METHOD AND APPARATUS FOR LOCATING INCLUSIONS IN A DIAMOND ]22[ ]31[ ]51[ ]71[ 03.12.2001 00204323.0 ]32[ 04.12.2000 Int. Cl.8 G01N 021/88 DIAMCAD N.V., BELGIUM SERGUEI BORISOVISH SIVOVOLENKO, RUSSIA WO/2002/046725 DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063 ]87[ ]74[ [57] A method for locating inclusions in a diamond, wherein said diamond is fixed on a holder, characterized in that a scan is taken of the outer surface of the diamond at an arbitrary initial position; the inclusion in the diamond is observed in at least a first and second direction of observation, wherein the translation and rotation for 156034 שיטה ומתקן עבור מיקום גוף זר ביהלום ]33[ EP ,ד"ר יצחק הס ושותפיו תל אביב,6451 .ד. ת, 279 רחוב הירקון every direction of observation is registered with reference to the initial position, wherein the registered translations and rotations and the scan of the outer surface are fed into a computer in order to locate the inclusion with respect to the outer surface of said diamond. __________ June 5, – ב' בסיון התשס"ח 1128 2008 ]11[]21[ 156075 מחשב רב–משימתי באמצעות חיווט וירטואלי ]54[ COMPUTER MULTI-TASKING VIA VIRTUAL THREADING ]22[ ]31[ ]51[ ]71[ 26.10.2001 721695 ]32[ 24.11.2000 ]33[ US Int. Cl.8 G06F 009/38, 009/45, 009/455, 009/46, 009/48, 009/54 CATHARON PRODUCTIONS, INC., U.S.A. WO/2003/007105 REINHOLD COHN AND ,ריינהולד כהן ושותפיו PARTNERS, תל אביב,4060 .ד. ת, 21 רחוב אחד העם 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] A method for operating a computer, comprising: storing in a computer memory a plurality of pseudocode instructions, at least some of said pseudocode instructions comprising a plurality of machine code instructions; for each of a plurality of tasks or jobs to be performed by the computer, automatically creating a respective virtual thread of execution context data including (a) a memory location of a next one of said pseudocode instructions to be executed in carrying out the respective task or job and (b) the values of any local variables required for carrying out the respective task or job, a plurality of said tasks or jobs each entailing execution of a respective one of said pseudocode instructions comprising a plurality of machine language instructions; processing each of said tasks or jobs in a respective series of time slices or processing slots under the control of the respective virtual thread; and in every context switch between different virtual threads, undertaking such context switch only after completed execution of a currently executing one of said pseudocode instructions. _________ 1129 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ METHOD AND DEVICE FOR REGULATING THE POWER OF MILLIMETER WAVES FOR A VBAND TR MODULE ]22[ ]31[ ]51[ ]71[ 09.11.2001 10060332.7 ]32[ 04.12.2000 Int. Cl.8 H01P 001/15, 001/22 EADS DEUTSCHLAND GMBH, GERMANY WO/2002/047245 DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063 ]87[ ]74[ [57] Method to control the power of millimeter waves for a V-band TR module at a frequency in the range of 50 GHz and higher, the method comprising the acts of: separating the transmitting and receiving path via two SPDT (single pole double throw) MMIC switches; for the 156147 שיטה ומתקן עבור וויסות הכוח של גלי V–BAND TR מילימטר עבור מודול ]33[ DE ,ד"ר יצחק הס ושותפיו תל אביב,6451 .ד. ת, 279 רחוב הירקון transmission, using the first SPDT MMIC switch as a variable attenuator and the second SPDT MMIC switch as a detector for the output power; and by way of an electronic control circuit, the control of the output power to a defined level is achieved. __________ June 5, – ב' בסיון התשס"ח 1130 2008 ]11[]21[ 156258 תהליך לסינטזה של פפטיד בעל שייר טריפתופן ]54[ PROCESS FOR THE SYNTHESIS OF A PEPTIDE HAVING A TRP RESIDUE ]22[ ]31[ ]51[ ]71[ 19.12.2001 2000/1079 ]32[ 22.12.2000 ]33[ IE Int. Cl.8 C07K 001/04, 001/06, 001/10, 007/08, 007/23 IPSEN MANUFACTURING IRELAND LIMITED, IRELAND WO/2002/051861 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] A process for making a peptide of the formula pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-ArgPro-Gly-NH2, (I) wherein the His residue is protected with a tosyl group and the indole –NH of any Trp residue is protected which comprises the steps of: (a) attaching a cesium-salt of Boc-Gly onto a chloromethylated polystyrene resin to yield Boc-Gly-resin; (b) deblocking Boc-Gly-resin by mixing the Boc-Gly-resin with a mixture of a Bocdeblocking organic acid to yield an organic acid salt of H2N-Gly-resin; © neutralizing the organic acid salt of H2N-Gly-resin with a base to yield H2NGly-resin; (d) coupling H2N-Gly-resin with a Boc-α – amine protected amino acid, said protected amino acid corresponding to the amino acid defined for formula (I) in the order shown from the C-terminal to the Nterminal, which comprises, (i) reacting H2N-Gly-resin with the Boc-α –amine protected amino acid in the presence of a peptide coupling agent to yield a Boc-blocked coupled product; (ii) deblocking the Boc group from the Boc-blocked coupled product by mixing the Boc-blocked coupled product with a 1131 Boc-deblocking organic acid to yield a coupled product; (iii) reacting the coupled product with a next Boc-α –amine protected amino acid in the presence of a peptide coupling agent to yield a Boc-blocked coupled product; (iv) deblocking the Boc group from the Boc-blocked coupled product by mixing the Boc-blocked coupled product with a Boc-deblocking organic acid to yield a next coupled product; (v) repeating steps (d)(iii) and (d)(iv) until the N-terminal amino acid of the peptide of formula (I) has been coupled, the Boc group of the N-terminal amino acid has been deblocked and the tosyl side chain protecting group of the His residue has been removed to yield a protected completed peptide-resin; (e) cleaving and deprotecting the protected completed peptide-resin to yield the peptide of formula (I), wherein said cleaving and deprotecting comprises: (i) making a solution of the protected completed peptide-resin in a methanol/inert polar aprotic solvent mixture; (ii) cooling the solution to about 0oC to 10oC; (iii) bubbling ammonia gas or ethylamine gas slowly and maintaining cooling until June 5, 2008– ב' בסיון התשס"ח the solution is well saturated with ammonia to yield a saturated solution; (iv) mixing the saturated solution without cooling for 15-36 hours until >95% of free methyl ester is converted to the corresponding amide, when ammonia gas is used, or the corresponding ethylamide, when ethylamine gas is used; (f) isolating said peptide from said solution. __________ ]11[]21[ 156436 נגזרות תיאזול ותכשירים רוקחיים המכילים אותם ]54[ THIAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM ]22[ ]31[ ]51[ 19.12.2001 0031107.6 ]32[ 20.12.2000 ]33[ GB Int. Cl.8 A61K 031/421, 031/426, A61P 003/08, 043/00, C07D 263/32, 263/34, 277/22, 277/32 GLAXO GROUP LIMITED, UNITED KINGDOM WO/2002/062774 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]71[ ]87[ ]74[ [57] A compound of the formula or a pharmaceutically acceptable salt, solvate, or hydrolysable ester thereof, wherein: R1 and R2 which are bonded to the same carbon atom may together with the carbon atom to which they are bonded form a 3-6 membered cycloalkyl ring, and at least one of R1 and R2 must be other than H; X2 is O, or S; R3, R4, and R5 are independently H, C1-3 alkyl, OCH3, CF3, allyl, or halogen; one of Y and Z is N, the other is S or O; R6 and R7 are independently H, phenyl, benzyl, fluorine OH, C1-6 alkyl, alkyl, R6 and R7 may, together with the carbon atom to which they are bonded, represent a carbonyl group; R9 is H, CF3 or CH3; each R8 is independently CF3, C1-3 alkyl, OCH3 or halogen; y is 1 or 2. __________ June 5, – ב' בסיון התשס"ח 1132 2008 ]11[]21[ ]54[ PROCESS AND DEVICE FOR APPLYING A RELEASE AGENT TO THE ROLLS OF A MACHINE FOR THE CONTINUOUS CASTING OF METAL STRIPS ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 05.02.2002 01/01724 ]32[ 08.02.2001 Int. Cl.8 B22D 011/06 NOVELIS, INC., CANADA WO/2002/062508 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A process for coating the rolls of a twin-roll continuous casting machine including the application of at least one release product to said rolls using spray means forming at least one release product jet said release product containing a 156732 שיטה והתקן לעטיפה חוזרת של מיסבים של מכונה ליציקה רצופה של רצועת מתכת ]33[ FR ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם release agent and a carrier fluid, characterised in that it includes an adjustment of the composition of said release product while it is applied to said rolls without modifying the flow of the spray means. _________ ]11[]21[ 156886 יחידת הזרקה ]54[ INJECTION UNIT ]22[ ]31[ ]51[ ]71[ 21.11.2001 791374 ]32[ 23.02.2001 ]33[ US Int. Cl.8 B22D 017/00, 017/20, B29C 045/17 HUSKY INJECTION MOLDING SYSTEMS LTD., CANADA WO/2002/066183 REINHOLD COHN AND ,ריינהולד כהן ושותפיו PARTNERS, תל אביב,4060 .ד. ת, 21 רחוב אחד העם 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] An injection assembly comprising: a barrel assembly (30), and a carriage assembly (34); the barrel assembly 1133 including first (44) and second (48) barrel portions having an axial bore therethrough, and a first barrel coupler (46), the location June 5, 2008– ב' בסיון התשס"ח of the first barrel coupler defining a boundary between the first barrel portion and the second barrel portion; the carriage assembly including a first carriage coupler to engage the first barrel coupler, and a carriage actuator (56, 58) for linking with a stationary platen of a clamp unit (12); wherein the first barrel coupler, in use, interlocks with the first carriage coupler to secure the barrel assembly in the carriage assembly, thereby isolating the second barrel portion from axial carriage force. __________ June 5, – ב' בסיון התשס"ח 1134 2008 ]11[]21[ ]54[ APPARATUS AND SYSTEM FOR THE AIR-TO-AIR ARMING OF AERIAL VEHICLES ]22[ ]51[ ]71[ ]74[ 14.08.2003 Int. Cl.8 B64D 001/00, F41A 009/00 NIR PADAN SOROKER-AGMON, 14 SHENKAR ST., HERZLIYA PITUAH 46725 [57] An apparatus for the air-to-air transfer of at least one ordnance unit from a first airborne aerial vehicle to a second airborne aerial vehicle, the apparatus comprising: an ordnance storage rack within a cargo space of the first airborne aerial vehicle to provide pre-transfer storage space to an at least one ordnance unit; a pylon installed on the second airborne aerial vehicle and intended to receive an at least one ordnance unit transferred from the first airborne aerial vehicle to the second airborne aerial vehicle; an at least one transferable ordnance unit positioned prior to transfer on the ordnance storage rack located 157401 מערכת ושיטה לחימוש אווירי של כלי טייס מושב שדה יצחק,ניר פדן ,אגמון-סורוקר הרצליה פיתוח,14 רחוב שנקר,בית נולטון within the cargo space of the first airborne aerial vehicle; an extendible arm assembly attached to the first airborne aerial vehicle, the arm first end is attached to the body of the first airborne aerial vehicle, the arm second end provided with freedom of movement; an ordnance transfer assembly coupled to said extendible arm, adapted to provide for the transfer of the at least one ordnance unit from the first airborne aerial vehicle onto the pylon on the second airborne aerial vehicle; and a power generator device to provide power for the movement of the arm and the ordnance transfer assembly. _________ 1135 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ DITHERLESS NON-UNIFORMITY COMPENSATION FOR INFRARED DETECTOR ARRAYS WITH RECURSIVE SPATIAL LOW PASS FILTERING ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 15.02.2002 09/785833 ]32[ 16.02.2001 Int. Cl.8 H04N 005/217, 005/33 RAYTHEON COMPANY, U.S.A. WO/2002/067575 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 [57] A ditherless method of compensating non-uniformities among detector elements of an infrared detector array that captures images of a scene, where each detector element of the array has at least one neighbor, comprising the steps of: determining whether there is relative motion of at least a portion of the scene and the detector array; if there is relative motion, performing a non-uniformity compensation process as follows: receiving two sets of output values, each set representing two matrices of output data from said array, the sets being from a first field and a second field detected by the array at different times; applying any June 5, – ב' בסיון התשס"ח 157424 פיצוי חסר רעידות לא אחיד עבור מערך גלאי אינפרא–אדום עם מסנן רקורסיבי מרחבי מעביר נמוכים ]33[ US ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה previously calculated offset correction values to the output values; for the first field, subtracting output values of neighbors in a first direction from detector element values; for the second field, subtracting output values of neighbors in a second direction from detector element values; adding the results of the two subtracting steps; "dividing" the sum by four, thereby obtaining new offset correction values; updating any previously calculated offset correction values with the new offset correction values; and repeating the above steps for a desired number of iterations. 1136 2008 __________ ]11[]21[ 157502 מפצה פיזור משתנה עם סיבים בעלי מודות מועטות וממירים בעלי מודות הניתנות להחלפה ]54[ ADJUSTABLE DISPERSION COMPENSATOR WITH FEW MODE FIBERS AND SWITCHABLE MODE CONVERTERS ]22[ ]31[ ]51[ ]71[ 20.08.2003 10/234287 ]32[ 04.09.2002 ]33[ US Int. Cl.8 G02B 006/02, 006/42, H04J 014/00 FITEL U.S.A. CORPORATION, U.S.A. SIDDHARTH RAMACHANDRAN JEREMY M. BEN-DAVID & CO. ,דוד ושות' בע"מ- בן.ירמיהו מ LTD., ,45087 .ד. ת, הר חוצבים,רחוב המרפא HAR HOTZVIM HI-TECH PARK, ירושלים P.O.B. 45087, JERUSALEM 91450 ]72[ ]74[ 1137 June 5, 2008– ב' בסיון התשס"ח [57] Method comprising: (a) transmitting an optical signal through a first mode converter (MC) having a first switched state for converting the optical signal from a first mode to a second mode and a second switched state that does not convert the optical signal light from the first mode to the second mode, (b) transmitting the optical signal through a first length of optical fiber having length L1, said first length of optical fiber supporting at least the first mode and the second mode, and having a first dispersion value when the optical signal is in the first mode and a second dispersion value when the optical signal is in the second mode, © transmitting the optical signal through a second mode converter (MC) having a first switched state for converting the signal from the second mode to a mode different from the second mode and a second switched state that does not convert the signal light from the second mode to a different mode, and wherein the second MC may be switched with the first MC in the first switched state and may be switched with the first MC in the second switched state, thereby producing an optical signal output, (d) switching the first MC to the first switched state to produce an optical signal output with the first dispersion value, and (e) switching the first MC to the second switched state to produce an optical signal output with the second dispersion value. ___________ ]11[]21[ ]54[ PROCESS FOR PRODUCING 5SUBSTITUTED OXAZOLE COMPOUNDS AND 5SUBSTITUTED IMIDAZOLE COMPOUNDS ]22[ ]31[ 20.03.2002 2001-84092 ]32[ 23.03.2001 2001-84183 23.03.2001 2001-84184 23.03.2001 Int. Cl.8 C07D 233/64, 263/00, 263/32 NIPPON SODA COMPANY LTD., JAPAN WO/2002/076958 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] A process for the preparation of a 5substituted oxazole or 5-substituted imidazole, characterized in that ptolylsufonylmethylisocyanide synthesized June 5, – ב' בסיון התשס"ח 157724 תהליך להכנת תרכובות אוקסזול מותמרות ותרכובות אימידאזול מותמרות5 בעמדה 5 בעמדה ]33[ JP JP JP ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם from N-(p-tolysulfonylmethyl) formamide with phosphorus oxychloride, phosgene or diphosgene, and a tertiary amine, which is not isolated and purified as crystals, is 1138 2008 reacted with an aldehyde or a compound represented by the formula [1]: R1CH=NR2 (wherein, R1 and R2 are optionally substituted phenyl, optionally substituted heterocyclic group or optionally substituted alkyl). ___________ ]11[]21[ ]54[ REINFORCED POLISHING PAD WITH A SHAPED OR FLEXIBLE WINDOW STRUCTURE ]22[ ]31[ ]51[ ]71[ 29.03.2002 823685 ]32[ 30.03.2001 Int. Cl.8 B24B 037/04 LAM RESEARCH CORPORATION, U.S.A. EUGENE Y. ZHAO, KANG JIA, MICHAEL DAVID STEIMAN, HERBERT ELLIOT LITVAK, CHRISTIAN DAVID FREDERICKSON WO/2002/078902 JEREMY M. BEN-DAVID & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O.B. 45087, JERUSALEM 91450 ]72[ ]87[ ]74[ [57] An optical window structure, comprising: a support layer (330), the layer including a reinforcement layer (330b) and a cushioning layer (330a), the cushioning layer being disposed above the reinforcement layer; a polishing pad (102) the polishing pad being attached to a top surface of the support layer; an optical 1139 157827 כר ליטוש מחוזק עם מבנה חלון מעוצב או גמיש ]33[ US ,דוד ושות' בע"מ- בן.ירמיהו מ ,45087 .ד. ת, הר חוצבים,רחוב המרפא ירושלים window opening (206); and a shaped optical window (372), the shaped optical window being configured to at least partially protrude into the optical window opening in the support layer and the polishing pad during operation, and the shaped optical window being separated from a side wall of the polishing pad. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ PESTICIDE TREATMENT OF SOILS OR SUBSTRATES WITH SULPHUR COMPOUNDS ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 04.03.2002 01/03674 ]32[ 19.03.2001 Int. Cl.8 A01N 025/18, 041/00 ARKEMA FRANCE, FRANCE WO/2002/074083 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] Pesticidal (nematicidal, fungicidal, insecticidal and bactericidal) treatment of soils or plant substrates by fumigation, with a cumulative effect, characterised in that at least one sulphur compound of the formula R-S-Sx-R1 is applied to the soil or the substrate at a dose between 150 and 157998 טיפול במזיקים של אדמות או סובסטרטים באמצעות תרכובות גופרית ]33[ FR ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם 1000 kg/ha: in which formula R represents an alkyl or alkenyl radical containing from 1 to 4 carbon atoms, x is a whole number equal to 0 or 1 and R1 represents an alkyl or alkenyl radical containing from 1 to 4 carbon atoms. _________ June 5, – ב' בסיון התשס"ח 1140 2008 ]11[]21[ ]54[ KNEE PROSTHESIS WITH A FLEXION HINGE ]22[ ]31[ ]51[ ]71[ 15.04.2002 01110261.3 ]32[ 25.04.2001 Int. Cl.8 A61F 002/38 WALDEMAR LINK GMBH & CO. KG, GERMANY WO/2002/085257 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] Knee prosthesis including a flexion hinge which is formed by a hinge fork with two branches (8) lying opposite each other, by a centre part (14) which is to be fitted into the hinge fork transversely with respect to a flexion axis of the latter, and by a hinge pin which, after the centre part has been fitted into the hinge fork, is to be 158220 תותב לברך עם ציר מתכופף ]33[ EP ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם mounted, by movement in its longitudinal direction, in aligned hinge bores of the hinge fork and of the centre part, wherein the hinge pin is formed by two pin stumps which, in an assembly position, are arranged inside the centre part and, in a mounted position, partially protrude from the latter. _____________ 1141 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ KNEE PROSTHESIS WITH ROTATION BEARING ]22[ ]31[ ]51[ ]71[ 15.04.2002 01110260.5 ]32[ 25.04.2001 Int. Cl.8 A61F 002/38 WALDEMAR LINK GMBH & CO. KG, GERMANY WO/2002/085258 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] Knee prosthesis, consisting of a femoral component (1), a tibial component (3) and an intermediate piece (10, 10') which connects these and forms a flexion bearing (11) with the femoral component and a rotation bearing (14, 15) with the tibial component, which rotation bearing June 5, – ב' בסיון התשס"ח 158221 תותב לברך עם מיסב לסיבוב ]33[ EP ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם can optionally be locked relative to the tibial component characterized in that the intermediate piece is alternatively provided with a projection (25) which engages in a matching recess (25) in the tibial component. 1142 2008 __________ ]11[]21[ ]54[ VIAL ADAPTER HAVING A NEEDLE-FREE VALVE FOR USE WITH VIAL CLOSURES OF DIFFERENT SIZES ]22[ ]31[ ]51[ ]71[ 07.02.2003 072052 ]32[ 08.02.2002 Int. Cl.8 A61J 003/00, A61M 039/00 CARDINAL HEALTH 303, INC., U.S.A. WO/2003/066152 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 ]87[ ]74[ [57] A vial adapter for interconnecting with vial closures of different diameter, each closure having a seal, comprising: an adapter housing (23) having a first end with an inner periphery with a circular array of claws, and having a second end, the housing having a thickness at the inner periphery; and a sharpened cannula (33) extending from the first end of the adapter housing for penetrating a seal of a vial closure to establish fluid communication between the vial and the first end; wherein the array of claws comprises: a first set of claws (29) extending radially inwardly 1143 158229 מתאם שפופרת בעל שסתום נטול–מחט לשימוש עם סגרי שפופרת בעל גדלים שונים ]33[ US , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, from the inner periphery, each of which has a first length; and a second set of claws (31) extending radially inwardly from the inner periphery, each of the second set of claws having a second length that is longer than the first length of the first set of claws, each of the second set of claws adapted such that when the vial adapter is placed over a closure exceeding a selected diameter, each of the second set of claws will deflect and plastically deform thereby permitting the second set of claws to accommodate the larger closure. June 5, 2008– ב' בסיון התשס"ח _________ ]11[]21[ ]54[ SYSTEM FOR GENERATING PSEUDORANDOM SEQUENCES ]22[ ]31[ 05.04.2002 60/282349 ]32[ 06.04.2001 046601 23.10.2001 Int. Cl.8 H03M 007/00, H04J 013/00 INTERDIGITAL TECHNOLOGY CORPORATION, U.S.A. WO/2002/082759 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] A system for generating an OVSF code comprising: a binary counter for providing a binary count comprising a plurality of sequential M-bit binary numbers, each binary number being ordered from most significant bit to least significant bit; bit reordering means, for selectively reordering the bits of each said binary number from least significant bit to June 5, – ב' בסיון התשס"ח 158259 מערכת ליצירת רצפים דמויי אקראיים ]33[ US US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם most significant bit; an index selector, for providing an M-bit binary identification of said OVSF code; and a logical reduction means having a first input from the reordering means and a second input from the index selector and having an output; whereby the desired OVSF code is output from said output. 1144 2008 _________ ]11[]21[ 158475 קוטלי עשבים המכילים בנזואילציקלוהקסאנדיאונים ומגיני צמחים ]54[ HERBICIDES COMPRISING BENZOYLCYCLOHEXANEDIONES AND SAFENERS ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 09.04.2002 10119721.7 ]32[ 21.04.2001 ]33[ DE Int. Cl.7 A01N 035/06, 041/10, 043/08, 043/40, 043/48, 043/80, 055/10, 057/10 BAYER CROPSCIENCE AG, GERMANY WO/2002/085120 EITAN, PEARL, LATZER AND COHEN , לצר וכהן צדק, פרל,איתן ZEDEK, הרצליה,12688 .ד. ת, 7 רחוב שנקר P.O.B. 12688, HERZLIYA 46733 [57] A herbicidal composition comprising (A) a herbicidally effective amount of one or more compounds of the formula in which the symbols and indices have the following definitions: R1 is nitro, amino, halogen, cyano, (C1C4)-alkyl, (C2-C4)-alkenyl, (C2-C4)alkynyl, (C1-C4)-haloalkyl, (C2-C4)haloalkenyl,-(C2-C4)-haloalkynyl, (C1-C4)haloalkoxy, (C1-C4)-haloalkylthio, (C1-C4)alkoxycarbonyl, (C1-C4)-alkylsuffonyl, (C1-C4)-alkylsulfinyl, (C1-C4)-alkylthio, (C1-C4)-alkoxy, (C1-C4)-alkoxy-(C1-C4)alkoxy, (C1-C4)-alkylcarbonyl, (C1- C4)-alkylaminosulfonyl, (C1-C4)dialkylaminosulfonyl, (C1-C4)alkylcarbamoyl, (C1-C4)-dialkylcarbamoyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C4)alkylamino or (C1-C4)-dialkylamino; R2 is (C1-C4)-haloalkoxy-(C1-C4)-alkyl, (C1-C4)alkoxy-(C1-C4)-alkoxy-(C1-C4)-alkoxy(C1-C4)-alkyl, (C3-C6)-cycloalkoxy-(C1C4)-alkyl, (C3-C6-cycloalkyl-(C1-C4)alkoxy, tetrahydrofuran-2-yl-methoxy-(C1C4)-alkyl, tetrahydrofuran-3-yl-methoxyJune 5, 2008– ב' בסיון התשס"ח 1145 (C1-C4)-alkyl, or a heterocyclic radical from the group consisting of isoxazol-3-yl and 4,5-dihydroisoxazol-3-yl which is substituted by a radical from the group consisting of cyanomethyl, ethoxymethyl and methoxymethyl; R3 is OR5, cyano, halogen, cyanato, thiocyanato, ((C1-C4)alkylthio, (C1-C4)-alkylsulfinyl, (C1-C4)alkylsulfonyl, (C2-C4)-alkenylthio, (C2C4)-alkenylsulfinyl, (C2-C4)alkenylsulfonyl, (C2-C4)-alkynylthio, (C2C4)-alkynylsulfinyl, (C2-C4)alkynylsulfonyl, (C1-C4)-haloalkylthio, (C2-C4)-haloalkenylthio, (C2-C4)haloalkynylthio, (C1-C4)-haloalkylsulfinyl, (C2-C4)-haloalkenylsufinyl, (C2-C4)haloalkynylsulfinyl, (C1-C4)haloalkylsulfonyl, (C2-C4)haloalkenylsulfonyl or (C2-C4)haloalkynylsulfonyl; R4 is (C1-C4)-alkyl; R5 is hydrogen, (C1-C4)-alkyl, (C1-C4)haloalkyl or (C1-C4)-alkoxy-(C1-C4)-alkyl; a is 0, 1, 2 or 3; b is 0, 1 or 2; and (B) an antidote-active amount of one or more compounds from groups (a) to (e): (a) compounds of the formulae in which the symbols and indices have the following definitions: n' is a natural number from 1 to 5; preferably from 1 to 3; T is a (C1- or C2-) alkanediyl chain which is unsubstituted or substituted by one or two (C1-C4)-alkyl radicals or by [(C1-C3)alkoxy] carbonyl; W is a radical from the group m' is 0 or 1; R17, R19 are identical or different and are hydrogen, halogen, (C1-C4)-alkyl, (C1-C4)alkoxy, nitro or (C1-C4)-haloalkyl; R18, R20 are identical or different and are OR24, SR24, NR24 R25 or a saturated or unsaturated 3- to 7-membered heterocyle containing at least one nitrogen atom and up to 3 heteroatoms which is bonded by the nitrogen atom to the carbonyl group in (II) or (III) and is unsubsituted or substituted by radicals from the group consisting of (C1-C4)-alkyl, (C1-C4)-alkoxy and unsubsituted or substituted phenyl, preferably a radical of the formula OR24, NHR25 or N(CH3)2, in particular of the formula OR24; R24 is hydrogen or an unsubsituted or substituted aliphatic hydrocarbon radical, preferably having a total of from 1 to 18 carbon atoms; R25 is hydrogen, (C1-C6)alkyl, (C1-C6)-alkoxy or substituted or June 5, – ב' בסיון התשס"ח 1146 2008 unsubsituted phenyl; R26 is hydrogen, (C1C8)-alkyl, (C1-C8)-haloalkyl, (C1-C4)alkoxy-(C1-C4)-alkyl, (C1-C6)hydroxyalkyl, (C3-C7)-cycloalkyl or tri(C1-C4)-alkylsilyl; R27, R28, R29 are identical or different and are hydrogen, (C1-C8)-alkyl, (C1-C6)haloalkyl, (C3-C12)-cycloalkyl or substituted or unsubstituted phenyl; R21 is (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C2-C4)-alkenyl, (C2-C4)-haloalkenyl, (C3C7)-cycloalkyl, preferably dichloromethyl; R22, R23 are identical or different and are hydrogen, (C1-C4)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C1-C4)-haloalkyl, (C2C4)-haloalkenyl, (C1-C4)-alkylcarbamoyl-( C1-C4)-alkyl, (C2-C4)-alkenylcarbamoyl-( C1-C4)-alkyl, (C2-C4)-alkoxy-( C1-C4)alkyl, (C1-C4)-alkyl, (C1-C4)-alkoxy-( C1C4)-alkyl, dioxolanyl-( C1-C4)-alkyl, thiazolyl, furyl, furylalkyl, thienyl, piperidyl, substituted or unsubstituted phenyl, or R22 and R23 together form a substituted or unsubstituted heterocyclic ring, preferably an oxazolidine, thiazolidine, piperidine, morpholine, hexahydropyrimidine or benzoxazine ring; (b) one or more compounds from the following group: 1,8-naphthalic anhydride, methyl diphenylmethoxyacetate, cyanomethoxyimino (phenyl) acetonitrile (cyometrinile), 1, 3-dioxolan-2ylmethoxyimino (phenyl) acetonitrile (oxabetrinil), 4'-chloro-2,2,2- trifluoroacetophenone O-1,3-dioxolan-2ylmethyl oxime (fluxofenim), 4,6-dichloro-2-phenylpyrimidine (fenclorim), benzyl 2-chloro-4-trifluoromethyl-1,3trifluoromethyl-1,3-thiazole-5-carboxylate (flurazole), 2-dichloromethyl-2-methyl1,3-dioxolane (MG-191), N-(4-methylphenyl)-N'-(1-methyl-1phenylethyl) urea (dymron), 1-[4-(N-2-methoxybenzoylsufamoyl) phenyl]-3-methylurea, 1-[4-(N-2-methoxybenzoylsulfamoyl) phenyl]-3,3-dimethylurea, 1-[4-(N-4,5-dimethylbenzoylsulfamoyl) phenyl]-3-methylurea, 1-[4-(N-naphthoylsulfamoyl) phenyl]-3,3dimethylurea, (2,4-dichlorophenoxy) acetic acid (2, 4-D), (4-chlorophenoxy) acetic acid, (R,S)-2-(4-chloro-o-tolyloxy) propionic acid (mecoprop), 4-(2,4-dichlorophenoxy) butyric acid (2,4DB), (4-chloro-o-tolyloxy) acetic acid (MCPA), 4-(4-chloro-o-tolyloxy) butyric acid, 4-(4-chlorophenoxy) butyric acid, 3,6-dichloro-2-methoxybenzoic acid (dicamba), 1-(ethoxycarbonyl)ethyl 3,6-dichloro-2methoxybenzoate (lactidichlor) and their salts and esters, preferably (C1C8); (c) N-acylsulfonamides and their salts of the formula in which R30 is hydrogen, a carbon-containing radical such as a hydrocarbon radical, a hydrocarbon-oxy radical, a hydrocarbon- thio radical or a heterocyclyl radical, each of the 4 last-mentioned radicals being unsubstituted or being substituted by one or more identical or different radicals 1147 June 5, 2008– ב' בסיון התשס"ח selected from the group consisting of halogen, cyano, nitro, amino, hydroxyl, carboxyl, formyl, carboxamide, sulfonamide and radicals of the formula – Za-Ra, each hydrocarbon moiety preferably having 1 to 20 carbon atoms and a carboncontaining radical R30 inclusive of substituents preferably having 1 to 30 carbon atoms; R31 is hydrogen or (C1-C4)-alkyl, preferably hydrogen, or R30 and R31 together with the group of the formula –CO-N- are the residue of a 3- to 8-membered saturated or unsaturated ring; R32 is identical or different and is halogen, cyano, nitro; amino, hydroxyl, carboxyl, formyl, CONH2, SO2NH2 or a radical of the formula –Zb-Rb; R33 is hydrogen or (C1-C4)-alkyl, preferably H; R34 is identical or different and is halogen, cyano, nitro, amino, hydroxyl, carboxyl, CHO, CONH2, SO2NH2 or a radical of the formula –Zc-Rc; Ra is a hydrocarbon radical or a heterocyclyl radical, each of the two lastmentioned radicals being unsubstituted or substituted by one or more identical or different radicals selected from the group consisting of halogen, cyano, nitro, amino, hydroxyl, mono-and di-[(C1-C4)alkyl]amino, or an alkyl radical in which a plurality, preferably 2 to 3, non-adjacent CH2 groups are in each case replaced by one oxygen atom; Rb, Rc are identical or different and are a hydrocarbon radical or a heterocyclyl radical, each of the two last-mentioned June 5, – ב' בסיון התשס"ח radicals being unsubstituted or substituted by one or more identical or different radicals selected from the group consisting of halogen, cyano, nitro, amino, hydroxyl, phosphoryl, halo-(C1-C4)-alkoxy, monoand di-[(C1-C4)-alkyl]amino, or an alkyl radical in which a plurality, preferably 2 or 3, non-adjacent CH2 groups are replaced in each case by one oxygen atom; Za is a divalent group of the formula –O-, S-, -CO-, -CO-O-, -CO-S-, -O-CO-, -SCO-, -SO-, -SO2-, -NR*-, -CO-NR*-, -NR*CO-, -SO2-NR*- or –NR*-SO2-, the bond given on the right-hand side of each of the divalent groups being the bond to the radical Ra, and the radicals R* in the 5 lastmentioned radicals independently of each other being in each case H, (C1-C4)-alkyl or halo- (C1-C4)- alkyl; Zb, Zc independently of one another are a direct bond or a divalent group of the formula –O-, -S-, -CO-, -CS-, -CO-O-, CO-S-, -O-CO-, -S-CO-, -SO-, -SO2-, NR*-, -SO2-NR*-, -NR*-SO2-, -CO-NR*or –NR*-CO-, the bond given on the righthand side of each of the divalent groups being the bond to the radical Rb or Rc and the radicals R* in the 5 last-mentioned radicals independently of one another being in each case H, (C1-C4)-alkyl or halo-(C1-C4)-alkyl; n is an integer from 0 to 4, preferably 0, 1 or 2, in particular 0 or 1, and m is an integer from 0 to 5, preferably 0, 1, 2 or 3, in particular 0, 1 or 2; (d) acylsulfamoylbenzamides optionally also in salt form, of the formula 1148 2008 in which X3 is CH or N; R35 is hydrogen, heterocyclyl or a hydrocarbon radical, the two lastmentioned radicals optionally being substituted by one or more identical or different radicals selected from the group consisting of halogen, cyano, nitro, amino, hydroxyl, carboxyl, CHO, CONH2, SO2NH2 and Za-Ra; R36 is hydrogen, hydroxyl, (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)alkoxy, (C2-C6)-alkenyloxy, the five lastmentioned radicals optionally being substituted by one or more identical or different radicals selected from the group consisting of halogen, hydroxyl, (C1-C4)alkyl, (C1-C4)-alkoxy and (C1-C4)alkylthio, or R35 and R36 together with the nitrogen atom to which they are attached are a 3-to 8-membered saturated or unsaturated ring; R37 is halogen, cyano, nitro, amino, hydroxyl, carboxyl, CHO, CONH2, SO2NH2 or –Zb-Rb; R38 is hydrogen, (C1-C4)-alkyl, (C2-C4)alkenyl or (C2-C4)-alkynyl; R39 is halogen, cyano, nitro, amino, hydroxyl, carboxyl, phosphoryl, CHO, CONH2, SO2NH2 or Zc-Rc; Ra is a (C2-C20)-alkyl radical whose carbon chain is interrupted once or more than once by oxygen atoms, or is heterocyclyl or a 1149 hydrocarbon radical, the two lastmentioned radicals optionally being substituted by one or more identical or different radicals selected from the group consisting of halogen, cyano, nitro, amino, hydroxyl, mono-and di-[(C1-C4)alkyl]amino; Rb, Rc are identical or different and are a (C2-C20)-alkyl radical whose carbon chain is interrupted once or more than once by oxygen atoms, or a heterocyclyl or a hydrocarbon radical, the two lastmentioned radicals optionally being substituted by one or more identical or different radicals selected from the group consisting of halogen, cyano, nitro, amino, hydroxyl, phosphoryl, (C1-C4)-haloalkoxy, mono-and di-[(C1-C4)-alkyl]amino; Za is a divalent unit selected from the group consisting of O, S, CO, CS, C(O)O, C(O)S, C(O)S, SO, SO2, NRd, C(O)NRd or SO2NRd; Zb, Zc are identical or different and are a direct bond or a divalent unit selected from the group consisting of O, S, CO, CS, C(O)O, C(O)S, SO, SO2, NRd, SO2NRd or C(O)NRd; Rd is hydrogen, (C1C4)-alkyl or (C1-C4)-alkyl or (C1-C4)haloalkyl; r is an integer from 0 to 4, and q in the event that X3 is CH, is an integer from 0 to 5 and, in the event that X is N, is an integer from 0 to 4; (e) compounds of the formula June 5, 2008– ב' בסיון התשס"ח in which the symbols and indices have the following definitions: X is CH or N, p in the event that X = N, is an integer from 0 to 2 and, in the event that X = CH, is an integer from 0 to 3; R40 is halogen, (C1-C4)-alkyl, (C1-C4)haloalkyl, (C1-C4)-alkoxy, (C1-C4)haloalkoxy, nitro, (C1-C4)-alkylthio, (C1C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl, phenyl or phenoxy, the two last-mentioned radicals being unsubstitued or substituted by one or more, preferably up to three, identical or different radicals from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, nitro and cyano; R41 is hydrogen or (C1-C4)-alkyl, and R42 is hydrogen, (C1-C8)-alkyl, (C3-C6)cycloalkyl, (C2-C6)-alkenyl, (C2-C6)alkynyl or aryl, each of the aforementioned carbon-containing radicals being unsubstituted or substituted by one or more, preferably up to three, identical or different radicals from the group consisting of halogen, nitro, cyano, hydroxyl, (C1C8)-alkoxy, in which one or more, preferably up to three, CH2 groups may be replaced by oxygen, (C1-C4)-alkylthio, (C1C4)-alkenyloxy and (C2-C4)-alkynyloxy, inclusive of the stereoisomers and the agriculturally customary salts. __________ ]11[]21[ ]54[ SYNTHESIS OF VERIFICATION LANGUAGES ]22[ ]31[ ]51[ ]71[ ]72[ 10.06.2002 09/880888 ]32[ 15.06.2001 Int. Cl.8 G06F 009/45 VERISITY LTD. YARON KASHAI, MATTHEW JOHN MORLEY WO/2002/103517 G.E. EHRLICH (1995) LTD., AYALON TOWER, 15TH FLOOR, 11 MENACHEM BEGIN ST., RAMAT GAN 52521 ]87[ ]74[ [57] A method for at least semiautomatically translating code written in a first language to a second target language, June 5, – ב' בסיון התשס"ח 158481 בניה של שפות ודאות ]33[ US ראש העין,וריסיטי בע"מ ,) בע"מ1995( ארליך.אי.ג'י ,11 רחוב מנחם בגין, 15 קומה,מגדל אילון רמת גן the first language featuring structural constraints and featuring dynamic behavior, wherein the first language 1150 2008 features a hierarchy of objects, such that relationships between the objects are determined by constraints, the method comprising: detecting an underlying control structure for the code in the first language; creating a static framework of resources for supporting the dynamic behavior of the code written in the first language; and mapping the dynamic behavior to the second target language according to said static framework of resources and said underlying control structure. _________ ]11[]21[ 158515 מד טווח לייזר ]54[ LASER RANGE FINDER ]22[ ]31[ ]51[ ]62[ ]71[ ]87[ ]74[ 17.05.1999 09/080437 ]32[ 18.05.1998 ]33[ US Int. Cl.8 G01C 003/08, G02B 005/30, H04N 007/00 DIVISION FROM 138684 LITTON SYSTEMS, INC., U.S.A. WO/1999/060787 LUZZATTO & LUZZATTO, ,לוצאטו את לוצאטו INDUSTRIAL PARK, OMER, באר שבע,5352 .ד. ת, עומר,גן תעשייה P.O.B. 5352, BEER-SHEVA 84152 [57] A laser range finder apparatus, said apparatus comprising: a laser light source (110) for projecting a pulse of laser light 1151 (110a) toward an object in a scene, the range to which is to be determined, so that a portion of said projected laser light June 5, 2008– ב' בסיון התשס"ח illuminates the object and is reflected back toward said apparatus; an image intensifier tube (14) receiving reflected laser light from the object and substantially upon receiving the reflected laser light responsively providing an electrical output, said image intensifier tube carrying a preamplifier circuit amplifying said electrical output; a timer device (130) for measuring a time interval from projection of said pulse of laser light until a time of said electrical output by said image intensifier tube; and a calculator (134) determining the range from the apparatus to the object using said time interval and the speed of light as a measuring standard. __________ ]11[]21[ ]54[ DEVICE WITH VACUUM BAG FOR PRESSURE THERAPY ]22[ ]31[ 21.10.2003 SIP]32[ 21.10.2002 200200258 Int. Cl.8 A61F 005/37, A61H 007/00 JOZE JELENC, REPUBLIC OF SLOVENIA VOGRIN SASA JEREMY M. BEN-DAVID & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O.B. 45087, JERUSALEM 91450 ]51[ ]71[ ]72[ ]74[ [57] A device with vacuum bag for pressure therapy, comprising a vacuum bag, a control and measuring unit, a housing (1), and special liner clothing (5), characterized in that a control and June 5, – ב' בסיון התשס"ח 158535 מכשיר עם שקית וקאום עבור טיפול בלחץ ]33[ SI ,דוד ושות' בע"מ- בן.ירמיהו מ ,45087 .ד. ת, הר חוצבים,רחוב המרפא ירושלים measuring unit is equipped with a pressure gauge (2) and with vacuum pump connections (3), to which suction tubes (4) for sucking the air from the bag are attached; that the bag has six evenly 1152 2008 arranged connections (6) for the suction tubes and a measuring connection (7) for a measuring tube, which links the interior of the bag with the pressure gauge, so that the under-pressure is measured directly in the bag; that special liner clothing is provided for the user, the liner clothing comprising several pieces designed for different parts of the body and that the said clothing pieces are made of two layers of fabric sewn together with longitudinal seams to form pockets, filled with granulated material; that the granulated material fits tight to the body because also the air between the granules is sucked out, when the air is sucked out of the vacuum bag; that the liner clothing pieces are bound together by means of hook and loop fasteners. __________ ]11[]21[ 158678 שימוש בחומצות שומניות בצירוף עם מעכב אנזים בהכת תרופה ]54[ USE OF FATTY ACIDS TOGETHER WITH ENZYME INHIBITOR IN THE PREPARATION OF A MEDICAMENT ]22[ ]31[ ]51[ ]71[ 09.05.2002 011282.0 ]32[ 09.05.2001 ]33[ GB Int. Cl.8 A61K 031/19, 031/20, 031/405, 031/415, A61P 019/02, 025/28, 035/00 AMARIN NEUROSCIENCE LIMITED, UNITED KINGDOM DAVID FREDERICK HORROBIN WO/2002/089787 JEREMY M. BEN-DAVID & CO. ,דוד ושות' בע"מ- בן.ירמיהו מ LTD., ,45087 .ד. ת, הר חוצבים,רחוב המרפא HAR HOTZVIM HI-TECH PARK, ירושלים P.O.B. 45087, JERUSALEM 91450 ]72[ ]87[ ]74[ 1153 June 5, 2008– ב' בסיון התשס"ח [57] Use of a fatty acid preparation containing: (a) more than 70% eicosapentaenoic acid (EPA) or eicosapentaenoic acid derivative and less than 10% docosahexaenoic acid or a docosahexaenoic acid derivative and less than 10% linoleic acid or a linoleic acid derivative; and (b) an enzyme inhibitor selected from an inhibitor of COX-1 and/or COX-2, an inhibitor of LOX and an inhibitor of one or more of the FACL enzymes in the preparation of a medicament for the treatment of any of the following diseases or disorders: any form of psychiatric disease including schizophrenia, schizoaffective disorders, schizotypy, depression, anxiety, bipolar disorder, mania, borderline personality disorder, alcoholism and attention deficit hyperactivity disorder or any other psychiatric illness; and any form of neurological or neurodegenerative disease including Parkinson's disease, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis or any other "triplet repeat" disease, multi-infarct or other form of dementia, multiple sclerosis, chronic fatigue and epilepsy. _________ ]11[]21[ 158722 מערכת ושיטה לגילוי ושליפת מאפיינים ביישומים של איתור רציף ופסיבי ]54[ SYSTEM AND METHOD FOR DETECTION AND FEATURE EXTRACTION IN PASSIVE COHERENT LOCATION APPLICATIONS ]22[ ]31[ ]51[ ]71[ 06.05.2002 60/288493 ]32[ 04.05.2001 ]33[ US Int. Cl.8 G01S 007/292, 013/00, 013/50, 013/87 LOCKHEED MARTIN CORPORATION, U.S.A. KEVIN W. BAUGH, ROBERT H. BENNER WO/2002/091009 SOROKER-AGMON, ,אגמון-סורוקר 14 SHENKAR ST., הרצליה פיתוח,14 רחוב שנקר,בית נולטון HERZLIYA PITUAH 46725 ]72[ ]87[ ]74[ [57] A passive coherent location radar system having a detection and feature extraction processing sub-system to detect targets and determine target parameters from ambiguity surface data of an ambiguity surface, comprising: a peak/noise discriminator to compare previous ambiguity surface data to said ambiguity surface data and to update bins June 5, – ב' בסיון התשס"ח correlating to said previous ambiguity surface data; new bins identified by said peak/noise discriminator for new target echoes within said ambiguity surface; a peak associator to group said bins and said new bins identified by said peak/noise discriminator to form peak detections correlating to said targets; and a parameter estimator to estimate said target parameters 1154 2008 from said peak detections. __________ ]11[]21[ ]54[ INTERVERTEBRAL DISC PROSTHESIS AND FITTING TOOLS ]22[ ]31[ ]51[ ]71[ ]72[ 03.05.2002 01/05982 ]32[ 04.05.2001 Int. Cl.8 A61F 002/44 LDR MEDICAL, FRANCE JACQUES BEAURAIN, JOEL DELECRIN, MICHAEL ONIMIS, HERVE CHATAIGNTER, JEROME ALLAIN, JEAN-PAUL FREDERIC STEIB WO/2002/089701 DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520 ]87[ ]74[ [57] An intervertebral disc prosthesis for replacement of a fibrocartilaginous disc between adjacent elements of a spinal 1155 158740 חולייתי וכלים-פרוטזה דיסק בין להתאמה ]33[ FR ,ד"ר מרק פרידמן בע"מ ,7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב גן-רמת column, comprising: an upper plate (3) comprising an internal face and an external face adapted to June 5, 2008– ב' בסיון התשס"ח support one of the adjacent elements of the spinal column; a lower plate (1) comprising an internal face and an external face adapted to support the other of the adjacent elements of the spinal column; a nucleus (2) displaceable in translation or rotation or both with respect to the upper plate and the lower plate, the nucleus comprising an upper face, a lower face, and a perimeter surface; loadbearing sliding surfaces (23) comprising a contact surface disposed on the internal face of the upper plate and a complementary contact surface disposed on the upper face of the nucleus and a contact surface disposed on the internal face of the lower plate and a complementary contact surface disposed on the lower face of the nucleus; and a stop (4) comprising plural parts including a peripheral part (1) of the nucleus disposed along the perimeter surface of the nucleus and a stop surface (12) protruding from at least one of the upper plate and the lower plate, said plural parts of the stop being arranged to limit the displacement of the nucleus in translation or rotation or both with respect to at least one of the upper plate and the lower plate. _________ ]11[]21[ 158840 מערכת ושיטה להצפנה אלחוטית ממערכת גידים פעילים בכבל ]54[ WIRELESS CRYPTOGRAPHIC FILL SYSTEM AND METHOD ]22[ ]31[ ]51[ ]71[ 12.11.2003 292442 ]32[ 13.11.2002 ]33[ US Int. Cl.8 G06F 002/100000 G06K 017/00, H04L 009/10 HARRIS CORPORATION, U.S.A. June 5, – ב' בסיון התשס"ח 1156 2008 ]74[ REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A cryptographic fill system (20) for providing a cryptographic key to a host processor (26) for enabling secure operations by the host processor, the system comprising: a portable fill device (22) configured to encode at least one cryptographic key; a host portion (24) configured to be communicatively coupled to the host processor (26); and a wireless communications system (28) configured to communicate said cryptographic key of ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם said device to said host portion to enable secure operations by the host processor; wherein said fill device and said host portion include mutually engageable physical components (38, 39) configured to prevent unauthorized access to the cryptographic key while the cryptographic key is communicated from said fill device to said host portion by the wireless communications system. __________ ]11[]21[ ]54[ MECHANICAL STRUCTURE PROVIDING SIX DEGREES OF FREEDOM ]22[ ]51[ ]71[ 13.11.2003 Int. Cl.8 B25J 009/06 TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. RAFAEL-ARMAMENT DEVELOPMENT AUTHORITY LTD. MOSHE SHOHAM, RONEN BEN HORIN, HAGAY BAMBERGER LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]72[ ]74[ 1157 158870 מבנה מכני המספק שש דרגות חופש חיפה,מוסד הטכניון למחקר ופיתוח בע"מ , רשות לפתוח אמצעי לחימה בע"מ-רפאל חיפה חגי במברגר,חורין- רונן בן,משה שהם ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה June 5, 2008– ב' בסיון התשס"ח [57] Mechanical structure providing motion in six degrees of freedom, which comprises: (a) a main plate (11); (b) a base (61); (c) at least three supporting structures (14), each comprising a lower, bridge-like section supported by the base, and an upper section connected to said bridge section and to said main plate, wherein: (I) said bridge-like structure comprising two supporting plates, two intermediate plates, (22, 24) and one middle plate (23), all being serially connected one to another by means of four transversal hinges; (II) each pair of said supporting plates being slidable in linear displacement parallel to the base; (III) said upper section comprising two plates (26, 27), a lower plate connected to said middle plate by means of a hinge transversal to said lower plate but longitudinal with respect to said middle plate, and an upper plate connected to said lower plate by means of a longitudinal hinge and to said main plate by means of a transversal hinge; (d) at least six linear motors connected each to a corresponding supporting plate, for applying a force thereon in order to effect a linear displacement of said plate; and (e) control means for determining the linear displacement of each linear motor. __________ ]11[]21[ ]54[ SELF-SYNCHRONIZING HALF DUPLEX MATRIX SWITCH ]22[ ]31[ ]51[ ]71[ ]87[ 20.08.2002 60/313825 ]32[ 22.08.2001 Int. Cl.8 G06F 013/00 AVOCENT CORPORATION, U.S.A. WO/2003/019760 June 5, – ב' בסיון התשס"ח 158880 מפסק מטריצה דו–מפלסי למחצה המסונכרן באופן עצמאי ]33[ US 1158 2008 ]74[ REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A datalink for operatively linking one or more computers to one or more computer peripheral devices and monitors remotely located from said one or more computers, the datalink comprising: a plurality of master state devices, each including a master transceiver for operatively linking one of said computers to the datalink, and each constructed and adapted to receive a stream of computer data packets from a computer connected thereto, to sample the computer data packets into a stream of consecutive computer samples, and to load the consecutive computer samples, sample-bysample, into a stream of master frames, one sample per master frame; one or more slave state devices, each including a slave transceiver for operatively linking one or more peripheral devices to the datalink, and each constructed and adapted to receive one or more streams of peripheral data packets from peripheral devices connected thereto, to sample the peripheral data packets into one or more streams of consecutive peripheral samples, and to load said peripheral samples into a stream of slave frames; and a matrix switch including: cross-point connection circuitry providing switchable paths between 1159 ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם selected master state devices and selected one or more slave state devices; and a processor, out of the switchable paths, controlling the establishment of said switchable paths, wherein each said master state device is further constructed and adapted to send as a downstream transmission a master frame in its stream of master frames to a slave transceiver connected thereto via a datalink path, to be decoded at the slave transceiver connected thereto into a stream of computer data packets and, wherein each slave state device is further constructed and adapted to send as an upstream transmission a slave frame in its stream of slave frames to a master transceiver connected thereto via a path in the datalink, said one of the slave frames to be decoded at the master transceiver connected thereto into streams of peripheral data packets, said selected master state devices self-synchronizing communications with said selected one or more slave state devices independently of each other's downstream transmissions of available computer data bits and awaiting receipt of upstream transmission of corresponding available peripheral data bits. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ METHOD OF COLOUR MARKING POLYMERIC MATERIAL ]22[ ]31[ ]51[ ]71[ 04.06.2002 0114266.0 ]32[ 12.06.2001 Int. Cl.8 C08J 007/00, G03C 001/73 CIBA SPECIALTY CHEMICALS HOLDING INC., SWITZERLAND WO/2002/101462 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ 158925 שיטת סימון חומרים פולימריים בצבע ]33[ GB ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם [57] Method of colouring a polymeric material, characterized in that a polymeric material containing (a) a latent acid of the formula wherein ring A can contain one or more hetero atoms and/or can contain an anelated ring, June 5, – ב' בסיון התשס"ח R1 is hydrogen, alkyl, alkenyl, aryl, R2, R3, R4 and R5 independently of each other are hydrogen or a functional 1160 2008 substituent, and R stands for C1-C6 alkyl, -Z1-Q1, or –Z2Q2, wherein Z1 is a single bond, S, NH or O, and Q1 is a heterocyclic ring system having from 5 to 9 ring atoms selected from C, S, O and N, with at least 2 carbon atoms in the ring system, preferably Q1 stands for morpholine, pyridine, which may be substituted one to three times with C1-C4 alkyl or hydroxy, mercaptobenzoxazole, mercaptobenzthiazole, and wherein Z2 stands for C1-C4 alkylene, which can be substituted by C1-C4 or Q3, wherein Q3 stands for phenyl which can be substituted one to three times with C1-C4 alkyl, hydroxy, C5-C8 cycloalkyl and/or a heterocylic ring system having from 5 to 9 ring atoms selected from C, S, O and N, with at least 2 carbon atoms in the ring system, and Q2 stands for phenyl which can be substituted one to three times with C1-C4 alkyl, hydroxy, C5-C8 cycloalkyl and/or a heterocyclic ring system having from 5 to 9 ring atoms selected from C, S, O and N, with at least 2 carbon atoms in the ring system, with the proviso that the hydrogen atom at the C-atom in α-position to R can be split off by irradiation (b) a colour former and (c) optionally further ingredients is irradiated with a UV-laser using UVlight of 285 to 400 nm. __________ ]11[]21[ ]54[ COOLING SYSTEM FOR A PHOTOCOSMETIC DEVICE ]22[ ]31[ 23.05.2002 60/292827 ]32[ 23.05.2001 10/052474 18.01.2002 60/363798 12.03.2002 60/363871 12.03.2002 Int. Cl.8 A61B 018/18 PALOMAR MEDICAL TECHNOLOGIES, INC., U.S.A. WO/2002/094116 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 ]51[ ]71[ ]87[ ]74[ [57] A photocosmetic device for use on an area of a patient's skin comprising: a treatment head for use in close proximity to the patient's skin; at least one source (125) for generating electromagnetic radiation positioned within the treatment head and configured to project radiation onto the area of skin; a cooling surface 1161 158982 מערכת קירור להתקן פוטוקוסמטי ]33[ US US US US ,' קולב ושות.סנפורד ט רחובות,2273 .ד. ת, מרמורק,4 שער הגיא thermally coupled to the at least one source; and a mechanism to direct phase change substance onto the cooling surface such that at least a portion of said substance changes its phase following contact with said surface in response to absorbing heat therefrom. June 5, 2008– ב' בסיון התשס"ח ,189272 The applications for division from this application have not yet been published בקשות חלוקה מבקשה זו .שטרם פורסמו _________ ]11[]21[ ]54[ OIL-BASED SUSPENSION CONCENTRATES ]22[ ]31[ ]51[ ]71[ 10.06.2002 10129855.2 ]32[ 21.06.2001 Int. Cl.8 A01N 025/04 BAYER CROPSCIENCE AG, GERMANY WO/2003/000053 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] Oil-based suspension concentrates, consisting of at least one agrochemical active compound which is solid at room temperature, at least one penetration June 5, – ב' בסיון התשס"ח 159149 תרכיזים בצורת סוספנסיה המבוססים על שמן ]33[ DE ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם promoter selected from alkanol alkoxylates of the formula R-O-(AO)mH in which 1162 2008 R represents straight-chain or branched alkyl having 4 to 20 carbon atoms, AO represents an ethylene oxide radical, a propylene oxide radical, a butylene oxide radical or mixture of ethylene oxide and propylene oxide radicals or butylene oxide radicals and m represents from 2 to 30, at least one vegetable oil, at least one non-ionic surfactant or dispersing aid and/or least one anionic surfactant or dispersing aid and optionally one or more additives from the groups consisting of the emulsifying agents, the antifoam agents, the preservatives, the anti-oxidants, the colourants and/or the inert filling materials. ___________ ]11[]21[ ]54[ ANTI-TAMPERING ENCLOSURE FOR ELECTRONIC CIRCUITRY ]22[ ]31[ ]51[ ]71[ ]72[ ]74[ 02.12.2003 10/326726 ]32[ 20.12.2002 Int. Cl.8 H01L 023/02 VERIFONE ISRAEL LTD. YITZCHAK COHEN, ARNON AVIV SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [57] An electronic circuit assembly comprising: a plurality of printed circuit boards (46) including electrical circuits, said plurality of printed circuit boards defining a protected enclosure including at least one protected enclosure wall defining printed circuit board and a protected enclosure surrounding edge defining printed circuit board; and electronic 1163 159163 סגירה מסביב המונעת נגיעה עבור מעגלים אלקטרוניים ]33[ US ראש העין,וריפון ישראל בע"מ ארנון אביב,יצחק כהן ,' קולב ושות.סנפורד ט רחובות,2273 .ד. ת, מרמורק,4 שער הגיא components (50), located within said protected enclosure, mounted on at least one of said plurality of printed circuit boards in electrical communication with said electrical circuits, said electronic components including at least an antitamper circuit and a destruct circuit operated by said anti-tamper circuit. June 5, 2008– ב' בסיון התשס"ח ___________ ]11[]21[ ]54[ SYSTEM AND METHOD FOR SECURING PRIVACY OF CHAT PARTICIPANTS ]22[ ]31[ ]51[ ]71[ 28.06.2002 09/901332 ]32[ 09.07.2001 Int. Cl.8 H04L 029/06 TELEFONAKTIEBOLAGET LM ERICSSON (PUBL), SWEDEN WO/2003/007574 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 ]87[ ]74[ [57] A method for providing privacy to a client accessing a chat application on a chat server, comprising the steps of: transmitting a request for the chat application from the client to a first proxy server; transmitting the request for the chat application from the first proxy server to a second proxy server; providing a unique ID to the first proxy server from the second proxy server responsive to the June 5, – ב' בסיון התשס"ח 159316 מערכת ושיטה להבטחת פרטיות משתתפי שיחה ]33[ US , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, request; transmitting the request for the chat application and the unique ID from the second proxy server to the chat server; transmitting a response and the unique ID from the chat server to the second proxy server responsive to the request; storing the response at the second proxy server with the unique ID; accessing the stored response from the first proxy server by providing the unique ID, and erasing the 1164 2008 stored response and the unique ID in the second proxy server responsive to an access by the first proxy server. __________ ]11[]21[ ]54[ COUPLED KNEE PROSTHESIS WITH A ROTATIONAL BEARING ]22[ ]31[ ]51[ ]71[ 21.06.2002 01115511.6 ]32[ 27.06.2001 Int. Cl.8 A61F 002/38 WALDEMAR LINK GMBH & CO. KG, GERMANY WO/2003/002039 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] A knee-joint prosthesis, consisting of: a femoral component that has sliding condylar surfaces (20), which surfaces are rigidly interconnected, tibia component (2) that is non-rotatably connected to tibia plateau (7), which plateau comprises: sliding tibial surfaces (21) interacting with the sliding condylar surfaces, and mating arrangement that together with the femoral component defines pivot and, together with the tibia component, defines 1165 159411 ברך תותבת מצומדת יחד עם מיסב מסתובב ]33[ EP ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם rotary bearing whose rotation axis (12) is inclined with respect to the tibia; characterized in that, in the side view or on the sagittal section, normal to the area to the sliding tibial surfaces, in which area said surfaces interact with the sliding condylar surface and in which area a load is transferred mainly in the extended position, is disposed at a smaller angle to the tibia than the angle between the rotary bearing axis and the tibia. June 5, 2008– ב' בסיון התשס"ח ___________ ]11[]21[ ]54[ DEVICE FOR REDUCING THE SIGNATURE OF HOT EXHAUSTING GASES ]22[ ]51[ ]71[ 21.06.2001 Int. Cl.8 B60K 013/04 FORSVARETS MATERIELVERK, SWEDEN URBAN MATHIASSON WO/2003/004296 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 ]72[ ]87[ ]74[ [57] A device for reducing the signature of hot gases from an exhaust (7) of a unit, June 5, – ב' בסיון התשס"ח 159447 מתקן להפחתת חתימת החום של גזי פליטה , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר said device comprising a mixing element (9) for mixing the hot gases with fresh air 1166 2008 from the exterior of the unit to form a gas mixture to be discharged to the exterior of the unit, and a protecting component (10) which relative to the unit is arranged outside the mixing element or parts thereof, said protecting component reducing reflection of incoming surveillance radiation and including through ducts for passing at least parts of the gas mixture to the exterior. ___________ ]11[]21[ 159494 –2'–6 נגזרות (פוספונומתאוקסי)אלקוקסי פירימידין בעלות פעילות נגד נגיפים ]54[ 6-2'-(PHOSPHONOMETHOXY)ALKOXY PYRIMIDINE DERIVATIVES HAVING ANTIVIRAL ACTIVITY ]22[ ]31[ ]51[ ]71[ 28.06.2002 60/302212 ]32[ 29.06.2001 ]33[ US Int. Cl.8 A61K 031/662, A61P 031/12, C07F 009/00, 009/6512 REGA STICHTING V.Z.W., BELGIUM THE INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC, CZECH REPUBLIC WO/2003/002580 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, אביב TEL AVIV 61040 ]87[ ]74[ [57] A compound of the formula 1167 June 5, 2008– ב' בסיון התשס"ח where R1 is H, amino or methylsulfanyl; R2 is methyl, halo, -N(R5)2, hydroxy, protected hydroxy or a group of the formula R3 is independently H, methyl, hydroxymethyl, halomethyl or protected hydroxymethyl; R4 is H or halo; X independently is oxygen, sulfur or a bond; Z independently is hydroxy, an ester or amide; R5 is independently H, C1-C8 alkyl or protecting group; and * designates a chiral carbon atom; and salts and solvates thereof. ___________ ]11[]21[ ]54[ EYE PROTECTION METHODS AND APPARATUS ]22[ ]31[ 30.12.2003 60/455583 ]32[ 19.03.2003 10/745580 29.12.2003 Int. Cl.8 A61F 009/00 GPT GLENDALE, INC., U.S.A. REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]74[ [57] An eye protection apparatus, comprising: a selectively darkenable element (102); and a controller (200) that detects a trigger signal (410) that triggers an emission of June 5, – ב' בסיון התשס"ח 159648 התקן ושיטה להגנת העיניים ]33[ US US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם diffuse light, and causes transmission of a darken signal that causes the selectively darkenable element to darken in conjunction with the emission of the diffuse light. 1168 2008 __________ ]11[]21[ ]54[ ELECTRO-HOLOGRAPHIC LENS ]22[ ]51[ ]71[ 30.12.2003 Int. Cl.8 G03H 001/00 JACOB HALEVY-POLITCH URIEL FISCHER ]74[ PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733 [57] An electro-optic system for concentrating a light beam (84) that is incident from a moving light source onto at least one predetermined target, the system comprising: at least one of a plurality of layers of electro-holographic lens devices comprising: an active layer (3) made from a transparent photo-refractive material, whose refractive index may be locally modified by locally applying an electric field; an array of electrodes (2) in a predetermined density, provided adjacent the active layer for locally providing 1169 159653 הולוגרפית-עדשה אלקטרו חיפה,פוליץ-יעקב הלוי חיפה,אוריאל פישר ,פרל כהן צדק לצר ,12704 .ד. ת, 5 רח' שנקר,1 ים-מרכז גב הרצליה electric fields across an array of predetermined locations in the active layer; a tracking unit (22) for tracking the position of the light source; a control unit (5) for applying and controlling application of electric fields in a dynamically controllable predetermined location obtained from the tracking unit, the information relating to the location of the light source for creating a dynamically changing holographic fringe pattern across the active layer, creating a dynamically changing concentrating lens, so as to June 5, 2008– ב' בסיון התשס"ח continuously focus the light beam onto the at least one predetermined target. __________ ]11[]21[ ]54[ PROTECTIVE HEADGEAR ]22[ ]31[ ]51[ ]71[ 10.07.2002 0117140.4 ]32[ 13.07.2001 Int. Cl.8 A42B 001/08 SCOTT INTERNATIONAL LIMITED, UNITED KINGDOM WO/2003/005843 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 ]87[ ]74[ [57] A shell for fitting withing a headcap to provide a degree of protection from impacts, said shell being of a generally concave shape, and being formed with a pair of slots (6), one on each side of the shell characterised by each slot opening into the back side (4) of the shell and June 5, – ב' בסיון התשס"ח 159660 כיסוי ראש מגן ]33[ GB , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, extending forwards in a generally back to front direction towards the front (3) of the shell over a greater proportion of the frontto-back length of the shell, so as to effectively divide the shell into different regions, together making up said concave shape: a top region (7) extending, when 1170 2008 worn, back to front over the top to the head and merging into a front region (8) which extends, when worn, across the front of the head and two lateral regions (10) extending, when worn, back to front across respective sides of the head and merging into the front region, and wherein each slot . separates a respective lateral region from the top region and the slots being of a width sufficient to enable the respective lateral region to be flexed towards and away from the top region to thereby enable the size of the shell to be altered to accommodate a range of head sizes. ____________ ]11[]21[ ]54[ PULSED ELECTRIC SHAVER ]22[ ]31[ 21.07.2002 60/306892 ]32[ 23.07.2001 60/354019 05.02.2002 Int. Cl.8 B26B 019/00 RADIANCY, INC., U.S.A. WO/2003/009976 FENSTER & COMPANY, INTELLECTUAL PROPERTY LTD., 12 BASEL ST., ENTRANCE 1, P.O.B. 10256 , PETACH TIKVA ]51[ ]71[ ]87[ ]74[ [57] A hair cutting apparatus comprising: a structure (506), a portion (512) of which being adapted for placement against a skin surface (524) where hair is to be cut; a heat generator (300) comprising one or more heat elements at least one of said heat elements being juxtaposed with said 1171 159910 מכונת גילוח חשמלית העובדת על בסיס פעימות ]33[ US US ,קניין רוחני בע"מ,'פנסטר ושות ,10256 .ד. ת, קרית אריה,1 כניסה12 בזל פתח תקוה portion; and a controller (320) that controls the power source to provide pulsed heating of said one or more heat elements characterized in that said one or more heat elements are positioned to touch the hair and are heated to a temperature sufficient to cut hair. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ ELECTRIC SHAVER ]22[ ]31[ 21.07.2002 60/306892 ]32[ 23.07.2001 60/354019 05.02.2002 Int. Cl.8 B26B 019/00 RADIANCY, INC., U.S.A. WO/2003/009977 ]51[ ]71[ ]87[ June 5, – ב' בסיון התשס"ח 159971 מכונת גילוח חשמלית ]33[ US US 1172 2008 ]74[ FENSTER & COMPANY, INTELLECTUAL PROPERTY LTD., 12 BASEL ST., ENTRANCE 1, P.O.B. 10256 , PETACH TIKVA [57] A hair cutting apparatus comprising: a structure (506), a portion (512) of which beign adapted for placement against a skin surface (524) where hair is to be cut; and a heat generator (300) comprising one or more heat elements heated to a temperature sufficient to cut hair, at least one of said heat elements being juxtaposed ,קניין רוחני בע"מ,'פנסטר ושות ,10256 .ד. ת, קרית אריה,1 כניסה12 בזל פתח תקוה with said portion, characterized in that said one or more heat elements are positioned to touch said skin; and in that it includes a controller (320) that controls said heat generator to prevent heat from being applied continuously in a single area for sufficient time to cause skin damage. __________ 1173 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ EMI SHIELDING FOR ELECTRONIC PACKAGES ]22[ ]31[ ]51[ ]71[ 26.07.2002 09/921062 ]32[ 01.08.2001 Int. Cl.8 H01L 023/552 INTERNATIONAL BUSINESS MACHINES CORPORATION, U.S.A. WO/2003/012867 ALPHAPATENT LTD., 55 REUVEN ST., BET SHEMESH 99544 ]87[ ]74[ [57] An electronic package incorporating shielding against the emissions of electromagnetic interference (EMI); comprising: a circuitized substrate (12) of a dielectric organic material having opposite first and second surfaces, said first surface having a first portion and second portion; an electrically-conductive ring-shaped continuous ground band (32) being embedded in said substrate extending proximate the perimeter of said substrate and extending between said second portion of said first surface and said second surface; a semiconductor chip (14) being arranged on said first portion of said first surface; a plurality of electrically conductive circuit members (16) being positioned on said first portion of said first surface of said substrate each being electrically coupled to said semiconductor chip; a lid member (18) comprising an electrically conductive material being arranged on a surface of said semiconductor chip distal from the surface facing said substrate, said ground band being electrically connected with at least June 5, – ב' בסיון התשס"ח 160070 מיגון אלקטרו–מגנטי עבור התקנים אלקטרוניים ]33[ US ,אלפאפטנט עמיתים בע"מ עו"פ בית שמש,55 רח' ראובן one electrically conductive member arranged on the second surface of said substrate, said lid member and at least one said electrically conductive circuit member on said first portion of the first surface of said substrate so as to impart an electromagnetic shield to said electronic package, a compliant and electrically conductive adhesive (20) being arranged between said semiconductor chip and said lid member, and an electrically conductive stiffener (24) being positioned on said second portion on the first surface of said substrate, said stiffener being electrically connected to at least one of said electrically conductive circuit members on said first portion on said first surface of said substrate, to at least one electrically conductive member on the second surface of said substrate through said electrically conductive ground band and in electrical connection with said lid member, an electrically conductive adhesive being arranged between said striffener and said ground band and between said stiffener and said lid member so as to form said 1174 2008 electrical connections between said elements. __________ ]11[]21[ ]54[ DENTAL IMPLANT OR THE LIKE COMPRISING A CORE AND A CERAMIC SLEEVE ASSEMBLED BY BONDING ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 17.07.2002 01/10428 ]32[ 03.08.2001 Int. Cl.8 A61C 008/00 SUDIMPLANT COMPANY, FRANCE WO/2003/013385 EITAN MEHULAL LAW GROUP, 10 ABBA EBEN BLVD., P.O. B. 2081, HERZLIYA 46120 [57] An implant for dental use or the like, of the type of implant comprising a metallic or synthetic core (1) and an external ceramic sheath (2) at least partially enveloping the core, these being connected to each other by adhesive bonding, characterised in that the external ceramic sheath is formed by a sleeve distinct from the core, attached to the latter by sliding fitting and fixed by adhesive bonding, forming between them a space 1175 160154 שתל דנטלי ודומיו הכולל ליבה ושרוול קרמי המחוברים על ידי הדבקה ]33[ FR קבוצת איתן – מהולל עורכי דין – עורכי ,פטנטים הרצליה,2081 .ד. ת, 10 שדרות אבא אבן (3) for the adhesive of sufficient volume to absorb impacts that an implant undergoes, thus fulfilling a damping role, without for all that causing any consequent play between the core and the ceramic sleeve, and in that the space for adhesive formed between the corresponding walls of the core and sleeve is formed by a separation J between these walls of between approximately 80 and 150 microns. June 5, 2008– ב' בסיון התשס"ח ___________ ]11[]21[ ]54[ LOW COST TOURNIQUET CUFF WITH IDENTIFICATION APPARATUS ]22[ ]31[ ]51[ ]71[ 08.08.2002 930341 ]32[ 14.08.2001 Int. Cl.8 A61B 017/135 WESTERN CLINICAL ENGINEERING LTD., CANADA JAMES ALLEN MCEWEN, KEVIN BRYANT INKPEN, MICHAEL JAMESON, KENNETH L. GLINZ WO/2003/015641 JEREMY M. BEN-DAVID & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O.B. 45087, JERUSALEM 91450 ]72[ ]87[ ]74[ [57] A low cost tourniquet cuff with identification apparatus, comprising: an outer strip (68); an inner strip (80) June 5, – ב' בסיון התשס"ח 160337 שרוולית של חסם בעלת עלות נמוכה עם מתקן זיהוי ]33[ US ,דוד ושות' בע"מ- בן.ירמיהו מ ,45087 .ד. ת, הר חוצבים,רחוב המרפא ירושלים positioned against the outer strip; a gastight seal (104) joining the inner strip to the outer strip to form a cuff having a 1176 2008 physical characteristic wherein the cuff includes an inflatable bladder (60) of a length greater than the circumference of a limb at a selected location; and a cuff connector (20) carried on the cuff and communicating pneumatically with the bladder for releasably connecting to a tourniquet instrument to establish a gas- tight passageway between the bladder and the instrument, wherein the cuff connector includes identification means (32) indicative of the physical characteristic and detectable by the tourniquet instrument upon establishment of the gas-tight passageway irrespective of whether the gas-tight passageway is pressurized. __________ 1177 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ 160486 ציטאלופרם לטיפול בלחץ דם גבוהה ]54[ CITALOPRAM FOR THE TREATMENT OF ELEVATED BLOOD PRESSURE ]22[ ]31[ ]51[ ]71[ 13.03.2003 P0200980 ]32[ 14.03.2002 ]33[ HU Int. Cl.8 A61K 031/343, 045/00, A61P 009/12, C07D 307/00, 307/87 EGIS GYOGYSZERGYAR RT., HUNGARY WO/2003/075914 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] Use of citalopram or a pharmaceutically acceptable salt thereof for the preparation of pharmaceutical compositions suitable for the treatment of elevated (high) blood pressure, normalization of blood pressure or the decrease of blood pressure and/or prevention of elevated blood pressure. __________ ]11[]21[ ]54[ MALLEABLE CRYOSURGICAL PROBE ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 19.09.2002 09/957337 ]32[ 20.09.2001 Int. Cl.8 A61B 017/00 ENDOCARE, INC., U.S.A. WO/2003/024313 DR. SHLOMO COHEN & CO., 124 IBN GABIROL ST., P.O.B. 11490, TEL AVIV 62038 [57] A malleable cryosurgical probe, comprising: (a) a cryostat assembly, comprising: (i) an elongated shaft assembly (12) having at least one malleable segment (28) thereof and a closed distal end (34), said shaft assembly, including: at least one freezing portion (24); at least one thermally insulated portion; and a thermally June 5, – ב' בסיון התשס"ח 160692 בוחן חשיל לניתוח בטמפרטורה נמוכה ]33[ US ,'ד"ר שלמה כהן ושות תל אביב,11490 .ד. ת, 124 אבן גבירול insulating element positioned about said thermally insulated portion, said thermally insulated element being adjustably positionable to control the location, size and shape of said freezing portion, (ii) a cryostat (14) operably associated with said elongated shaft assembly, comprising: a cryostat inlet (42) for receiving gas entering said cryostat; a 1178 2008 cryostat outlet (44); and a heat exchanger having a distal end positioned proximally from said freezing portion, said heat exchanger being positioned between said cryostat outlet and said cryostat inlet, said heat exchanger for receiving gas from said cryostat inlet and providing heat transfer between gas flowing within said cryostat and fluid exterior thereto; and, (iii) a plurality of longitudinally spaced Joule-Thomson nozzles (16) in fluid communication with said cryostat outlet, said plurality of Joule-Thomson nozzles for expanding gas expelled therefrom, the expanded cold fluid communicating with said at least one freezing portion to provide cooling thereof; and, (b) a cryoprobe assembly (18), comprising: a handle assembly for supporting said cryostat assembly, said handle assembly having an outer diameter greater than said freezing portion and said thermally insulated portion, said handle assembly, comprising: an anchor (48) securely connected to said cryostat assembly; an oring (50) secured to said anchor for preventing fluid from escaping through said handle assembly: and a handle securely connected to said anchor; and, a fluid supply line assembly connectable to a fluid source at one end and to said cryostat inlet at a second end, wherein said heat exchanger is positioned at a location longitudinally spaced from said at least one freezing portion and inside a volume formed by said handle assembly. _________ ]11[]21[ 160887 מתקן חיבור לחיזוק מעמד מיטה למיטת משאית ]54[ FASTENING ASSEMBLY FOR SECURING BEDLINER TO TRUCK BED ]22[ ]31[ ]51[ ]71[ 15.03.2004 0303000218 ]32[ 18.03.2003 ]33[ Int. Cl.8 B60R 013/01, B62D 025/20, 027/00 AEROFLEX INTERNATIONAL CO., LTD., THAILAND 1179 TH June 5, 2008– ב' בסיון התשס"ח ]74[ LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 [57] A fastening assembly for securing a bed linear to a truck bed, the truck bed having an inward extended bed rail, the bed liner having at least one hole (42), the fastening assembly comprising: a base member (1) for engaging a clamp member (4) through the bed liner hole, the base member including a back surface that is pressed by the clamp member with the bed liner wall and the bed rail in between, the base member having at least one extended direction control rod (14) unitarily formed thereon and extending generally perpendicularly from the back surface for insertion through the bed liner hole, the clamp member having at least one continuous closed cross-sectional through ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה hole for insertion of the extended direction control rod of the base member therein, the hole of the clamp member can be moved along the extended direction control rod of the base member when the clamp member is assembled to the base member, the hole extending through the clamp member from a first side to a second side, the first side facing the base member and the second side facing away from the base member in an assembled position, the clamp member able to be inserted through the hole in the bed liner wall when the clamp member is engaged with the base member; and a tiedown ring for attaching to the base member. ___________ June 5, – ב' בסיון התשס"ח 1180 2008 ]11[]21[ 160924 ייצוב של הידרוכלוריד אמרובצ'ין ]54[ STABILIZATION OF AMRUBICIN HYDROCHLORIDE ]22[ ]31[ 22.10.2002 2001-324591 ]32[ 23.10.2001 ]33[ JP 2001-324596 23.10.2001 JP Int. Cl.8 A61K 031/704, A61P 035/00, C07H 005/06, 015/252 SUMITOMO CHEMICAL COMPANY, LIMITED, JAPAN DAINIPPON SUMITOMO PHARMA CO., LTD., JAPAN WO/2003/035660 DR. YITZHAK HESS & PARTNERS, ,ד"ר יצחק הס ושותפיו 279 HAYARKON ST., תל אביב,6451 .ד. ת, 279 רחוב הירקון P.O.B. 6451, TEL AVIV 61063 ]51[ ]71[ ]87[ ]74[ [57] A stabilized amrubicin hydrochloride composition which comprises 92 to 97% by weight of amrubicin hydrochloride and 3 to 8% by weight of water. __________ ]11[]21[ ]54[ CUTTING TOOL ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 20.09.2002 09/969234 ]32[ 02.10.2001 Int. Cl.8 B23B 051/02 KENNAMETAL INC., U.S.A. WO/2003/028930 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [57] A rotary cutting tool comprising: a shank having a receiver comprising: a shank guide at a trailing end of the receiver; opposing shank drive keys at a leading end of the receiver; and a shank locator axially between the shank 1181 161077 כלי חיתוך ]33[ US , ברגמן וגולר,וולף ירושלים,1352 .ד.ת guide and the shank drive keys, the shank drive keys each comprising an axially extending shank drive key radical stop surface that is disposed at an angle relative to a plane extending through a central axes of the receiver; and a head having a June 5, 2008– ב' בסיון התשס"ח connector comprising: a head guide at a trailing end of the connector; opposing head drive keys at a leading end of the connector; and a head locator portion axially between the head guide and the head drive keys, the head drive keys each comprising an axially extending head drive key radial stop surface that is disposed at an angle relative to a plane extending through a central axes of the connector, wherein each shank drive key radial stop surface is adapted to angularly align with a corresponding head drive key radial stop. __________ ]11[]21[ ]54[ COMPOSITIONS FOR DELIVERY OF DRUG COMBINATIONS ]22[ ]31[ 03.10.2002 60/326671 ]32[ 03.10.2001 60/341529 17.12.2001 60/356759 15.02.2002 2383529 23.04.2002 60/401984 07.08.2002 60/408733 06.09.2002 Int. Cl.8 A61K 009/00 CELATOR PHARMACEUTICALS, INC. WO/2003/028696 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 ]51[ ]71[ ]87[ ]74[ [57] A pharmaceutical composition for parenteral administration, comprising particulate delivery vehicles having associated therewith at least a first June 5, – ב' בסיון התשס"ח 161214 תכשירים לנתינה של תערובת תרופות ]33[ US US US CA US US , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, antineoplastic agent and a second antineoplastic agent, wherein said first and second agents are in a mole ratio which exhibits a non-antagonistic cytotoxic or 1182 2008 cytostatic effect and wherein said first and second agents are associated with the delivery vehicles to maintain a non- antagonistic ratio in the blood on administration. ,188774 The applications for division from this application have not yet been published בקשות חלוקה מבקשה זו .שטרם פורסמו __________ ]11[]21[ 161238 התקן אלקטרוני לקופסאות של חבילות ושיטות הפעלה עבורן ]54[ ELECTRONIC DEVICE FOR PACKET BOXES AND RELATED OPERATING METHOD ]22[ ]31[ ]51[ ]71[ ]72[ ]87[ ]74[ 07.10.2002 10149622.2 ]32[ 09.10.2001 ]33[ DE Int. Cl.8 A47G 029/14, G07C 009/00, G07F 017/12 DEUTSCHE POST AG, GERMANY BORIS MAYER, GUELDERN TUNA WO/2003/032789 EITAN MEHULAL LAW GROUP, קבוצת איתן – מהולל עורכי דין – עורכי 10 ABBA EBEN BLVD., ,פטנטים P.O. B. 2081, הרצליה,2081 .ד. ת, 10 שדרות אבא אבן HERZLIYA 46120 [57] An electronic parcel compartment system with a user interface, whereby the user interface has a means for acquiring information from users of the electronic parcel compartment system, characterized in that the electronic parcel compartment system has a means for assigning the users 1183 to user groups and in that the electronic parcel compartment system is provided with a system control that allows a user to have access to a selection of several functions of the electronic parcel compartment system, depending on the user group to which the user belongs. June 5, 2008– ב' בסיון התשס"ח ___________ ]11[]21[ 161239 שיטות לבקרת מערכות של תאי חבילות אלקטרוניות ]54[ METHOD FOR CONTROLLING ELECTRONIC PARCEL COMPARTMENT SYSTEMS ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 07.10.2002 10149619.2 ]32[ 09.10.2001 ]33[ DE Int. Cl.8 A47G 029/14, G07C 009/00, G07F 017/12 DEUTSCHE POST AG, GERMANY WO/2003/032788 EITAN MEHULAL LAW GROUP, קבוצת איתן – מהולל עורכי דין – עורכי 10 ABBA EBEN BLVD., ,פטנטים P.O. B. 2081, הרצליה,2081 .ד. ת, 10 שדרות אבא אבן HERZLIYA 46120 [57] A method for controlling electronic parcel package compartment systems, characterized in that data for controlling the electronic parcel compartment system is stored on a server and converted into control commands for controlling the parcel compartment system, in that a checking procedure is carried out in the area of a server to see whether changes have been made in the data stored on the server and in that the control commands are transmitted via an interface to the parcel compartment system as soon as a predefinable number of changes have been made to the data stock. __________ ]11[]21[ ]54[ METHOD AND APPARATUS FOR CONTROLLING ATMOSPHERIC CONDITIONS ]22[ ]31[ ]51[ ]71[ 25.12.2002 147287 ]32[ 25.12.2001 Int. Cl.8 A01G 015/00, E01H 013/00 YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM WO/2003/061370 ]87[ June 5, – ב' בסיון התשס"ח 161632 שיטה ומכשיר לשליטה בתנאי אטמוספירה ]33[ IL יישום חברה לפיתוח המחקר של ירושלים,האוניברסיטה העברית בירושלים 1184 2008 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם [57] A method of controlling atmospheric conditions in a portion of the atmosphere containing microscopic water droplets dispersed therein so as to produce their desired coalescence and precipitation, the method including: (a) providing a predetermined amount of a seeding material having uncharged seeding elements of a predetermined size distribution; (b) calculating a predetermined polarity and charge magnitude of seeding elements by using a collision model describing collisions between said charged seeding elements and said microscopic water droplets; (c) electrically charging the uncharged seeding elements so as to produce charged seeding elements having said predetermined polarity and charge magnitude, and (d) seeding said charged seeding elements in said portion of the atmosphere. ]74[ ___________ ]11[]21[ 161736 תולדות בנזופאנון או מלחים מזה ]54[ BENZOPHENONE DERIVATIVES OR SALTS THEREOF ]22[ ]31[ 13.11.2002 2001-351217 ]32[ 16.11.2001 ]33[ JP 2002-209382 18.07.2002 JP Int. Cl.7 A61K 031/185, 031/192, A61P 019/02, 029/00, C07C 059/90, 065/34, 065/40, 069/738, 069/76, 069/88, 069/94, 217/76, 235/42, 255/54, 259/10, 271/64, C07D 209/48, 239/88, 241/08, 257/04, 261/12, 333/22 TOYAMA CHEMICAL CO., LTD., JAPAN WO/2003/042150 DR. YITZHAK HESS & PARTNERS, ,ד"ר יצחק הס ושותפיו 279 HAYARKON ST., תל אביב,6451 .ד. ת, 279 רחוב הירקון P.O.B. 6451, TEL AVIV 61063 ]51[ ]71[ ]87[ ]74[ [57] A benzophenone derivative of the formula: 1185 June 5, 2008– ב' בסיון התשס"ח wherein R1 represents a substituted or unsubstituted heterocyclic group, a substituted phenyl group, or a substituted or unsubstituted alkyl group; Z represents a substituted or unsubstituted alkylene group; R2 represents a substituted or unsubstituted heterocylic group, a substituted or unsubstituted heterocyclic carbonyl group or a protected or unprotected carboxyl group; R3 represents a hydrogen atom, a halogen atom, a cyano group, a nitro group, a protected or unprotected carboxyl group, a protected or unprotected hydroxyl group, a protected or unprotected amino group, a mercapto group, a carbamoyl group or a substituted or unsubstituted alkyl, alkenyl, cycloalkyl, aryl, aralkyl, alkoxy, aryloxy, acyl, alkoxycarbonyl, aryloxycarbonyl, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, acylamino, alkylsulfonylamino, arylsulfonylamino or heterocyclic group; R4 represents a substituted or unsubstituted alkoxy, cycloalkyloxy, cycloalkenyloxy, alkyl, cycloalkyl, heterocyclic-oxy or heterocyclic group; R3 represents a hydrogen atom, a halogen atom or a hydroxyl group, provided that, when R1 represents a substituted or unsubstitued alkyl group, R4 represents a substituted or unsubstituted cycloalkyloxy group, an alkoxy group substituted with a substituted or unsubstituted phenyl or heterocylic group or a substituted or unsubstituted heterocylic-oxy group, or a salt thereof. __________ ]11[]21[ ]54[ RECLOSABLE POURING ELEMENT ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 26.11.2002 10157685.4 ]32[ 26.11.2001 Int. Cl.8 B65D 005/74 SIG ALLCAP AG, SWITZERLAND WO/2003/045797 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 June 5, – ב' בסיון התשס"ח 161922 אלמנט מזיגה הניתן לסגירה חוזרת ]33[ DE ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם 1186 2008 [57] A reclosable pouring element for being applied to a multilayer composite packaging, particularly a parallelepipedshaped cardboard/plastic composite packaging, with a base body (1) and a pouring tube (3) that is integrally joined thereto in an articulated fashion and simultaneously designed as an opening element for puncturing the packaging wall of the packaging in a weakened zone provided for this purpose, characterized in that the pouring tube is joined to the base body by means of a surrounding flexible membrane (4) and folded flat in the closed state, namely such that the flatly folded pouring tube is clamped in a sealed fashion between a clamping edge (8) and a clamping crosspiece (10) of the base body. _________ ]11[]21[ ]54[ INSECT HOLDER ]22[ ]31[ ]51[ ]71[ 20.12.2002 01310854.3 ]32[ 22.12.2001 Int. Cl.8 A01K 049/00 INSCENTINEL LIMITED, UNITED KINGDOM WO/2003/055301 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]87[ ]74[ [57] An insect holder for holding an insect of a particular type, the holder comprising a housing (40) with a chamber adapted to receive said insect, an inlet to the chamber through which said insect can pass to enter the chamber, a head opening 1187 162526 מתקן לחרקים ]33[ EP ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם (56) to the chamber adapted to permit the head of said insect in the chamber to pass therethrough to the exterior of the housing while retaining the insect in the housing, and retaining means for retaining said insect in the chamber with the head to the June 5, 2008– ב' בסיון התשס"ח insect protruding through the head opening to the exterior of the housing, such that the insect is unable to turn around in the chamber, wherein the retaining means comprise a collar or barb (70) locatable between the head and thorax, between the thorax and abdomen or behind the abdomen of an insect in the chamber, and wherein the collar or bard is movable between an open position and a closed or latched position. __________ ]11[]21[ ]54[ COMPOSITE SEMIPERMEABLE MEMBRANE AND PRODUCTION PROCESS THEREOF ]22[ ]31[ 16.06.2004 2003-172955 ]32[ 18.06.2003 2003-306322 29.08.2003 Int. Cl.8 B01D 067/00, 069/12, 071/56 TORAY INDUSTRIES, INC., JAPAN ]51[ ]71[ June 5, – ב' בסיון התשס"ח 162552 ממברנה מרובעת חדירה למחצה ותהליך לייצורה ]33[ JP JP 1188 2008 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם [57] A composite semipermeable membrane which comprises a separating functional layer comprising polyamide formed on a porous substrate film, wherein a monofunctional primary amine or an aliphatic acyl group is bound to or adsorbed in the inside or on the surface of the separating functional layer; wherein the composite semipermeable membrane removes boron while satisfying the following relationship when seawater at 25oC having a pH of 6.5, a boron concentration of 5 ppm and a total dissolved solids (TDS) concentration of 3.5% by weight is permeated under an operation pressure of 5.5 MPa; boron removal ratio (%)≥95-4 x membrane permeation flow rate (m3/m2•day) and wherein the composite semipermeable membrane has a TDS transmission coefficient which is 3 x 10-8 m/s or less, when seawater at 25oC having a pH of 6.5, a boron concentration of 5 ppm and a TDS concentration of 3.5% by weight is permeated under an operation pressure of 5.5 MPa. ]74[ ___________ ]11[]21[ ]54[ PREPARATION FOR WOUND HEALING AND PREVENTION OF BANDAGE ADHESION TO THE WOUND ]22[ ]31[ 15.01.2003 PUV02]32[ 18.01.2002 12746 Int. Cl.8 A61L 015/00, 026/00 CPN SPOL S.R.O., CZECH REPUBLIC WO/2003/059404 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 ]51[ ]71[ ]87[ ]74[ [57] Preparation for wound healing and prevention of adhesion to the wound characterized by the content of a physiologically acceptable salt of 162801 תכשיר לריפוי פצעים ולמניעת הדבקות תחבושות לפצעים ]33[ CZ , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר hyaluronic acid having the molecular weight from 200 000 to 2 500 000, iodine and potassium iodide. ____________ 1189 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ REVERSIBLE GROOVED TUBE FOR HEAT EXCHANGERS ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 10.03.2003 02/03067 ]32[ 12.03.2002 Int. Cl.8 F28F 001/40 TREFIMETAUX S.A., FRANCE WO/2003/076861 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] Grooved metal tubes, of thickness T f at the bottom of the groove, outer diameter De, intended for the manufacture of heat exchangers operating in evaporation or condensation or in reversible mode and using a phase transition coolant, said tubes being grooved internally with N helical ribs of an apex angle α, height H, base width LN and helical angle β, two consecutive ribs being separated by a typically flat-bottomed groove of width LR, with a pitch P equal to LR+LN, and wherein said tubes show a Cavallini factor at least equal to 3.1, the tubes further comprising an axial grooving creating in said ribbing notches with a triangular profile with a rounded top, said top showing an angle y ranging from 25 to 65 o, June 5, – ב' בסיון התשס"ח 162942 צינור מחורץ הפיץ לשימוש במחליפי חום ]33[ FR ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם said top is at a distance h from the bottom of said grooves ranging from 0 to 0.2 mm, characterised in that, (a) the outer diameter De is between 4 and 20 mm, (b) the number N of ribs ranges from 46 to 98, particularly as a function of the diameter De, (c) the rib height H ranges from 0.18 mm to 0.40 mm, particularly as a function of the diameter De, (d) the apex angle α ranges from 15o to 30o, (e) the helical angle β ranges from 18o to 35o so as to obtain simultaneously a high heat exchange coefficient both in evaporation and condensation, a low pressure loss and the lightest possible tube. 1190 2008 __________ ]11[]21[ ]54[ POLYTHIOPHENES HAVING ALKYLENEOXYTHIATHIOPHENE UNITS IN ELECTROLYTE CAPACITORS ]22[ ]31[ ]51[ ]71[ ]74[ 12.07.2004 10331673.6 ]32[ 14.07.2003 Int. Cl.7 C08G 075/00, H01G 009/025 H.C. STARCK GMBH, GERMANY REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 162969 פוליתיאופנים הכוללים יחידות אלקילנאוקסיתיאתיאופן בקבלים אלקטרוליטים ]33[ DE ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם [57] Electrolyte capacitor comprising: a layer of an oxidizable metal; a solid electrolyte; contacts; characterized in that it comprises, as the solid electrolyte, polythiophenes having repeating units of the general formula (I) or repeating units of the general formulae (I) and (II), where A is an optionally substituted C1-C5- alkylene radical, 1191 June 5, 2008– ב' בסיון התשס"ח R is a linear or branched, optionally substituted C1-C18-alkyl radical, an optionally substituted C5-C12-cycloalkyl radical, an optionally substituted C6-C14aryl radical, an optionally substituted C7C18-aralkyl radical, an optionally substituted C1-C4-hydroxyalkyl radical or a hydroxyl radical, x is an integer from 0 to 8 and in the case that a plurality of R radicals are bonded to A, may be the same or different, and optionally counterions. __________ ]11[]21[ ]54[ BACKFLOW PREVENTER ]22[ ]51[ ]71[ 21.07.2004 Int. Cl.8 E03C 001/10 A.R.I. FLOW CONTROL ACCESSORIES AGRICULTURAL COOPERATIVE ASSOCIATION LTD. REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]74[ [57] A reduced pressure zone backflow preventer (10) comprising a body (12) formed with an inlet port (14) accommodating an inlet check valve assembly (120) and an outlet port accommodating an outlet check valve assembly (122), said check valve assemblies extending along a coaxial axis coinciding with a longitudinal axis of the body, a central space (60) formed between said check valves accessible through a service opening in the body, a relief valve assembly (70) received within the central space and a drain port (88) extending from said space; said relief assembly is June 5, – ב' בסיון התשס"ח 163133 מונע זרימה חוזרת אביזרים להולכת נוזלים אגודה.י.ר.א קיבוץ כפר חרוב,שתופית חקלאית בע"מ ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם responsive to pressure differential between the inlet port and the space by a flow passage (210) extending between the inlet port and an upper side (220) of a pressure diaphragm (72) of the relief valve assembly; wherein the entire body is made of plastic material and wherein the space accommodates a retention member (68) fixedly receivable within the space and extending between the check valve assemblies so as to bear axial loads applied by said check valves, though without transferring axial loads between said check valve assemblies. 1192 2008 __________ ]11[]21[ ]54[ PERSONAL DESCENT APPARATUS ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 18.02.2003 10/085291 ]32[ 28.02.2002 Int. Cl.8 A62B 001/12 BORIS GELMAN, TURKEY WO/2003/072199 G.E. EHRLICH (1995) LTD., AYALON TOWER, 15TH FLOOR, 11 MENACHEM BEGIN ST., RAMAT GAN 52521 [57] A portable, lightweight apparatus for use by a user for safely descending from a high elevation, said apparatus comprising: (a) a drum (12) rotatably mounted on a mounting frame (14); (b) a body securing device (40) for securing said mounting frame to the body of the user; and (c) a line (20) wound around the drum, said line having a first end attached to the drum and a second end (22) for attachment to any fixed object at the high elevation; such that the user may conveniently use 1193 163425 מתקן נסיגה אישי ]33[ US ,) בע"מ1995( ארליך.אי.ג'י ,11 רחוב מנחם בגין, 15 קומה,מגדל אילון רמת גן the device to safely descend from the high elevation by attaching the mounting frame to the user's body and the second end of the line to the fixed object at the high elevation; and (d) a descent control device comprising an oil damper including a shaft coaxially coupled to said drum wherein drum rotation causes said oil damper to pump oil through a channel against resistance, said resistance exerting a retarding force against said rotation of said drum thereby controlling the rate of descent of the user. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ INTERNAL COMBUSTION ENGINE WITH COUPLED CYLINDERS AND METHOD FOR OPERATING IT ]22[ ]51[ ]71[ ]74[ 10.08.2004 Int. Cl.8 F01C 003/02, F02B 053/00 LEONID GERBER LEONID GERBER, 417/3 NEVE YAKOV, JERUSALEM [57] A rotary internal combustion engine (2) comprising: (a) a stator (4) containing a single toroidal volume; (b) a rotor (20), at least a portion of which travels a path defined by said toroidal volume; wherein said rotor and said stator define between them at least a first pair (24) of toroidal cylinders deployed within said single toroidal volume, said pair of toroidal cylinders being in selective fluid communication such that a first of said pair June 5, – ב' בסיון התשס"ח 163427 מנוע בעירה פנימית בעל צילנדרים משולבים ושיטה להפעלתו ירושלים,לאוניד גרבר ,לאוניד גרבר ירושלים,417/3 נווה יעקב of toroidal cylinders performs intake and compression strokes, a resultant compressed fuel/air mixture is transferred to a second (22) of said pair of toroidal cylinders, in which combustion occurs and expansion and exhaust strokes are performed, and during each cycle there is at least one period when said first and second toroidal cylinders are isolated and at least one period when said selective fluid communication is established so as to allow said transfer of said compressed fuel/air mixture. 1194 2008 ___________ ]11[]21[ ]54[ MARKING DEVICE ]22[ ]31[ ]51[ ]71[ 12.02.2003 PS0489 ]32[ 13.02.2002 Int. Cl.8 B41J 002/01, B41K 001/36 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2003/068519 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]87[ ]74[ [57] A marking device for printing indicia on print media, the marking device including: a housing (10); a printing mechanism (30) within the housing, including; a printing means for printing said indicia; storage means for storing information required to print said indicia; 1195 163493 מכשיר סימון ]33[ AU ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה moving means for moving said printing means with respect to said housing and said print media during printing, processor means for processing said information and for controlling said printing means to print said indicia as said printing means is moved with respect to said print media. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ ]54[ PROCESS FOR THE PREPARATION OF A DIESTER OF N – [3 – (TBUTYLOXYCARBONYLAMINO) PROPYL] – 2 –AMINOETHYL PHOSPHONIC ACID ]22[ ]31[ ]51[ ]62[ ]71[ ]87[ ]74[ 31.07.1998 905091 ]32[ 08.01.1997 Int. Cl.8 C07F 009/00, 009/40, 009/645 DIVISION FROM 134082 WYETH, U.S.A. WO/1999/006417 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A process for the preparation of N[3-(t-butyloxycarbonylamino) propyl]-2aminoethylphosphonic acid di-C1-C6 alkyl ester which comprises reacting a 163574 – N – [3 תהליך להכנת ד' אסטר של ](טרט בוטילקוסיקרבונילאמינו) – פרופיל – אמינואתיל חומצה פוספונית2 – ]33[ US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם vinylphosphonate di-C1-C6 alkyl ester with 3-aminopropyl carbamic acid 1,1dimethylethyl ester. _________ June 5, – ב' בסיון התשס"ח 1196 2008 ]11[]21[ ]54[ ENERGETIC PLASTICIZER FOR EXPLOSIVE CHARGES ]22[ ]51[ ]71[ 29.08.2004 Int. Cl.8 C06B 025/12 RAFAEL ADVANCED DEFENSE SYSTEMS LTD. ]74[ DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520 163785 [57] An energetic material suitable for high-energy, plastic-bonded, explosive charges, the material comprising an energetic plasticizer including an energetic מרכך אנרגטי עבור מטעני חומר נפץ ,רפאל מערכות לחימה מתקדמות בע"מ חיפה ,ד"ר מרק פרידמן בע"מ ,7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב גן-רמת nitrobutyl formal, wherein a composition of said energetic plasticizer contains at least 50%, by weight, of said energetic nitrobutyl formal. ,190353 The applications for division from this application have not yet been published בקשות חלוקה מבקשה זו .שטרם פורסמו _________ ]11[]21[ 163907 מתקן להגנה עצמית מוחזק–ביד ]54[ HAND-HELD SELF DEFENSE DEVICE ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 06.03.2003 10/093695 ]32[ 11.03.2002 ]33[ US Int. Cl.8 B05B 011/04, F41H 009/00, G01F 011/00 CHAIM DAVIDIAN בצרה,חיים דוידיאן WO/2003/076881 DR. MARK FRIEDMAN LTD., ,ד"ר מרק פרידמן בע"מ MOSHE AVIV TOWER, 54TH ,7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב FLOOR, גן-רמת 7 JABOTINSKY ST., RAMAT GAN 52520 [57] A self-defense device (16) for holding in a single hand of a user, the selfdefense device comprising: (a) a chamber including: (i) a rigid outer wall (10) having a butt for 1197 bracing the device against a palm of the hand, and (ii) a flexible outer wall (13) attached to said rigid outer wall, and (b) an ejection assembly including: June 5, 2008– ב' בסיון התשס"ח (i) a tube (28) extending through said chamber, and having a first end for fluidly communicating therewith; (ii) a valve (44) attached to said tube, for opening and closing thereof; (iii) a mechanism attached to said valve and configured to alter a position of said valve using a single digit of the single hand while grasping the device in a firing position, and (iv) a nozzle (24) attached to a second end of said tube and communicating with an environment external to the device, said chamber being designed and configured such that external pressure exerted upon said flexible outer wall increases an internal pressure of said chamber, such that fluid is forcefully and directedly ejected from the device through said tube and out said nozzle. ___________ ]11[]21[ 164095 תכשיר לטיפול במחלות הקשורות בין תאית לקויהGAP בתקשורת ]54[ COMPOSITION FOR TREATMENT OF DISEASES INVOLVING DEFECTIVE GAP JUNCTIONAL COMMUNICATION ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 21.03.2003 60/366363 ]32[ 21.03.2002 ]33[ US Int. Cl.8 A23G 001/00, A23K 001/16, A61K 031/353, A61P 003/06 MARS, INCORPORATED, U.S.A. WO/2003/079998 REINHOLD COHN AND PARTNERS, ,ריינהולד כהן ושותפיו 21 AHAD HA'AM ST., תל אביב,4060 .ד. ת, 21 רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 [57] Use of a compound selected from a cocoa flavanol and an oligomer thereof in June 5, – ב' בסיון התשס"ח the manufacture of a medicament, food, nutraceutical or dietary supplement for use 1198 2008 in treating a subject suffering from cognitive dysfunction, wherein the cocoa flavanol has the structure: and the oligomer is a compound or pharmaceutically acceptable salt thereof of the formula wherein n is an integer from 2 to 18, such that there is at least one terminal monomeric unit A, and one or a plurality of additional monomeric units; R is 3-(α)-OH, 3-(β)-OH; bonding between adjacent monomers takes place at positions selected from the group consisting of 4, 6 and 8; a bond of an additional monomeric unit in position 4 has alpha or beta stereochemistry; X, Y and Z are selected from the group consisting of monomeric units A or hydrogen, with the provisos that as to the at least one terminal monomeric unit, bonding of the additional monomeric unit thereto is at position 4 and optionally Y=Z=hydrogen. ___________ 1199 June 5, 2008– ב' בסיון התשס"ח ]11[]21[ ]54[ OIL RECOVERY AND ENVIRONMENTAL CLEANUP COMPOSITIONS ]22[ ]31[ ]51[ ]71[ 03.04.2003 PS1612 ]32[ 08.04.2002 Int. Cl.8 B01D 039/14, B01J 020/26 DAVID CHARLES ROBINSON, AUSTRALIA WO/2003/086623 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 ]87[ ]74[ [57] An oil adsorbent polymeric composition for adsorption of chemicals and hydrocarbons from land and water, the adsorbent composition including 164475 תכשירים לניקוי סביבתי וספיחת שמנים ]33[ AU , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר polyethylene/vinyl acetate copolymer, catalyst, cross linking agent, lubricant, blowing agent and bulking agent, wherein said lubricant is a fatty acid. _________ ]11[]21[ ]54[ APPARATUS FOR CONTROLLING THE ENVIRONMENT OF A PARKED VEHICLE ]22[ ]31[ 22.04.2003 60/375038 ]32[ 22.04.2002 241208 11.09.2002 Int. Cl.8 B60H 001/22 IDLEAIRE TECHNOLOGIES CORP., U.S.A. WO/2003/089262 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] A unit (10) for providing services to a stationary vehicle (11) through an opening (19) in said vehicle comprising: a June 5, – ב' בסיון התשס"ח 164553 מערכת לשליטה בסביבה של רכב חונה ]33[ US US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם head unit (18) having a generally mating configuration with said opening; said head unit having a body portion and a cover 1200 2008 (34); said cover adapted to open into said vehicle to provide access to said services; a closure mechanism adapted to release said cover permitting opening of said cover only when said head is located in said opening and further adapted to prevent said head from separating from said opening if said cover is not closed on said head. __________ ]11[]21[ ]54[ SYSTEM AND METHOD FOR MUNITION IMPACT ASSESSMENT ]22[ ]31[ ]51[ ]62[ ]71[ ]72[ ]74[ 05.06.2000 09/449750 ]32[ 26.11.1999 Int. Cl.8 F42B 015/04 DIVISION FROM 136565 TADIRAN SPECTRALINK LTD. MOSHE SHNAPS DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520 [57] A system for determining the impact success of a self guided munition (10) which is launched or dropped from a platform, the system comprising an impact verification assembly (24) being integrateable into the self guided munition, said impact verification assembly including: (a) a processing unit (26) for receiving and 1201 164747 מערכת ושיטה להערכת פגיעת נשק ]33[ US חולון,תדיראן ספקטרלינק בע"מ משה שנפס ,ד"ר מרק פרידמן בע"מ ,7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב גן-רמת processing information from an onboard guidance system (18) of the self guided munition, said information pertaining to an in-flight trajectory position of the self guided munition prior to impact, said processing unit further being for generating a signal including information pertaining to an accuracy of said in-flight trajectory position of the self guided June 5, 2008– ב' בסיון התשס"ח munition prior to impact with respect to a target; and (b) a transmitter (28) being in communication with said processing unit, said transmitter being for transmitting said signal generated by said processing unit in a manner receivable by a receiving device of the platform; wherein said signal pertaining to said accuracy of said in-flight trajectory position of the guided munition prior to impact includes information indicating an impact success or an impact failure of the self guided missile. __________ ]11[]21[ 164873 מבנה ותהליך להאצת הליכי טבע להפקה על ידי,מתמשכת של מי שתיה ממי–ים ניצול אנרגיית השמש הרוח וגלי הים ]54[ PROCESS AND STRUCTURE FOR SUPERACCELERATING NATURE, PRODUCING A CONTINUOUS SUPPLY OF FRESH WATER FROM SALT WATER BY USING SOLAR, WIND AND WAVE ENERGY ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 30.04.2003 60/377,769 ]32[ 02.05.2002 ]33[ Int. Cl.8 B01D 003/02, 005/00, C02F 001/14 DESAL, LLC, U.S.A. WO/2003/092847 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [57] A process for desalinating water, said process comprising providing a blackened surface (46) in contact with a body of water so as to heat air and June 5, – ב' בסיון התשס"ח US , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר evaporate said water from said blackened surface; channeling said heated air and water vapor upward through a vertical Venturi wind shaft (10) creating an 1202 2008 adiabatic pressure variance so as to release said water vapor into a first chamber of a series of interconnected chambers (5) allowing said water vapor to condense within said chambers; draining said desalinated water from said chambers; expelling said heated air from said chambers; and, retaining said desalinated water. _________ ]11[]21[ 165071 פפטיד עם היכולת להמריץ תת–קבוצה של מחולי טרשת נפוצהT –תאי ]54[ PEPTIDE CAPABLE OF STIMULATING A SUBGROUP OF T-CELLS FROM MULTIPLE SCLEROSIS PATIENTS ]22[ ]31[ ]51[ 28.03.1991 502559 ]32[ 30.03.1990 ]33[ US Int. Cl.8 A61K 038/17, A61P 025/00, 029/00, C07K 007/08, 014/47, 014/705, 014/725 DIVISION FROM 97709 AUTOIMMUNE, INC., U.S.A. BRIGHAM AND WOMEN'S HOSPITAL, U.S.A. SANFORD T.COLB & CO., ,' קולב ושות.סנפורד ט P.O.B. 2273, רחובות,2273 .ד. ת, מרמורק,4 שער הגיא REHOVOT 76122 ]62[ ]71[ ]74[ [57] A peptide the amino acid sequence of which is all or a segment of the sequence SEQ ID NO: 2 provided that said segment comprises a portion of the sequence SEQ ID NO: 1 sufficient to impart to said peptide the property of stimulating, as determined by proliferation assay, the subgroup of T-cells of the DR2+ 1203 type from remitting-relapsing multiple sclerosis patients that is reactive with another peptide the sequence of which consists of SEQ ID NO:1, said peptide stimulating said subgroup of T-cells to about the same degree as said another peptide. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ 165621 כלי חיתוך ושימת חיתוך עבורו ]54[ CUTTING TOOL AND CUTTING INSERT THEREFOR ]22[ ]51[ ]71[ ]72[ ]74[ 07.12.2004 Int. Cl.8 B23C 005/08, 005/22, B23D 027/04 ISCAR LTD. GIL HECHT, EHUD LEVANON ISCAR LTD., P.O.B. 11, TEFEN 24959 [57] A cutting insert (14) comprising: an upper surface (26), a lower surface (28) and a peripheral surface therebetween, the peripheral surface comprising: opposing forward (30) and rear (32) surfaces and opposing side surfaces (34) extending between the forward and rear surfaces, a through bore (36) extending between the forward and rear surfaces, the upper תפן,ישקר בע"מ אהוד לבנון,גיל הכט ,ישקר בע"מ תפן,11 .ד. ת, surface comprising a rake surface (38), the forward surface comprising a forward relief surface (40) and the intersection of the rake surface and the forward relief surface forming a forward cutting edge (44) the lower and rear surfaces being generally V-shaped in both a first crosssection and a second cross-section, respectively. ____________ June 5, – ב' בסיון התשס"ח 1204 2008 ]11[]21[ ]54[ CUTTING INSERT HAVING TWO OPPOSITE CUTTING HEADS ]22[ ]31[ ]51[ ]71[ 16.06.2003 GM400/2002 ]32[ 21.06.2002 Int. Cl.8 B23B 027/04 CERATIZIT AUSTRIA GESELLSCHAFT M.B.H, AUSTRIA WO/2004/000492 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 ]87[ ]74[ [57] Cutting insert (1) having two cutting heads (2, 2') which lie opposite one another in relation to its longitudinal axis A and which are connected together by a centre part which is offset inwards in the direction of the longitudinal axis A, so that the centre part is narrower than the cutting heads, and wherein each cutting head comprises an end-face cutting edge (3) which extends substantially transversely to the longitudinal axis A and two lateral cutting edge portions (4) which extend substantially in the direction of the longitudinal axis A of the cutting insert, wherein the associated flanks of the cutting 1205 165854 שימת חיתוך בעלת שני ראשי חתוך מנוגדים ]33[ AT , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר edges form an angle α1 of less than 90o with a plane Pr through the highest point of the cutting edges parallel to the longitudinal axis A, wherein the flanks of the lateral cutting edge portions of the two opposite cutting heads, which are disposed on the same side of the cutting insert, in each case lie in a common plane E, characterised in that the end-face cutting edge is circular, and that the lateral cutting edges extend away from the end-face cutting edge in a downward sloping manner at an angle α2 in the range of 5o to 25o in relation to the plane Pr. June 5, 2008– ב' בסיון התשס"ח __________ ]11[]21[ 166089 מחליף חום כפול מתאדה בזרימה נגדית ]54[ EVAPORATIVE DUPLEX COUNTERHEAT EXCHANGER ]22[ ]31[ 15.07.2003 60/397322 ]32[ 20.07.2002 ]33[ US 60/421754 28.10.2002 US Int. Cl.8 B01F 003/04, B01J 012/00, F28C 001/00 IDALEX TECHNOLOGIES, INC., U.S.A. LELAND E. GILLAN, ALAN D. GILLAN, VALERIY S. MAISOTSENKO, TIMOTHY L. HEATON WO/2004/009225 DR. MARK FRIEDMAN LTD., ,ד"ר מרק פרידמן בע"מ MOSHE AVIV TOWER, 54TH ,7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב FLOOR, גן-רמת 7 JABOTINSKY ST., RAMAT GAN 52520 ]51[ ]71[ ]72[ ]87[ ]74[ [57] A duplex exchanger (22); comprising: a first heat exchanger (24) including a first main flow channel (28) and a first counterheat channel (30) joined in flow communication therewith; a second heat exchanger (26) including a second main June 5, – ב' בסיון התשס"ח flow channel (32) and a second counterheat channel (34) joined in flow communication with said first heat exchanger; and means for injecting an evaporative coolant into said first counterheat channel. 1206 2008 __________ ]11[]21[ 166505 התקן לוויברציה מהירה של מבחנות המכילות דגימות ]54[ DEVICE FOR FAST VIBRATION OF TUBES CONTAINING SAMPLES ]22[ ]31[ 16.07.2003 02.09832 ]32[ 01.08.2002 ]33[ FR 03.02308 25.02.2003 FR Int. Cl.8 B01F 011/00, C12N 015/10, G01N 001/28 BERTIN TECHNOLOGIES S.A., FRANCE WO/2004/012851 REINHOLD COHN AND ,ריינהולד כהן ושותפיו PARTNERS, תל אביב,4060 .ד. ת, 21 רחוב אחד העם 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]51[ ]71[ ]87[ ]74[ [57] Apparatus for rapidly vibrating tubes containing samples, in particular biological samples, the apparatus comprising a disk (12) for supporting the tubes (24), means for preventing the disk from turning about its own axis, and means for driving the disk in oscillating motion about a center of rotation situated on the axis of the disk, 1207 wherein the disk is supported and centered on an elastically-suspended portion (26) of the apparatus by means of two concentric bearings (28, 30) mounted one within the other, one of the bearings being of the spherical type enabling the disk to execute oscillating motion about the center of rotation. June 5, 2008– ב' בסיון התשס"ח ___________ ]11[]21[ ]54[ VEHICLE BARRIER/ADVERTISEMENT SYSTEM ]22[ ]31[ ]51[ ]71[ ]72[ 14.08.2003 10/228437 ]32[ 27.08.2002 Int. Cl.8 E01C 011/22 BUMPADS, INC., U.S.A. SCOTT J. FENIMORE, RICHARD MILITANA WO/2004/065695 YORAM TSIVION, 2 HATOHEN ST., P.O.B. 3148, PARDESS HANA 38900 ]87[ ]74[ [57] A vehicle barrier/advertisement system comprising: a vehicle barrier (14) having a vertical front face (16) and a vertical rear face (18) and a horizontal upper face (20) and a pair of angled intermediate faces (12) therebetween, the barrier also having a generally horizontal lower face with a plurality of recesses (24) extending June 5, – ב' בסיון התשס"ח 166759 גובל לחנית רכב ומערכת פרסום הנסמכת עליו ]33[ US ,יורם צביון ,3148 .ד. ת, פארק התעשיה,2 רח' הטוחן חנה-פרדס between the front and rear faces and with a pair of end faces (26), the barrier being fabricated of concrete with at least two vertical securement holes (28) therethrough extending between the upper and lower faces offset from the ground with bars (30) extending through the holes and into the ground for securement purposes; a barrier cover (32) having a 1208 2008 vertical front face and a vertical rear face (36) and a horizontal upper face (38) and a pair of angled intermediate faces (40) the cover also having a generally horizontal lower opening, the cover being sized and shaped to be securely positioned over a vehicle parking barrier; a plurality of straps (48), each strap having a central extent positioned within a recess, each strap having end extents (52) extending through an associated slot (46) in the cover, each end extent having a lower toothed surface and an associated toothed keeper receiving the end extents and positioned in contact with an associated slot for holding the cover in contact with the barrier, and an advertisement sheet (58) having an interior surface (60) positioned with respect to an angled intermediate face of the cover, the sheet also having an exterior surface with advertising indicia thereon. ___________ ]11[]21[ ]54[ ]22[ ]51[ ]71[ ]87[ ]74[ APPARATUS FOR COOLING CATTLE IN SHEDS 01.01.2004 Int. Cl.8 A01K 001/00 ARIEH JEHUDA POLAK WO/2005/065447 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 [57] Apparatus for cooling cattle, particularly cows, which are distributed to predetermined locations, particularly distributed in rows, and more particularly in a shed, which comprises: (I) a plurality of fans (12), arranged in a configuration such that an air stream 1209 167092 מתקן לקירור בקר בסככות אביב- תל,אריה יהודה פולק ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה generated by each of said fans is directed to a corresponding predetermined location of the cattle; (II) a support (16) to which each corresponding fan is mounted, said support being slid with a shaft (21) which is June 5, 2008– ב' בסיון התשס"ח rotatably mounted in a sleeve (19) attached to a static element (15); (III) actuating means for concurrently actuating and concurrently stopping all of said fans; (IV) kinematic connecting means between two adjacent fans for concurrently controlling the direction of the streams of air generated by said fans, wherein said kinematic connecting means comprises, for each of said fans, a two-way continuous flexible member (30) which passes around each shaft of said two adjacent fans and a gearing (33) carried by said flexible member; and (V) transmission means for transmitting rotation from a preceding fan to a second fan, wherein said transmission means comprises a first gear wheel (23) rotatable with the preceding fan and a second gear wheel (25) rotatable with the second fan, said gearing carried by said flexible member meshing with said first and second gear wheels. This specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968 לתקנות35 פירוט זה נבחן בהתאם לתקנה 1968 – תשכ"ח,הפטנטים __________ ]11[]21[ ]54[ COMPOSITIONS CONTAINING MICROSPHERES WITH ANTIINFLAMMATORY PROPERTIES ]22[ ]31[ ]51[ ]71[ ]87[ 04.09.2003 10/234274 ]32[ 04.09.2002 Int. Cl.8 A61F 009/00, A61K 009/00 POLYHEAL LTD. WO/2004/021942 June 5, – ב' בסיון התשס"ח 167226 תכשירים המכילים כדוריות–מיקרו בעלות תכונות אנטי–דלקתיות ]33[ US נשר,פוליהיל בע"מ 1210 2008 ]74[ ,'ד"ר וב ושות רחובות,2189 .ד. ת, 2 רח' פקריס WEBB & ASSOCIATES, 2 PEKERIS ST., P.O.B. 2189, REHOVOT 76121 [57] A therapeutic composition, contained in a package for storing and mixing the composition from which the composition can be dispensed and applied to an ocular surface, said composition comprising about 0.001-25% by weight of microspheres in suspension, said microspheres being capable of forming multi-point contacts with a cellular membrane and said microspheres being substantially non-biodegradable during the period of therapy; and a pharmaceutically acceptable carrier for said microspheres, said microspheres being substantially insoluble in said carrier. ___________ ]11[]21[ ]54[ STEERING SYSTEM AND METHOD FOR GUIDED FLYING APPARATUS ]22[ ]51[ ]71[ 29.03.2005 Int. Cl.8 F42B 010/66 ISRAEL AEROSPACE INDUSTRIES LTD. REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ]74[ [57] A steering system for use in a traveling guided flying apparatus, the system comprising: an outer housing (111), an inner housing, a plurality of support fins extending radially inwardly from the outer housing and holding the inner housing thereon; the outer housing and the inner housing defining a ram air inlet at a nose of the forward portion, defining an annular inlet air passage (115), defining an annular pressure chamber (116), and outlet air passage between an inside wall of the outer housing and an outside wall of the inner housing; a plurality of exhaust outlets (120) arranged in the outer housing; a plurality of separately controlled valves mounted at the 1211 167721 מערכת היגוי ושיטה להתקן לטיסה מונחת לוד,התעשיה האוירית לישראל בע"מ ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם exhaust outlets; the valves being configured to vary the flow of escaping air through the exhaust outlets; a target seeker mounted at the nose of the forward portion and configured for sensing a target and producing a target sensor signal representative of the relative location of the target, at least one pressure sensor (119a) mounted in the pressure chamber and configured for measuring the gas pressure therein and producing a pressure sensor signal representative of changes of gas pressure in the pressure chamber; a control unit mounted within the flying apparatus and operatively coupled to the controlled valves, the target seeker, and the pressure sensor, said control unit being June 5, 2008– ב' בסיון התשס"ח responsive to said target sensor signal and said pressure sensor signal, and configured for controlling flight of the guided projectile by generating a valve control signal and providing said valve control signal to said plurality of separately controlled valves, an electrical power source module mounted within the flying apparatus and operable to provide electrical power required for operating said target seeker, said at least one pressure sensor and said plurality of separately controlled valves. __________ ]11[]21[ ]54[ VALVE FOR AUTOMATIC AND CONTINUOUS FLUID FLOW DISTRIBUTION AND REGULATION COMPRISING A MAGNETIC SEAL ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 29.09.2003 P200202241 ]32[ 02.10.2002 Int. Cl.8 F16K 011/072, 031/08 IRRIMON, S.A.U., SPAIN WO/2004/031633 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [57] Continuous automatic fluid flow control and distributor valve, with a magnetic seal, of the type of valves that permit the flow of a fluid to be distributed among three inlet (7', 7'') and outlet (7) ways, one of which is shared and remains open all the time, and the other two and are the progressive opening and closing type, June 5, – ב' בסיון התשס"ח 167816 שסתום לחלוקה או לבקרה אוטומטית וממושכת המכיל שדה מגנטי ]33[ ES ,' קולב ושות.סנפורד ט רחובות,2273 .ד. ת, מרמורק,4 שער הגיא characterised in that its structure is made up of the following items: a cylindricallyshaped seal made up of two identical ferromagnetic discs (1), which enclose between them another smaller-diameter concentric disc (2) and a permanent magnet, the rims (3) of the two outer discs being bevel-cut towards the inner magnetic 1212 2008 disc, with the result that the three discs conjointly define a perimeter groove that acts as a housing for a spring ring (4) which forms the direct means of sealing, a valve case or body composed of two superimposed parts (5, 5'), one of which forms the rolling track of the outer discs with the beveled rims of the seal and is of ferromagnetic material, being provided with an intercommunicating chamber (6) between the fluid distribution ways (inlets and outlets), which are of dimensions that permit small movements to take place in its interior owing to the rolling of the seal, the axes of the inlet ways and of the outlet way or vice versa being disposed perpendicularly, seal movement means composed of: a bi-metal conductor (8) capable of contracting when an electrical voltage is applied to it, causing with its contraction the movement of the seal limited by lateral stops (10); and an opposing spring (9), disposed to keep the seal in dynamic equilibrium or take it up to its home position when no electrical voltage is applied to the bi-metal conductor. __________ ]11[]21[ ]54[ STRUCTURE COUPLER AND COUPLER THEREFOR ]22[ 07.04.2005 1213 167905 חיבור למבנים ומחבר עבורו June 5, 2008– ב' בסיון התשס"ח ]51[ ]71[ ]74[ Int. Cl.8 B64G 001/64, F42B 015/10, 015/36 ISRAEL AEROSPACE לוד,התעשייה האוירית לישראל בע"מ INDUSTRIES LTD. REINHOLD COHN AND ,ריינהולד כהן ושותפיו PARTNERS, תל אביב,4060 .ד. ת, 21 רחוב אחד העם 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A coupler (36) comprising a lower lug (40) and an upper lug (42) each formed with a locking recess engageable with a corresponding locking piece (52) slidingly received within a cavity (50) extending between lugs; said locking piece is displaceable between a locked position in which it engages the locking recess of each of said upper lug and lower lug where said lugs are tightly coupled to one another, and an open position in which it disengages from the recesses to allow detaching of the lugs from one another; and further wherein at least one of said upper lug and lower lug and the locking piece are formed with one or more ejecting surfaces to facilitate disengagement and separation of the lugs from one another and sliding displacement of the locking piece, and further comprising a power activated separation system for displacing the locking piece into its open position. ____________ ]11[]21[ ]54[ PRINT CARTRIDGE ]22[ ]51[ ]62[ ]71[ 30.06.2000 Int. Cl.8 B41J 002/175 DIVISION FROM 153526 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2002/002333 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]87[ ]74[ June 5, – ב' בסיון התשס"ח 168177 מחסנית דיו למדפסת ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה 1214 2008 [57] A print cartridge (10) comprising: a support arrangement (14); an ink supply container (58) arranged within the support arrangement; and a supply of print media (34) rotatably received about the ink supply container. ___________ ]11[]21[ ]54[ THERMAL INK JET PRINTHEAD WITH HEATERS FORMED FROM LOW ATOMIC NUMBER ELEMENTS AND A METHOD OF EJECTING A DROP OF BUBBLE FORMING LIQUID FROM THE PRINTHEAD ]22[ ]31[ ]51[ ]71[ 17.11.2003 10/302618 ]32[ 23.11.2002 Int. Cl.8 B41J 002/05 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2004/048101 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]87[ ]74[ [57] An ink jet printhead (1) comprising: a plurality of nozzles (3); and at least one respective heater element (10) corresponding to each nozzle, wherein each heater element is formed of solid material more then 90% of which, by atomic proportion, is constituted by at least one periodic element having an atomic number below 50, each heater element is 1215 168706 ראש מדפסת להזרקת דיו תרמי עם מחממים העשויים מחלקים עם מספר אטומי נמוך ושיטה להוצאת טיפה של נוזל היוצרת בועה מראש המדפסת ]33[ US ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה arranged for being in thermal contact with a bubble forming liquid; each heater element is configured to heat at least part of the bubble forming liquid to a temperature above its boiling point to form a gas bubble therein thereby to cause the ejection of a drop (16) of the bubble forming liquid through the nozzle corresponding to that heater element; and June 5, 2008– ב' בסיון התשס"ח wherein the bubble which each heater element is configured to form is collapsible and has a point of collapse, and wherein each heater element is configured such that the point of collapse of a bubble formed thereby is spaced from that heater element. ___________ ]11[]21[ ]54[ THERMAL INK JET PRINTHEAD WITH LOW HEATER MASS ]22[ ]31[ ]51[ ]71[ 17.11.2003 10/302617 ]32[ 23.11.2002 Int. Cl.8 B41J 002/05 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2004/048106 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 ]87[ ]74[ [57] An ink jet printhead (1) comprising: a plurality of nozzles (3); and at least one respective heater element (10), which includes solid material, corresponding to each nozzle, wherein each heater element is in thermal contact with a bubble forming liquid, and each heater element has a mass of less than 10 nanograms of the solid material and is heated to a temperature June 5, – ב' בסיון התשס"ח 168707 ראש מדפסת להזרקת דיו תרמי עם מסת חימום נמוכה ]33[ US ,לוצאטו את לוצאטו באר שבע,5352 .ד. ת, עומר,גן תעשייה above the boiling point of the bubble forming liquid, thereby to heat at least part of the bubble forming liquid to a temperature above said boiling point to form a gas bubble therein, thereby to cause the ejection of a drop of said bubble forming liquid through the nozzle corresponding to that heater element. 1216 2008 ___________ ]11[]21[ 169629 מימדים דיגיטלי3 מערכת ליצירת אוביקט פעיל ]54[ DIGITALLY ACTIVE 3-D OBJECT CREATION SYSTEM ]22[ ]31[ ]51[ ]71[ 09.01.2004 2003900180 ]32[ 16.01.2003 ]33[ AU Int. Cl.8 B41J 002/01, D04H 001/16, G06F 019/00 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2004/062925 LUZZATTO & LUZZATTO, ,לוצאטו את לוצאטו INDUSTRIAL PARK, OMER, באר שבע,5352 .ד. ת, עומר,גן תעשייה P.O.B. 5352, BEER-SHEVA 84152 ]87[ ]74[ [57] A three dimensional object creation system that prints objects layer by layer, the system including a plurality of 1217 printheads (102, 108, 112), the system printing at least part of each of multiple layers (110, 114, 118) simultaneously. June 5, 2008– ב' בסיון התשס"ח _________ ]11[]21[ סטנט מורכב ]54[ STENT GRAFT ]22[ ]31[ 30.12.1999 60/114731 ]32[ 31.12.1998 60/116726 20.01.1999 Int. Cl.8 A61F 002/06, A61L 031/10 DIVISION FROM 143922 ANGIOTECH PHARMACEUTICALS, INC., CANADA UNIVERSITY OF BRITISH COLUMBIA, CANADA WO/2000/040278 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 ]51[ [62] ]71[ ]87[ ]74[ 173240 [57] A stent graft comprising an agent that induces the in vivo adhesion of the stent ]33[ US US , ברגמן וגולר,וולף ירושלים,1352 .ד. ת, graft to a vessel wall without releasing said agent. __________ June 5, – ב' בסיון התשס"ח 1218 2008 ]11[]21[ ]54[ אפימריזציה של אלכוהולים אלליים EPIMERISATION OF ALLYLIC ALCOHOLS ]22[ ]31[ ]51[ ]71[ ]87[ ]74[ 22.08.2005 60/606135 ]32[ 01.09.2004 Int. Cl.8 A61K 031/59, C07C 401/00 LEO PHARMA A/S, DENMARK WO/2006/024296 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [57] A method of epimerising an epimer or epimeric mixture of a compound comprising a side chain of the formulae at the position of the carbon atom to which the hydroxy group and R3 are attached to; by contacting said epimer or epimeric mixture with an acid in the presence of water; wherein R3 is alkyl, alkenyl, alkynyl, or cycloalkyl, optionally substituted with one or more substituents selected from the group consisting of alkyl, alkoxycarbonyl, halogen, hydroxy, methoxy, and ethoxy; wherein the carbon marked with an asterisk is connected by a single bond to the C-17 carbon atom of a 1219 180248 ]33[ US ,ריינהולד כהן ושותפיו תל אביב,4060 .ד. ת, 21 רחוב אחד העם vitamin D analogue fragment; or wherein the carbon marked with an asterisk is connected by a single bond to a fragment of a precursor for the synthesis of a vitamin D analogue at its C-17 analogous position; wherein the fragment of a precursor for the synthesis of a vitamin D analogue is a fragment of a steroid ring system or a fragment of a CD ring system of a steroid; wherein the fragment of the steroid ring system is represented by the formula June 5, 2008– ב' בסיון התשס"ח wherein the fragment of a CD ring system of a steroid is represented by formulas wherein PG represents hydrogen or a hydroxy protecting group; June 5, – ב' בסיון התשס"ח wherein the vitamin D analogue fragment is represented by any one of the fragments 1220 2008 wherein R1 and/or R2 may be the same or different and represent hydrogen or a hydroxy protecting group. לתקנות35 פירוט זה נבחן בהתאם לתקנה 1968 – תשכ"ח,הפטנטים This specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968 __________ ]11[]21[ ]54[ ]22[ ]31[ ]51[ ]62[ ]71[ ]87[ ]74[ COMPOSITIONS FOR LOWERING PLASMA LIPOPROTEIN(A) AND RISK FACTORS OF CARDIOVASCULAR DISEASES 03.10.2001 60/237186 ]32[ 03.10.2000 Int. Cl.8 A61K 045/00, A61P 009/00 DIVISION FROM 155238 MATTHIAS RATH, U.S.A. WO/2002/028379 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [57] Composition of biochemical substances comprising ascorbic acid, ascorbyl palmitate, beta-, gamma-, deltatocopherol-mix, beta-carotene, biotin, calcium ascorbate, calcium glycinate, carotenoid mix, cholecalciferol, chromium glycinate, citrus bioflavonoids, coenzyme Q10, copper glycinate, cyanocobalamin, dalpha-tocopherol, d-calcium pantothenate, dicalcium phosphate, folic acid, inositol, L-arginine, L-carnitine, L-cysteine, L- 1221 185384 הרכבים רוקחיים להורדת רמות ) בפלסמה והורדת גורמיA( ליפופרוטאין סיכון למחלות קרדיווסקולריות ]33[ US , לצר וכהן צדק, פרל,איתן הרצליה,12688 .ד. ת, 7 רחוב שנקר lysine, L-proline, Lselenomethionine,magnesium ascorbate, magnesium glycinate, manganese chelate, molybdenum glycinate, niacin, niacinamide, potassium chelate, pycnogenol, pyridoxine, riboflavin, thiamine, and zinc glycinate, wherein the composition is in therapeutically effective amounts to lower plasma concentration of a lipoprotein in a mammal. June 5, 2008– ב' בסיון התשס"ח The parent application from which this application has been divided has not yet been published 155238 בקשת הורה לבקשה זו שטרם פורסמה ___________ 889 April 13, 2008– ח' בניסן התשס"ח פטנטים PATENTS פטנטים שניתנו PATENTS GRANTED 154668 136283 פטנטים שחודשו PATENTS RENEWED 94049 94183 109185 109251 109308 109389 115707 123287 123963 124073 124195 127240 129633 131318 131894 131994 132192 132258 132301 132379 132481 132940 135036 137691 139109 143959 145950 148200 148925 149138 149957 150949 151752 152570 153535 94042 94152 109095 109245 109287 109381 111369 123074 123961 124069 124190 127239 129139 130880 131849 131977 132166 132256 132296 132364 132435 132844 135020 137471 138982 143149 145933 147894 148875 149054 149923 150744 151715 152409 153511 94021 94147 108677 109242 109284 109366 111361 122575 123952 124044 124146 127070 128701 130646 131832 131974 132160 132246 132293 132357 132424 132819 134368 136218 138980 142629 145922 147871 148694 149041 149824 150737 151603 152349 153509 ח' בניסן התשס"ח –April 13, 2008 94020 94128 107557 109222 109271 109350 109472 119660 123949 124033 124145 126971 127610 130369 131821 131969 132107 132240 132286 132351 132415 132749 134286 136076 138955 141899 145548 147293 148684 149021 149625 150690 151349 152340 153304 94006 94119 94243 109219 109270 109338 109466 119527 123943 123998 124129 126734 127588 130363 131746 131965 132101 132236 132276 132339 132403 132563 133777 135930 138444 141395 145546 147285 148475 148988 149227 150480 151330 152247 153301 94002 94113 94241 109216 109267 109327 109427 119526 123942 123981 124104 125602 127527 130093 131726 131962 132068 132217 132275 132325 132392 132548 133282 135361 138443 141145 145307 146681 148327 148979 149188 150359 151135 152073 153110 93983 94112 94217 109206 109263 109318 109395 119474 123819 123969 124089 125464 127448 130089 131593 131913 132047 132214 132271 132319 132390 132494 133067 135343 138034 140980 144777 146660 148304 148961 149165 150182 151054 151874 152820 93695 94077 94186 109186 109254 109316 109390 118579 123727 123967 124085 124253 127433 129940 131592 131900 132002 132208 132259 132303 132380 132493 133039 135287 137809 139687 144153 146233 148216 148926 149159 150154 151053 151816 152687 1221 154835 155695 157277 158110 158709 161792 166727 1222 154797 155428 157051 157994 158621 161420 166160 154668 155425 156631 157795 158551 161254 165403 154646 155359 156623 157761 158434 160238 164977 154616 155271 156554 157733 158373 160189 164466 179148 154252 155229 156260 157647 158295 159186 162686 169302 153739 155066 156051 157646 158284 159075 162637 168911 153587 155065 155862 157542 158240 158833 161796 166920 ח' בניסן התשס"ח –April 13, 2008 פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL FEES 91321 91438 106821 106891 121662 128613 128739 1223 91377 106710 106825 119134 121666 128661 128748 91398 106720 106830 121568 121675 128664 138652 91422 106724 106844 121589 125435 128667 144926 91423 106759 106846 121615 127616 128668 154393 91424 106782 106864 121636 128160 128688 91425 106785 106872 121644 128465 128713 91428 106812 106873 121654 128500 128734 April 13, 2008– ח' בניסן התשס"ח Patents for which applications have been filed for extension of the patent term under chapter 4, part B1 of the Patents Law פטנטים שלגביהם הוגשו בקשות להארכת תקופת ההגנה על פי פרק לחוק הפטנטים1'ד' סימן ב 136727 April 13, 2008– ח' בניסן התשס"ח 1224 הודעה NOTICE לחוק60 לפי סעיף 1967- תשכ"ז,הפטנטים הוגשה בקשה להחזר תוקפו של הפטנט המפורט שתוקפו פקע מחמת,מטה אי תשלום אגרות החידוש :הקבועות Under section 60 of the Patent Law, 5727-1967 Application has been filed for the restoration of the patent recorded below, which has lapsed through non-payment of the prescribed renewal fees: No. of Patent Acceptance published in journal no: Proprietors: 109269 8/1996 מס' הפטנט :'קיבול פורסם ביומן מס :שם בעל הפטנט פלסטיק מגן תעשיות (אגש"ח) בע"מ PLASTIC MAGEN INDUSTRIES (A.S.C.) LTD. :שם האמצאה Title of invention: מחליף חום HEAT EXCHANGER Any person may oppose the said application within three months from the date of this Patents Journal, as prescribed by section 61 of the law and by regulation 92 of the Patent Regulations, 5728-1968 1225 כל אדם רשאי להתנגד לבקשה האמורה תוך שלושה חודשים מתאריך כפי שנקבע,יומן פטנטים זה 92 לחוק ובתקנה61 בסעיף - תשכ"ח,לתקנות הפטנטים 1968 April 13, 2008– ח' בניסן התשס"ח הודעה NOTICE לחוק60 לפי סעיף 1967- תשכ"ז,הפטנטים הוגשה בקשה להחזר תוקפו של הפטנט המפורט שתוקפו פקע מחמת,מטה אי תשלום אגרות החידוש :הקבועות Under section 60 of the Patent Law, 5727-1967 Application has been filed for the restoration of the patent recorded below, which has lapsed through non-payment of the prescribed renewal fees: No. of Patent Acceptance published in journal no: Proprietors: 114739 3/2005 מס' הפטנט :'קיבול פורסם ביומן מס :שם בעל הפטנט מיכאל פורת MICHAEL PORAT Title of invention: :שם האמצאה אמצעים למניעת התפרצות דם בהוצאת מחטמאיבר מוביל דם SYSTEM FOR PREVENTION OF BLOOD SPURTS FROM BLOOD VESSELS DURING REMOVAL OF NEEDLE Any person may oppose the כל אדם רשאי להתנגד said application within three לבקשה האמורה תוך months from the date of this שלושה חודשים מתאריך Patents Journal, as שנקבע כפי,יומן פטנטים זה prescribed by section 61 of 92 ובתקנה לחוק61 בסעיף the law and by regulation 92 - תשכ"ח,לתקנות הפטנטים of the Patent Regulations, 5728-1968 1968 April 13, 2008– ח' בניסן התשס"ח 1226 הודעה NOTICE לחוק60 לפי סעיף 1967- תשכ"ז,הפטנטים הוגשה בקשה להחזר תוקפו של הפטנט המפורט שתוקפו פקע מחמת,מטה אי תשלום אגרות החידוש :הקבועות Under section 60 of the Patent Law, 5727-1967 Application has been filed for the restoration of the patent recorded below, which has lapsed through non-payment of the prescribed renewal fees: No. of Patent Acceptance published in journal no: Proprietors: 121021 6/2004 מס' הפטנט :'קיבול פורסם ביומן מס :שם בעל הפטנט NDS LIMITED Title of invention: :שם האמצאה מערכת משוב תפעול הדדי של משתמש USER INTERACTION FEEDBACK SYSTEM Any person may oppose the כל אדם רשאי להתנגד said application within three לבקשה האמורה תוך months from the date of this שלושה חודשים מתאריך Patents Journal, as כפי שנקבע,יומן פטנטים זה prescribed by section 61 of 92 לחוק ובתקנה61 בסעיף the law and by regulation 92 תשכ"ח,לתקנות הפטנטים of the Patent Regulations, 5728-1968 1968 1227 April 13, 2008– ח' בניסן התשס"ח הודעה NOTICE לחוק60 לפי סעיף 1967- תשכ"ז,הפטנטים הוגשה בקשה להחזר תוקפו של הפטנט המפורט שתוקפו פקע מחמת,מטה אי תשלום אגרות החידוש :הקבועות Under section 60 of the Patent Law, 5727-1967 Application has been filed for the restoration of the patent recorded below, which has lapsed through non-payment of the prescribed renewal fees: No. of Patent Acceptance published in journal no: Proprietors: 122104 7/2000 מס' הפטנט :'קיבול פורסם ביומן מס :שם בעל הפטנט טירוב טכנולוגיה תעשיתית בע"מ TAIROB INDUSTRIAL TECHNOLOGY LTD. :שם האמצאה מכשיר לחלוקת תבלינים APPARATUS FOR DISPENSING SEASONINGS Any person may oppose the כל אדם רשאי להתנגד said application within three לבקשה האמורה תוך months from the date of this שלושה חודשים מתאריך Patents Journal, as כפי שנקבע,יומן פטנטים זה prescribed by section 61 of 92 לחוק ובתקנה61 בסעיף the law and by regulation 92 - תשכ"ח,לתקנות הפטנטים of the Patent Regulations, 5728-1968 1968 Title of invention: April 13, 2008– ח' בניסן התשס"ח 1228 הודעה NOTICE לחוק60 לפי סעיף 1967- תשכ"ז,הפטנטים הוגשה בקשה להחזר תוקפו של הפטנט המפורט שתוקפו פקע מחמת,מטה אי תשלום אגרות החידוש :הקבועות Under section 60 of the Patent Law, 5727-1967 Application has been filed for the restoration of the patent recorded below, which has lapsed through non-payment of the prescribed renewal fees: No. of Patent Acceptance published in journal no: Proprietors: 132913 7/2004 מס' הפטנט :'קיבול פורסם ביומן מס :שם בעל הפטנט מיכאל פורת MICHAEL PORAT :שם האמצאה מכשיר ושיטה לסגירה וחיתוך של צינור גמיש DEVICE AND METHOD FOR CLAMPING AND CUTTING A FLEXIBLE DEFORMABLE TUBE Any person may oppose the כל אדם רשאי להתנגד said application within three לבקשה האמורה תוך months from the date of this שלושה חודשים מתאריך Patents Journal, as שנקבע כפי,יומן פטנטים זה prescribed by section 61 of 92 ובתקנה לחוק61 בסעיף the law and by regulation 92 - תשכ"ח,לתקנות הפטנטים of the Patent Regulations, 5728-1968 1968 Title of invention: 1229 April 13, 2008– ח' בניסן התשס"ח הודעה NOTICE לחוק60 לפי סעיף 1967- תשכ"ז,הפטנטים הוגשה בקשה להחזר תוקפו של הפטנט המפורט שתוקפו פקע מחמת,מטה אי תשלום אגרות החידוש :הקבועות Under section 60 of the Patent Law, 5727-1967 Application has been filed for the restoration of the patent recorded below, which has lapsed through non-payment of the prescribed renewal fees: No. of Patent Acceptance published in journal no: Proprietors: 145737 5/2006 מס' הפטנט :'קיבול פורסם ביומן מס :שם בעל הפטנט דניאל כץ DANIEL KATZ :שם האמצאה שיטה ומערכת לשליטה ואיסוף נתונים מרחוק SYSTEM AND METHOD FOR REMOTE SUPERVISORY CONTROL AND DATA ACQUISITION Any person may oppose the כל אדם רשאי להתנגד said application within three לבקשה האמורה תוך months from the date of this שלושה חודשים מתאריך Patents Journal, as שנקבע כפי,יומן פטנטים זה prescribed by section 61 of 92 ובתקנה לחוק61 בסעיף the law and by regulation 92 - תשכ"ח,לתקנות הפטנטים of the Patent Regulations, 5728-1968 1968 Title of invention: April 13, 2008– ח' בניסן התשס"ח 1230 הודעה NOTICE לחוק60 לפי סעיף 1967- תשכ"ז,הפטנטים הוגשה בקשה להחזר תוקפו של הפטנט המפורט שתוקפו פקע מחמת,מטה אי תשלום אגרות החידוש :הקבועות Under section 60 of the Patent Law, 5727-1967 Application has been filed for the restoration of the patent recorded below, which has lapsed through non-payment of the prescribed renewal fees: No. of Patent Acceptance published in journal no: Proprietors: 147929 5/2005 מס' הפטנט :'קיבול פורסם ביומן מס :שם בעל הפטנט מיכאל פורת STARBURST TECHNOLOGIES LIMITED :שם האמצאה Title of invention: מסכת פנים FACE MASK Any person may oppose the said application within three months from the date of this Patents Journal, as prescribed by section 61 of the law and by regulation 92 of the Patent Regulations, 5728-1968 1231 כל אדם רשאי להתנגד לבקשה האמורה תוך שלושה חודשים מתאריך כפי שנקבע,יומן פטנטים זה 92 לחוק ובתקנה61 בסעיף - תשכ"ח,לתקנות הפטנטים 1968 April 13, 2008– ח' בניסן התשס"ח הודעה NOTICE Under section 66 of the Patents Law, 5727-1967 This is to notify that permission has been granted to the owner of Patent Application No. Acceptance published in journal To amend the specification of the said Patent Application. Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968. April 13, 2008– ח' בניסן התשס"ח 122705 11/2000 , לחוק הפטנטים66 לפי סעיף 1967-תשכ"ז מודע בזאת כי ניתנה רשות 'לבעלת בקשת הפטנט מס דבר הקיבול פורסם ביומן לתקן את הפירוט של בקשת הפטנט האמורה כל אדם רשאי להתנגד למתן הרשות תוך שלושה חודשים כפי,מתאריך יומן פטנטים זה לחוק ובתקנה67 שנקבע בסעיף - התשכ"ח, לתקנות הפטנטים99 .1968 1232 הודעה NOTICE Under section 66 of the Patents Law, 5727-1967 This is to notify that permission has been granted to the owner of Patent Application No. Acceptance published in journal To amend the specification of the said Patent Application. Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968. 1233 133696 1/2006 , לחוק הפטנטים66 לפי סעיף 1967-תשכ"ז מודע בזאת כי ניתנה רשות 'לבעלת בקשת הפטנט מס דבר הקיבול פורסם ביומן לתקן את הפירוט של בקשת הפטנט האמורה כל אדם רשאי להתנגד למתן הרשות תוך שלושה חודשים כפי,מתאריך יומן פטנטים זה לחוק ובתקנה67 שנקבע בסעיף - התשכ"ח, לתקנות הפטנטים99 .1968 April 13, 2008– ח' בניסן התשס"ח הודעה NOTICE Under section 66 of the Patents Law, 5727-1967 This is to notify that permission has been granted to the owner of Patent Application No. Acceptance published in journal To amend the specification of the said Patent Application. Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968. April 13, 2008– ח' בניסן התשס"ח 135522 7/2005 , לחוק הפטנטים66 לפי סעיף 1967-תשכ"ז מודע בזאת כי ניתנה רשות 'לבעלת בקשת הפטנט מס דבר הקיבול פורסם ביומן לתקן את הפירוט של בקשת הפטנט האמורה כל אדם רשאי להתנגד למתן הרשות תוך שלושה חודשים כפי,מתאריך יומן פטנטים זה לחוק ובתקנה67 שנקבע בסעיף - התשכ"ח, לתקנות הפטנטים99 .1968 1234 הודעה NOTICE Under section 66 of the Patents Law, 5727-1967 This is to notify that permission has been granted to the owner of Patent Application No. Acceptance published in journal To amend the specification of the said Patent Application. Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968. 1235 136941 2/2006 , לחוק הפטנטים66 לפי סעיף 1967-תשכ"ז מודע בזאת כי ניתנה רשות 'לבעלת בקשת הפטנט מס דבר הקיבול פורסם ביומן לתקן את הפירוט של בקשת הפטנט האמורה כל אדם רשאי להתנגד למתן הרשות תוך שלושה חודשים כפי,מתאריך יומן פטנטים זה לחוק ובתקנה67 שנקבע בסעיף - התשכ"ח, לתקנות הפטנטים99 .1968 April 13, 2008– ח' בניסן התשס"ח שינויים בפרטים רשומים בפנקס CHANGES IN PARTICULARS ENTERED IN REGISTER שינוי בעלות CHANGES IN PROPRIETORSHIP 144654 No. of Patent: Previous Proprietors: CURIS, INC. New Proprietors: ES CELL INTERNATIONAL PTE LTD. :הבעלים החדשים 183688 No. of Patent: Previous Proprietors: EREZ NISSAN-COHEN כהן-ארז ניסן 184964 New Proprietors: ES CELL INTERNATIONAL PTE LTD. April 13, 2008– ח' בניסן התשס"ח :מס' פטנט :הבעלים הקודמים :הבעלים החדשים לך לכל הלוחות בע"מ- סימפל New Proprietors: No. of Patent: Previous Proprietors: :מס' פטנט :הבעלים הקודמים :מס' פטנט :הבעלים הקודמים :הבעלים החדשים 1236 תיקוני טעויות CORRIGENDA Journal 1/2008 יומן P. 339 Patent application No. 156347 156347 ' בקשת פטנט מס339 'ע Delete the application. .מחק את הבקשה The application was published by mistake. .הבקשה פורסמה בטעות The application has not yet been accepted and הבקשה עוד לא קובלה ואיננה פתוחה לעיון is not open to the public הציבור Journal P. 326 Patent No. 154803 Correct priority claim to- 1/2008 יומן 154803 ' פטנט מס326 'ע -תקן דין קדימה ל PCT/SE00/01994 13.10.2000 SE 1237 April 13, 2008– ח' בניסן התשס"ח קודים למדינת המופיעים ביומן COUNTRY CODES APPEARING IN THIS JOURNAL Code AR AT AU BA BE BR CA CH CN CU CZ DE DK EC EP ES FI FR GB GE GR GT HR HU IE IL IN IT JP KR LK LU LV MX Country or Organization Argentina Austria Australia Herzegovina Belgium Brazil Canada Switzerland China Cuba Czech Republic Germany Denmark Ecuador European Patent Office Spain Finland France United Kingdom Georgia Greece Guatemala Croatia Hungary Ireland Israel India Italy Japan Republic of Korea Sri Lanka Luxembourg Latvia Mexico MY Malaysia April 13, 2008– ח' בניסן התשס"ח 1238 NL NO NZ PL PT RU SE SG SI SK TH TR TW UA US UY UZ WO ZA 1239 The Netherlands Norway New Zealand Poland Portugal Russian Federation Sweden Singapore Slovenia Slovakia Thailand Turkey Taiwan Ukraine United States of America Uruguay Uzbekistan World Intellectual Property Organization (W.I.P.O.) South Africa April 13, 2008– ח' בניסן התשס"ח מדגמים DESIGNS מדגמים שנרשמו DESIGNS REGISTERED Class 41896 28(03) 24. 1.2006 סוג לה טוויז ישראל בע"מ LA TWEEZ ISRAEL LTD. פינצטה מאירה Luminous tweezer Class 42553 3(01) 6. 6.2006 סוג SMITHKLINE BEECHAM CORPORATION Pill case 8.12.2005 Convention date (U.S.A.) Class קופסא לגלולה )הברית )הברית (ארצות (ארצות האמנה תאריךאמנה תאריך 42589, 42590 4(02) 8. 6.2006 סוג THE GILLETTE COMPANY Toothbrush 27.4.2005 Convention date (OHIM) Class 42704, 42708, 42709, 42713, 42171, 42718 14(03) מברשת שיניים )הברית )(אוהיים האמנה(ארצות תאריך אמנה סוג RESEARCH IN MOTION LTD. Handheld communication device Convention date (U.S.A.) Class YAIR MESULAM Food and water heater April 13, 2008– ח' בניסן התשס"ח 17.5.2004 43210 7(02) 18. 10.2006 מכשיר תקשורת ידני )הברית )(ארצותהברית האמנה(ארצות תאריך אמנה סוג יאיר משולם מתקן לחימום מים ואוכל 1240 Class 43236 21(02) 23. 10.2006 סוג גד עירשי GAD IRSAY טניס-סלסלת איסוף לכדורי Tennis ball collection basket Class 43270 25(01) 1. 11.2006 סוג פרופיל גלס בע"מ PROFILE GLASS LTD. פרופיל Profile Class 43313 24(02) 13. 11.2006 סוג קיו קור בע"מ Q-CORE LTD. ידית בקרה למשאבה פריסטלטית Control handle for peristaltic pump Class 43316 24(02) 13. 11.2006 סוג קיו קור בע"מ Q-CORE LTD. יחידת בקרה למשאבה פריסטלטית Control unit for a peristaltic pump Class 43318 24(02) 13. 11.2006 סוג קיו קור בע"מ Q-CORE LTD. Passive mechanical interface for a peristaltic pump Class 43329 9(01) 15. 11.2006 מימשק מכני פסיבי למשאבה פריסטלטית סוג BACARDI AND COMPANY LIMITED Bottle Convention date (Liechtenstein) 1241 17.5.2006 בקבוק )הברית )(ליכטנשטיין האמנה(ארצות תאריך אמנה April 13, 2008– ח' בניסן התשס"ח Class 43424 11(01) 3. 12.2006 סוג ג'ראלדו בע"מ GERALDO LTD. תכשיט Jewel Class 43529 9(05) 19. 12.2006 סוג SOCIETE DES PRODUITS NESTLE S.A. Ice cream cone Convention date (Switzerland) Class 22.6.2006 גביע גלידה )ץ)הברית (ארצות האמנה (שווי תאריך אמנה 43634, 43635, 43636 19(08) 17. 1.2007 סוג VISA INTERNATIONAL SERVICE ASSOCIATION VISA U.S.A. INC. Card 17.7.2006 Convention date (U.S.A.) Class כרטיס )הברית )(ארצותהברית האמנה(ארצות תאריך אמנה 43657 23(02) 22. 1.2007 MOSHE PAZ AND EFRAT HAGAI סוג משה פז ואפרת חגי פילטר למערכת הביוב Filter for sewage outlet Class 43939, 45453, 45456 24(04) 12. 3.2007 סוג GLAXO GROUP LIMITED Inhaler Convention date (United Kingdom) Class MENSASHE ROGOTNER Tray April 13, 2008– ח' בניסן התשס"ח 14.9.2006 44063 9(03) 17. 4.2007 משאף תאריך האמנה (הממלכה )המאוחדת סוג מנשה רוגוטנר מגש 1242 )צות הברית 44067 9(07) 18. 4.2007 Class סוג GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH & CO KG Dispenser Convention date (United Kingdom) 20.10.2006 44160 21(01) 10. 5.2007 Class מנפק תאריך האמנה (הממלכה )המאוחדת סוג אלכסיי אפשטיין ALEKSEI EPSHTEIN משחק Game 44262, 44263 19(03) 31. 5.2007 Class ארגו פיתוח וייצור בע"מ ARGO DEVELOPMENT AND MANUFACTURING LTD. התקני להצמדת חומר למשטח Device for coupling material to a surface Class סוג 44275, 44278, 44280 44284, 44285, 44286, 44287, 44291 2(02) 5. 6.2007 סוג DIESEL S.P.A. מכנסיים Pants Class ICHIBAN SPORT LTD. Training doll 1243 44316 21(01) 7. 6.2007 סוג איצ'בן ספורט בע"מ בובת אימונים April 13, 2008– ח' בניסן התשס"ח )צות הברית Class 44394, 44395, 44396 13(03) 18. 4.2007 סוג BTICINO S.P.A. Protective box for electrical Convention date (OHIM) 5.2.2007 44461 3(01) 5. 7.2007 Class תיבת הגנה למכשיר חשמל )הברית )(אוהיים האמנה(ארצות תאריך אמנה סוג תמי כהן רז וניצן כהן רז TAMMY COHEN RAZ AND NITZAN COHEN RAZ מינשא לתינוק Baby Carrier Class 44531, 44532, 44534, 44535, 44536 10(07) 19. 7.2007 סוג ZENITH INTERNATIONAL SA חוגת שעון Watch dial 44546 12(12) 23. 7.2007 Class סוג זכריה צ'וקראן TAMMY COHEN RAZ AND NITZAN COHEN RAZ עגלה Baby Carrier Class 44552, 44553, 44554, 44555 25(01) 24. 7.2007 סוג אקסטל בע"מ EXTAL LTD. פרופיל Profile Class AMIT LEVI Bottle crusher April 13, 2008– ח' בניסן התשס"ח 44577 8(05) 30. 7.2007 סוג עמית לוי מכווץ בקבוקים 1244 Class 44580 25(03) 30. 7.2007 סוג קיסריה עיצוב בנוסף בע"מ CAESARE LANDSCAPE DESIGN LTD. פרגולה Pergola Class 44590 9(03) 1. 8.2007 סוג יוסף הימן YOSEF HEIMAN מיכל Container Class 44615 6(09) 9. 8.2007 AMINACH BEDDING & FURNITURE MANUFACTURING LTD. סוג עמינח תעשית רהיטים ומזרונים מזרן Mattress Class 44620 9(03) 12. 8.2007 RAF-KO CLEANING UTENSILS INDUSTRIES LTD. סוג רפקו תעשיות כלי ניקוי בע"מ מיכל Container Class 44621 9(03) 12. 8.2007 סוג ) בע"מ1990( ווק-פלסטו PLASTO-VACK (1990) LTD. מיכל Container Class 44622 7(05) 12. 8.2007 SMART FIBER AG PERFORATED DEODORANT BALL 1245 סוג מפיג ריחות כדורי מחורר April 13, 2008– ח' בניסן התשס"ח Convention date (OHIM) Class 28.2.2007 44624 8(08) 13. 8.2007 )הברית )(אוהיים האמנה(ארצות תאריך אמנה סוג שלמה אשכנזי SHLOMO ASHKENZAI מתלון Hanger Class 44661 8(03) 19. 8.2007 סוג ישקר בע"מ ISCAR LTD. שימת חיתוך Cutting insert Class 44664 25(01) 20. 8.2007 סוג יגאל בלכר IGAL BLECHER פרופיל Profile Class 44680 19(04) 26. 8.2007 סוג רוני בלנקלדר RONI BLANKLEDER התקן תצוגה Display rack Class 44683, 44684, 44685 25(01) 28. 8.2007 סוג אקסטל בע"מ EXTAL LTD. פרופיל Profile Class +3CM LTD. Insole April 13, 2008– ח' בניסן התשס"ח 44718 2(04) 29. 8.2007 סוג פלוס שלוש סי אם בע"מ רפידה 1246 Class 44725 6(03) 30. 8.2007 סוג כתר פלסטיק בע"מ KETER PLASTIC LTD. שולחן Table Class 44741 10(02) 3. 9.2007 סוג BULGARI TIME (SWITZERLAND) S.A. WATCH Convention date (OHIM) Class 19.3.2007 44757 12(11) 4. 9.2007 שעון )הברית )(אוהיים האמנה(ארצות תאריך אמנה סוג איתי דרור ITAY DROR אופניים Bicycle Class 44777, 44901 25(01) 10. 9.2007 סוג שרון בלגזל KETER PLASTIC LTD. פרופיל Table Class 44780 9(03) 11. 9.2007 סוג אבנר פלק AVNER FALK מתקן לאחסון מיכל Storage device for container Class LA TWEEZ ISRAEL LTD. Tweezer case 1247 44829 28(03) 24. 1.2006 סוג לה טוויז ישראל בע"מ מארז לפינצטה April 13, 2008– ח' בניסן התשס"ח Class 44841 7(01) 25. 9.2007 סוג BRITA GMBH WATER PITCHER WITH FILTER Convention date (Germany) Class 5.4.2007 44884 23(01) 14. 10.2007 קנקן מים עם מסנן )הברית )(גרמניה האמנה(ארצות תאריך אמנה סוג אגודה שיתופית חקלאית-ברמז בע"מ BERMAD CS LTD. שסתום בקרה הידראולי Hydraulic control valve Class 44891 3(02) 16. 10.2007 סוג דני גסנר DANI GASSNER קופת חיסכון Money Box Class 44985 9(05) 6. 11.2007 סוג גינאדי איבאנוב GENADI IVANOV ידית לשקיות Handle for bags Class 45070, 45071 23(04) 15. 11.2007 סוג SARA LEE HOUSHOLD AND BODY CARE NEDERLAND B.V. מתקן לבישום אוויר Air deodorizing apparatus Convention date (OHIM) April 13, 2008– ח' בניסן התשס"ח 16.8.2007 )הברית )(אוהיים האמנה(ארצות תאריך אמנה 1248 סוג 45183, 45184, 45185, 45186, 45187, 45188, 45189, 45190, 45191, 45192, 45193, 45194, 45195, 45196, 45197, 45198, 45199, 45200, 45201, 45202, 45204, 45205 )2(04 12. 12.2007 נעלי גזית ט .וינר ובניו בע"מ Class GAZIT SHOES T. VINER LTD. נעל Shoe סוג 45203 )2(04 12. 12.2007 נעלי גזית ט .וינר ובניו בע"מ Class GAZIT SHOES T. VINER LTD. נעל Shoe סוג נעלי גזית ט .וינר ובניו בע"מ סוליה ח' בניסן התשס"ח –April 13, 2008 45203 )2(04 12. 12.2007 Class GAZIT SHOES T. VINER LTD. Sole 1249 מדגמים שחודשו DESIGNS RENEWED 29812 29910 37307 37759 37936 38080 38217 1250 29748 29909 30040 37758 37934 38079 38216 29675 29908 30039 37738 37933 38078 38086 41207 29547 29876 29991 37696 37930 38077 38085 38557 29546 29875 29990 37694 37926 38076 38084 38455 29545 29831 29968 37693 37910 38075 38083 38251 29544 29814 29912 37652 37864 37994 38082 38224 29291 29813 29911 37584 37828 37992 38081 38218 ח' בניסן התשס"ח –April 13, 2008 מדגמים שבוטלו DESIGNS VOID 20622 22970 28551 28615 36928 36943 36975 37013 20623 28500 28557 28617 36929 36944 36977 37018 20653 28508 28561 28633 36930 36946 36979 37019 Dr. Meir Noam Commissioner of Patents, Designs and Trade Marks 1251 20654 28524 28562 36920 36937 36965 36980 20696 28532 28589 36922 36939 36966 36981 20698 28533 28590 36925 36940 36972 37003 20737 28534 28591 36926 36941 36973 37004 22969 28550 28593 36927 36942 36974 37012 ד"ר מאיר נועם המדגמים,רשם הפטנטים וסימני מסחר April 13, 2008– ח' בניסן התשס"ח מפתחות לבקשות שקובלו INDICES OF APPLICATIONS ACCEPTED מפתח שמי NAME INDEX א.ר.י .אביזרים להולכת נוזלים אגודה שתופית חקלאית בע"מ 163133 אבי קליימן 148526 אוניברסיטת בן-גוריון בנגב ,הרשות למחקר ופיתוח 147823 אוניברסיטת בן-גוריון בנגב ,הרשות למחקר ופיתוח 154808 ,153435 אורבוטק בע"מ 147565 ,142354 אוריאל פישר 159653 אי.סי.איי .טלקום בע"מ 155449 ,153941 אלכסנדר שיינפלד 143810 אמיל כץ 143810 אנטולי בקרמן 151592 אקסלנז ביוסיינס בע"מ 121793 אריה יהודה פולק 167092 מגנוליה מדיקל טכנולוג'יס בע"מ 149523 מדיגוס בע"מ 138632 מדינול בע"מ 152109 ,152107 מוסד הטכניון למחקר ופיתוח בע"מ 158870 מור יישום מחקרים בע"מ 145535 מיטרוניקס בע"מ 150848 ג'נטיקו בע"מ 119135 ניר פדן 157401 דקסון בע"מ 142929 דקסל פארמה טכנולוגיות בע"מ 146708 דרייקור בע"מ 155042 סימנס קומפיוטר איידד דיאגנוסיס בע"מ 153162 סלע הנדסת מוליכים למחצה בע"מ 140712 סנקטום בע"מ 149322 התעשיה האוירית לישראל בע"מ 167721 התעשייה האוירית לישראל בע"מ 167905 האוניברסיטה העברית בירושלים 161632 יעקב הלוי-פוליץ 159653 ישקר בע"מ 129665 ,127192 ישקר בע"מ 165621 ,129665 ,127192 ישקר בע"מ 165621 לאוניד גרבר 163427 פוליהיל בע"מ 167226 ולדימיר גורביץ 130032 וריסיטי בע"מ 158481 וריפון ישראל בע"מ 159163 חיים דוידיאן 163907 ידע חברה למחקר ופיתוח בע"מ ,143019 145842 יוסף בקרמן 151592 יישום חברה לפיתוח המחקר של i 2008 קודאק איי אל בע"מ 140299 קליימן מטאור בע"מ 148526 רפא"ל רשות לפיתוח אמצעי לחימה בע"מ 154894 ,152966 רפאל מערכות לחימה מתקדמות בע"מ 151672 ,109014 רפאל מערכות לחימה מתקדמות בע"מ 163785 ח' בניסן התשס"ח – April 13, רשות לפתוח אמצעי לחימה בע"מ-רפאל 158870 164747 תדיראן ספקטרלינק בע"מ A.R.I. FLOW CONTROL ACCESSORIES AGRICULTURAL COOPERATIVE ASSOCIATION LTD. 163133 ABBOTT LABORATORIES 135517 AEROFLEX INTERNATIONAL CO., LTD. 160887 ALCAN RHENALU 156732 ALEXANDER SCHOENFELD 143810 ALZA CORPORATION 141914 AMARIN NEUROSCIENCE LIMITED 158678 ANATOLY BEKKERMAN 151592 ANDRE BENHAMOU 160154 ANGIOTECH PHARMACEUTICALS, INC. 173240 ARIEH JEHUDA POLAK 167092 ARKEMA FRANCE 157998 ASPEN AEROGELS, INC. 155922 ASTRAZENECA AB 150126, 150201, 151626 AUBURN UNIVERSITY 155319 AUTOIMMUNE, INC. 165071 AVENTIS PHARMA S.A. 139102 AVENTIS PHARMACEUTICALS INC. 153797 AVENTIS PHARMACEUTICALS INC. 155120 AVI KLAYMAN 148526 AVIGENICS 135604 AVOCENT CORPORATION 158880 BASF AKTIENGESELLSCHAFT 154094 BAVARIAN NORDIC A/S 150736 BAYER CROPSCIENCE AG 158475 BAYER CROPSCIENCE AG 159149 BAYER SCHERING PHARMA AG 152248 ii BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY 147823 BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY 153435, 154808 BERTIN TECHNOLOGIES S.A. 166505 Biogen Idec MA Inc. 143403 BIOTECON GESELLSCHAFT FUR BIOTECHNOLOGISCHE ENTWICKLUNG UND CONSULTING MBH 139478 BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 140701 BORIS GELMAN 163425 BRIGHAM AND WOMEN'S HOSPITAL 165071 BUMPADS, INC. 166759 CARDINAL HEALTH 303, INC. 158229 CARMEL SYSTEMS LLC 152301 CATHARON PRODUCTIONS, INC. 156075 CELATOR PHARMACEUTICALS, CORP. 161214 CELATOR PHARMACEUTICALS, INC. 161214 CERATIZIT AUSTRIA GESELLSCHAFT M.B.H 165854 CHAIM DAVIDIAN 163907 CIBA SPECIALTY CHEMICALS HOLDING INC. 154220, 158925 COMPUTER ASSOCIATES THINK, INC. 147824 COMPUTER ASSOCIATES THINK, INC. 152132 CPN SPOL S.R.O. 162801 CREATIVE PLASTIC TECHNOLOGY, LLC 146498 April 13, 2008– ח' בניסן התשס"ח CROSSCARE RESEARCH & DEVELOPMENT LIMITED 153263 CUBIC CORPORATION 156006 CURIS, INC. 143403 CV THERAPEUTICS, INC. 128652 GENETICO LTD. 119135 GEOX S.P.A. 151834 GILEAD SCIENCES, INC. 147872 GLAXO GROUP LIMITED 156436 GPT GLENDALE, INC. 159648 DAIICHI SANKYO COMPANY LIMITED 140731, 148196 DAINIPPON SUMITOMO PHARMA CO., LTD. 160924 DAVID CHARLES ROBINSON 164475 DAVIES INDUSTRIAL COMMUNICATIONS LIMITED 150172 DESAL, LLC 164873 DEUTSCHE POST AG 161238, 161239 DEXCEL PHARMA TECHNOLOGIES LTD. 146708 DEXXON LTD. 142929 DIAMCAD N.V. 156034 DRYKOR, LTD. 155042 H. LUNDBECK A/S 150366 H.C. STARCK GMBH 162969 HARRIS CORPORATION 158840 HUSKY INJECTION MOLDING SYSTEMS LTD. 156886 EADS DEUTSCHLAND GMBH 156147 ECI TELECOM LTD. 153941, 155449 EGIS GYOGYSZERGYAR RT. 160486 EISAI CO.,LTD. 155447 EISAI R&D MANAGEMENT CO., LTD. 155447 ELBION AG 155386 EMIL KATZ 143810 ENDOCARE, INC. 160692 EURO-CELTIQUE S.A. 151417 EXALENZ BIOSCIENCE LTD. 121793 F. HOFFMANN-LA ROCHE AG 153837 FABBRICA D'ARMI PIETRO BERETTA S.P.A 149475 FITEL U.S.A. CORPORATION 157502 FORSVARETS MATERIELVERK 159447 GALDERMA RESEARCH & DEVELOPMENT, S.N.C. 142759 GE MEDICAL SYSTEMS GLOBAL TECHNOLOGY COMPANY, LLC 155286 GENENTECH, INC. 125939, 138488 GENENTECH, INC. 149171 April 13, – ח' בניסן התשס"ח ID BIOMEDICAL CORPORATION 117483, 137921 IDALEX TECHNOLOGIES, INC. 166089 IDLEAIRE TECHNOLOGIES CORP. 164553 IMOVE INC. 155563 INFINEON TECHNOLOGIES AG 153829 INSCENTINEL LIMITED 162526 INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH AN DER FREIEN UNIVERSITAT BERLIN 141384 INSTITUTO BIOMAR, S.A. 153679 INTERDIGITAL TECHNOLOGY CORPORATION 158259 INTERNATIONAL BUSINESS MACHINES CORPORATION 160070 IPSEN MANUFACTURING IRELAND LIMITED 156258 IRRIMON, S.A.U. 167816 ISCAR LTD. 127192, 129665 ISCAR LTD. 127192, 129665, 165621 ISCAR LTD. 165621 ISHIHARA SANGYO KAISHA LTD. 150965 ISOGENICA LIMITED 131435 ISOTRON, INC. 148634 ISRAEL AEROSPACE INDUSTRIES LTD. 167721 ISRAEL AEROSPACE INDUSTRIES LTD. 167905 JACOB HALEVY-POLITCH 159653 iii 2008 JOSEF BEKERMAN 151592 JOZE JELENC 158535 KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO 153496 KENNAMETAL INC. 161077 KENT STATE UNIVERSITY 139911 KLAYMAN METEOR LTD. 148526 KODAK IL LTD. 140299 KOSAN BIOSCIENCES, INC. 143069 LABORATOIRE THERAMEX 149141 LAM RESEARCH CORPORATION 157827 LDR MEDICAL 158740 LEO PHARMA A/S 180248 LEONID GERBER 163427 LITTON SYSTEMS, INC. 158515 LOCKHEED MARTIN CORPORATION 158722 LOYOLA UNIVERSITY OF CHICAGO 135528 MAGNOLIA MEDICAL TECHNOLOGIES LTD. 149523 MARS, INCORPORATED 164095 MATTHIAS RATH 140947 MATTHIAS RATH 185384 MAYTRONICS LTD. 150848 MEDA PHARMA GMBH & CO. KG 151106 MEDIGUS LTD. 138632 MEDINOL LTD. 152107, 152109 MOR RESEARCH APPLICATIONS, LTD. 145535 MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY 140265 NIPPON SODA COMPANY LTD. 157724 NIR PADAN 157401 NOVELIS, INC. 156732 OBTECH MEDICAL AG 151134 ORBOTECH LTD. 142354, 147565 ORIDION BREATHID LTD. 121793 iv PALOMAR MEDICAL TECHNOLOGIES, INC. 158982 PANACEA BIOTEC LIMITED 148864 PANTHERIX LIMITED 154593 PEPSCAN SYSTEMS B.V. 140381 PFIZER PRODUCTS, INC. 149226 PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. 141764 POLYHEAL LTD. 167226 PURADYN FILTER TECHNOLOGIES INCORPORATED 152238 Q MED AB 154062 QLT INC. 132066 QUALCOMM INCORPORATED 146267, 151350, 151706, 151708, 152712 QUALCOMM INCORPORATED 146363 RADIANCY, INC. 159910, 159971 RAFAEL ADVANCED DEFENSE SYSTEMS LTD. 109014, 151672 RAFAEL ADVANCED DEFENSE SYSTEMS LTD. 163785 RAFAEL ARMAMENT DEVELOPMENT AUTHORITY LTD. 152966, 154894 RAFAEL-ARMAMENT DEVELOPMENT AUTHORITY LTD. 158870 RAYTHEON COMPANY 157424 RECKITT BENCKISER HEALTHCARE (UK) LIMITED 150030 RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED 150030 REEFEDGE, INC. 154132, 154719 REGA STICHTING V.Z.W. 159494 ROBERT G. JAMES 144998 ROLLING RAZOR, INC. 153208 SANCTUM LTD. 149322 SANDOZ AG 154220 SANGAMO BIOSCIENCES, INC. 150069 SANOFI-AVENTIS DEUTSCHLAND GMBH 151518 SCOTT INTERNATIONAL LIMITED April 13, 2008– ח' בניסן התשס"ח 159660 SELA SEMICONDUCTOR ENGINEERING LABORATORIES LTD. 140712 SELEX COMMUNICATIONS LIMITED 150172 SEQUELLA, INC. 140731, 148196 SERGUEI BORISOVISH SIVOVOLENKO 156034 SHIRE BIOCHEM INC. 117483 SHIRE BIOCHEM INC. 137921 SHIRE HUMAN GENETIC THERAPIES, INC. 149029 SHUICHI HIRONO 161736 SHUNICHI SHIOZAWA 161736 SIEMENS COMPUTER AIDED DIAGNOSIS LTD. 153162 SIG ALLCAP AG 161922 SILVERBROOK RESEARCH PTY. LTD. 146608, 146671, 163493, 168706, 168707, 169629 SILVERBROOK RESEARCH PTY. LTD. 149954, 168177 SMITHKLINE BEECHAM P.L.C. 153231 SOCIETE DES PRODUITS NESTLE S.A. 154594 SUDIMPLANT COMPANY 160154 SUMITOMO CHEMICAL COMPANY, LIMITED 160924 SWITCH BIOTECH AG 143699 SYMANTEC CORPORATION 154132, 154719 SYMANTEC INTERNATIONAL LIMITED 154132, 154719 TADIRAN SPECTRALINK LTD. 164747 TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. 158870 TELEFONAKTIEBOLAGET LM ERICSSON (PUBL) 159316 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 153324 THE BOOTS COMPANY PLC 150030 April 13, – ח' בניסן התשס"ח THE INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC 159494 THE REGENTS OF THE UNIVERSITY OF MICHIGAN 146222 THE TEXAS A&M UNIVERSITY SYSTEM 154684 THE TRUSTEES OF PRINCETON UNIVERSITY 146242 THE UNIVERSITY OF BRITISH COLUMBIA 132066 THE UNIVERSITY OF SOUTHERN CALIFORNIA 146242 TORAY INDUSTRIES, INC. 162552 TOYAMA CHEMICAL CO., LTD. 161736 TOYAMA CHEMICAL CO., LTD. 161736 TREFIMETAUX S.A. 162942 TYCO ELECTRONICS CORPORATION 152323 UCB, S.A. 150842 UNIVERSITAT STUTTGART (INST. FUR CHEMISCHE VERFAHRENSTECHNIK) 141972 UNIVERSITY OF BRITISH COLUMBIA 173240 UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC. 135604 URIEL FISCHER 159653 VERENIUM CORPORATION 124794 VERIFONE ISRAEL LTD. 159163 VERISITY LTD. 158481 VLADIMIR GUREVICH 130032 WALDEMAR LINK GMBH & CO. KG 158220, 158221, 159411 WATCHFIRE CORPORATION 149322 WESTERN CLINICAL ENGINEERING LTD. 160337 WISCONSIN ALUMNI RESEARCH FOUNDATION 141203 WYETH 163574 v 2008 WYETH HOLDINGS CORPORATION 151249 YEDA RESEARCH AND DEVELOPMENT CO. LTD. 143019, 145842 YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM 161632 vi April 13, 2008– ח' בניסן התשס"ח מפתח ענייני SUBJECT MATTER INDEX A01G – 153435, 161632 A01K – 135604, 148526, 162526, 167092 B01J – 164475, 166089 B01J – 164475, 166089 B22D – 156732, 156886 A01N – 155319, 157998, 158475, 159149 B23B– 161077, 165854 A21D – 154594 B23C – 129665 A41D – 151834 B23D – 165621 A42B – 159660 B24B – 157827 A47G – 161238, 161239 B25J – 158870 A61B – 138632, 149523, 151134, 158982, 160337, 160592 B26B – 153208, 159910, 159971 B26D – 127192 A61C – 160154 A61F – 143810, 152107, 152109, 153324, 158220, 158221, 158535, 158740, 159411, 159648, 167226, 173240 B41J – 163493, 168177, 168706, 168707 B41M – 140299 B60H– 164553 A61K– 132066, 135528, 139478, 140701, 140947, 141384, 141764, 141914, 142929, 143403, 146222, 146708, 148864, 150030, 150965, 151106, 152248, 153231, 153263, 158678, 160924, 161214, 164095, 180248, 185384 B60K – 159447 B60R –160887 B64D – 157401 B64G – 167905 B65D– 161922 A61L– 144998, 162801 C02F– 164873 A61M – 146948, 154062, 158229 C06B – 163785 A61N– 141203, 148634 C07C –142759, 153496, 154220 A62B – 163425 April 13, – ח' בניסן התשס"ח vii 2008 C07D – 143019, 150126, 150201, 150366, 150842, 151249, 151417, 151518, 151626, 153679, 155386, 155447, 156436, 157724, 160486, 161736 F28F – 162942 F41A – 149475 F41G – 152966, 156006 F41H – 151672, 163907 C07F – 159494, 163574 F42B – 109014, 164747 C07H – 128652, 149226 C07J – 149141 G01N – 121793, 139911, 140712, 143699, 145535, 149171, 156034 C07K – 139102, 156258, 165701 G01R – 147565 C08F – 155120 G01S – 158722 C08G – 162969 G01T – 155286 C08J – 158925 G02B – 154894, 157502 C08K – 152238 G02C – 151592 C08L – 141972 G03F – 142354 C12N – 119135, 125939, 137921, 138488, 140265, 140381, 143069, 149029, 150736, 166505 C12P – 135517, 140731, 145842, 147823, 148196 G03H – 159653 G06F – 147824, 152132, 152301, 156075, 158481, 158840, 158880, 169629 C12Q –124794, 147872, 153797 G06K – 146608, 146671, 149322, 153162 C40B – 131435, 150069 H01H – 130032 D04H – 155922 H01L – 146242, 159163, 160070 E01F – 154684 H01P – 156147 E03C – 163133 H02G – 152323 F61C– 163427 H02M – 154808 F04D – 150848 H03M – 158259 F24F – 155042 H04B – 150172, 151708, 153941 viii April 13, 2008– ח' בניסן התשס"ח H04L – 151350, 153829, 154132, 154719, 155449, 159316 H04M – 149954 H04N – 155563, 157424, 158515 H04Q – 146267, 146363, 151706, 152712 April 13, – ח' בניסן התשס"ח ix 2008 ירושלים, משרד המשפטים,נערך ע"י רשות הפטנטים ירושלים,הופק והודפס במדפיס הממשלתי EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER
